
<html lang="en"     class="pb-page"  data-request-id="22f7060c-a1b4-4372-bd57-946df83a5639"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.6b00390;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-13;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and In Vitro and In Vivo Evaluation of an 18F-Labeled Sphingosine 1-Phosphate Receptor 1 (S1P1) PET Tracer" /></meta><meta name="dc.Creator" content="Adam J.  Rosenberg" /></meta><meta name="dc.Creator" content="Hui  Liu" /></meta><meta name="dc.Creator" content="Hongjun  Jin" /></meta><meta name="dc.Creator" content="Xuyi  Yue" /></meta><meta name="dc.Creator" content="Sean  Riley" /></meta><meta name="dc.Creator" content="Steven J.  Brown" /></meta><meta name="dc.Creator" content="Zhude  Tu" /></meta><meta name="dc.Description" content="Sphingosine 1-phosphate receptor 1 (S1P1) plays a pivotal signaling role in inflammatory response; because S1P1 modulation has been identified as a therapeutic target for various diseases, a PET tr..." /></meta><meta name="Description" content="Sphingosine 1-phosphate receptor 1 (S1P1) plays a pivotal signaling role in inflammatory response; because S1P1 modulation has been identified as a therapeutic target for various diseases, a PET tr..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 22, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00390" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00390" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00390" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00390" /></link>
        
    
    

<title>Design, Synthesis, and In Vitro and In Vivo Evaluation of an 18F-Labeled Sphingosine 1-Phosphate Receptor 1 (S1P1) PET Tracer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00390" /></meta><meta property="og:title" content="Design, Synthesis, and In Vitro and In Vivo Evaluation of an 18F-Labeled Sphingosine 1-Phosphate Receptor 1 (S1P1) PET Tracer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0015.jpeg" /></meta><meta property="og:description" content="Sphingosine 1-phosphate receptor 1 (S1P1) plays a pivotal signaling role in inflammatory response; because S1P1 modulation has been identified as a therapeutic target for various diseases, a PET tracer for S1P1 would be a useful tool. Fourteen fluorine-containing analogues of S1P ligands were synthesized and their in vitro binding potency measured; four had high potency and selectivity for S1P1 (S1P1 IC50 &lt; 10 nM, &gt;100-fold selectivity for S1P1 over S1P2 and S1P3). The most potent ligand, 28c (IC50 = 2.63 nM for S1P1) was 18F-labeled and evaluated in a mouse model of LPS-induced acute liver injury to determine its S1P1-binding specificity. The results from biodistribution, autoradiography, and microPET imaging showed higher [18F]28c accumulation in the liver of LPS-treated mice than controls. Increased expression of S1P1 in the LPS model was confirmed by immunohistochemical analysis (IHC). These data suggest that [18F]28c is a S1P1 PET tracer with high potential for imaging S1P1 in vivo." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00390"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00390">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00390&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00390&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00390&amp;href=/doi/10.1021/acs.jmedchem.6b00390" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 6201-6220</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00374" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00406" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and <i>In Vitro</i> and <i>In Vivo</i> Evaluation of an <sup>18</sup>F-Labeled Sphingosine 1-Phosphate Receptor 1 (S1P<sub>1</sub>) PET Tracer</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adam+J.++Rosenberg">Adam J. Rosenberg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hui++Liu">Hui Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongjun++Jin">Hongjun Jin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xuyi++Yue">Xuyi Yue</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sean++Riley">Sean Riley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+J.++Brown">Steven J. Brown</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhude++Tu">Zhude Tu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Radiology, Washington University School of Medicine, 510 South Kingshighway Boulevard, St. Louis, Missouri 63110, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">The Scripps Research Institute Molecular Screening Center, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States</span></div><div class="corresp-info"><strong>*</strong>Tel: 314-362-8487. Fax: 314-362-8555. E-mail: <a href="/cdn-cgi/l/email-protection#5622232c163b3f2478212325223a78333223"><span class="__cf_email__" data-cfemail="1f6b6a655f72766d31686a6c6b73317a7b6a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00390&amp;href=/doi/10.1021%2Facs.jmedchem.6b00390" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 6201–6220</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 9, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 March 2016</li><li><span class="item_label"><b>Published</b> online</span>22 June 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 July 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00390" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00390</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6201%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAdam%2BJ.%2BRosenberg%252C%2BHui%2BLiu%252C%2BHongjun%2BJin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D13%26contentID%3Dacs.jmedchem.6b00390%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BIn%2BVitro%2Band%2BIn%2BVivo%2BEvaluation%2Bof%2Ban%2B18F-Labeled%2BSphingosine%2B1-Phosphate%2BReceptor%2B1%2B%2528S1P1%2529%2BPET%2BTracer%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6220%26publicationDate%3DJuly%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00390"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1439</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00390" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and In Vitro and In Vivo Evaluation of an 18F-Labeled Sphingosine 1-Phosphate Receptor 1 (S1P1) PET Tracer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;J. Rosenberg&quot;},{&quot;first_name&quot;:&quot;Hui&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Hongjun&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Xuyi&quot;,&quot;last_name&quot;:&quot;Yue&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;Riley&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;J. Brown&quot;},{&quot;first_name&quot;:&quot;Zhude&quot;,&quot;last_name&quot;:&quot;Tu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;6201-6220&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00390&quot;},&quot;abstract&quot;:&quot;Sphingosine 1-phosphate receptor 1 (S1P1) plays a pivotal signaling role in inflammatory response; because S1P1 modulation has been identified as a therapeutic target for various diseases, a PET tracer for S1P1 would be a useful tool. Fourteen fluorine-containing analogues of S1P ligands were synthesized and their in vitro binding potency measured; four had high potency and selectivity for S1P1 (S1P1 IC50 &lt; 10 nM, &gt;100-fold selectivity for S1P1 over S1P2 and S1P3). The most potent ligand, 28c (IC50 = 2.63 nM for S1P1) was 18F-labeled and evaluated in a mouse model of LPS-induced acute liver injury to determine its S1P1-binding specificity. The results from biodistribution, autoradiography, and microPET imaging showed higher [18F]28c accumulation in the liver of LPS-treated mice than controls. Increased expression of S1P1 in the LPS model was confirmed by immunohistochemical analysis (IHC). These data suggest that [18F]28c is a S1P1 PET tracer with high potential for imaging S1P1 in vivo.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00390&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00390" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00390&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00390" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00390&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00390" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00390&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00390&amp;href=/doi/10.1021/acs.jmedchem.6b00390" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00390" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00390" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00390%26sid%3Dliteratum%253Aachs%26pmid%3D27280499%26genre%3Darticle%26aulast%3DRosenberg%26date%3D2016%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BIn%2BVitro%2Band%2BIn%2BVivo%2BEvaluation%2Bof%2Ban%2B18F-Labeled%2BSphingosine%2B1-Phosphate%2BReceptor%2B1%2B%2528S1P1%2529%2BPET%2BTracer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D13%26spage%3D6201%26epage%3D6220%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291334" title="Biodistribution">Biodistribution</a>,</li><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/jmcmar.2016.59.issue-13/20160714/jmcmar.2016.59.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Sphingosine 1-phosphate receptor 1 (S1P<sub>1</sub>) plays a pivotal signaling role in inflammatory response; because S1P<sub>1</sub> modulation has been identified as a therapeutic target for various diseases, a PET tracer for S1P<sub>1</sub> would be a useful tool. Fourteen fluorine-containing analogues of S1P ligands were synthesized and their <i>in vitro</i> binding potency measured; four had high potency and selectivity for S1P<sub>1</sub> (S1P<sub>1</sub> IC<sub>50</sub> < 10 nM, >100-fold selectivity for S1P<sub>1</sub> over S1P<sub>2</sub> and S1P<sub>3</sub>). The most potent ligand, <b>28c</b> (IC<sub>50</sub> = 2.63 nM for S1P<sub>1</sub>) was <sup>18</sup>F-labeled and evaluated in a mouse model of LPS-induced acute liver injury to determine its S1P<sub>1</sub>-binding specificity. The results from biodistribution, autoradiography, and microPET imaging showed higher [<sup>18</sup>F]<b>28c</b> accumulation in the liver of LPS-treated mice than controls. Increased expression of S1P<sub>1</sub> in the LPS model was confirmed by immunohistochemical analysis (IHC). These data suggest that [<sup>18</sup>F]<b>28c</b> is a S1P<sub>1</sub> PET tracer with high potential for imaging S1P<sub>1</sub><i>in vivo</i>.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02415" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02415" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sphingosine 1-phosphate (S1P, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) receptors are a class of G-protein-coupled receptors (GPCRs) with five distinct subtypes, denoted as S1P<sub>1–5</sub>.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> These receptors are regulated by S1P and have important regulatory functions in both normal biological processes and in disease, particularly in pathological processes involving the immune system, the central nervous system (CNS), and the cardiovascular system. Because the S1P/S1P-receptor pathway is especially important in cancer and autoimmune disorders including multiple sclerosis (MS), tremendous development efforts have focused on therapeutically targeted S1P receptor ligands. These efforts discovered promising compounds, 2-amino-2-[2-(4-octyl-phenyl)-ethyl]-propane-1,3-diol <b>1</b> (FTY720, Fingolimod, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), which was approved by the US Food and Drug Administration (FDA) for treatment of relapse remitting multiple sclerosis in 2010. Compound <b>1</b> is phosphorylated <i>in vivo</i> by sphingosine kinase 2; this stereospecific process generates the biologically active metabolite (<i>S</i>)-FTY720-Phosphate (<b>(</b><i><b>S</b></i><b>)-1-P</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), a potent S1P receptor agonist.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a><b>(</b><i><b>S</b></i><b>)-1-P</b> is a nonselective S1P receptor ligand, which binds to each of the S1P receptor subtypes except S1P<sub>2</sub>. Since its primary mechanism of action in MS is believed to be through S1P<sub>1</sub>,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> recent development has focused on ligands having high potency and selectivity for S1P<sub>1</sub> with suitable pharmacological properties for therapeutic applications. Although rodent studies using S1P receptor ligands suggested that adverse cardiovascular effects were the result of S1P<sub>3</sub> agonism,<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> the Phase I study of a S1P<sub>1</sub> selective therapeutic reported bradycardia associated with the first dose administered to human subjects.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Because activity at S1P<sub>3</sub> has clear effects on the vascular system and does not appear to contribute to therapeutic efficacy of these ligands in the immune system,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> our efforts have focused on identifying subtype-selective ligands. S1P<sub>1</sub> ligands are also being evaluated in cancer,<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> rheumatoid arthritis,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> ulcerative colitis,<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> as well as liver and lung injury among other therapeutic uses.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15-18)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0017.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of S1P, FTY720, and (S)-FTY720-phosphate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Positron emission tomography (PET) is a widely utilized imaging modality which can be used to noninvasively quantify molecular targets <i>in vivo</i>. PET is used in drug discovery to assess receptor occupancy, downstream functional changes, and impact on disease pathophysiology.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> A S1P<sub>1</sub> specific PET tracer could greatly assist the evaluation of new therapeutics by measuring the relationship between drug exposure (dose administered or plasma concentration) and receptor occupancy, thus enabling accelerated dose selection during early clinical trials.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20-22)</a> A successful PET ligand should have a binding potency <10 nM and must be specific to the target versus neighboring nontarget tissues to allow for quantification of the regions of interest during the time frame of clinical studies (0–2 h).<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a></div><div class="NLM_p">To date, no S1P receptor imaging agent suitable for clinical studies has been reported, although since 2011, several groups have reported their efforts to develop a S1P<sub>1</sub> receptor tracer.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a> The iodinated analogue, 2-amino-2-[2-(2-iodo-4-octylphenyl)ethyl]-1,3-propandiol <b>2</b> (BZM055, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), was <sup>123</sup>I-labeled for single photon emission computed tomography (SPECT) studies and could be <sup>124</sup>I-labeled for PET imaging.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Although compound <b>2</b> showed pharmacokinetic trends similar to those of compound <b>1</b>, its lower rate of phosphorylation (required for receptor binding) compared to that of compound <b>1</b> limits its effectiveness as an imaging agent. The long half-lives of either iodine-123 (<i>t</i><sub>1/2</sub> = 13.2 h) or iodine-124 (<i>t</i><sub>1/2</sub> = 4.2 days) would enable the study of both the distribution kinetics of the parent ligand and its elimination kinetics. Haufe and co-workers separately reported <sup>18</sup>F-labeled PET imaging agents based on the only known S1P<sub>1</sub> antagonist, [(3<i>R</i>)-amino-4-[(3-hexylphenyl)amino]-4-oxobutyl]-phosphonic acid, mono(trifluoroacetate) (W146),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and based on compound <b>1</b>.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The <sup>18</sup>F-labeled W146 analogue (<i>R</i>)-1-[[3-(6-fluorohexyl)phenyl]amino-4-oxobutyl]phosphonic acid, ([<sup>18</sup>F]<b>3</b>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) was shown to bind with S1P<sub>1</sub> and unlike <b>1</b> does not require a preliminary phosphorylation step for binding potency. However, despite its <i>in vitro</i> stability in mouse serum, PET imaging of [<sup>18</sup>F]<b>3</b> in wild-type mice showed rapid total body clearance as well as bone uptake, which is a measure of <i>in vivo</i> defluorination. Their recent report describes the more favorable evaluation of <sup>18</sup>F-labeled <b>2</b> analogues, with either an 8-carbon (2-amino-2-[4-(8-fluorooctyl)phenethyl]propane-1,3-diol, [<sup>18</sup>F]<b>4a</b>) or a 6-carbon (2-amino-2-[4-(6-fluorohexyl)phenethyl]propane-1,3-diol, [<sup>18</sup>F]<b>4b</b>) aliphatic tail (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). The ligand with the shorter tail, [<sup>18</sup>F]<b>4b</b>, showed reduced <i>in vitro</i> activity, but both tracers demonstrated uptake in S1P target organs of wild-type mice with no evidence of <i>in vivo</i> defluorination. Unlike [<sup>18</sup>F]<b>3</b>, the <b>1</b> analogues require phosphorylation before binding to S1P receptors. While potentially useful tools, at this time it is unclear how rapidly and to what extent the ligands undergo phosphorylation during the typical time frame for PET imaging (1–2 h postinjection).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of S1P receptor imaging agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We have also used the wealth of knowledge in this field to investigate PET radiotracers for S1P receptors using rodent models of human disease.<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28-30)</a> Our group previously reported the radiosynthesis of the <sup>11</sup>C-labeled S1P<sub>1</sub> selective ligand 3-((2-fluoro-4-(5-(2′-methyl-2-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)-1,2,4-oxadiazol-3-yl)benzyl)-(methyl)amino)-propanoic acid <b>5</b> ([<sup>11</sup>C]TZ3321, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) and demonstrated the feasibility of PET imaging S1P<sub>1</sub> as a measure of inflammatory response in both the femoral artery wire-injury mouse model of restenosis<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and in the experimental autoimmune encephalomyelitis (EAE) rat model of multiple sclerosis (MS).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Here, we present the synthesis and screening of fluorine-containing ligands based on reported compounds with either a benzoxazole core<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> or an oxadiazole core.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> Compound <b>28c</b> was identified as a potent and selective ligand for S1P<sub>1</sub> over S1P<sub>2</sub> or S1P<sub>3</sub> in our competitive binding assay,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> so was <sup>18</sup>F-labeled for biological evaluation in the mouse model of LPS-induced liver injury.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthetic strategy is discussed in detail below, but the two lead compounds used for development of an <sup>18</sup>F-labeled tracer were selected due to published data indicating that they are not prodrugs which require <i>in vivo</i> phosphorylation and due to their favorable biological behavior.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> Our screening focused on S1P<sub>1</sub> selective ligands because the efficacy of <b>2</b> in MS is attributed to its high binding potency toward to S1P<sub>1</sub>.<a onclick="showRef(event, 'ref6 ref35'); return false;" href="javascript:void(0);" class="ref ref6 ref35">(6, 35)</a> As shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, <b>28c</b> has a high potency (IC<sub>50</sub> = 2.63 ± 0.27 nM) and selectivity for S1P<sub>1</sub> over S1P<sub>2</sub> or S1P<sub>3</sub> (IC<sub>50</sub> > 1000 nM). The synthesis of [<sup>18</sup>F]<b>28c</b> was accomplished. The mouse model of LPS-induced acute liver injury was used for the <i>in vivo</i> evaluation of [<sup>18</sup>F]<b>28c</b>. Biodistribution studies were carried out with both [<sup>18</sup>F]<b>28c</b> and the liver imaging agent [<sup>99m</sup>Tc]-<i>N</i>-(3-bromo-2,4,6-trimethyacetanilide) iminodiacetic acid ([<sup>99m</sup>Tc]mebrofenin) in LPS and sham mice.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The absence of a significant difference in the liver uptake of [<sup>99m</sup>Tc]mebrofenin in LPS-treated mice vs controls at 60 min postinjection suggested that the higher liver uptake of [<sup>18</sup>F]<b>28c</b> in LPS-treated mice compared to that of control mice was not caused by reduced hepatobiliary clearance in the liver injury model. MicroPET imaging in LPS and sham-treated mice also showed increased retention of [<sup>18</sup>F]<b>28c</b> in the injured liver which correlated with increased S1P<sub>1</sub> expression observed in IHC studies, while no difference in liver uptake of [<sup>15</sup>O]water was seen between LPS-treated and sham mice,<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> suggesting that the higher injured liver accumulation of [<sup>18</sup>F]<b>28c</b> is not due to a change in blood flow in the injured liver. These data indicate that a liver uptake of [<sup>18</sup>F]<b>28c</b> correlates well with the expression of S1P<sub>1</sub> in mouse livers.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">2.1 Chemistry</h3><div class="NLM_p">Ligands with a benzoxazole core were prepared as shown in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The starting halogenated trifluoromethylbenzoic acids were functionalized by either palladium catalyzed Suzuki coupling with the desired aryl boronic acid to provide the biaryl moieties or by nucleophilic aromatic substitution with the desired alcohol to give the ethereal products. The appendant carboxylic acid was transformed to the corresponding acid chloride with oxalyl chloride and catalytic DMF, which was then reacted with a functionalized 2-hydroxyaniline under Schotten–Baumann conditions to give amides <b>10</b>. These amides were subsequently heated under acidic conditions to cyclize and provide the benzoxazole cores. The installation of the polar head groups was accomplished by a variety of methods. β-Amino acids <b>15a</b> and <b>15b</b>, were prepared by reduction of a methyl ester to an alcohol and functional group transformation to a chloride, and subsequently to the azetidine ester, which was unmasked to provide <b>15</b>. Acid <b>16</b> was prepared by a Suzuki coupling with a thiophene boronic acid. Palladium-catalyzed amination with methylpiperidine-4-carboxylate gave the protected products, which were subsequently saponified to give acids <b>18</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Benzoxazole Cores<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(OAc)<sub>2</sub>, SPhos, CsF, R<sup>1</sup>B(OH)<sub>2</sub>, 1,4-dioxane/H<sub>2</sub>O for <b>7b</b>–<b>g</b>; (b) NaH, R<sup>1</sup>OH, DMSO for <b>7a</b>; (c) (i) (COCl)<sub>2</sub>, cat. DMF, CH<sub>2</sub>Cl<sub>2</sub>; (ii) Et<sub>3</sub>N, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (d) <i>p</i>-TsOH, toluene for <b>11a</b>, <b>11b</b>, <b>11e</b>, <b>11h</b>; (e) (i) <i>p</i>-TsOH, toluene; (ii) Cs<sub>2</sub>CO<sub>3</sub>, fluoroethyltosylate, DMF for <b>11c</b>, <b>11d</b>; (f) Ph<sub>3</sub>P, DIAD, THF for <b>11f</b>; (g) PPTS, toluene for <b>11g</b>.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Benzoxazole Targets<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIBAI-H, THF; (b) cyanuric chloride, DMF, CH<sub>2</sub>Cl<sub>2</sub>; (c) methyl azetidine-3-carboxylate hydrochloride, <i>i</i>-Pr<sub>2</sub>NEt, MeCN; (d) LiOH, THF/H<sub>2</sub>O; (e) Pd(OAc)<sub>2</sub>, SPhos, KF, 2-carboxythiophene-5-boronic acid, 1,4-Dioxane/H<sub>2</sub>O; (f) Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub>, XPhos, NaO<sup><i>t</i></sup>Bu, methylpiperidine-4-carboxylate; (g) LiOH, THF/H<sub>2</sub>O.</p></p></figure><div class="NLM_p">Ligands with an oxadiazole core were synthesized according to <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The required carboxylic acids were prepared as described above or from methyl 4-hydroxybenzoate (<b>22</b>) by alkylation and saponification. The desired carboxylic acid was reacted with <i>N</i>′-hydroxy-4-(hydroxymethyl)benzimidamide (<b>25</b>) under standard peptide coupling conditions, and subsequently thermally cyclized to give the oxadiazole cores. <i>O</i>-(Benzotriazol-1-yl)-<i>N,N,N</i>′<i>,N</i>′-tetramethyluronium tetrafluoroborate (TBTU) was also used as a coupling agent, followed by thermal cyclization.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The appendant benzyl alcohol was oxidized under Swern conditions to give aldehydes <b>27</b>. The β-amino acid headgroup was affixed by reductive amination with the desired amine to provide the targeted ligands <b>28a</b>–<b>f</b>. The lipophilicity of a radiotracer, expressed as logP, impacts nonspecific binding and its ability to cross the BBB, which is a key physical constraint for targets in the CNS and intracellular targets including enzymes.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The calculated lipophilicity at a pH of 7.4 of the new compounds is reported as cLogD values in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The oxadiazole <b>28c</b> had a cLogD of 2.32 which is within the desired range for CNS tracers and, as discussed below, a favorable <i>in vitro</i> binding profile; thus, we elected to pursue its development as a radiotracer and synthesized precursors for radiolabeling. Precursor <b>32</b> for radiolabeling using [<sup>18</sup>F]2-fluoroethyltosylate was prepared from phenol <b>29</b>, as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, using a synthetic route similar to that used for the oxadiazole analogues. Formation of the oxadiazole proceeded as expected; however, the oxidation step required different conditions due to the presence of the unprotected phenol. Oxidation with manganese(IV) oxide provided smooth conversion to the desired aldehyde <b>31</b>. Reductive amination under buffered conditions afforded <b>32</b>. Precursor <b>34</b> for direct labeling was also prepared as shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Starting with aldehyde <b>31</b>, the free phenol was alkylated with ethylene ditosylate to provide compound <b>33</b>, which was subjected to reductive amination to yield <b>34</b>. The reductive amination conditions were modified to utilize sodium triacetoxyborohydride because harsher reducing agents tended to reduce the alkyl tosylate.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Benzoxazole Targets<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIBAI-H, THF; (b) cyanuric chloride, DMF, CH<sub>2</sub>Cl<sub>2</sub>; (c) methyl azetidine-3-carboxylate hydrochloride, <i>i</i>-Pr<sub>2</sub>NEt, MeCN; (d) LiOH, THF/H<sub>2</sub>O; (e) Pd(OAc)<sub>2</sub>, SPhos, KF, 2-carboxythiophene-5-boronic acid, 1,4-dioxane/H<sub>2</sub>O; (f) Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub>, XPhos, NaO<sup><i>t</i></sup>Bu, methylpiperidine-4-carboxylate; (g) LiOH, THF/H<sub>2</sub>O.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure–Activity Relationships in the Benzoxazole Core Series</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0011.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0012.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure–Activity Relationships in the Oxadiazole Core Series</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0013.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0014.gif" alt="" id="fx4" /></img><div></div></div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Radiolabeling Precursor <b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TBTU, HOBt, <b>25</b>, DMF; (b) MnO<sub>2</sub>, 1,4-dioxane (c) methyl azetidine-3-carboxylate hydrochloride, NaBH<sub>3</sub>CN, AcOH, DIPEA, MeOH.</p></p></figure><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Direct Radiolabeling Precursor <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (CH<sub>2</sub>OTs)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, MeCN; (b) (i) DIPEA, 1,2-DCE/MeOH; (ii) NaBH(OAc)<sub>3</sub>, AcOH, 1,2-DCE.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">2.2 <i>In Vitro</i> Binding Assays</h3><div class="NLM_p">Competitive inhibition of the binding of radiolabeled [<sup>32</sup>P]S1P to the new analogues was measured to determine the affinity of the ligands for S1P<sub>1</sub>, S1P<sub>2</sub>, and S1P<sub>3</sub>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The results are reported in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The benzoxazole series of ligands displayed nanomolar activity in the functional assay (EC<sub>50</sub>); however, the ligands displayed lower IC<sub>50</sub> value for S1P<sub>1</sub> in the competitive binding assay (IC<sub>50</sub>). Although the reason for this discrepancy in the assay results is not clear, similar results have been observed with other S1P receptor ligands.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Additionally, while functional assays can be extremely useful in the preliminary stages of imaging agent development, the binding potency of a ligand cannot be determined without a competitive binding assay.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> While none of the ligands in this series had sufficient binding affinity (IC<sub>50</sub> < 10 nM) to be pursued as a PET tracer, structure–activity relationships (SAR) became apparent. The residues and shape of the S1P<sub>1</sub> binding pocket have been well documented with a published crystal structure.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The binding pocket consists of two major components, a charged head portion and a lipophilic tail area. The strong recognition for ligand binding is thought to be derived from interactions between the positively charged Arg<sup>120</sup> and the phosphate in S1P, and interactions between the negatively charged Glu<sup>121</sup> and the ammonium in S1P. The lipophilic part of the binding pocket appears to be quite tolerant of a variety of functional groups, with the noted exception of the <i>ortho</i>-substituted fluoroethyl ether <b>18b</b> (IC<sub>50</sub> = 894 ± 367 nM).</div><div class="NLM_p last">The oxadiazole ligand series showed much more promise than the benzoxazole series, as seen in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. We explored the effects of modifying the lipophilic side chain of <b>28a</b> (IC<sub>50</sub> = 8.53 ± 3.14 nM). Addition of a fluorine (<b>28b</b>, IC<sub>50</sub> = 9.94 ± 1.03 nM) had no significant change on the binding potency, while an <i>ortho</i>-trifluoromethyl group noticeably improved the affinity to 2.63 ± 0.27 nM (<b>28c</b>). Next, we turned to the polar headgroup. While some S1P<sub>1</sub> ligands without a polar headgroup have a high degree of potency, we elected to maintain this property in our explorations. Changing the azetidine ring of <b>28c</b> to a piperidine (<b>28d</b>) gave a 20-fold decrease in binding affinity to 45.4 ± 2.7 nM. Bioisosteric substitution of the acid to a tetrazole resulted in significant loss of activity of over 100-fold to 509 ± 167 nM (<b>28e</b>), while shortening the two-carbon tail to a methyl group adversely impacted the binding potency giving an IC<sub>50</sub> > 100 nM (<b>28f</b>). Finally, the benzyl alcohol <b>26c</b> was synthesized to determine how critical the amino acid headgroup was; surprisingly, this headgroup was not required as <b>26c</b> was quite potent with an IC<sub>50</sub> of 6.67 ± 0.70 nM. All compounds with a IC<sub>50</sub> value under 50 nM were screened for selectivity versus S1P<sub>2</sub> and S1P<sub>3</sub>; no tested compounds showed detectable binding with S1P<sub>2</sub> or S1P<sub>3</sub>. <b>28c</b> had a high potency for S1P<sub>1</sub> (IC<sub>50</sub> = 2.63 ± 0.27 nM) with no measurable potency for S1P<sub>2</sub> (IC<sub>50</sub> > 1000 nM) or S1P<sub>3</sub> (IC<sub>50</sub> > 1000 nM) with a cLogD of 2.32; thus, we elected to pursue <b>28c</b> as our lead compound for <sup>18</sup>F-labeling.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.3 Radiochemistry</h3><div class="NLM_p">The radiosynthesis of <b>28c</b> was initially attempted using the versatile indirect approach of labeling with [<sup>18</sup>F]2-fluoroethyltosylate. The precursor <b>32</b> was prepared as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Unfortunately, attempts to label <b>32</b> indirectly resulted only in extremely low yields under a variety of conditions (<5% radiochemical yield for the alkylation step), likely due to the low nucleophilicity of the electron-deficient phenol. Because of this concern, as well as a desire to avoid a three-step, two-pot radiosynthesis, we subsequently pursued a direct labeling approach starting with the tosylate precursor (<b>34</b>) as shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>.</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Radiosynthesis of [<sup>18</sup>F]<b>28c</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The tosylate precursor (<b>34</b>) was reacted with Kryptofix 222 (K<sub>222</sub>) and [<sup>18</sup>F]KF in acetonitrile for 15 min at 110 °C to install the fluoroethyl tail. The carboxylic acid headgroup was unmasked by saponification with sodium hydroxide. The resulting crude product was purified by high performance liquid chromatography (HPLC) to give [<sup>18</sup>F]<b>28c</b> in 25.7 ± 4.6% (<i>n</i> = 10, decay corrected to start of synthesis), with >98% chemical and radiochemical purity, and a high specific activity (1.43 ± 0.12 Ci/μmol).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">2.4 Biological Studies</h3><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">2.4.1 Biodistribution in Normal Rats</h4><div class="NLM_p">To investigate the tissue distribution of [<sup>18</sup>F]<b>28c</b> in living subjects, a biodistribution study was performed in adult male Sprague–Dawley (SD) rats. As shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, the results showed significant uptake and retention in the liver, without evidence of <i>in vivo</i> defluorination (no increased accumulation in bone was observed from 5 to 120 min postinjection). Relatively high uptake was observed for the heart, lungs, pancreas, and spleen, all organs known to have high S1P<sub>1</sub> expression. The surprisingly low brain uptake of [<sup>18</sup>F]<b>28c</b> as shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> may potential limit its utility for CNS applications.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biodistribution of [<sup>18</sup>F]28c in Adult Male SD Rats (% ID/g ± SD)(<i>n</i> = 4)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organ</th><th class="colsep0 rowsep0" align="center">5 min</th><th class="colsep0 rowsep0" align="center">30 min</th><th class="colsep0 rowsep0" align="center">60 min</th><th class="colsep0 rowsep0" align="center">120 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="left">0.304 ± 0.058</td><td class="colsep0 rowsep0" align="left">0.240 ± 0.024</td><td class="colsep0 rowsep0" align="left">0.223 ± 0.007</td><td class="colsep0 rowsep0" align="left">0.178 ± 0.039</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="left">0.753 ± 0.097</td><td class="colsep0 rowsep0" align="left">0.413 ± 0.005</td><td class="colsep0 rowsep0" align="left">0.341 ± 0.024</td><td class="colsep0 rowsep0" align="left">0.272 ± 0.053</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">6.076 ± 1.134</td><td class="colsep0 rowsep0" align="left">5.509 ± 0.567</td><td class="colsep0 rowsep0" align="left">5.081 ± 0.324</td><td class="colsep0 rowsep0" align="left">3.355 ± 0.772</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="left">0.589 ± 0.067</td><td class="colsep0 rowsep0" align="left">0.282 ± 0.030</td><td class="colsep0 rowsep0" align="left">0.251 ± 0.014</td><td class="colsep0 rowsep0" align="left">0.202 ± 0.033</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="left">2.026 ± 0.250</td><td class="colsep0 rowsep0" align="left">1.080 ± 0.000</td><td class="colsep0 rowsep0" align="left">1.117 ± 0.052</td><td class="colsep0 rowsep0" align="left">0.845 ± 0.091</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="left">0.121 ± 0.013</td><td class="colsep0 rowsep0" align="left">0.145 ± 0.013</td><td class="colsep0 rowsep0" align="left">0.156 ± 0.010</td><td class="colsep0 rowsep0" align="left">0.135 ± 0.007</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fat</td><td class="colsep0 rowsep0" align="left">0.051 ± 0.011</td><td class="colsep0 rowsep0" align="left">0.061 ± 0.003</td><td class="colsep0 rowsep0" align="left">0.051 ± 0.003</td><td class="colsep0 rowsep0" align="left">0.059 ± 0.011</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="left">0.811 ± 0.167</td><td class="colsep0 rowsep0" align="left">0.445 ± 0.030</td><td class="colsep0 rowsep0" align="left">0.379 ± 0.015</td><td class="colsep0 rowsep0" align="left">0.316 ± 0.061</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="left">0.027 ± 0.004</td><td class="colsep0 rowsep0" align="left">0.018 ± 0.002</td><td class="colsep0 rowsep0" align="left">0.017 ± 0.002</td><td class="colsep0 rowsep0" align="left">0.015 ± 0.002</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bone</td><td class="colsep0 rowsep0" align="left">0.215 ± 0.027</td><td class="colsep0 rowsep0" align="left">0.114 ± 0.002</td><td class="colsep0 rowsep0" align="left">0.105 ± 0.100</td><td class="colsep0 rowsep0" align="left">0.100 ± 0.012</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pancreas</td><td class="colsep0 rowsep0" align="left">0.755 ± 0.207</td><td class="colsep0 rowsep0" align="left">0.320 ± 0.047</td><td class="colsep0 rowsep0" align="left">0.298 ± 0.089</td><td class="colsep0 rowsep0" align="left">0.265 ± 0.128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">thymus</td><td class="colsep0 rowsep0" align="left">0.150 ± 0.023</td><td class="colsep0 rowsep0" align="left">0.151 ± 0.010</td><td class="colsep0 rowsep0" align="left">0.161 ± 0.007</td><td class="colsep0 rowsep0" align="left">0.182 ± 0.013</td></tr></tbody></table></div></div></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">2.4.2 <i>In Vitro</i> Autoradiography and IHC in LPS-Treated Mice</h4><div class="NLM_p">We utilized the mouse model of LPS-induced liver injury and inflammation, in which inflammation caused by LPS is known to cause increased liver expression of S1P<sub>1</sub> after ∼24 h to evaluate [<sup>18</sup>F]<b>28c</b> in tissue from an animal model of inflammatory disease.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a><i>In vitro</i> autoradiographic data showed increased uptake of [<sup>18</sup>F]<b>28c</b> in the liver of LPS-treated mice, compared with the sham liver shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A. The specificity of [<sup>18</sup>F]<b>28c</b> for S1P<sub>1</sub> was demonstrated by incubation of adjacent mouse liver slices with the tracer in the presence of either the native ligand (S1P) or the S1P<sub>1</sub> selective compound, SEW2871.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The upregulation of S1P<sub>1</sub> in the liver at the 24 h time point following LPS treatment was further confirmed by IHC staining as shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B. These blocking studies in conjunction with the IHC results suggest that the binding of [<sup>18</sup>F]<b>28c</b> in the liver of LPS-treated mice is the result of specific binding to the receptor and is increased when S1P<sub>1</sub> expression is increased.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Representative <i>in vitro</i> autoradiographic images of serial liver sections from LPS-treated and sham mice after incubation with [<sup>18</sup>F]<b>28c</b> under baseline or blocking conditions. (B) IHC staining for S1P<sub>1</sub> in mouse liver sections. Positive staining for S1P<sub>1</sub> (brown, indicated by black arrows) was observed in the liver of both LPS-treated (left) and sham (right) mice. The number of S1P<sub>1</sub>-positive cells in the liver of LPS-treated mice was much greater than that in sham mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">2.4.3 MicroPET Imaging of LPS-Treated Mice with [<sup>18</sup>F]28c and [<sup>15</sup>O]Water</h4><div class="NLM_p">Subsequent microPET imaging in the LPS model of liver inflammation also clearly showed increased accumulation of [<sup>18</sup>F]<b>28c</b> in the liver of LPS-treated mice compared to that in sham controls (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). Time–activity curves (TAC) confirmed higher tracer uptake in the liver of LPS pretreated mice compared with that in the sham controls (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). Quantification of the liver region of interest (ROI) in the microPET scan from 100 to 120 min shows a 61% increase (<i>P</i> < 0.001, <i>n</i> = 4) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C). These results were confirmed by euthanasia of the mice post-PET for an acute biodistribution study. The liver uptake of [<sup>18</sup>F]<b>28c</b> in the LPS-treated mouse at 2 h was 1.95-fold higher than that in the sham mice (12.5 vs 24.4% ID/gram, <i>P</i> < 0.001, <i>n</i> = 4). To further demonstrate that the increased uptake of [<sup>18</sup>F]<b>28c</b> in the liver was not attributed to changes in blood flow in the LPS-induced model of liver injury, additional microPET studies were performed with an injection of [<sup>15</sup>O]water 30 min prior to the injection of [<sup>18</sup>F]<b>28c</b>. [<sup>15</sup>O]Water is a widely used radiotracer for assessing blood flow.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>D, the liver TAC for [<sup>15</sup>O]water in LPS-treated mice showed no significant change compared to that in the sham mice. This suggested that the increase <i>in vivo</i> uptake of [<sup>18</sup>F]<b>28c</b> in the liver of LPS-treated mice is the result of increased S1P<sub>1</sub> expression and not increased blood flow.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Representative summed 120 min transverse PET/CT images of [<sup>18</sup>F]<b>28c</b> in a sham (left) and LPS-treated (right) mouse. (B) Liver time–activity curves (TAC) of [<sup>18</sup>F]<b>28c</b> standardized uptake values (SUV) in sham and LPS-treated mice. (C) Sham vs LPS-treated summed liver SUVs from 100 to 120 min postinjection. <i>P</i> < 0.001. (D) Liver TACs of [<sup>15</sup>O]H<sub>2</sub>O in sham and LPS-treated mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">2.4.4 Biodistribution of [<sup>18</sup>F]28c and [<sup>99m</sup>Tc]Mebrofenin in LPS-Treated Mice</h4><div class="NLM_p">To confirm that the uptake of [<sup>18</sup>F]<b>28c</b> was associated with S1P<sub>1</sub> expression, we utilized a mouse model of LPS-induced liver injury and inflammation, in which inflammation caused by LPS is known to cause increased liver expression of S1P<sub>1</sub> after ∼24 h.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> Biodistribution studies comparing [<sup>18</sup>F]<b>28c</b> uptake in saline-treated sham controls vs the LPS-treated mouse model demonstrated a large increase in liver uptake (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). In order to demonstrate that tracer retention in the liver was not due to impaired hepatobiliary clearance in the liver injury model, an additional study was carried out with this model using a liver imaging agent. [<sup>99m</sup>Tc]Mebrofenin is used to detect if the hepatobiliary transport is impaired. Increased liver uptake of [<sup>99m</sup>Tc]mebrofenin indicates the potential for nonspecific retention of drugs (in this case, [<sup>18</sup>F]<b>28c</b>) in the liver due to impaired clearance, rather than uptake specific to the pathological increase in S1P<sub>1</sub> at the molecular level.<a onclick="showRef(event, 'ref36 ref49 ref50 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref36 ref49 ref50 ref32 ref33">(36, 49, 50, 32, 33)</a> We hypothesized that increased liver uptake of [<sup>99m</sup>Tc]mebrofenin in LPS-treated mice versus the sham control mice at 60 min would suggest that increased uptake of the S1P<sub>1</sub> tracer resulted from a severely damaged liver; however, if the liver uptake of [<sup>99m</sup>Tc]mebrofenin in LPS-treated mice versus the sham mice was similar at 60 min (as we observed), the increase should reflect an increase in S1P<sub>1</sub> rather than impaired clearance.<a onclick="showRef(event, 'ref36 ref49'); return false;" href="javascript:void(0);" class="ref ref36 ref49">(36, 49)</a> To confirm that this increase in uptake of [<sup>18</sup>F]<b>28c</b> resulted from the increase expression of S1P<sub>1</sub> receptor response to liver injury, the biodistribution study of [<sup>99m</sup>Tc]mebrofenin was performed in the LPS-induced liver injury models. Although increased [<sup>99m</sup>Tc]mebrofenin was observed in the liver of LPS-treated mice at 30 min p.i. compared with sham mice, at 60 min p.i. there was no significant difference between the sham and LPS study groups. The uptake of [<sup>18</sup>F]<b>28c</b> showed a significant increase in the LPS-treated mice compared to that of the sham control mice at both 30 and 60 min (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). The biodistribution data demonstrated that the increased hepatobiliary uptake of [<sup>18</sup>F]<b>28c</b> in LPS-treated mice is mainly caused by the upregulation of S1P<sub>1</sub> expression in the liver.</div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Liver uptake in LPS-treated and sham mice 30 min (A) and 60 min (B) postinjection of [<sup>18</sup>F]<b>28c</b> or [<sup>99m</sup>Tc]mebrofenin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">3 Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11476" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11476" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We synthesized 14 fluorine-containing analogues based on two lead pharmacophores and determined their affinity for S1P<sub>1</sub>. Potent compounds (IC<sub>50</sub> < 50 nM for S1P<sub>1</sub>) were subsequently screened for their S1P<sub>2</sub> and S1P<sub>3</sub> binding affinities. Seven compounds were found to have IC<sub>50</sub> values <100 nM, while three were very potent with S1P<sub>1</sub> IC<sub>50</sub> values <10 nM. We explored the SAR studies on the oxadiazole containing pharmacophore by optimizing the lipophilic tail binding portion of the binding pocket. The oxadiazole <b>28c</b> had a high potency (2.63 nM for S1P<sub>1</sub>) and selectivity (>100-fold for S1P<sub>1</sub> versus S1P<sub>2/3</sub>), and was successfully radiolabeled in high yield and high specific activity. Biodistribution in normal rats showed no evidence of defluorination, so the mouse model of liver inflammation was used for subsequent biological evaluation of [<sup>18</sup>F]<b>28c</b> as a PET tracer for imaging S1P<sub>1</sub>. <i>In vitro</i> autoradiography and microPET imaging studies showed increased binding <i>in vitro</i> and <i>in vivo</i> retention of [<sup>18</sup>F]<b>28c</b> in the liver of LPS-treated vs control mice. IHC staining studies confirmed that S1P<sub>1</sub> expression was increased in the liver of LPS-treated mice. Additional microPET imaging showed no difference in liver uptake of [<sup>15</sup>O]water between LPS-treated and control mice,<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> further supporting the hypothesis that the higher uptake and retention of [<sup>18</sup>F]<b>28c</b> in the liver of LPS-treated mice was a reflection of increased S1P<sub>1</sub> due to inflammation and not due to a change in blood flow. Parallel acute biodistribution studies in the LPS model were carried out with both [<sup>18</sup>F]<b>28c</b> and the liver imaging agent [<sup>99m</sup>Tc]mebrofenin.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The absence of a significant difference in liver uptake of [<sup>99m</sup>Tc]mebrofenin in LPS-treated vs control liver uptake 60 min postinjection suggested that the increased liver uptake of [<sup>18</sup>F]<b>28c</b> observed in the PET studies of LPS-treated mice was not the result of reduced hepatobiliary clearance due to liver injury. Together, these data indicate that uptake of [<sup>18</sup>F]<b>28c</b> reflects the expression of S1P<sub>1</sub> and suggest that [<sup>18</sup>F]<b>28c</b> is a S1P<sub>1</sub> specific radiotracer with potential for use in quantifying S1P<sub>1</sub> receptor expression in response to inflammation.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">4 Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">4.1 Chemistry Materials and Methods</h3><div class="NLM_p">Unless otherwise indicated, all reactions were conducted in oven-dried (140 °C) glassware. Stainless steel syringes or cannulae that had been oven-dried (140 °C) and cooled under a nitrogen atmosphere or in a desiccator were used to transfer air- and moisture-sensitive liquids. Yields refer to chromatographically and spectroscopically (<sup>1</sup>H NMR) homogeneous materials, unless otherwise stated. Reactions were monitored by thin-layer chromatography (TLC) carried out on precoated glass plates of silica gel (0.25 mm) 60 F<sub>254</sub> from EMD Chemicals Inc. Visualization was accomplished with ultraviolet light (UV 254 nm) or by shaking the plate in a sealed jar containing silica gel and iodine. Alternatively, plates were treated with one of the following solutions (this was accomplished by holding the edge of the TLC plate with forceps or tweezers and immersing the plate into a wide-mouth jar containing the desired staining solution) and carefully heating with a hot-air gun (450 °C) for approximately 1–2 min (note: excess stain was removed by resting the TLC on a paper towel prior to heating): 10% phosphomolybdic acid in ethanol, 1% potassium permanganate/7% potassium carbonate/0.5% sodium hydroxide aqueous solution, and/or anisaldehyde in ethanol with 10% sulfuric acid. Flash column chromatography was performed using Silia Flash P60 silica gel (40–63 μm) from Silicycle. All workup and purification procedures were carried out with reagent grade solvents in air.</div><div class="NLM_p"><sup>1</sup>H NMR spectra were recorded on a Varian 400 MHz instrument. Chemical shifts are reported in parts per million (ppm) and are calibrated using residual undeuterated solvent as an internal reference (CDCl<sub>3</sub>, δ 7.26 ppm; MeOD-<i>d</i><sub>4</sub>, δ 3.31 ppm; DMSO-<i>d</i><sub>6</sub>, δ 2.50 ppm). Data are reported as follows: chemical shift, multiplicity, coupling constants (Hz), and integration. The following abbreviations or combinations thereof were used to explain the multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, pent = pentet, sext = sextet, sept = septet, m = multiplet, at = apparent triplet, aq = apparent quartet, and b = broad. <sup>13</sup>C NMR spectra were recorded on a Varian instrument (100 MHz) spectrometer with complete proton decoupling. Chemical shifts are reported in ppm and are calibrated using a residual undeuterated solvent as an internal reference (CDCl<sub>3</sub>, δ 77.16 ppm; MeOD-<i>d</i><sub>4</sub>, 49.00 ppm; and DMSO-<i>d</i><sub>6</sub>, 39.52 ppm). Elemental compositions (C, H, and N) are within ±0.4% of the calculated values and were determined by Atlantic Microlab, Inc. Lipophilicity values as cLogD are reported as the calculated Log P value at pH 7.4 and were obtained using ACD/I-Lab version 7.0 (Advanced Chemistry Development, Inc. Toronto, Ontario, Canada). The biological activity of all of the final compounds was determined by an analytical HPLC method with purity ≥ 95%.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">4.1.1 Synthesis</h4><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> General Procedure A: Suzuki Coupling</h5><div class="NLM_p last">To an oven-dried round-bottomeded flask equipped with a stir bar was added Pd(OAc)<sub>2</sub> (2 mol %), 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (SPhos, 5 mol %), commercially available 4-bromo-3-(trifluoromethyl)benzoic acid (<b>6</b>) (1 equiv), the boronic acid (1.1 equiv), and a fluoride base (3 equiv). 1,4-Dioxane (0.37 M) and degassed H<sub>2</sub>O (0.37 M) were added to the reaction mixture, and the reaction was degassed by sparging with N<sub>2(g)</sub> for 10 min, at which time it was equipped with a condenser and placed in a preheated 110 °C oil-bath. The reaction mixture was stirred for the time indicated, cooled to room temperature (r.t.), and poured into a 1:1 mixture of ethyl acetate and 1 N HCl <sub>(aq)</sub>. The quenched reaction mixture was stirred for 20 min, and the layers were then separated. The aqueous layer was extracted with ethyl acetate (×2). The combined organic layers were dried over MgSO<sub>4</sub>, concentrated <i>in vacuo</i>, and purified as specified.</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> General Experimental B: Amide Formation</h5><div class="NLM_p last">To an oven-dried round-bottomeded flask equipped with a stir bar was added carboxylic acid (1 equiv) followed by CH<sub>2</sub>Cl<sub>2</sub> (0.1 M). Five drops of <i>N,N</i>-dimethylformamide was added via pipet followed by the slow addition of oxalyl chloride (2.3 equiv) via a syringe. The reaction was then stirred at r.t. for 2 h, at which time it was concentrated <i>in vacuo</i>. The crude acid chloride was then dissolved in toluene (0.15 M), and 10% NaHCO<sub>3(aq)</sub> (0.3 M) was added. The aniline <b>9a</b> or commercially available 2-amino-4-bromophenol (<b>9b</b>) (1 equiv) was added, and the reaction was stirred overnight. Upon completion of the reaction, the resulting precipitate was filtered and washed with H<sub>2</sub>O, toluene, and hexanes to give the desired amide.</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> General Experimental C: Benzoxazole Formation</h5><div class="NLM_p last">To a round-bottomeded flask equipped with a stir bar was added the amide (1 equiv), toluene (0.1 M), and <i>p</i>-toluenesulfonic acid (2.1 equiv) or pyridinium <i>p</i>-toluenesulfonate (2.1 equiv). The reaction was equipped with a reflux condenser and lowered into a preheated 130 °C oil-bath. The reaction mixture was stirred for the specified time, cooled to r.t., diluted with EtOAc, and washed with sat. NaHCO<sub>3(aq)</sub> (×2), and brine. The organic layer was dried over MgSO<sub>4</sub> and concentrated <i>in vacuo</i> to give the desired benzoxazole.</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> General Procedure D: Buchwald–Hartwig Coupling</h5><div class="NLM_p last">To an oven-dried flask (pressure-vessel or Schlenk tube) equipped with a stir bar was added Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub> (2 mol %), XPhos (8 mol %), sodium <i>tert</i>-butoxide (1.4 equiv), and the aryl bromide (1 equiv). Toluene (0.5 M) was added followed by the amine (1.2 equiv), and the reaction mixture was degassed by sparging with N<sub>2(g)</sub> for 10 min. The reaction vessel was sealed with a Teflon screw-cap and lowered into a preheated 110 °C oil-bath. After 18–20 h, the reaction mixture was allowed to cool to r.t. and diluted with ethyl acetate. The reaction mixture was then concentrated <i>in vacuo</i> and purified as specified.</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> General Procedure E: Saponification</h5><div class="NLM_p last">To a 16 × 150 mm test tube equipped with a stir bar was added the ester (1 equiv), THF (0.24 M), H<sub>2</sub>O (1.2 M), and lithium hydroxide (2 equiv). The reaction mixture was stirred at r.t. for 16–18 h, at which time it was acidified to pH 1 with 1 M HCl<sub>(aq)</sub>. The reaction mixture was extracted with ethyl acetate (×4). The combined organic layers were washed with brine and concentrated <i>in vacuo</i> to give the desired products.</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> General Procedure F: Oxadiazole Formation</h5><div class="NLM_p last">To an oven-dried round-bottomeded flask equipped with a stir bar was added the acid (1 equiv), EDC·HCl (1 equiv), HOBt (1 equiv), and DMF (0.8 M). The reaction mixture was stirred at r.t. for 30 min, at which time amidoxime (1 equiv) was added. A reflux condenser was attached, and the reaction vessel was placed in a preheated 120–140 °C oil-bath and stirred overnight (14–18 h). The reaction mixture was cooled to r.t. and diluted with EtOAc and water. The layers were separated, and the aqueous layer was extracted with EtOAc (×1). The combined organic layers were washed with water, 1 M HCl<sub>(aq)</sub>, water, and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give the desired product.</div></div><div id="sec4_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> General Procedure G: Reductive Amination</h5><div class="NLM_p last">To a round-bottomeded flask equipped with a stir bar was added aldehyde (1 equiv), amine (1.05 equiv), methanol (0.07 M), and acetic acid (2 M). The reaction mixture was stirred for 30 min at which time sodium cyanoborohydride (0.5 equiv) was added as a solution in methanol (0.25 M). The reaction mixture was stirred for 1–2 h, at which time the solids were filtered and washed with methanol to give the desired product.</div></div><div id="sec4_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 4-(2-Fluoroethoxy)-3-(trifluoromethyl)benzoic Acid (<b>7a</b>)</h5><div class="NLM_p last">To an oven-dried 500 mL round-bottomed flask equipped with a stir bar was added 4-fluoro-3-(trifluoromethyl)benzoic acid (<b>8</b>)(8.32 g, 40.0 mmol), 100 mL of DMSO, and 2-fluoroethanol (3.52 mL, 60.0 mmol). Sodium hydride (3.60 g, 90.0 mmol) was added portionwise, and the reaction mixture was stirred for 16 h. The reaction mixture was poured into water and acidified with 12 M HCl<sub>(aq)</sub> to pH 1. The resulting precipitate was filtered and washed with water and hexanes to give a tan solid (9.8 g, 97% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 12.18 (s, 1H), 8.18 (dd, <i>J</i> = 8.8 Hz, 2.0 Hz, 1H), 8.11 (d, <i>J</i> = 2.0 Hz, 1H), 7.39 (d, <i>J</i> = 8.8 Hz, 1H), 4.85–4.40 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 166.0, 159.44, 135.6, 128.0 (q, <i>J</i><sub><i>C–F</i></sub> = 4.9 Hz), 123.2 (q, <i>J</i><sub><i>C–F</i></sub> = 274 Hz), 123.2, 117.4 (q, <i>J</i><sub><i>C–F</i></sub> = 31.1 Hz), 113.9, 81.8 (d, <i>J</i><sub><i>C–F</i></sub> = 168 Hz), 68.6 (d, <i>J</i><sub><i>C–F</i></sub> = 19.1 Hz), MP: 131–133 °C. HRMS (EI-TOF) <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>7</sub>F<sub>4</sub>O<sub>3</sub> [M – H] 251.0337. Found [M – H] 251.0289.</div></div><div id="sec4_1_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 4′-Fluoro-2-(trifluoromethyl)-[1,1′-biphenyl]-4-carboxylic Acid (<b>7b</b>)</h5><div class="NLM_p last">Following general experimental procedure A, Pd(OAc)<sub>2</sub> (67 mg, 0.30 mmol), SPhos (306 mg, 0.75 mmol), <b>6</b> (4.0 g, 14.9 mmol), 4-fluorophenylboronic acid (2.29 g, 16.4 mmol), cesium fluoride (6.79 g, 44.7 mmol), 1,4-dioxane (40 mL), and degassed H<sub>2</sub>O (40 mL) were combined. The reaction mixture was stirred for 18 h, to give 3.0 g of a tan solid which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 13.56 (br s, 1H), 8.28 (s, 1H), 8.23 (d, <i>J</i> = 8 Hz, 1H), 7.57 (d, <i>J</i> = 8 Hz, 1H), 7.43–7.38 (m, 2H), 7.35–7.29 (m, 2H).</div></div><div id="sec4_1_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 2′-Hydroxy-2-(trifluoromethyl)-[1,1′-biphenyl]-4-carboxylic Acid (<b>7c</b>)</h5><div class="NLM_p last">Following general experimental procedure A, Pd(OAc)<sub>2</sub> (84 mg, 0.37 mmol), SPhos (382 mg, 0.93 mmol), <b>6</b> (5.0 g, 18.6 mmol), 2-hydroxyphenylboronic acid (2.82 g, 20.4 mmol), cesium fluoride (8.48 g, 55.8 mmol), 1,4-dioxane (50 mL), and degassed H<sub>2</sub>O (50 mL) were combined. The reaction mixture was stirred for 20 h and purified on a silica gel column, eluting with 5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, to provide 5.2 g of a yellow semisolid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 9.54 (s, 1H), 8.25 (s, 1H), 8.18 (d, <i>J</i> = 8 Hz, 1H), 7.47 (d, <i>J</i> = 8 Hz, 1H), 7.23 (td, <i>J</i> = 8.8 Hz, 1.6 Hz, 1H), 7.04 (d, <i>J</i> = 7.2 Hz, 1H), 6.91 (d, <i>J</i> = 8.4 Hz, 1H), 6.85 (t, <i>J</i> = 7.2 Hz, 1H).</div></div><div id="sec4_1_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 4′-Hydroxy-2-(trifluoromethyl)-[1,1′-biphenyl]-4-carboxylic Acid (<b>7d</b>)</h5><div class="NLM_p last">Following general experimental procedure A, Pd(OAc)<sub>2</sub> (67 mg, 0.30 mmol), SPhos (306 mg, 0.75 mmol), <b>6</b> (4.0 g, 14.9 mmol), 4-hydroxyphenylboronic acid (2.46 g, 17.8 mmol), cesium fluoride (6.79 g, 44.7 mmol), 1,4-dioxane (40 mL), and degassed H<sub>2</sub>O (40 mL). The reaction mixture was stirred for 20 h and purified on a silica gel column, eluting with 5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, to provide 4.2 g of a yellow semisolid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 9.73 (s, 1H), 8.25 (s, 1H), 8.18 (d, <i>J</i> = 8 Hz, 1H), 7.52 (d, <i>J</i> = 8 Hz, 1H), 7.16 (d, <i>J</i> = 8.4 Hz, 2H), 6.83(d, <i>J</i> = 8.8 Hz, 2H).</div></div><div id="sec4_1_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 2,4′-Bis(trifluoromethyl)-[1,1′-biphenyl]-4-carboxylic Acid (<b>7e</b>)</h5><div class="NLM_p last">Following general experimental procedure A, Pd(OAc)<sub>2</sub> (42 mg, 0.19 mmol), SPhos (191 mg, 0.47 mmol), <b>6</b> (2.5 g, 9.3 mmol), 4-(trifluorofluoromethyl)phenylboronic acid (2.12 g, 11.2 mmol), potassium fluoride (4.24 g, 27.9 mmol), 1,4-dioxane (25 mL), and degassed H<sub>2</sub>O (25 mL). The reaction mixture was stirred for 22 h to give 2.35 g of a yellow solid, which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 12.67 (br s, 1H), 8.31 (d, <i>J</i> = 1.2 Hz, 1H), 8.26 (d, <i>J</i> = 8 Hz, 1H), 7.85 (d, <i>J</i> = 8.4 Hz, 2H), 7.61 (t, <i>J</i> = 7.6 Hz, 3H).</div></div><div id="sec4_1_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 4-(6-Fluoropyridin-3-yl)-3-(trifluoromethyl)benzoic Acid (<b>7f</b>)</h5><div class="NLM_p last">Following general experimental procedure A, Pd(OAc)<sub>2</sub> (50 mg, 0.22 mmol), SPhos (230 mg, 0.56 mmol), <b>6</b> (3.0 g, 11.15 mmol), (6-fluoropyridin-3-yl)boronic acid (1.89 g, 13.4 mmol), cesium fluoride (5.08 g, 33.5 mmol), 30 mL of 1,4-dioxane, and 30 mL of degassed H<sub>2</sub>O. The reaction mixture was stirred for 18 h to give a yellow solid, which was used without further purification (3.0 g, 94% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 13.63 (br s, 1H), 8.31 (s, 1H), 8.30–8.24 (m, 2H), 8.09–7.98 (m, 1H), 7.66 (d, <i>J</i> = 7.6 Hz), 7.34 (dd, <i>J</i> = 8.4 Hz, 2.8 Hz, 1H).</div></div><div id="sec4_1_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 3′-Methoxy-2-(trifluoromethyl)-[1,1′-biphenyl]-4-carboxylic Acid (<b>7g</b>)</h5><div class="NLM_p last">Following general experimental procedure A, Pd(OAc)<sub>2</sub> (50 mg, 0.22 mmol), SPhos (230 mg, 0.56 mmol), <b>6</b> (3.0 g, 11.15 mmol), 3-methoxyphenylboronic acid (2.04 g, 13.4 mmol), cesium fluoride (5.08 g, 33.5 mmol), 30 mL of 1,4-dioxane, and 30 mL of degassed H<sub>2</sub>O. The reaction mixture was stirred for 18 h, to give a yellow solid, which was used without further purification (3.12 g, 95% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 13.22 (br s, 1H), 8.28 (d, <i>J</i> = 1.2 Hz, 1H), 8.22 (dd, <i>J</i> = 8.0 Hz, 1.6 Hz, 1H), 7.57 (d, <i>J</i> = 8.0 Hz, 1H), 7.38 (t, <i>J</i> = 8.4 Hz, 1H), 7.06–7.01 (m, 1H), 6.93–6.86 (m, 2H), 3.78 (s, 3H).</div></div><div id="sec4_1_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> Methyl 3-amino-4-hydroxybenzoate (<b>9a</b>)</h5><div class="NLM_p last">To a 250 mL round-bottomed flask equipped with a stir bar was added methyl 4-hydroxy-3-nitrobenzoate (5.0 g, 25.4 mmol), 120 mL of EtOH, and 540 mg of 10% Pd/C. One balloon of H<sub>2(g)</sub> was bubbled through the reaction mixture, and then it was stirred under 1 atm of H<sub>2(g)</sub> overnight (16 h). At this time, the reaction was filtered through a Celite plug, washing with EtOH, and concentrated <i>in vacuo</i> to give a brown solid (4.17 g, 98% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 7.45 (d, <i>J</i> = 2.0 Hz, 1H), 7.42 (dd, <i>J</i> = 8.0 Hz, 2.0 Hz, 1H), 7.75 (d, <i>J</i> = 8.4 Hz, 1H), 3.87 (s, 3H).</div></div><div id="sec4_1_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> Methyl 3-(4-(2-fluoroethoxy)-3-(trifluoromethyl)benzamido)-4-hydroxybenzoate (<b>10a</b>)</h5><div class="NLM_p last">To an oven-dried 100 mL of round-bottomed flask equipped with a stir bar was added acid <b>7a</b> (2.50 g, 9.91 mmol), 50 mL of CH<sub>2</sub>Cl<sub>2</sub>, and 10 drops of DMF. Oxalyl chloride (1.68 mL, 19.8 mmol) was added carefully, and the reaction mixture was stirred for 2 h at r.t. The reaction was concentrated <i>in vacuo</i> and dissolved in 33 mL of CH<sub>2</sub>Cl<sub>2</sub>. Triethylamine (5.52 mL, 39.6 mmol) was added followed by DMAP (120 mg, 0.99 mmol) and aniline <b>9a</b> (1.66 g, 9.91 mmol). The reaction mixture was stirred overnight and diluted with MTBE, at which point a precipitate had formed. The precipitate was filtered, washed with MTBE, and hexanes to give a white solid which was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 10.75 (br s, 1H), 9.83 (s, 1H), 8.27 (app q, <i>J</i> = 2.4 Hz, 2H), 8.23 (d, <i>J</i> = 2.4 Hz, 1H), 7.70 (dd, <i>J</i> = 8.4 Hz, 2.4 Hz, 1H), 7.43 (d, <i>J</i> = 9.2 Hz, 1H), 7.02 (d, <i>J</i> = 8.4 Hz, 1H), 4.87–4.68 (m, 2H), 4.57–4.42 (m, 2H).</div></div><div id="sec4_1_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> <i>N</i>-(5-Bromo-2-hydroxyphenyl)-4′-fluoro-2-(trifluoromethyl)-[1,1′-biphenyl]-4-carboxamide (<b>10b</b>)</h5><div class="NLM_p last">Following general experimental procedure B, carboxylic acid <b>7b</b> (720 mg, 2.53 mmol), 25.3 mL of CH<sub>2</sub>Cl<sub>2</sub>, oxalyl chloride (0.49 mL, 5.82 mmol), 17 mL of toluene, 8.5 mL of 10% NaHCO<sub>3(aq)</sub>, and <b>9b</b> (476 mg, 2.53 mmol) were combined to give amide <b>10b</b> as a tan solid (1.11 g, 99% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.30 (s, 1H), 8.19 (d, <i>J</i> = 8 Hz, 1H), 7.99 (s, 1H), 7.51 (d, <i>J</i> = 8 Hz, 1H), 7.35–7.25 (m, 4H), 7.08 (d, <i>J</i> = 8 Hz, 1H), 6.76 (d, <i>J</i> = 8 Hz, 1H).</div></div><div id="sec4_1_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> <i>N</i>-(5-Bromo-2-hydroxyphenyl)-2′-hydroxy-2-(trifluoromethyl)-[1,1′-biphenyl]-4-carboxamide (<b>10c</b>)</h5><div class="NLM_p last">Following general experimental procedure B, carboxylic acid <b>7c</b> (3.5 g, 12.4 mmol), 124 mL of CH<sub>2</sub>Cl<sub>2</sub>, oxalyl chloride (2.41 mL, 28.5 mmol), 82 mL of toluene, 41 mL of 10% NaHCO<sub>3(aq)</sub>, and <b>9b</b> (2.33 g, 12.4 mmol) were combined to give amide <b>10c</b> as a brown solid (1.15 g, 20% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.32 (s, 1H), 8.19 (d, <i>J</i> = 8.0 Hz, 1H), 7.87 (d, <i>J</i> = 2.4 Hz, 1H), 7.48 (d, <i>J</i> = 7.6 Hz, 1H), 7.28–7.17 (m, 2H), 7.05 (d, <i>J</i> = 6.8 Hz, 1H), 6.92 (d, <i>J</i> = 8.0 Hz, 1H), 6.89–6.82 (m, 2H).</div></div><div id="sec4_1_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> <i>N</i>-(5-Bromo-2-hydroxyphenyl)-4′-hydroxy-2-(trifluoromethyl)-[1,1′-biphenyl]-4-carboxamide (<b>10d</b>)</h5><div class="NLM_p last">Following general experimental procedure B, carboxylic acid <b>7d</b> (4.2 g, 14.9 mmol), 149 mL of CH<sub>2</sub>Cl<sub>2</sub>, oxalyl chloride (2.90 mL, 34.3 mmol), 100 mL of toluene, 50 mL of 10% NaHCO<sub>3(aq)</sub>, and <b>9b</b> (2.80 g, 14.9 mmol) were combined to give amide <b>10d</b> as a brown solid which was used in the next step without further purification (3.4 g, 50% yield).</div></div><div id="sec4_1_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> <i>N</i>-(5-Bromo-2-hydroxyphenyl)-2,4′-bis(trifluoromethyl)-[1,1′-biphenyl]-4-carboxamide (<b>10e</b>)</h5><div class="NLM_p last">Following general experimental procedure B, acid <b>7e</b> (2.27 g, 6.79 mmol), 68 mL of CH<sub>2</sub>Cl<sub>2,</sub> oxalyl chloride (1.21 mL, 14.3 mmol), 46 mL toluene, 23 mL of 10% NaHCO<sub>3(aq)</sub>, and <b>9b</b> (1.28 g, 6.79 mmol) were combined to give a light brown solid (2.81 g, 82% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 10.09 (br s, 1H), 8.42 (s, 1H), 8.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.92–7.84 (m, 3H), 7.65–7.56 (m, 3H), 7.23 (dd, <i>J</i> = 8.8 Hz, 2.4 Hz, 1H), 6.89 (d, <i>J</i> = 8.8 Hz, 1H).</div></div><div id="sec4_1_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> <i>N</i>-(5-Bromo-2-hydroxyphenyl)-4-(6-fluoropyridin-3-yl)-3-(trifluoromethyl)benzamide (<b>10f</b>)</h5><div class="NLM_p last">Following general experimental procedure B, acid <b>7f</b> (1.00 g, 3.51 mmol), 35 mL of CH<sub>2</sub>Cl<sub>2</sub>, oxalyl chloride (0.68 mL, 8.1 mmol), 24 mL of toluene, 12 mL of 10% NaHCO<sub>3(aq)</sub>, and <b>9b</b> (660 mg, 3.51 mmol) were combined to give a tan solid (1.0 g, 63% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 10.32 (br s, 1H), 8.40 (s, 1H), 8.35–8.18 (m, 2H), 8.03 (t, <i>J</i> = 8.4 Hz, 1H), 7.89 (d, <i>J</i> = 1.6 Hz, 1H), 7.64 (d, <i>J</i> = 7.6 Hz, 1H), 7.35 (d, <i>J</i> = 6.4 Hz, 1H), 7.19 (d, <i>J</i> = 8.4 Hz, 1H), 6.87 (d, <i>J</i> = 8.8 Hz, 1H).</div></div><div id="sec4_1_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> Methyl 3-(4-(6-Fluoropyridin-3-yl)-3-(trifluoromethyl)benzamido)-4-hydroxybenzoate (<b>10g</b>)</h5><div class="NLM_p last">To an oven-dried 100 mL round-bottomed flask equipped with a stir bar was added acid <b>7f</b> (1.50 g, 5.26 mmol), 53 mL of CH<sub>2</sub>Cl<sub>2</sub>, and 10 drops of DMF. Oxalyl chloride (0.89 mL, 10.5 mmol) was added carefully, and the reaction was stirred for 2 h, where upon it was concentrated <i>in vacuo</i> to give a yellow semisolid. The crude acid chloride was suspended in 26 mL of CH<sub>2</sub>Cl<sub>2</sub>, and triethylamine (2.93 mL, 21.0 mmol) was added, followed by DMAP (64 mg, 0.53 mmol). The reaction was stirred for 5 min at which time aniline <b>9a</b> (880 mg, 5.26 mmol) was added. The reaction mixture was stirred overnight (18 h), quenched with 1 M HCl<sub>(aq)</sub>, and diluted with CH<sub>2</sub>Cl<sub>2</sub>, causing a suspension to form in the organic layer. The layers were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (×3). The combined organic layers were diluted with hexanes and filtered to give a brown solid (1.02 g, 45% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 10.78 (br s, 1H), 10.05 (br s, 1H), 8.45 (s, 1H), 8.33 (d, <i>J</i> = 7.6 Hz, 1H), 8.29 (s, 2H), 8.05 (t, <i>J</i> = 6.4 Hz, 1H), 7.73 (d, <i>J</i> = 8.4 Hz, 1H), 7.68 (d, <i>J</i> = 8.0 Hz, 1H), 7.35 (d, <i>J</i> = 8.4 Hz, 1H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 3.82 (s, 3H).</div></div><div id="sec4_1_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> <i>N</i>-(5-Bromo-2-hydroxyphenyl)-3′-methoxy-2-(trifluoromethyl)-[1,1′-biphenyl]-4-carboxamide (<b>10h</b>)</h5><div class="NLM_p last">Following general experimental procedure B, acid <b>7g</b> (3.1 g, 10.5 mmol), 105 mL of CH<sub>2</sub>Cl<sub>2</sub>, oxalyl chloride (2.04 mL, 24.2 mmol), 70 mL of toluene, 35 mL of 10% NaHCO<sub>3(aq)</sub>, and <b>9b</b> (1.97 g, 10.5 mmol) were combined to give a brown solid which was used in the next step without further purification (3.96 g, 81% yield).</div></div><div id="sec4_1_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> Methyl 2-(4-(2-Fluoroethoxy)-3-(trifluoromethyl)phenyl)benzo[<i>d</i>]oxazole-5-carboxylate (<b>11a</b>)</h5><div class="NLM_p last">Following general experimental procedure C, amide <b>10a</b> (crude from previous step), 99 mL of toluene, and <i>p</i>-toluenesulfonic acid (3.77 g, 19.8 mmol) were combined to give a tan solid (1.1 g, 29% yield over two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.56–8.49 (m, 1H), 8.45 (d, <i>J</i> = 1.6 Hz, 1H), 8.41 (dd, <i>J</i> = 8.8 Hz, 2.4 Hz, 1H), 8.12 (dd, <i>J</i> = 8.4 Hz, 1.6 Hz, 1H), 7.62 (d, <i>J</i> = 8.4 Hz, 1H), 7.17 (d, <i>J</i> = 8.4 Hz, 1H), 4.93–4.75 (m, 2H), 4.48–4.37 (m, 2H), 3.97 (s, 3H).</div></div><div id="sec4_1_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 5-Bromo-2-(4′-fluoro-2-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)benzo[<i>d</i>]oxazole (<b>11b</b>)</h5><div class="NLM_p last">Following general experimental procedure C, amide <b>10b</b> (980 mg, 2.17 mmol), 21.7 mL of toluene, and <i>p</i>-toluenesulfonic acid (867 mg, 4.56 mmol) were combined to give oxazole <b>11b</b> as a red solid (760 mg, 80% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.52 (s, 1H), 8.48 (d, <i>J</i> = 8 Hz, 1H), 8.13 (d, <i>J</i> = 2 Hz, 1H), 7. 86 (d, <i>J</i> = 8.8 Hz, 1H), 7.69 (d, <i>J</i> = 8 Hz, 1H), 7.66 (dd, <i>J</i> = 8.8 Hz, 2 Hz, 1H), 7.50–7.41 (m, 2H), 7.35 (t, <i>J</i> = 8.8 Hz, 2H).</div></div><div id="sec4_1_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 5-Bromo-2-(2′-(2-fluoroethoxy)-2-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)benzo[<i>d</i>]oxazole (<b>11c</b>)</h5><div class="NLM_p">Following general experimental procedure C, amide <b>10c</b> (1.06 g, 2.34 mmol), 23.4 mL of toluene, and <i>p</i>-toluenesulfonic acid (0.94 g, 4.92 mmol) were combined to give the crude product which was applied to a silica gel column, eluted with 20% EtOAc/hexanes, to provide the phenol intermediate as a red solid (820 mg, 80% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 9.64 (s, 1H), 8.49 (s, 1H), 8.43 (d, <i>J</i> = 8.0 Hz, 1H), 8.13 (d, <i>J</i> = 1.6 Hz, 1H), 7.86 (d, <i>J</i> = 8.4 Hz, 1H), 7.65 (dd, <i>J</i> = 8.8 Hz, 2.0 Hz, 1H), 7.60 (d, <i>J</i> = 8.8 Hz, 1H), 7.26 (t, <i>J</i> = 7.6 1H), 7.09 (d, <i>J</i> = 7.2 Hz, 1H), 6.94 (d, <i>J</i> = 8.4 Hz, 1H), 6.87 (t, <i>J</i> = 7.2 Hz, 1H).</div><div class="NLM_p last">To an oven-dried 16 × 125 mm test tube equipped with a stir bar was added the phenol prepared above (290 mg, 0.67 mmol), cesium carbonate (437 mg, 1.34 mmol), and 2.2 mL of <i>N,N</i>-dimethylformamide. 2-Fluoroethyl 4-methylbenzenesulfonate (160 mg, 0.73 mmol) was added via syringe, and the reaction vessel was placed in a preheated 70 °C oil-bath and stirred for 4 h. The reaction mixture was cooled to r.t. and diluted with EtOAc and H<sub>2</sub>O, and the layers were separated. The organic layer was washed with H<sub>2</sub>O (×5) and brine, dried over sodium sulfate, and concentrated <i>in vacuo</i> to give a light brown solid, which was used without further purification (310 mg, 97% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.58 (s, 1H), 8.34 (d, <i>J</i> = 8.4 Hz, 1H), 7.89 (s, 1H), 7.53–7.43 (m, 3H), 7.38 (t, <i>J</i> = 7.6 Hz, 1H), 7.20 (d, <i>J</i> = 7.2 Hz, 1H), 7.04 (t, <i>J</i> = 7.6 Hz, 1H), 6.95 (d, <i>J</i> = 8.4 Hz, 1H), 4.52 (dt, <i>J</i> = 47.2 Hz, 4 Hz, 2H), 4.31–4.03 (m, 2H).</div></div><div id="sec4_1_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 5-Bromo-2-(4′-(2-fluoroethoxy)-2-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)benzo[<i>d</i>]oxazole (<b>11d</b>)</h5><div class="NLM_p">Following general experimental procedure C, amide <b>10d</b> (3.4 g, 7.52 mmol), 75 mL of toluene, and <i>p</i>-toluenesulfonic acid (3.0 g, 15.8 mmol) were combined to give the crude product, which was applied to a silica gel column, eluted with 20% EtOAc/hexanes, to provide the phenol intermediate as a red solid (1.21 g, 37% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 9.77 (s, 1H), 8.46 (s, 1H), 8.41 (d, <i>J</i> = 8 Hz, 1H), 8.10 (d, <i>J</i> = 1.6 Hz, 1H), 7.83 (d, <i>J</i> = 8.8 Hz, 1H), 7.63 (d, <i>J</i> = 8 Hz, 1H), 7.66 (dd, <i>J</i> = 8.8 Hz, 2 Hz, 1H), 7.20 (d, <i>J</i> = 8.4 2H), 7.86 (d, <i>J</i> = 8.4 Hz, 2H).</div><div class="NLM_p last">To an oven-dried 16 × 125 mm test tube equipped with a stir bar was added the phenol prepared above (217 mg, 0.50 mmol), cesium carbonate (326 mg, 1.0 mmol), and 1.7 mL of <i>N,N</i>-dimethylformamide. 2-Fluoroethyl 4-methylbenzenesulfonate (120 mg, 0.55 mmol) was added via a syringe, and the reaction vessel was placed in a preheated 70 °C oil-bath and stirred for 4 h. The reaction mixture was cooled to r.t. and diluted with EtOAc and H<sub>2</sub>O, and the layers were separated. The organic layer was washed with H<sub>2</sub>O (×5) and brine, dried over sodium sulfate, and concentrated <i>in vacuo</i> to give 232 mg of a light brown solid, which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.51 (s, 1H), 8.46 (d, <i>J</i> = 8 Hz, 1H), 8.13 (d, <i>J</i> = 2 Hz, 1H), 7.86 (d, <i>J</i> = 8.4 Hz, 1H), 7.70–7.62 (m, 2H), 7.34 (d, <i>J</i> = 8.4 Hz, 2H), 7.09 (d, <i>J</i> = 8.8 Hz, 2H), 4.87–4.70 (m, 2H), 4.37–4.25 (m, 2H).</div></div><div id="sec4_1_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 2-(2,4′-Bis(trifluoromethyl)-[1,1′-biphenyl]-4-yl)-5-bromobenzo[<i>d</i>]oxazole (<b>11e</b>)</h5><div class="NLM_p last">Following general experimental procedure C, amide <b>10e</b> (2.70 g, 5.35 mmol), 54 mL of toluene, and <i>p</i>-toluenesulfonic acid monohydrate (2.14 g, 11.2 mmol) were combined to give a light red solid (2.39 g, 92% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.55 (s, 1H), 8.52 (d, <i>J</i> = 8.0 Hz, 1H), 8.15 (d, <i>J</i> = 2.0 Hz, 1H), 7.92–7.85 (m, 3H), 7.75 (d, <i>J</i> = 8.4 Hz, 1H), 7.69–7.61 (m, 3H).</div></div><div id="sec4_1_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 5-Bromo-2-(4-(6-fluoropyridin-3-yl)-3-(trifluoromethyl)phenyl)benzo[<i>d</i>]oxazole (<b>11f</b>)</h5><div class="NLM_p last">To an oven-dried 25 mL round-bottomed flask equipped with a stir bar was added amide <b>10f</b> (935 mg, 2.05 mmol) and 8.2 mL of THF. Triphenylphosphine (1.19 g, 4.52 mmol) was added followed by diisopropylazodicarboxylate (0.89 mL, 4.52 mmol). The reaction mixture was stirred at r.t. for 22 h and concentrated <i>in vacuo</i>. The crude product was diluted with diethyl ether and filtered through a Celite plug, washing with ether. The ether mixture was concentrated <i>in vacuo</i> and applied to a silica gel column, eluting with 15% EtOAc/hexanes to give a pink solid (500 mg, 56% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.66 (d, <i>J</i> = 1.2 Hz, 1H), 8.46 (dd, <i>J</i> = 8.0 Hz, 1.6 Hz, 1H), 8.24 (d, <i>J</i> = 2.0 Hz, 1H), 7.82 (td, <i>J</i> = 8.0 Hz, 2.4 Hz, 1H), 7.55–7.47 (m, 3H), 7.04 (dd, <i>J</i> = 8.4 Hz, 2.8 Hz, 1H).</div></div><div id="sec4_1_1_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> Methyl 2-(4-(6-Fluoropyridin-3-yl)-3-(trifluoromethyl)phenyl)benzo[<i>d</i>]oxazole-5-carboxylate (<b>11g</b>)</h5><div class="NLM_p last">Following general experimental procedure C, amide <b>10g</b> (500 mg, 1.15 mmol), 11.5 mL of toluene, and pyridinium <i>p</i>-toluenesulfonate (607 mg, 2.42 mmol) were combined to give a yellow solid (415 mg, 87% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.64 (d, <i>J</i> = 1.2 Hz, 1H), 8.48–8.42 (m, 2H), 8.22 (d, <i>J</i> = 2.0 Hz, 1H), 8.13 (dd, <i>J</i> = 8.4 Hz, 1.6 Hz, 1H), 7.81 (td, <i>J</i> = 8.0 Hz, 2.4 Hz, 1H), 7.64 (d, <i>J</i> = 8.4 Hz, 1H), 7.50 (d, <i>J</i> = 8.0 Hz, 1H), 7.03 (dd, <i>J</i> = 8.4 Hz, 2.8 Hz, 1H), 3.96 (s, 3H).</div></div><div id="sec4_1_1_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> 5-Bromo-2-(3′-methoxy-2-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)benzo[<i>d</i>]oxazole (<b>11h</b>)</h5><div class="NLM_p last">Following general experimental procedure C, amide <b>10h</b> (3.96 g, 8.49 mmol), 85 mL of toluene, and <i>p</i>-toluenesulfonic acid (3.39 g, 17.8 mmol) were combined to give a red solid (3.24 g, 85% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.61 (d, <i>J</i> = 1.6 Hz, 1H), 8.39 (dd, <i>J</i> = 8.0 Hz, 1.6 Hz, 1H), 7.96–7.93 (m, 1H), 7.57–7.49 (m, 3H), 7.36 (t, <i>J</i> = 7.6 Hz, 1H), 7.02–6.90 (m, 3H), 3.85 (s, 3H).</div></div><div id="sec4_1_1_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> (2-(4-(6-Fluoropyridin-3-yl)-3-(trifluoromethyl)phenyl)benzo[<i>d</i>]oxazol-5-yl)methanol (<b>12a</b>)</h5><div class="NLM_p last">To a 25 mL round-bottomed flask equipped with a stir bar was added ester <b>11g</b> (415 mg, 0.99 mmol) and 5 mL of THF. The reaction was cooled in a −78 °C cooling bath (CO<sub>2(s)</sub>/acetone), and DIBAl-H (2.99 mL, 2.99 mmol, 1.0 M in hexanes) was added slowly. The reaction was allowed to warm in the bath to −15 °C for 1 h, at which time TLC indicated consumption of the starting ester. The reaction was quenched with 2 mL of EtOAc and 5 mL of saturated Rochelle’s salt solution and stirred for 30 min. The reaction mixture was diluted with EtOAc and the layers separated. The aqueous layer was extracted with EtOAc (×2). The combined organic layers were washed with H<sub>2</sub>O, brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give a white solid (350 mg, 91% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.69 (s, 1H), 8.48 (dd, <i>J</i> = 8.0 Hz, 1.6 Hz, 1H), 8.24 (d, <i>J</i> = 2.0 Hz, 1H), 7.86–7.78 (m, 2H), 7.62 (d, <i>J</i> = 8.4 Hz, 1H), 7.51 (d, <i>J</i> = 8.0 Hz, 1H), 7.45 (dd, <i>J</i> = 8.4 Hz, 1.6 Hz, 1H), 7.04 (dd, <i>J</i> = 8.4 Hz, 3.2 Hz, 1H), 4.86 (s, 2H).</div></div><div id="sec4_1_1_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> (2-(4-(2-Fluoroethoxy)-3-(trifluoromethyl)phenyl)benzo[<i>d</i>]oxazol-5-yl)methanol (<b>12b</b>)</h5><div class="NLM_p last">To an oven-dried 50 mL round-bottomed flask equipped with a stir bar was added ester <b>11a</b> (844 mg, 2.2 mmol) and 11 mL of 2-methyltetrahydrofuran. The reaction mixture was cooled to −78 °C (CO<sub>2(s)</sub>/acetone bath), and DIBAl-H (1.0 M solution in hexanes, 6.6 mL, 6.6 mmol) was added carefully. The reaction mixture was allowed to warm to −5 °C in the bath over 1 h, at which time TLC showed the consumption of the ester. The reaction was quenched with EtOAc and saturated Rochelle’s salt solution<sub>(aq)</sub>, and stirred for 30 min when a precipitate had formed. The reaction mixture was filtered through a Celite plug, washing with EtOAc and water. The layers were separated, and the aqueous layer was extracted with EtOAc (×1). The combined organic layers were washed with water, brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give a white solid (743 mg, 95% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.48 (d, <i>J</i> = 2.0 Hz, 1H), 8.37 (dd, <i>J</i> = 8.8 Hz, 2.0 Hz, 1H), 7.74 (s, 1H), 7.55 (d, <i>J</i> = 8.4 Hz, 1H), 7.40–7.35 (m, 1H), 7.14 (d, <i>J</i> = 8.8 Hz, 1H), 4.90–4.74 (m, 2H), 4.82 (s, 2H), 4.47–4.35 (m, 2H).</div></div><div id="sec4_1_1_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 5-(Chloromethyl)-2-(4-(6-fluoropyridin-3-yl)-3-(trifluoromethyl)phenyl)benzo[<i>d</i>]oxazole (<b>13a</b>)</h5><div class="NLM_p last">To an oven-dried 10 mL round-bottomed flask equipped with a stir bar was added 0.11 mL of DMF, followed by cyanuric chloride (194 mg, 1.05 mmol). The reaction was stirred for 30 min, at which time TLC analysis showed the consumption of the cyanuric chloride. Then, 2.5 mL of CH<sub>2</sub>Cl<sub>2</sub> was added, followed by alcohol <b>12a</b> (388 mg, 1.00 mmol). The reaction was stirred for 1 h, at which time TLC analysis showed the consumption of the alcohol. The reaction was quenched with H<sub>2</sub>O and diluted with CH<sub>2</sub>Cl<sub>2</sub>. The layers were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (×1). The combined organic layers were washed with sat. sodium carbonate solution, 1 M HCl<sub>(aq)</sub>, brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give 398 mg of an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.68 (s, 1H), 8.48 (d, <i>J</i> = 8.0 Hz, 1H), 8.24 (d, <i>J</i> = 2.0 Hz, 1H), 7.86–7.77 (m, 2H), 7.63 (d, <i>J</i> = 8.4 Hz, 1H), 7.52 (d, <i>J</i> = 8.0 Hz, 1H), 7.47 (dd, <i>J</i> = 8.4 Hz, 1.6 Hz, 1H), 7.04 (dd, <i>J</i> = 8.4 Hz, 2.4 Hz, 1H), 4.75 (s, 2H).</div></div><div id="sec4_1_1_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 5-(Chloromethyl)-2-(4-(2-fluoroethoxy)-3-(trifluoromethyl)phenyl)benzo[<i>d</i>]oxazole (<b>13b</b>)</h5><div class="NLM_p last">To an oven-dried 50 mL round-bottomed flask equipped with a stir bar was added 0.23 mL of DMF and cyanuric chloride (218 mg, 1.18 mmol). The reaction mixture was stirred for 1 h at which time 3 mL of CH<sub>2</sub>Cl<sub>2</sub> and alcohol <b>12b</b> (400 mg, 1.13 mmol) were added. The reaction mixture was stirred for 18 h and diluted with CH<sub>2</sub>Cl<sub>2</sub> and water. The layers were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (×2). The combined organic layers were washed with sat. Na<sub>2</sub>CO<sub>3(aq)</sub>, 1 M HCl <sub>(aq)</sub>, and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give a tan solid (250 mg, 59% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.47 (s, 1H), 8.38 (dd, <i>J</i> = 8.8 Hz, 2.4 Hz, 1H), 7.76 (s, 1H), 7.56 (d, <i>J</i> = 8.4 Hz, 1H), 7.40 (dd, <i>J</i> = 8.4 Hz, 1.6 Hz, 1H), 7.15 (d, <i>J</i> = 8.8 Hz, 1H), 4.92–4.74 (m, 2H), 4.73 (s, 2H), 4.48–4.36 (m, 2H).</div></div><div id="sec4_1_1_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> Methyl 1-((2-(4-(6-Fluoropyridin-3-yl)-3-(trifluoromethyl)phenyl)benzo[<i>d</i>]oxazol-5-yl)methyl)azetidine-3-carboxy-late (<b>14a</b>)</h5><div class="NLM_p last">To a 10 mL round-bottomed flask equipped with a stir bar was added chloride <b>13a</b> (260 mg, 0.64 mmol), methyl azetidine-3-carboxylate hydrochloride (146 mg, 0.96 mmol), 2.1 mL of acetonitrile, and potassium carbonate (265 mg, 1.92 mmol). The reaction was stirred for 3 h, at which time no progress was observed by TLC. <i>i</i>Pr<sub>2</sub>NEt (0.33 mL, 1.92 mmol) was added and the reaction stirred for 20 h at r.t. The reaction was diluted with water and EtOAc and the layers separated. The aqueous layer was extracted with EtOAc (×1). The combined organic layers were washed with water (×2), brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give a yellow semisolid. The crude product was then purified on a silica gel column, eluting with EtOAc to give a white solid (110 mg, 35% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.63 (d, <i>J</i> = 1.2 Hz, 1H), 8.43 (dd, <i>J</i> = 8 Hz, 1.6 Hz, 1H), 8.21 (d, <i>J</i> = 2.0 Hz, 1H), 7.80 (td, <i>J</i> = 8.4 Hz, 2.4 Hz, 1H), 7.69 (d, <i>J</i> = 0.8 Hz, 1H), 7.54 (d, <i>J</i> = 8.4 Hz, 1H), 7.47 (d, <i>J</i> = 8.0 Hz, 1H), 7.33 (dd, <i>J</i> = 8.4 Hz, 1.6 Hz, 1H), 7.01 (dd, <i>J</i> = 8.4 Hz, 3.2 Hz, 1H), 3.73 (s, 2H), 3.70 (s, 3H), 3.57–3.52 (m, 2H), 3.40–3.30 (m, 3H).</div></div><div id="sec4_1_1_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> Methyl 1-((2-(4-(2-Fluoroethoxy)-3-(trifluoromethyl)phenyl)benzo[<i>d</i>]oxazol-5-yl)methyl)azetidine-3-carboxylate (<b>14b</b>)</h5><div class="NLM_p last">To a 10 mL round-bottomed flask equipped with a stir bar was added chloride <b>13b</b> (187 mg, 0.5 mmol), methyl azetidine-3-carboxylate hydrochloride (114 mg, 0.75 mmol), 1.7 mL of MeCN, and DIPEA (0.26 mL, 1.5 mmol). The reaction was placed in a preheated 60 °C oil-bath and stirred overnight (∼18 h). The reaction mixture was allowed to cool to r.t. and diluted with water and EtOAc. The layers were separated and the aqueous layer extracted with EtOAc (×2). The combined organic layers were washed with water (×3), brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give a tan solid (150 mg, 66% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.41 (s, 1H), 8.29 (d, <i>J</i> = 8.8 Hz, 1H), 7.60 (s, 1H), 7.44 (d, <i>J</i> = 8.4 Hz, 1H), 7.23 (d, <i>J</i> = 8.0 Hz, 1H), 7.07 (d, <i>J</i> = 8.8 Hz, 1H), 4.85–4.67 (m, 2H), 4.40–4.28 (m, 2H), 3.75–3.65 (m, 4H), 3.55–3.45 (m, 2H), 3.36–3.25 (m, 2H).</div></div><div id="sec4_1_1_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> 1-((2-(4-(6-Fluoropyridin-3-yl)-3-(trifluoromethyl)phenyl)benzo[<i>d</i>]oxazol-5-yl)methyl)azetidine-3-carboxylic Acid (<b>15a</b>)</h5><div class="NLM_p last">To a 13 × 100 mm test tube equipped with a stir bar was added ester <b>14a</b> (70 mg, 0.14 mmol), 1.1 mL of THF, and 0.21 mL of 2 M LiOH<sub>(aq)</sub>. The reaction was stirred overnight at r.t. and quenched with 1 M HCl<sub>(aq)</sub> to give a white precipitate. The precipitate was removed by filtration and dried under reduced pressure to provide 30 mg of the product. <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 8.69 (s, 1H), 8.57 (dd, <i>J</i> = 8.0 Hz, 2.0 Hz, 1H), 8.23 (d, <i>J</i> = 2.0 Hz, 1H), 8.07–7.97 (m, 2H), 7.86 (d, <i>J</i> = 8.4 Hz, 1H), 7.71 (d, <i>J</i> = 8.0 Hz, 1H), 7.66 (d, <i>J</i> = 8.4 Hz, 1H), 7.22 (dd, <i>J</i> = 8.4 Hz, 2.8 Hz, 1H), 4.63 (d, <i>J</i> = 22.4 Hz, 2H), 4.48 (t, <i>J</i> = 10.4 Hz, 1H), 4.39–4.32 (m, 3H), 3.83–3.71 (m, 1H).</div></div><div id="sec4_1_1_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 1-((2-(4-(2-Fluoroethoxy)-3-(trifluoromethyl)phenyl)benzo[<i>d</i>]oxazol-5-yl)methyl)azetidine-3-carboxylic Acid (<b>15b</b>)</h5><div class="NLM_p last">To a 10 mL round-bottomed flask equipped with a stir bar and containing ester <b>14b</b> (120 mg, 0.27 mmol) was added 2.1 mL of THF and 0.4 mL of 2 M LiOH<sub>(aq)</sub>. The reaction mixture was stirred overnight (18 h) and quenched with 1 M HCl<sub>(aq)</sub>. The reaction mixture was neutralized with sat. NaHCO<sub>3(aq)</sub>, which caused the formation of a precipitate. This precipitate was filtered and washed with Et<sub>2</sub>O to give a white solid (41 mg, 35% yield). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 8.50–8.43 (m, 2H), 7.90 (s, 1H), 7.80 (d, <i>J</i> = 8.4 Hz, 1H), 7.54 (d, <i>J</i> = 8.4 Hz, 1H), 7.45 (d, <i>J</i> = 9.6 Hz, 1H), 4.86–4.71 (m, 2H), 4.56 (d, <i>J</i> = 8.0 Hz, 2H), 4.54–4.25 (m, 6H), 3.72 (pent, <i>J</i> = 9.2 Hz, 1H).</div></div><div id="sec4_1_1_40" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 5-(2-(4-(6-Fluoropyridin-3-yl)-3-(trifluoromethyl)phenyl)benzo[<i>d</i>]oxazol-5-yl)thiophene-2-carboxylic Acid (<b>16</b>)</h5><div class="NLM_p last">To an oven-dried 25 mL Schlenk tube equipped with a stir bar was added palladium acetate (2.2 mg, 0.01 mmol), bromide <b>11f</b> (219 mg, 0.5 mmol), 2-carboxythiophene-5-boronic acid (95 mg, 0.55 mmol), cesium fluoride (228 mg, 1.5 mmol), 1.35 mL of 1,4-dioxane, and 1.35 mL of degassed H<sub>2</sub>O. The reaction vessel was equipped with a cold finger, placed in a preheated 110 °C oil-bath, and heated overnight (∼18 h). The reaction was cooled to r.t. and poured into a 1:1 mixture of EtOAc/1 M HCl<sub>(aq)</sub>. The layers were separated, and the aqueous layer was extracted with EtOAc (×3). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i> to give a brown solid (223 mg, 92% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 13.19 (br s, 1H), 8.57 (s, 1H), 8.54 (d, <i>J</i> = 8.0 Hz, 1H), 8.31 (d, <i>J</i> = 2.4 Hz, 1H), 8.26 (d, <i>J</i> = 2.0 Hz, 1H), 8.09 (td, <i>J</i> = 8.0 Hz, 2.4 Hz, 1H), 7.95 (d, <i>J</i> = 8.8 Hz, 1H), 7.86 (dd, <i>J</i> = 8.8 Hz, 2.0 Hz, 1H), 7.79 (d, <i>J</i> = 8.0 Hz, 1H), 7.75 (d, <i>J</i> = 3.6 Hz, 1H), 7.68 (d, <i>J</i> = 4.0 Hz, 1H), 7.37 (dd, <i>J</i> = 8.8 Hz, 2.8 Hz, 1H).</div></div><div id="sec4_1_1_41" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> Methyl 1-(2-(4′-Fluoro-2-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)benzo[<i>d</i>]oxazol-5-yl)piperidine-4-carboxylate (<b>17a</b>)</h5><div class="NLM_p last">Following general experimental procedure D, Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub> (10 mg, 0.01 mmol), XPhos (19 mg, 0.040 mmol), sodium <i>tert</i>-butoxide (67 mg, 0.70 mmol), oxazole <b>11b</b> (218 mg, 0.5 mmol), toluene (1 mL), and methylpiperidine-4-carboxylate (81 μL, 0.60 mmol) were combined to give the crude product which was applied to a silica gel column, eluting with 5–15% ethyl acetate in hexanes to give ester <b>17a</b> as a yellow solid (165 mg, 66% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.59 (s, 1H), 8.36 (d, <i>J</i> = 8.0 Hz, 1H), 7.47 (d, <i>J</i> = 6.0 Hz, 1H), 7.44 (d, <i>J</i> = 4.4 Hz, 1H), 7.37–7.27 (m, 3H), 7.11 (t, <i>J</i> = 8.4 Hz, 2H), 7.07 (dd, <i>J</i> = 8.8 Hz, 2.4 Hz, 1H), 3.71 (s, 3H), 3.61 (dt, <i>J</i> = 8.8 Hz, 3.2 Hz, 2H), 2.82 (td, <i>J</i> = 12 Hz, 2.0 Hz, 2H), 2.47 (tt, <i>J</i> = 11.2 Hz, 4 Hz, 1H), 2.13–2.02 (m, 2H), 2.01–1.87 (m, 2H).</div></div><div id="sec4_1_1_42" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> Methyl 1-(2-(2′-(2-Fluoroethoxy)-2-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)benzo[<i>d</i>]oxazol-5-yl)piperidine-4-carboxylate (<b>17b</b>)</h5><div class="NLM_p last">Following general experimental procedure D, Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub> (6.2 mg, 0.006 mmol), XPhos (11.4 mg, 0.024 mmol), sodium <i>tert</i>-butoxide (40 mg, 0.42 mmol), oxazole <b>11c</b> (144 mg, 0.30 mmol), toluene (0.6 mL), and methylpiperidine-4-carboxylate (48 μL, 0.36 mmol) were combined to give the crude product which was applied to a silica gel column, eluting with 20% ethyl acetate in hexanes to give ester <b>17b</b> as a yellow solid (90 mg, 56% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.60 (s, 1H), 8.37 (d, <i>J</i> = 8.0 Hz, 1H), 7.47 (dd, <i>J</i> = 9.2 Hz, 4.0 Hz, 2H), 7.39 (t, <i>J</i> = 7.6 Hz, 1H), 7.32 (br s, 1H), 7.21 (d, <i>J</i> = 7.2 Hz, 1H), 7.13–7.01 (m, 2H), 6.97 (d, <i>J</i> = 8.4 Hz, 1H), 4.54 (dt, <i>J</i> = 47.6 Hz, 4.0 Hz, 2H), 4.29–4.04 (m, 2H), 3.72 (s, 3H), 3.62 (d, <i>J</i> = 12.4 Hz, 2H), 2.84 (t, <i>J</i> = 11.2 Hz, 2H), 2.53–2.44 (m, 1H), 2.14–2.04 (m, 2H), 2.03–1.85 (m, 2H).</div></div><div id="sec4_1_1_43" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> Methyl 1-(2-(4′-(2-Fluoroethoxy)-2-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)benzo[<i>d</i>]oxazol-5-yl)piperidine-4-carboxy-late (<b>17c</b>)</h5><div class="NLM_p last">Following general experimental procedure D, Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub> (7.2 mg, 0.007 mmol), XPhos (13 mg, 0.028 mmol), sodium <i>tert</i>-butoxide (47 mg, 0.49 mmol), oxazole <b>11d</b> (168 mg, 0.35 mmol), toluene (0.7 mL), and methylpiperidine-4-carboxylate (57 μL, 0.42 mmol) were combined to give the crude product, applied to a silica gel column, eluting with 20% ethyl acetate in hexanes to give ester <b>17c</b> as a yellow solid (95 mg, 50% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.59 (s, 1H), 8.36 (d, <i>J</i> = 8.0 Hz, 1H), 7.47 (d, <i>J</i> = 6.0 Hz, 1H), 7.44 (d, <i>J</i> = 4.4 Hz, 1H), 7.37–7.27 (m, 3H), 7.11 (t, <i>J</i> = 8.4 Hz, 2H), 7.07 (dd, <i>J</i> = 8.8 Hz, 2.4 Hz, 1H), 3.71 (s, 3H), 3.61 (dt, <i>J</i> = 8.8 Hz, 3.2 Hz, 2H), 2.82 (td, <i>J</i> = 12 Hz, 2.0 Hz, 2H), 2.47 (tt, <i>J</i> = 11.2 Hz, 4 Hz, 1H), 2.13–2.02 (m, 2H), 2.01–1.87 (m, 2H).</div></div><div id="sec4_1_1_44" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> Methyl 1-(2-(2,4′-Bis(trifluoromethyl)-[1,1′-biphenyl]-4-yl)benzo[<i>d</i>]oxazol-5-yl)piperidine-4-carboxylate (<b>17d</b>)</h5><div class="NLM_p last">Following general experimental procedure D, Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub> (21 mg, 0.02 mmol), XPhos (38 mg, 0.08 mmol), sodium <i>tert</i>-butoxide (135 mg, 1.4 mmol), bromide <b>11e</b> (486 mg, 1.0 mmol), and 2 mL of toluene were combined to provide the crude product. This was applied to a silica gel column, eluting with 20% EtOAc/hexanes to provide a yellow powder (265 mg, 48% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.63 (s, 1H), 8.41 (d, <i>J</i> = 8.0 Hz, 1H), 7.70 (d, <i>J</i> = 8.0 Hz, 2H), 7.52–7.45 (m, 4H), 7.31 (d, <i>J</i> = 2.4 Hz, 1H), 7.10 (dd, <i>J</i> = 8.8 Hz, 2.0 Hz, 1H), 3.73 (s, 3H), 3.63 (dt, <i>J</i> = 12.4 Hz, 3.2 Hz, 2H), 2.84 (td, <i>J</i> = 11.6 Hz, 2.4 Hz, 2H), 2.47 (tt, <i>J</i> = 10.8 Hz, 4.0 Hz, 1H), 2.13–2.04 (m, 2H), 2.02–1.87 (m, 2H).</div></div><div id="sec4_1_1_45" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> Methyl 1-(2-(3′-Methoxy-2-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)benzo[<i>d</i>]oxazol-5-yl)piperidine-4-carboxylate (<b>17e</b>)</h5><div class="NLM_p last">Following general experimental procedure D, Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub> (21 mg, 0.02 mmol), XPhos (38 mg, 0.08 mmol), sodium <i>tert</i>-butoxide (135 mg, 1.4 mmol), bromide <b>11h</b> (447 mg, 1.0 mmol), and 2 mL of toluene were combined to provide the crude product. This was applied to a silica gel column, eluting with 20% EtOAc/hexanes to provide a yellow powder (93 mg, 18% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.60 (s, 1H), 8.36 (d, <i>J</i> = 8.0 Hz, 1H), 7.49 (t, <i>J</i> = 8.0 Hz, 2H), 7.38–7.29 (m, 2H), 7.08 (d, <i>J</i> = 8.4 Hz, 1H), 7.00–6.87 (m, 3H), 3.84 (s, 3H), 3.72 (s, 3H), 3.62 (d, <i>J</i> = 12.4 Hz, 2H), 2.84 (t, <i>J</i> = 10.8 Hz, 2H), 2.53–2.42 (m, 1H), 2.13–2.04 (m, 2H), 2.03–1.86 (m, 2H).</div></div><div id="sec4_1_1_46" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> 1-(2-(4′-Fluoro-2-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)benzo[<i>d</i>]oxazol-5-yl)piperidine-4-carboxylic Acid (<b>18a</b>)</h5><div class="NLM_p last">Following general experimental procedure E, ester <b>17a</b> (150 mg, 0.30 mmol), 1.25 mL of tetrahydrofuran, 0.25 mL of H<sub>2</sub>O, and lithium hydroxide (14 mg, 0.60 mmol) were combined to give carboxylic acid <b>18a</b> as an off-white pearly solid (129 mg, 89% yield). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 8.67 (s, 1H), 8.54 (d, <i>J</i> = 8.0 Hz, 1H), 8.18 (d, <i>J</i> = 2.0 Hz, 1H), 7.98 (d, <i>J</i> = 9.2 Hz, 1H), 7.78 (dd, <i>J</i> = 8.8 Hz, 2.4 Hz, 1H), 7.65 (d, <i>J</i> = 8 Hz, 1H), 7.41 (dd, <i>J</i> = 8.4 Hz, 5.2 Hz, 2H), 7.22 (t, <i>J</i> = 8.8 Hz, 2H), 3.93–3.74 (m, 4 H), 2.93–2.82 (m, 1H), 2.41 (dd, <i>J</i> = 15.2 Hz, 3.6 Hz, 2H), 2.32–2.16 (m, 2H).</div></div><div id="sec4_1_1_47" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> 1-(2-(2′-(2-Fluoroethoxy)-2-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)benzo[<i>d</i>]oxazol-5-yl)piperidine-4-carboxylic Acid (<b>18b</b>)</h5><div class="NLM_p last">Following general experimental procedure E, ester <b>17b</b> (90 mg, 0.17 mmol), 0.70 mL of tetrahydrofuran, 0.13 mL of H<sub>2</sub>O, and lithium hydroxide (8.0 mg, 0.332 mmol were combined to give carboxylic acid <b>18b</b> as an off-white pearly solid (82 mg, 94% yield). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 8.52 (s, 1H), 8.35 (d, <i>J</i> = 8.0 Hz, 1H), 7.64 (d, <i>J</i> = 8.4 Hz, 1H), 7.56 (s, 1H), 7.48 (d, <i>J</i> = 8.0 Hz, 1H), 7.45–7.31 (m, 2H), 7.16 (d, <i>J</i> = 7.2 Hz, 1H), 7.08 (d, <i>J</i> = 8.4 Hz, 1H), 7.03 (t, <i>J</i> = 7.2 Hz, 1H), 4.51 (d, <i>J</i> = 48 Hz, 2H), 3.31–3.05 (m, 2H), 3.68 (d, <i>J</i> = 12 Hz, 2H), 3.14 (t, <i>J</i> = 10.4 Hz, 2H), 2.59 (t, <i>J</i> = 10.4 Hz, 1H), 2.26–2.10 (m, 2H), 2.09–1.92 (m, 2H).</div></div><div id="sec4_1_1_48" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> 1-(2-(4′-(2-Fluoroethoxy)-2-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)benzo[<i>d</i>]oxazol-5-yl)piperidine-4-carboxylic Acid (<b>18c</b>)</h5><div class="NLM_p last">Following general experimental procedure E, ester <b>17c</b> (90 mg, 0.166 mmol), 0.7 mL of tetrahydrofuran, 0.13 mL of H<sub>2</sub>O, and lithium hydroxide (8.0 mg, 0.332 mmol) were combined to give carboxylic acid <b>18c</b> as a light tan solid (87 mg, 99% yield). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 8.64 (s, 1H), 8.50 (d, <i>J</i> = 7.6 Hz, 1H), 8.29 (s, 1H), 7.96 (d, <i>J</i> = 8.8 Hz, 1H), 7.83 (dd, <i>J</i> = 8.8 Hz, 2.0 Hz, 1H), 7.63 (d, <i>J</i> = 8.0 Hz, 1H), 7.32 (d, <i>J</i> = 8.4 Hz, 2H), 7.06 (d, <i>J</i> = 8.8 Hz, 2H), 4.77 (dt, <i>J</i> = 48 Hz, 4 Hz, 2H), 4.29 (dt, <i>J</i> = 28.8 Hz, 3.6 Hz, 2H), 3.90–3.74 (m, 4H), 2.93–2.83 (m, 1H), 2.49–2.35 (m, 2H), 2.35–2.20 (m, 2H).</div></div><div id="sec4_1_1_49" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> 1-(2-(2,4′-Bis(trifluoromethyl)-[1,1′-biphenyl]-4-yl)benzo[<i>d</i>]oxazol-5-yl)piperidine-4-carboxylic Acid (<b>18d</b>)</h5><div class="NLM_p last">Following general experimental procedure E, ester <b>17d</b> (102 mg, 0.19 mmol), 0.79 mL of THF, and 0.16 mL of H<sub>2</sub>O, and LiOH (8.9 mg, 0.37 mmol) were combined to give an off-white solid. (101 mg, 99% yield). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 8.70 (s, 1H), 8.58 (d, <i>J</i> = 8.0 Hz, 1H), 8.28 (d, <i>J</i> = 2.0 Hz, 1H), 7.99 (d, <i>J</i> = 9.2 Hz, 1H), 7.89 (dd, <i>J</i> = 8.8 Hz, 2.4 Hz, 1H), 7.80 (d, <i>J</i> = 8.4 Hz, 2H), 7.69 (d, <i>J</i> = 8.0 Hz, 1H), 7.60 (d, <i>J</i> = 8.0 Hz, 2H), 3.92–3.81 (m, 4H), 2.96–2.85 (m, 1H), 2.47–2.25 (m, 4H).</div></div><div id="sec4_1_1_50" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> 1-(2-(3′-Methoxy-2-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)benzo[<i>d</i>]oxazol-5-yl)piperidine-4-carboxylic Acid (<b>18e</b>)</h5><div class="NLM_p last">Following general experimental procedure E, ester <b>17e</b> (92 mg, 0.18 mmol), 0.9 mL of THF, and 0.2 mL of H<sub>2</sub>O, and LiOH (8.6 mg, 0.36 mmol) were combined to give an off-white solid (72 mg, 81% yield). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 8.62 (s, 1H), 8.47 (d, <i>J</i> = 8.0 Hz, 1H), 7.91 (s, 1H), 7.85 (d, <i>J</i> = 8.4 Hz, 1H), 7.65–7.56 (m, 2H), 7.37 (t, <i>J</i> = 8.0 Hz, 1H), 7.02 (dd, <i>J</i> = 8.4 Hz, 2.8 Hz, 1H), 6.95–6.89 (m, 2H), 3.83 (s, 3H), 3.84–3.73 (m, 2H), 3.58–3.43 (m, 2H), 2.76 (br s, 1H), 2.35–2.25 (m, 2H), 2.21–2.16 (m, 2H).</div></div><div id="sec4_1_1_51" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> <i>N</i>-(Cyanomethyl)benzamide (<b>19</b>)</h5><div class="NLM_p last">To an oven-dried 250 mL round-bottomed flask equipped with a stir bar was added aminoacetonitrile hydrochloride (8.0 g, 86.5 mmol). Pyridine (50 mL) was carefully added dropwise via an addition funnel. Benzoyl chloride (10.5 mL, 90 mmol) was added via an addition funnel dropwise over 30 min, and the reaction was stirred overnight (20 h). Then, 70 mL of H<sub>2</sub>O was added to dissolve the pyridinium hydrochloride and precipitate the product. The new precipitate was filtered, washed with H<sub>2</sub>O, dried, and recrystallized from 95% ethanol to give a white crystalline solid (9.5 g, 69% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 9.22 (t, <i>J</i> = 5.2 Hz, 1H), 7.86 (dd, <i>J</i> = 8.0 Hz, 0.8 Hz, 2H), 7.58 (tt, <i>J</i> = 7.2 Hz, 1.2 Hz, 1H), 7.50 (t, <i>J</i> = 7.6 Hz, 2H), 4.31 (d, <i>J</i> = 5.6 Hz, 2H).</div></div><div id="sec4_1_1_52" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> <i>N</i>-((1<i>H</i>-Tetrazol-5-yl)methyl)benzamide (<b>20</b>)</h5><div class="NLM_p last">To a 100 mL round-bottomed flask equipped with a stir bar was added nitrile <b>19</b> (5.9 g, 36.8 mmol), 32 mL of DMF, sodium azide (2.51 g, 38.7 mmol), and ammonium chloride (2.17 g, 40.5 mmol). The reaction vessel was lowered into a preheated 125 °C oil-bath and stirred overnight (18 h). The reaction was cooled to r.t. and diluted with 85 mL of 2 M HCl<sub>(aq)</sub> causing the product to precipitate. The precipitate was filtered, washed with copious amounts of H<sub>2</sub>O, and air-dried to give a white fluffy solid (6.89 g, 92% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 9.27 (t, <i>J</i> = 5.6 Hz, 1H), 7.89 (dd, <i>J</i> = 8.4 Hz, 1.2 Hz, 2H), 7.57 (tt, <i>J</i> = 7.2 Hz, 2.4 Hz, 1H), 7.49 (t, <i>J</i> = 7.2 Hz, 2H), 4.76 (d, <i>J</i> = 5.6 Hz, 2H).</div></div><div id="sec4_1_1_53" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> (1<i>H</i>-Tetrazol-5-yl)methanamine Hydrochloride (<b>21</b>)</h5><div class="NLM_p last">To a 250 mL round-bottomed flask equipped with a stir bar was added amide <b>20</b> (6.89 g, 33.9 mmol) and 50.6 mL of 12 M HCl<sub>(aq)</sub>. The reaction was equipped with a reflux condenser, placed in a preheated 110 °C oil-bath, and stirred at reflux overnight (18 h). The reaction was cooled to r.t., then to 0 °C causing the formation of a precipitate. The reaction mixture was filtered, and the filtrate was washed with Et<sub>2</sub>O (×2) and concentrated <i>in vacuo</i> to give a white solid. This solid was triturated with ethanol and dried under vacuum to give a pale yellow solid (3.59 g, 78% yield). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ = 4.59 (s, 2H).</div></div><div id="sec4_1_1_54" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> Methyl 4-(2-fluoroethoxy)benzoate (<b>23</b>)</h5><div class="NLM_p last">To a 500 mL round-bottomed flask equipped with a stir bar was added methyl 4-hydroxybenzoate (<b>22</b>) (5.0 g, 32.9 mmol), potassium carbonate (13.6 g, 98.6 mmol), and 219 mL of acetone. The reaction vessel was heated to reflux in a preheated 70 °C oil-bath, and stirred for 30 min. 1-Bromo-2-fluoroethane (7.34 mL, 98.6 mmol) was added via syringe, and the reaction mixture was stirred for 20 h. The reaction mixture was cooled to r.t. and concentrated <i>in vacuo</i>. The resulting solid was dissolved in EtOAc and H<sub>2</sub>O. The layers were separated, and the aqueous layer was extracted with EtOAc (×1). The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give a white solid (6.25 g, 96% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.00 (d, <i>J</i> = 8.8 Hz, 2H), 6.94 (d, <i>J</i> = 9.2 Hz, 2H), 4.78 (ddd, <i>J</i> = 47.2 Hz, 5.6 Hz, 4.0 Hz, 2H), 4.27 (ddd, <i>J</i> = 27.6 Hz, 5.6 Hz, 4.4 Hz, 2H), 3.89 (s, 3H).</div></div><div id="sec4_1_1_55" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> 4-(2-Fluoroethoxy)benzoic Acid (<b>24</b>)</h5><div class="NLM_p last">To a 500 mL round-bottomed flask equipped with a stir bar was added ester <b>23</b> (5.84 g, 29.5 mmol), followed by 98 mL of methanol, and 49 mL of H<sub>2</sub>O. NaOH (4.71 g, 118 mmol) was added, and the reaction mixture was stirred for 16 h at r.t. The reaction was acidified with conc HCl<sub>(aq)</sub> to pH 1 and diluted with H<sub>2</sub>O. The resulting precipitate was filtered, washed with H<sub>2</sub>O and hexanes, and air-dried to give a white solid (5.41 g, 99%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.05 (d, <i>J</i> = 9.2 Hz, 2H), 6.97 (d, <i>J</i> = 8.8 Hz, 2H), 4.86–4.72 (m, 2H), 4.34–4.23 (m, 2H).</div></div><div id="sec4_1_1_56" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> <i>N</i>′-Hydroxy-4-(hydroxymethyl)benzimidamide (<b>25</b>)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></h5><div class="NLM_p last">To a 500 mL round-bottomed flask equipped with a stir bar was added 4-(hydroxymethyl)benzonitrile (13.3 g, 100 mmol), hydroxyamine hydrochloride (11.1 g, 160 mmol), sodium bicarbonate (26.9 g, 320 mmol), and 167 mL of methanol. The reaction was equipped with a reflux condenser and lowered into a preheated 70 °C oil-bath. The reaction mixture was stirred for 5 h and then cooled to r.t. The precipitate was filtered and washed with methanol. The filtrate was concentrated <i>in vacuo</i> to give a white solid (16.5 g, 99% yield). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) data match the literature values.</div></div><div id="sec4_1_1_57" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> (4-(5-(4-Ethoxyphenyl)-1,2,4-oxadiazol-3-yl)phenyl)methanol (<b>26a</b>)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></h5><div class="NLM_p last">Following general experimental procedure F, 4-ethoxybenzoic acid (2.49 g, 15.0 mmol), EDC·HCl (2.88 g, 15.0 mmol), HOBt (2.03 g, 15.0 mmol), 19 mL of DMF, and amidine <b>25</b> (2.49 g, 15.0 mmol) were combined to give an off-white solid (2.2 g, 50% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.18–8.11 (m, 4H), 7.50 (d, <i>J</i> = 8.0 Hz, 2H), 7.02 (d, <i>J</i> = 8.8 Hz, 2H), 4.79 (s, 2H), 4.13 (q, <i>J</i> = 7.2 Hz, 2H), 1.47 (t, <i>J</i> = 6.8 Hz, 3H).</div></div><div id="sec4_1_1_58" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> (4-(5-(4-(2-Fluoroethoxy)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)methanol (<b>26b</b>)</h5><div class="NLM_p last">Following general experimental procedure F, carboxcyclic acid <b>24</b> (2.76 g, 15.0 mmol), EDC·HCl (2.88 g, 15.0 mmol), HOBt (2.03 g, 15.0 mmol), 19 mL of DMF, and amidine <b>25</b> (2.49 g, 15.0 mmol) were combined to provide the crude product, which was used without further purification for the next step.</div></div><div id="sec4_1_1_59" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> (4-(5-(4-(2-Fluoroethoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)methanol (<b>26c</b>)</h5><div class="NLM_p last">Following general experimental procedure F, acid <b>7a</b> (3.78 g, 15.0 mmol), EDC·HCl (2.88 g, 15.0 mmol), HOBt (2.54 g, 15.0 mmol), 19 mL of DMF, and amidine <b>25</b> (2.49 g, 15.0 mmol) were combined to give an off-white solid (3.12 g, 55% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.45 (d, <i>J</i> = 2.0 Hz, 1H), 8.33 (dd, <i>J</i> = 8.8 Hz, 2.0 Hz, 1H), 8.13 (d, <i>J</i> = 8.0 Hz, 2H), 7.50 (d, <i>J</i> = 8.0 Hz, 2H), 7.16 (d, <i>J</i> = 8.4 Hz, 1H), 4.90–4.74 (m, 4H), 4.48–4.35 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ = 174.4, 168.9, 159.7, 144.4, 133.4, 127.8, 127.8 (q, <i>J</i><sub><i>C–F</i></sub> = 5.2 Hz), 127.3, 122.9, (q, <i>J</i><sub><i>C–F</i></sub> = 274 Hz), 120.4 (q, <i>J</i><sub><i>C–F</i></sub> = 32.1 Hz), 117.2, 113.5, 81.4 (d, <i>J</i><sub><i>C–F</i></sub> = 173 Hz), 68.5 (d, <i>J</i><sub><i>C–F</i></sub> = 21.1 Hz), 64.9. MP: 146–147 °C. HRMS (ESI) calcd for C<sub>10</sub>H<sub>14</sub>F<sub>4</sub>N<sub>2</sub>O<sub>3</sub> [M + H<sup>+</sup>] 383.1013. Found [M + H<sup>+</sup>] 383.1011.</div></div><div id="sec4_1_1_60" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> (4-(5-(4-Methoxy-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)methanol (<b>26d</b>)</h5><div class="NLM_p last">To a 100 mL round-bottomed flask equipped with a stir bar was added 4-methoxy-3-(trifluoromethyl)benzoic acid (2.2 g, 10.0 mmol), HOBt (0.39 g, 2.0 mmol), TBTU (3.21 g, 10.0 mmol), 20 mL of DMF, and DIPEA (5.23 mL, 30.0 mmol). The reaction was stirred at r.t. for 30 min, and <i>N</i>′-hydroxy-4-(hydroxymethyl)benzimidamide (1.66 g, 10.0 mmol) was added. The reaction was stirred at r.t. for 1 h, heated in a 120 °C oil-bath for 3 h, and cooled to r.t. The reaction mixture was diluted with EtOAc and water. The layers were separated, and the aqueous layer was extracted with EtOAc (×1). The combined organic layers were washed with 1 M HCl<sub>(aq)</sub>, water, sat. NaHCO<sub>3(aq)</sub>, water (×3), and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give a tan solid (2.6 g, 74% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.45 (d, <i>J</i> = 2.0 Hz, 1H), 8.35 (dd, <i>J</i> = 8.8 Hz, 2.0 Hz, 1H), 8.15 (d, <i>J</i> = 8.0 Hz, 2H), 7.51 (d, <i>J</i> = 8.0 Hz, 2H), 7.16 (d, <i>J</i> = 8.8 Hz, 1H), 4.80 (s, 2H), 4.02 (s, 3H).</div></div><div id="sec4_1_1_61" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> 4-(5-(4-Ethoxyphenyl)-1,2,4-oxadiazol-3-yl)benzaldehyde (<b>27a</b>)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></h5><div class="NLM_p last">To an oven-dried 100 mL round-bottomed flask equipped with a stir bar was added 32 mL of CH<sub>2</sub>Cl<sub>2</sub> and dimethyl sulfoxide (1.27 mL, 17.9 mmol). The reaction mixture was cooled in a −78 °C bath (CO<sub>2(s)</sub>/acetone). Oxalyl chloride (1.03 mL, 12.1 mmol) was added carefully, and the reaction stirred for 30 min. Alcohol <b>26a</b> (1.71 g, 5.77 mmol) was added, and the reaction mixture was stirred 30 min. Triethylamine (6.43 mL, 46.2 mmol) was added, and the reaction was allowed to warm to r.t. over 2 h. The reaction mixture was concentrated <i>in vacuo</i> and partitioned between EtOAc and 1 M HCl<sub>(aq)</sub>. The layers were separated, and the aqueous layer was extracted with EtOAc (×1). The combined organic layers were washed with sat. NaHCO<sub>3(aq)</sub>, water, brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give an off-white solid (930 mg, 55% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 10.11 (s, 1H), 8.34 (d, <i>J</i> = 8.4 Hz, 2H), 8.15 (d, <i>J</i> = 8.8 Hz, 2H), 8.02 (d, <i>J</i> = 8.4 Hz, 2H), 7.03 (d, <i>J</i> = 8.8 Hz, 2H), 4.14 (q, <i>J</i> = 6.8 Hz, 2H), 1.47 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_1_1_62" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> 4-(5-(4-(2-Fluoroethoxy)phenyl)-1,2,4-oxadiazol-3-yl)benzaldehyde (<b>27b</b>)</h5><div class="NLM_p last">To an oven-dried 250 mL round-bottomed flask equipped with a stir bar was added 53 mL of CH<sub>2</sub>Cl<sub>2</sub> and dimethyl sulfoxide (2.1 mL, 29.6 mmol). The reaction mixture was cooled in a −78 °C bath (CO<sub>2(s)</sub>/acetone). Oxalyl chloride (1.7 mL, 20.0 mmol) was added carefully and the reaction stirred 30 min. Alcohol <b>26b</b> (3.00 g, 9.54 mmol) was added, and the reaction mixture was stirred 30 min. Triethylamine (10.6 mL, 76.3 mmol) was added, and the reaction was allowed to warm to r.t. over 2 h. The reaction mixture was concentrated <i>in vacuo</i> and partitioned between EtOAc and 1 M HCl<sub>(aq)</sub>. The layers were separated, and the aqueous layer was extracted with EtOAc (×1). The combined organic layers were washed with sat. NaHCO<sub>3(aq)</sub>, water, and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give an off-white solid (1.31 g, 44% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 10.11 (s, 1H), 8.34 (d, <i>J</i> = 8.4 Hz, 2H), 8.18 (d, <i>J</i> = 9.2 Hz, 2H), 8.02 (d, <i>J</i> = 8.4 Hz, 2H), 7.09 (d, <i>J</i> = 8.8 Hz, 2H), 4.89–4.70 (m, 2H), 4.38–4.25 (m, 2H).</div></div><div id="sec4_1_1_63" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> 4-(5-(4-(2-Fluoroethoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)benzaldehyde (<b>27c</b>)</h5><div class="NLM_p last">To an oven-dried 100 mL round-bottomed flask equipped with a stir bar was added 29 mL of CH<sub>2</sub>Cl<sub>2</sub> and DMSO (1.15 mL, 16.2 mmol). The reaction mixture was cooled to −78 °C (acetone/CO<sub>2(s)</sub>), and oxalyl chloride (0.93 mL, 11.0 mmol) was added carefully. The reaction mixture was stirred for 30 min at which time alcohol <b>26c</b> (2.0 g, 5.23 mmol) was added. The reaction mixture was stirred for 30 min at which time Et<sub>3</sub>N (5.83 mL, 41.8 mmol) was added. The cooling bath was removed, and the reaction was allowed to warm to r.t. over 2 h. The reaction mixture was concentrated <i>in vacuo</i> and partitioned between EtOAc and 1 M HCl<sub>(aq)</sub>. The layers were separated, and the aqueous layer was extracted with EtOAc (×2). The combined organic layers were washed with 1 M HCl<sub>(aq)</sub>, sat. NaHCO<sub>3(aq)</sub>, brine, dried over MgSO<sub>4</sub>, concentrated <i>in vacuo,</i> and triturated with MTBE to give a pale-yellow solid (1.75 g, 88% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 10.11 (s, 1H), 8.47 (d, <i>J</i> = 1.6 Hz, 1H), 8.39–8.31 (m, 3H), 8.02 (d, <i>J</i> = 8.4 Hz, 2H), 7.19 (d, <i>J</i> = 8.8 Hz, 1H), 4.93–4.75 (m 2H), 4.49–4.35 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ = 191.7, 174.9, 168.3, 159.9, 138.2, 133.5, 132.2, 130.2, 128.3, 127.9 (q, <i>J</i><sub><i>C–F</i></sub> = 5.4 Hz), 122.9 (q, <i>J</i><sub><i>C–F</i></sub> = 274 Hz), 120.5 (q, <i>J</i><sub><i>C–F</i></sub> = 32.3 Hz), 116.9, 113.6, 81.4 (d, <i>J</i><sub><i>C–F</i></sub> = 173 Hz), 68.6 (d, <i>J</i><sub><i>C–F</i></sub> = 21.1 Hz). MP: 149–150 °C. HRMS (ESI) calcd for C<sub>18</sub>H<sub>13</sub>F<sub>4</sub>N<sub>2</sub>O<sub>3</sub> [M + H<sup>+</sup>] 381.0857. Found [M + H<sup>+</sup>] 381.0857.</div></div><div id="sec4_1_1_64" class="NLM_sec NLM_sec_level_4"><div id="ac_i87" class="anchor-spacer"></div><h5 class="article-section__title" id="_i87"> 4-(5-(4-Methoxy-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)benzaldehyde (<b>27d</b>)</h5><div class="NLM_p last">To an oven-dried 100 mL round-bottomed flask equipped with a stir bar was added 32 mL of CH<sub>2</sub>Cl<sub>2</sub> and DMSO (1.26 mL, 17.7 mmol). The reaction mixture was cooled to −78 °C (acetone/CO<sub>2(s)</sub>), and oxalyl chloride (1.01 mL, 12.0 mmol) was added carefully. The reaction mixture was stirred for 30 min at which time alcohol <b>26d</b> (2.0 g, 5.71 mmol) was added. The reaction mixture was stirred for 30 min at which time Et<sub>3</sub>N (6.37 mL, 45.7 mmol) was added. The cooling bath was removed, and the reaction was allowed to warm to r.t. over 2 h. The reaction mixture was concentrated <i>in vacuo</i> and partitioned between EtOAc and 1 M HCl<sub>(aq)</sub>. The layers were separated, and the aqueous layer was extracted with EtOAc (×2). The combined organic layers were washed with 1 M HCl<sub>(aq)</sub>, sat. NaHCO<sub>3(aq)</sub>, brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give a pale-yellow solid (1.51 g, 76% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 10.11 (s, 1H), 8.46 (s, 1H), 8.40–8.32 (m, 3H), 8.03 (d, <i>J</i> = 8.0 Hz, 2H), 7.19 (d, <i>J</i> = 8.8 Hz, 1H), 4.04 (s, 3H).</div></div><div id="sec4_1_1_65" class="NLM_sec NLM_sec_level_4"><div id="ac_i88" class="anchor-spacer"></div><h5 class="article-section__title" id="_i88"> 1-(4-(5-(4-Ethoxyphenyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>28a</b>)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></h5><div class="NLM_p last">Following general experimental procedure G, aldehyde <b>27a</b> (500 mg, 1.70 mmol), azetidine-3-carboxylic acid (180 mg, 1.79 mmol), 24 mL of methanol, 0.85 mL of acetic acid, and NaBH<sub>3</sub>CN (53 mg, 0.85 mmol) in 3.4 mL of MeOH were combined to give a white solid (331 mg, 51% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.11 (d, <i>J</i> = 8.8 Hz, 2H), 8.01 (d, <i>J</i> = 8.0 Hz, 2H), 7.47 (d, <i>J</i> = 8.4 Hz, 2H), 7.17 (d, <i>J</i> = 8.8 Hz, 2H), 4.16 (q, <i>J</i> = 7.2 Hz, 2H), 3.64 (s, 2H), 3.45–3.38 (m, 1H), 3.28–3.15 (m, 4H), 1.37 (t, <i>J</i> = 6.8 Hz, 3H).</div></div><div id="sec4_1_1_66" class="NLM_sec NLM_sec_level_4"><div id="ac_i89" class="anchor-spacer"></div><h5 class="article-section__title" id="_i89"> 1-(4-(5-(4-(2-Fluoroethoxy)phenyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>28b</b>)</h5><div class="NLM_p last">Following general experimental procedure G, aldehyde <b>27b</b> (500 mg, 1.60 mmol), azetidine-3-carboxylic acid (170 mg, 1.68 mmol), 23 mL of methanol, 0.8 mL of acetic acid, and NaBH<sub>3</sub>CN (50 mg, 0.80 mmol) in 3.2 mL of methanol were combined to give 400 mg of 85% pure acetate salt. <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 8.21 (d, <i>J</i> = 8.0 Hz, 2H), 8.18 (d, <i>J</i> = 8.8 Hz, 2H), 7.62 (d, <i>J</i> = 8.0 Hz, 2H), 7.19 (d, <i>J</i> = 8.8 Hz, 2H), 4.85–4.69 (m, 2H), 4.42–4.30 (m, 2H), 4.37 (s, 2H), 4.19–4.09 (m, 4H), 3.41 (pent, <i>J</i> = 8.4 Hz, 1H), 1.96 (s, 3H).</div></div><div id="sec4_1_1_67" class="NLM_sec NLM_sec_level_4"><div id="ac_i90" class="anchor-spacer"></div><h5 class="article-section__title" id="_i90"> 1-(4-(5-(4-(2-Fluoroethoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>28c</b>)</h5><div class="NLM_p last">Following general experimental procedure G, aldehyde <b>27c</b> (500 mg, 1.31 mmol), azetidine-3-carboxylic acid (139 mg, 1.38 mmol), 19 mL of MeOH, 0.70 mL of AcOH, and NaBH<sub>3</sub>CN (41 mg, 0.70 mmol) in 2.6 mL of MeOH were combined to give an off-white solid (317 mg, 52% yield). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 8.45–8.38 (m, 2H), 8.23 (d, <i>J</i> = 8.0 Hz, 2H), 7.64 (d, <i>J</i> = 8.0 Hz, 2H), 7.46 (d, <i>J</i> = 9.6 Hz, 1H), 4.87–4.71 (m, 2H), 4.54–4.43 (m, 2H), 4.43 (s, 2H), 4.25–4.15 (m, 4H), 3.44 (pent, <i>J</i> = 8.8 Hz, 1H). <sup>13</sup>C NMR (101 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 166.3, 160.5, 151.8, 137.2, 125.3, 119.0, 118.8, 118.7, 118.6 (q, <i>J</i><sub><i>C–F</i></sub> = 5.45 Hz), 117.3, 114.9 (q, <i>J</i><sub><i>C–F</i></sub> = 273 Hz), 111.3 (q, <i>J</i><sub><i>C–F</i></sub> = 32.0 Hz), 108.4, 105.8, 105.8, 73.1 (d, <i>J</i><sub><i>C–F</i></sub> = 70.4 Hz), 60.7, 60.5, 55.2 (d, <i>J</i><sub><i>C–F</i></sub> = 11.0 Hz), 55.1. MP: 146–148 °C. Anal. Calcd for C<sub>22</sub>H<sub>19</sub>F<sub>4</sub>N<sub>3</sub>O<sub>4</sub>·2H<sub>2</sub>O: C, 52.70; H, 4.62; N, 8.38. Found: C, 52.93; H, 4.46; N, 8.37. HRMS (ESI) calcd for C<sub>22</sub>H<sub>20</sub>F<sub>4</sub>N<sub>3</sub>O<sub>4</sub> [M + H<sup>+</sup>] 466.1384. Found [M + H<sup>+</sup>] 466.1383.</div></div><div id="sec4_1_1_68" class="NLM_sec NLM_sec_level_4"><div id="ac_i91" class="anchor-spacer"></div><h5 class="article-section__title" id="_i91"> 1-(4-(5-(4-(2-Fluoroethoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)benzyl)piperidine-4-carboxylic Acid (<b>28d</b>)</h5><div class="NLM_p last">Following general experimental procedure G, aldehyde <b>27c</b> (380 mg, 1.0 mmol), piperidine-4-carboxylic acid (136 mg, 1.05 mmol), 14.3 mL of MeOH, 0.5 mL of AcOH, and NaBH<sub>3</sub>CN (31 mg, 0.5 mmol) in 2 mL of methanol were combined to give a white solid (193 mg, 39% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.45 (dd, <i>J</i> = 8.8 Hz, 1.6 Hz, 1H), 8.33 (d, <i>J</i> = 1.6 Hz, 1H), 8.05 (d, <i>J</i> = 8.0 Hz, 2H), 7.58 (d, <i>J</i> = 8.8 Hz, 1H), 7.51 (d, <i>J</i> = 8.0 Hz, 2H), 4.75–4.50 (m, 4H), 3.54 (s, 2H), 3.25–1.51 (m, 9H).</div></div><div id="sec4_1_1_69" class="NLM_sec NLM_sec_level_4"><div id="ac_i92" class="anchor-spacer"></div><h5 class="article-section__title" id="_i92"> <i>N</i>-((1<i>H</i>-Tetrazol-5-yl)methyl)-1-(4-(5-(4-(2-fluoroethoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)methanamine (<b>28e</b>)</h5><div class="NLM_p last">Following general experimental procedure G, aldehyde <b>27c</b> (380 mg, 1.0 mmol), <b>21</b> (142 mg, 1.05 mmol), 14.3 mL of MeOH, 0.5 mL of AcOH, and NaBH<sub>3</sub>CN (31 mg, 0.5 mmol) in 2 mL of methanol were combined. The reaction mixture was stirred for 3 h and diluted with MTBE to give a precipitate. The precipitate was filtered to give an off-white solid (145 mg, 31% yield). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 8.46–8.42 (m, 2H), 8.24 (d, <i>J</i> = 8.4 Hz, 2H), 7.70 (d, <i>J</i> = 8.0 Hz, 2H), 7.48 (d, <i>J</i> = 8.4 Hz, 1H), 4.83–4.72 (m, 2H), 4.54–4.44 (m, 2H), 4.50 (s, 2H), 4.40 (s, 2H).</div></div><div id="sec4_1_1_70" class="NLM_sec NLM_sec_level_4"><div id="ac_i93" class="anchor-spacer"></div><h5 class="article-section__title" id="_i93"> 1-(4-(5-(4-Methoxy-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid (<b>28f</b>)</h5><div class="NLM_p last">Following general experimental procedure G, aldehyde <b>27d</b> (500 mg, 1.44 mmol), azetidine-3-carboxylic acid (152 mg, 1.51 mmol), 21 mL of methanol, 0.72 mL of acetic acid, and NaBH<sub>3</sub>CN (45 mg, 0.72 mmol) in 2.9 mL of methanol were combined to give a white solid (300 mg, 48% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.43 (d, <i>J</i> = 8.4 Hz, 1H), 8.30 (s, 1H), 8.02 (d, <i>J</i> = 7.2 Hz, 2H), 7.60–7.42 (m, 3H), 4.03 (s, 3H), 3.64 (br s, 2H), 3.23 (br s, 3H).</div></div><div id="sec4_1_1_71" class="NLM_sec NLM_sec_level_4"><div id="ac_i94" class="anchor-spacer"></div><h5 class="article-section__title" id="_i94"> 4-(3-(4-(Hydroxymethyl)phenyl)-1,2,4-oxadiazol-5-yl)-2-(trifluoromethyl)phenol (<b>30</b>)</h5><div class="NLM_p last">To a 100 mL round-bottomed flask equipped with a stir bar was added 4-hydroxy-3-(trifluoromethyl)benzoic acid (<b>29</b>) (2.06 g, 10.0 mmol), HOBt (0.39 g, 2.0 mmol), TBTU (3.21 g, 10.0 mmol), 20 mL of DMF, and DIPEA (5.23 mL, 30.0 mmol). The reaction was stirred at r.t. for 30 min, and <b>25</b> (1.66 g, 10.0 mmol) was added. The reaction was stirred at r.t. for 1 h, heated in a 120 °C oil-bath for 3 h, and cooled to r.t. The reaction mixture was diluted with EtOAc and water. The layers were separated, and the aqueous layer was extracted with EtOAc (×1). The combined organic layers were washed with 1 M HCl<sub>(aq)</sub>, water, sat. NaHCO<sub>3(aq)</sub>, water (×3), and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to give a tan solid (1.7 g, 51% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 11.83 (br s, 1H), 8.29–8.22 (m, 2H), 8.04 (d, <i>J</i> = 8.0 Hz, 2H), 7.52 (d, <i>J</i> = 8.0 Hz, 2H), 7.27 (d, <i>J</i> = 8.4 Hz, 1H), 5.38 (br s, 1H), 4.60 (s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 174.3, 168.1, 160.0, 146.4, 133.5, 126.9, 126.8 (q, <i>J</i><sub><i>C–F</i></sub> = 5.6 Hz), 124.5, 123.3 (q, <i>J</i><sub><i>C–F</i></sub> = 274 Hz), 118.2, 118.1, 116.4 (q, <i>J</i><sub><i>C–F</i></sub> = 31.0 Hz), 114.0, 62.5. MP: >200 °C. HRMS (ESI, <i>m</i>/<i>z</i>) calcd for C<sub>16</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H<sup>+</sup>] 337.0795. Found [M + H<sup>+</sup>] 337.0789.</div></div><div id="sec4_1_1_72" class="NLM_sec NLM_sec_level_4"><div id="ac_i95" class="anchor-spacer"></div><h5 class="article-section__title" id="_i95"> 4-(5-(4-Hydroxy-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)benzaldehyde (<b>31</b>)</h5><div class="NLM_p last">To a 250 mL round-bottomed flask equipped with a stir bar was added alcohol <b>30</b> (1.0 g, 2.97 mmol), 59 mL of 1,4-dioxane, and 10 g of MnO<sub>2</sub>. A reflux condenser was added, then the reaction was heated in an 80 °C oil-bath and stirred 4 h at which point TLC showed consumption of the alcohol. The reaction mixture was cooled to r.t. and filtered through a Celite plug, washing with EtOAc. The filtrate was concentrated <i>in vacuo</i> to give a tan solid (620 mg, 62% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 10.11 (s, 1H), 8.34–8.22 (m, 4H), 8.10 (d, <i>J</i> = 8.0 Hz, 2H), 7.24 (d, <i>J</i> = 8.4 Hz, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 192.7, 174.9, 167.5, 160.7, 138.0, 133.7, 131.2, 130.2, 127.8, 126.9 (q, <i>J</i><sub><i>C–F</i></sub> = 5.66 Hz), 123.3 (q, <i>J</i><sub><i>C–F</i></sub> = 274 Hz), 118.3, 116.4 (q, <i>J</i><sub><i>C–F</i></sub> = 30.8), 113.3. MP: >200 °C. HRMS (ESI, <i>m</i>/<i>z</i>) calcd for C<sub>16</sub>H<sub>8</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M – H] 333.0493. Found [M – H] 333.0400.</div></div><div id="sec4_1_1_73" class="NLM_sec NLM_sec_level_4"><div id="ac_i96" class="anchor-spacer"></div><h5 class="article-section__title" id="_i96"> Methyl 1-(4-(5-(4-hydroxy-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (<b>32</b>)</h5><div class="NLM_p last">To a 25 mL round-bottomed flask equipped with a stir bar was added aldehyde <b>31</b> (300 mg, 0.90 mmol), 4.1 mL of CH<sub>2</sub>Cl<sub>2</sub>, methyl azetidine-3-carboxylate hydrochloride (204 mg, 1.35 mmol), AcOH (0.21 mL, 3.6 mmol), DIPEA (0.24 mL, 1.35 mmol), and 4.1 mL of MeOH. The reaction mixture was stirred for 30 min, and sodium cyanoborohydride (57 mg, 0.90 mmol) was added. The reaction mixture was stirred for 2 h at which time TLC showed the consumption of the aldehyde. The reaction mixture was concentrated <i>in vacuo</i>, dissolved in EtOAc, and quenched with sat. NaHCO<sub>3(aq)</sub>. The layers were separated, and the aqueous layer was extracted with EtOAc (×2). The combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified on a silica gel column eluted with 75–100% EtOAc/hexanes to give a white crystalline solid (193 mg, 49% yield). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 8.14 (d, <i>J</i> = 1.2 Hz, 1H), 8.00 (d, <i>J</i> = 8.8 Hz, 1.6 Hz, 1H), 7.91 (d, <i>J</i> = 8.0 Hz, 2H), 7.33 (d, <i>J</i> = 8.0 Hz, 2H), 6.95 (d, <i>J</i> = 8.8 Hz, 1H), 3.72–3.62 (m, 5H), 3.56 (t, <i>J</i> = 8.0 Hz, 2H), 3.45 (t, <i>J</i> = 6.8 Hz, 2H), 3.34 (pent, <i>J</i> = 7.6 Hz, 1H). <sup>13</sup>C NMR (101 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 174.8, 173.1, 168.1, 161.4, 139.6, 132.7, 129.0, 127.1, 126.9 (q, <i>J</i><sub><i>C–F</i></sub> = 5.15 Hz), 126.0, 123.5 (q, <i>J</i><sub><i>C–F</i></sub> = 273 Hz), 117.8, 117.4 (q, <i>J</i><sub><i>C–F</i></sub> = 31.1 Hz), 113.5, 61.8, 56.1, 51.2, 33.4. MP: 125 °C (decomposition). HRMS (ESI, <i>m</i>/<i>z</i>) calcd for C<sub>22</sub>H<sub>18</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H<sup>+</sup>] 434.1322. Found [M + H<sup>+</sup>] 434.1320.</div></div><div id="sec4_1_1_74" class="NLM_sec NLM_sec_level_4"><div id="ac_i97" class="anchor-spacer"></div><h5 class="article-section__title" id="_i97"> 2-(4-(3-(4-Formylphenyl)-1,2,4-oxadiazol-5-yl)-2-(trifluoromethyl)phenoxy)ethyl 4-methylbenzenesulfonate (<b>33</b>)</h5><div class="NLM_p last">To a 50 mL round-bottomed flask equipped with a stir bar was added phenol <b>31</b> (450 mg, 1.35 mmol), ethylene 1,2-bis(tosylate) (748 mg, 2.02 mmol), potassium carbonate (933 mg, 6.75 mmol), and 6.8 mL of acetonitrile. The reaction vessel was equipped with a reflux condenser placed in a preheated 90 °C oil-bath. The reaction mixture was stirred overnight (∼18 h), cooled to r.t., and diluted with EtOAc and water. The layers were separated, and the aqueous layer was extracted with EtOAc (×3). The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The product was purified by silica-gel chromatography to give an off-white solid (210 mg, 29% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 10.07 (s, 1H), 8.37 (d, <i>J</i> = 1.6 Hz), 8.34–8.24 (m, 3H), 7.98 (d, <i>J</i> = 8.4 Hz, 2H), 7.79 (d, <i>J</i> = 8.4 Hz, 2H), 7.33 (d, <i>J</i> = 8.4 Hz, 2H), 7.09 (d, <i>J</i> = 8.8 Hz, 1H), 4.46–4.33 (m 4H), 2.43 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ = 191.7, 174.7, 168.2, 159.4, 145.3, 138.2, 133.5, 132.4, 132.1, 130.1, 130.0, 128.2, 128.0, 127.7 (q, <i>J</i><sub><i>C–F</i></sub> = 5.35 Hz), 122.7, (q, <i>J</i><sub><i>C–F</i></sub> = 274 Hz), 120.2, (q, <i>J</i><sub><i>C–F</i></sub> = 32.1 Hz), 116.9, 113.5, 67.4, 66.7, 21.7. MP: 125 °C (decomposition). HRMS (ESI, <i>m</i>/<i>z</i>) calcd for C<sub>25</sub>H<sub>20</sub>F<sub>3</sub>N<sub>2</sub>O<sub>6</sub>S [M + H<sup>+</sup>] 533.0989. Found [M + H<sup>+</sup>] 533.0990.</div></div><div id="sec4_1_1_75" class="NLM_sec NLM_sec_level_4"><div id="ac_i98" class="anchor-spacer"></div><h5 class="article-section__title" id="_i98"> Methyl 1-(4-(5-(4-(2-(tosyloxy)ethoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate (<b>34</b>)</h5><div class="NLM_p last">To a 25 mL round-bottomed flask equipped with a stir bar was added aldehyde <b>33</b> (200 mg, 0.38 mmol), methyl 3-azetidinecarboxylate hydrochloride (61 mg, 0.40 mmol), 1.9 mL of 1,2-dichloroethane, and 6.3 mL of methanol. Diisopropylethylamine (0.07 mL, 0.41 mmol) was added to the reaction mixture, and it was stirred for 1 h at r.t. The reaction mixture was concentrated <i>in vacuo</i>, suspended in 1.9 mL of 1,2-dichloroethane, at which time sodium triacetoxyborohydride (250 mg, 1.18 mmol) and acetic acid (0.02 mL, 0.38 mmol) were added. The reaction mixture was stirred overnight (∼18 h), diluted with EtOAc, and quenched with sat. NaHCO<sub>3(aq)</sub>. The layers were separated, and the aqueous layer extracted with EtOAc (×3). The combined organic layers were washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i>. The crude product was purified on a silica gel column eluted with 2–3% MeOH/CH<sub>2</sub>Cl<sub>2</sub> to give a clear oil (110 mg, 41% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.40 (s, 1H), 8.29 (d, <i>J</i> = 8.8 Hz, 1H), 8.08 (d, <i>J</i> = 6.8 Hz, 2H), 7.79 (d, <i>J</i> = 7.2 Hz), 7.41 (d, <i>J</i> = 5.6 Hz, 2H), 7.33 (d, <i>J</i> = 5.6 Hz, 2H), 7.07 (dd, <i>J</i> = 8.4 Hz, 2.4 Hz, 1H), 4.45–4.32 (m 4H), 3.74–3.64 (m, 5H), 3.60–3.50 (m, 2H), 3.42–3.28 (m, 3H), 2.45–2.38 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ = 174.1, 173.5, 168.8, 159.0, 145.2, 141.2, 133.3, 132.3, 129.9, 128.9, 127.9, 127.6 (q, <i>J</i><sub><i>C–F</i></sub> = 5.35 Hz), 127.6, 125.5, 122.6, (q, <i>J</i><sub><i>C–F</i></sub> = 274 Hz), 119.7 (q, <i>J</i><sub><i>C–F</i></sub> = 32.2 Hz), 117.2, 113.2, 67.2, 66.5, 63.1, 56.9, 52.0, 33.9, 21.6. HRMS (ESI, <i>m</i>/<i>z</i>) calcd for C<sub>30</sub>H<sub>29</sub>F<sub>3</sub>N<sub>3</sub>O<sub>7</sub>S [M + H<sup>+</sup>] 632.1673. Found [M + H<sup>+</sup>] 632.1669.</div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99">4.2 <i>In Vitro</i> Screening</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100">4.2.1 <i>In Vitro</i> Functional Assay (EC<sub>50</sub>)</h4><div class="NLM_p last">The functional assay of the test compounds was carried out according to a published procedure.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Briefly, S1P<sub>1</sub>-TANGO-U2OS cells were suspended at a concentration of 312,500 cells/mL in assay medium (Freestyle Expression Medium without supplements). Thirty-two microliters of the cell suspension was seeded in each well of a black, clear-bottomed 384-well plate, followed by 48 h of incubation at 37 °C in 5% CO<sub>2</sub> and 95% relative humidity. After incubation, 100 nL of the test compound in DMSO was added to sample wells, while DMSO alone (0.5% final concentration) was added to control wells. Plates were then incubated at 37 °C in 5% CO<sub>2</sub> for 5 h. After incubation, 8 μL/well of the LiveBLAzer FRET substrate mixture, prepared according to the manufacturer’s protocol and containing 10 mM Probenicid, was added to all wells. After 2 h of incubation at r.t. in the dark, plates were read on an EnVision plate reader (PerkinElmer Lifesciences, Turku, Finland) at an excitation wavelength of 405 nm and emission wavelengths of 460 and 535 nm.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101">4.2.2 <i>In Vitro</i> Binding Assay (IC<sub>50</sub>)</h4><div class="NLM_p last">The potency of the test compounds for S1P receptors was determined according to our published procedure.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In brief, test compounds dissolved in DMSO were preincubated for 30 min at r.t. in assay buffer (50 mM HEPES-Na (pH 7.5), 5 mM MgCl<sub>2</sub>, 1 mM CaCl<sub>2</sub>, and 0.5% fatty acid-free BSA) with cell membranes expressing recombinant human S1P<sub>1–3</sub> (S1P<sub>1</sub> cell membranes were purchased from ChanTest Corp, Cleveland, OH, and S1P<sub>2</sub> and S1P<sub>3</sub> cell membranes were from Chemicon/Millipore Inc., Billerica, MA). Diluted [<sup>32</sup>P]S1P, prepared in-house, was added to give a final volume of 150 μL containing 0.1–0.2 nM [<sup>32</sup>P]S1P with 1–2 μg of membrane protein in each well of a 96-well plate. Samples were incubated for 60 min at r.t., and filter-bound radioactivity was measured by Cherenkov counting on a Beckman LS 3801 scintillation counter. Nonspecific binding was determined from samples incubated with an additional 1 μM cold S1P.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102">4.3 Radiochemistry</h3><div class="NLM_p last">[<sup>18</sup>F]Fluoride was produced by <sup>18</sup>O(p,n)<sup>18</sup>F reaction through proton irradiation of enriched <sup>18</sup>O water (95%) using Washington University’s RDS111 cyclotron (Siemens/CTI Molecular Imaging, Knoxville, TN). [<sup>18</sup>F]Fluoride was first passed through an ion-exchange resin and then eluted with 0.02 M potassium carbonate (K<sub>2</sub>CO<sub>3</sub>) solution. A sample of ∼200 mCi [<sup>18</sup>F]/fluoride was added to a reaction vessel containing Kryptofix 222 (5–6 mg), and the solution was evaporated under nitrogen (oil-bath temperature 110 °C). Acetonitrile (3 × 1.0 mL) was added and evaporated to ensure complete removal of water. After all of the water was removed, 1 mg of <b>34</b> was added as a solution in 200 μL of acetonitrile. The reaction tube was capped, briefly mixed, and placed in a preheated 110 °C oil-bath. The reaction mixture was incubated at 110 °C for 15 min, shaking occasionally. The reaction vessel was removed from the oil-bath, at which time 300 μL of EtOH and 200 μL of NaOH<sub>(aq)</sub> were added. The reaction mixture was heated in an 80 °C preheated oil-bath for 5 min, shaking occasionally. The reaction vessel was removed from the oil-bath, quenched with 400 μL of 1 M HCl<sub>(aq)</sub> and diluted with 1.9 mL of the HPLC mobile phase (38% MeCN in 0.1 M ammonium formate buffer, pH 4.5), passed through an alumina Neutral Sep-Pak Plus cartridge. The crude product was then loaded onto an Agilent SB-C18 semipreparative HPLC column (250 mm × 10 mm) with a UV detector set at 254 nm. The HPLC system used a 5 mL injection loop. With the above-mentioned mobile phase at 4.0 mL/min flow rate. The retention time of the product was approximately 18 min. After the HPLC collection was diluted with ∼50 mL of sterile water, the product was trapped on a C18 Sep-Pak Plus cartridge. The trapped product was eluted with ethanol (0.3 mL), and this portion was discarded. The Sep-Pak was sequentially eluted with ethanol (0.3 mL), which was followed by 2.7 mL of 0.9% saline. After sterile filtration into a glass vial, the final product was ready for quality control (QC) analysis and animal studies. An aliquot of sample was assayed by an analytical HPLC system (Agilent Zorbax, SB-C18 column, 250 × 4.6 mm), UV at 254 nm; the mobile phase consists of acetonitrile/0.1 M, pH 4.5, ammonium formate buffer (50/50, v/v). At this condition, the retention time for [<sup>18</sup>F]<b>28c</b> was approximately 5.1 min at a flow rate of 1.0 mL/min. The radioactive dose was authenticated by co-injection with the corresponding nonradioactive compound <b>28c</b> onto an analytical HPLC system. The radiochemical purity was >98%, the labeling yield was 25.7 ± 4.6% (<i>n</i> = 10, decay corrected to start of synthesis), and the specific activity was 1.43 ± 0.12 Ci/μmol (decay corrected to the end of synthesis). The entire procedure took about 90 min.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103">4.4 Biological Evaluation in Rodents</h3><div class="NLM_p">All animal experiments were conducted under Washington University Animal Studies Committee IACUC-approved protocols in accordance with the US National Research Council’s Guide for the Care and Use of Laboratory Animals. Adult male Sprague–Dawley rats (Charles River, Inc.) were used to determine the biodistribution in normal rodents. Adult male C57BL/6 mice (Charles River Inc., Frederick, MD) were used for the mouse model of LPS-induced liver injury and inflammation to demonstrate specificity of the S1P<sub>1</sub> tracer.<a onclick="showRef(event, 'ref50 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref50 ref52 ref53 ref54">(50, 52-54)</a> LPS-treated mice received an intraperitoneal injection of LPS from <i>E. coli</i> 055:B5 (Sigma-Aldrich, St. Louis, MO, USA) in saline (3 mg/mL) at 15 mg/kg (5 mL/kg) dose 24 h prior to use, and sham mice received a saline injection.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104">4.4.1 Biodistribution in Normal Rats</h4><div class="NLM_p last">The biodistribution of [<sup>18</sup>F]<b>28c</b> in normal rodents was determined using adult male SD rats (230–270 g). Rats were anesthetized with isoflurane (2–3% in oxygen) and injected in the tail vein with ∼50 μCi (1.85 MBq) of [<sup>18</sup>F]<b>28c</b> in 5% ethanol/saline. At the appropriate time, rats were again anesthetized and were euthanized at 5, 30, 60, and 120 min postinjection (<i>n</i> = 4 for each group). Tissues of interest including blood, heart, lung, muscle, fat, pancreas, spleen, bone, thymus, brain, kidney, and liver were collected, weighed, and counted with a dilution of the injectate on an automated well counter (Beckman Gamma 8000 well counter). Uptake in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> is reported as decay-corrected percent injected dose per gram (% ID/g).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105">4.4.2 <i>In Vitro</i> Autoradiography Study of LPS-Treated Mouse Liver</h4><div class="NLM_p last">Livers from sham and LPS-treated mice were collected and snap frozen. Twenty micrometer sequential sections were cut with a Microm cryotome and thaw mounted on glass slides. The slides were then incubated for 60 min with ∼0.1 nM [<sup>18</sup>F]<b>28c</b> at r.t. Blocking studies were performed using adjacent sections incubated with an additional 10 μM of either S1P or SEW2871. Following the incubation, the slides were washed and exposed to the storage phosphor screen in an imaging cassette for 12 h in −80 °C in the dark. The distribution of radioactivity was visualized with a Fuji Bio-Imaging Analyzer FLA-7000 (Fuji Photo Film, Tokyo, Japan).</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106">4.4.3 IHC Staining of S1P<sub>1</sub> Expression in Mouse Liver</h4><div class="NLM_p last">Liver samples were fixed in 10% formalin immediately, then embedded in paraffin and cut into 5 μm sections. Sections were deparaffinized in xylene and rehydrated through a graded alcohol series to water. Endogenous peroxidase activity was quenched with 3% H<sub>2</sub>O<sub>2</sub> in methanol for 5 min. Slides were incubated in blocking buffer (10% normal goat serum in PBS) for 30 min before the incubation with a 1:50 dilution of a rabbit antimouse S1P<sub>1</sub> antibody (Santa Cruz biotechnology, Santa Cruz, CA) overnight at 4 °C. The primary antibody binding was detected using an anti–rabbit HRP-DAB staining kit (R&D Systems, Minneapolis, MN) according to the manufacturer’s instructions. A Nikon E600 microscope coupled with a charge-coupled device camera was used to obtain all photomicrographs.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107">4.4.4 MicroPET Imaging of LPS-Treated Mice with [<sup>18</sup>F]<b>28c</b> and [<sup>15</sup>O]Water</h4><div class="NLM_p">MicroPET studies were performed using adult male C57BL/6 mice (18–23 g) ∼24 h after pretreatment with either saline (<i>n</i> = 4) or LPS (<i>n</i> = 3), and PET scans were conducted under light anesthesia (2–3% isoflurane) delivered by a nose cone. Mice were secured using a custom-designed acrylic restraining device and placed in transaxial position with their whole bodies inside the field of the window of the Inveon PET/CT system. Following a transmission scan and a CT for anatomical coregistration, animals received a bolus injection. [<sup>18</sup>F]<b>28c</b> (∼300 μCi (11.1 MBq), in 10% ethanol/saline) was injected i.v. and a microPET dynamic scan acquired from 0–120 min.</div><div class="NLM_p">[<sup>15</sup>O]Water MicroPET Study: Small-animal microPET imaging using [<sup>15</sup>O]water serves as a noninvasive method to measure liver blood flow in rodents.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> A microPET scan was performed ∼30 min before the [<sup>18</sup>F] scan on an Inveon PET/CT system (Siemens Inc., Erlangen, Germany). Following a transmission scan and a CT for anatomical coregistration, animals received a bolus injection (30–55 MBq) of [<sup>15</sup>O]water via the tail vein, immediately followed by a 10 min scan (1 × 3 s, 6 × 2 s, 5 × 5 s, 11 × 10 s, 5 × 30 s, 5 × 60 s).</div><div class="NLM_p last">MicroPET Data Processing: Image reconstructions were performed using microPET Manager 2.3.3.6, ASIPro 6.3.3.0 (Siemens Inc., Erlangen, Germany). The list-mode data of the emission scans were reframed into a dynamic sequence. The data were reconstructed per time frame employing an iterative reconstruction algorithm and corrected for decay, random coincidences, scatter, and attenuation. Three-dimensional ROI of the mouse liver was drawn according to a standard mouse anatomy atlas. Averaged regional radioactivity was obtained and expressed as dimensionless standardized uptake values (SUVs). The parameter standardized uptake value (SUV) is defined as [tissue activity concentration (MBq/g) × body weight (g)/injected dose (MBq)]. For statistical analysis, two-tailed Student’s <i>t</i> test was applied, and significant difference is defined as a <i>P</i> value <0.05.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108">4.4.5 Biodistribution of [<sup>18</sup>F]<b>28c</b> and [<sup>99m</sup>Tc]Mebrofenin in LPS-Treated Mice</h4><div class="NLM_p last">The acute biodistribution studies in sham and LPS-treated mice, as described above, was carried out to determine tracer uptake in a rodent model with increased S1P<sub>1</sub>. Approximately 24 h after treatment, one set of sham and LPS-treated mice was injected in the tail vein with ∼20 μCi (0.74 MBq) of [<sup>18</sup>F]<b>28c</b> in 10% ethanol/saline. A separate set of sham and LPS-treated mice were injected with ∼4 μCi (148 KBq) of [<sup>99m</sup>Tc]mebrofenin (Cardinal Health Nuclear Pharmacy Services, Overland, MO) under 2–3% isoflurane/oxygen anesthesia. Animals (<i>n</i> = 4 per each group for each tracer) were euthanized at 30 or 60 min postinjection. Tissues of interest were collected, weighed, and counted with a dilution of the injectate on an automated well counter (Beckman Gamma 8000 well counter). Uptake is reported as background- and decay-corrected percent injected dose per gram (% ID/g).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i109"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00390">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00390" class="ext-link">10.1021/acs.jmedchem.6b00390</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings of the final products (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00390/suppl_file/jm6b00390_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00390/suppl_file/jm6b00390_si_001.csv">jm6b00390_si_001.csv (1.54 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00390" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34172" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34172" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhude Tu</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Washington University School
of Medicine, 510 South
Kingshighway Boulevard, St. Louis, Missouri 63110, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#53272629133e3a217d242620273f7d363726"><span class="__cf_email__" data-cfemail="eb9f9e91ab868299c59c9e989f87c58e8f9e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam J. Rosenberg</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Washington University School
of Medicine, 510 South
Kingshighway Boulevard, St. Louis, Missouri 63110, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Washington University School
of Medicine, 510 South
Kingshighway Boulevard, St. Louis, Missouri 63110, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongjun Jin</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Washington University School
of Medicine, 510 South
Kingshighway Boulevard, St. Louis, Missouri 63110, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xuyi Yue</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Washington University School
of Medicine, 510 South
Kingshighway Boulevard, St. Louis, Missouri 63110, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean Riley</span> - <span class="hlFld-Affiliation affiliation">The
Scripps Research Institute Molecular Screening Center, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven J. Brown</span> - <span class="hlFld-Affiliation affiliation">The
Scripps Research Institute Molecular Screening Center, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1804e6402-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i110">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41227" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41227" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Ms. Lynne Jones for many helpful discussions. This research work was directly supported by the Department of Energy (DOE, No. DESC0008432 and No. DESC0012737), and the National Institutes of Health through the National Institute of Neurological Disorders and Stroke (NINDS, R01NS075527), and the National Institute of Mental Health (NIMH, No. MH092797). During the process of accomplishing this work, we also used the NIH/NIGMS Biomedical Mass Spectrometry Resource at Washington University in St. Louis, MO, which is supported by National Institutes of Health/National Institute of General Medical Sciences Grant No. 8P41GM103422. We are grateful to the Washington University Cyclotron Facility and its personnel for [<sup>18</sup>F]fluoride production. We thank the Department of Chemistry staff and the Washington University High Resolution NMR Facility for assistance with NMR spectra; purchase of the 400 MHz NMR instrument was partially supported by Grant S10 RR027207 from the NIH Shared Instrument Grant program. We also thank the Elvie L. Taylor Histology Core Facility of Washington University School of Medicine for sample embedding, and the MIR Preclinical PET-CT facility of the Washington University School of Medicine, which was funded in part through the National Institute of Health HEI grant (S10 RR025097).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i111" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i111"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i112" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i112"> Abbreviations Used</h2><tr><td class="NLM_term">% ID/g</td><td class="NLM_def"><p class="first last">percent injected dose per gram</p></td></tr><tr><td class="NLM_term">EDC·HCl</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>′-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">ROI</td><td class="NLM_def"><p class="first last">region of interest</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">S1P</td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate</p></td></tr><tr><td class="NLM_term">S1P<sub>1–5</sub></td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate receptor 1–5</p></td></tr><tr><td class="NLM_term">SPhos</td><td class="NLM_def"><p class="first last">2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl</p></td></tr><tr><td class="NLM_term">SUV</td><td class="NLM_def"><p class="first last">standardized uptake value</p></td></tr><tr><td class="NLM_term">TAC</td><td class="NLM_def"><p class="first last">time–activity curve</p></td></tr><tr><td class="NLM_term">[<sup>99m</sup>Tc]-mebrofenin</td><td class="NLM_def"><p class="first last">[<sup>99m</sup>Tc]-<i>N</i>-(3-bromo-2,4,6-trimethyacetanilide) iminodiacetic acid</p></td></tr><tr><td class="NLM_term">XPhos</td><td class="NLM_def"><p class="first last">2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i113">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 54 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">O’Sullivan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dev, K. K.</span><span> </span><span class="NLM_article-title">The structure and function of the S1P1 receptor</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span><span class="refDoi"> DOI: 10.1016/j.tips.2013.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.tips.2013.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=23763867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlGltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=401-412&author=C.+O%E2%80%99Sullivanauthor=K.+K.+Dev&title=The+structure+and+function+of+the+S1P1+receptor&doi=10.1016%2Fj.tips.2013.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The structure and function of the S1P1 receptor</span></div><div class="casAuthors">O'Sullivan, Catherine; Dev, Kumlesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">401-412</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) receptors (S1PRs) belong to the class A family of G protein-coupled receptors (GPCRs).  S1PRs are widely expressed on many cell types, including those of the immune, cardiovascular, and central nervous systems.  The S1PR family is rapidly gaining attention as an important mediator of many cellular processes, including cell differentiation, migration, survival, angiogenesis, calcium homeostasis, inflammation and immunity.  Importantly, S1PRs are known drug targets for multiple sclerosis (MS), for which the newly developed oral therapy fingolimod, an S1PR modulator, has recently been approved for clin. use.  Much progress has also recently been made in the field of structural biol. and in the modeling of heterotrimeric GPCRs allowing the crystal structure of the S1PR1 subtype to be elucidated and key interactions defined.  Here, we outline the structure and function of S1PR1, highlighting the key residues involved in receptor activation, signaling, transmembrane interactions, ligand binding, post-translational modification, and protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpczbmBBxVca7Vg90H21EOLACvtfcHk0lg9TCxU3e9_SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlGltLw%253D&md5=bed981847f79833ad5a49325b2e500b5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DC.%26aulast%3DDev%26aufirst%3DK.%2BK.%26atitle%3DThe%2520structure%2520and%2520function%2520of%2520the%2520S1P1%2520receptor%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D401%26epage%3D412%26doi%3D10.1016%2Fj.tips.2013.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Rosen, H.; Germana Sanna, M.; Gonzalez-Cabrera, P. J.; Roberts, E.</span><span> </span><span class="NLM_article-title">The Organization of the Sphingosine 1-Phosphate Signaling System</span>. In  <span class="citation_source-book">Sphingosine-1-Phosphate Signaling in Immunology and Infectious Diseases</span>, <span class="NLM_edition">2014/04/15</span> ed.; <span class="NLM_contrib-group">Oldstone, M. B. A.; Rosen, H.</span>, Eds.; <span class="NLM_publisher-name">Springer International Publishing</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">378</span>, pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1007%2F978-3-319-05879-5_1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=1-21&author=H.+Rosen&author=M.+Germana+Sanna&author=P.+J.+Gonzalez-Cabrera&author=E.+Robertsauthor=M.+B.+A.+Oldstone&author=H.+Rosen&title=Sphingosine-1-Phosphate+Signaling+in+Immunology+and+Infectious+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-05879-5_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-05879-5_1%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DThe%2520Organization%2520of%2520the%2520Sphingosine%25201-Phosphate%2520Signaling%2520System%26btitle%3DSphingosine-1-Phosphate%2520Signaling%2520in%2520Immunology%2520and%2520Infectious%2520Diseases%26aulast%3DOldstone%26aufirst%3DM.%2BB.%2BA.%26pub%3DSpringer%2520International%2520Publishing%26date%3D2014%26volume%3D378%26spage%3D1%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornancin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechtcheriakova, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urtz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span> </span><span class="NLM_article-title">Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">47408</span><span class="NLM_x">–</span> <span class="NLM_lpage">47415</span><span class="refDoi"> DOI: 10.1074/jbc.M307687200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1074%2Fjbc.M307687200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=13129923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Cqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=47408-47415&author=A.+Billichauthor=F.+Bornancinauthor=P.+Devayauthor=D.+Mechtcheriakovaauthor=N.+Urtzauthor=T.+Baumruker&title=Phosphorylation+of+the+immunomodulatory+drug+FTY720+by+sphingosine+kinases&doi=10.1074%2Fjbc.M307687200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases</span></div><div class="casAuthors">Billich, Andreas; Bornancin, Frederic; Devay, Piroska; Mechtcheriakova, Diana; Urtz, Nicole; Baumruker, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">47408-47415</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The immunomodulatory drug FTY720 is phosphorylated in vivo, and the resulting FTY720 phosphate as a ligand for sphingosine-1-phosphate receptors is responsible for the unique biol. effects of the compd.  So far, phosphorylation of FTY720 by murine sphingosine kinase (SPHK) 1a had been documented.  We found that, while FTY720 is also phosphorylated by human SPHK1, the human type 2 isoform phosphorylates the drug 30-fold more efficiently, because of a lower Km of FTY720 for SPHK2.  Similarly, murine SPHK2 was more efficient than SPHK1a.  Among splice variants of the human SPHKs, an N-terminally extended SPHK2 isoform was even more active than SPHK2 itself.  Further SPHK superfamily members, namely ceramide kinase and a "SPHK-like" protein, failed to phosphorylate sphingosine and FTY720.  Thus, only SPHK1 and 2 appear to be capable of phosphorylating FTY720.  Using selective assay conditions, SPHK1 and 2 activities in murine tissues were measured.  While activity of SPHK2 toward sphingosine was generally lower than of SPHK1, FTY720 phosphorylation was higher under conditions favoring SPHK2.  In human endothelial cells, while activity of SPHK1 toward sphingosine was 2-fold higher than of SPHK2, FTY720 phosphorylation was 7-fold faster under SPHK2 assay conditions.  Finally, FTY720 was poorly phosphorylated in human blood as compared with rodent blood, in line with the low activity of SPHK1 and in particular of SPHK2 in human blood.  To conclude, both SPHK1 and 2 are capable of phosphorylating FTY720, but SPHK2 is quant. more important than SPHK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR5e-dVWnBT7Vg90H21EOLACvtfcHk0lgzp1Ak0PQiJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Cqtr0%253D&md5=26820503680682863dc76a69ea02fc7e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M307687200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M307687200%26sid%3Dliteratum%253Aachs%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DDevay%26aufirst%3DP.%26aulast%3DMechtcheriakova%26aufirst%3DD.%26aulast%3DUrtz%26aufirst%3DN.%26aulast%3DBaumruker%26aufirst%3DT.%26atitle%3DPhosphorylation%2520of%2520the%2520immunomodulatory%2520drug%2520FTY720%2520by%2520sphingosine%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D47408%26epage%3D47415%26doi%3D10.1074%2Fjbc.M307687200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1126/science.1070238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1126%2Fscience.1070238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=11923495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVWhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.+J.+Sheiauthor=D.+Cardauthor=C.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+lymphocyte+trafficking+by+sphingosine-1-phosphate+receptor+agonists&doi=10.1126%2Fscience.1070238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span></div><div class="casAuthors">Mandala, Suzanne; Hajdu, Richard; Bergstrom, James; Quackenbush, Elizabeth; Xie, Jenny; Milligan, James; Thornton, Rosemary; Shei, Gan-Ju; Card, Deborah; Keohane, Carolann; Rosenbach, Mark; Hale, Jeffrey; Lynch, Christopher L.; Rupprecht, Kathleen; Parsons, William; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5566</span>),
    <span class="NLM_cas:pages">346-349</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Blood lymphocyte nos., essential for the development of efficient immune responses, are maintained by recirculation through secondary Lymphoid organs.  We show that lymphocyte trafficking is altered by the lysophospholipid sphingosine-1-phosphate (S1P) and by a phosphoryl metabolite of the immunosuppressive agent FTY720.  Both species were high-affinity agonists of at least four of the five S1P receptors.  These agonists produce lymphopenia in blood and thoracic duct lymph by sequestration of lymphocytes in lymph nodes, but not spleen.  S1P receptor agonists induced emptying of lymphoid sinuses by retention of lymphocytes on the abluminal side of sinus-lining endothelium and inhibition of egress into lymph.  Inhibition of lymphocyte recirculation by activation of S1P receptors may result in therapeutically useful immunosuppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPvwG_lLsA8LVg90H21EOLACvtfcHk0lgzp1Ak0PQiJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVWhsrc%253D&md5=b57cbcffe41d144e701dbd42459cf38a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1070238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1070238%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.%2BJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520lymphocyte%2520trafficking%2520by%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349%26doi%3D10.1126%2Fscience.1070238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmouder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aradhye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span><span class="refDoi"> DOI: 10.1038/nrd3248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1038%2Fnrd3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=21031003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=883-897&author=V.+Brinkmannauthor=A.+Billichauthor=T.+Baumrukerauthor=P.+Heiningauthor=R.+Schmouderauthor=G.+Francisauthor=S.+Aradhyeauthor=P.+Burtin&title=Fingolimod+%28FTY720%29%3A+Discovery+and+development+of+an+oral+drug+to+treat+multiple+sclerosis&doi=10.1038%2Fnrd3248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span></div><div class="casAuthors">Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmouder, Robert; Francis, Gordon; Aradhye, Shreeram; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">883-897</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory drug, has opened up new approaches to the treatment of multiple sclerosis, the most common inflammatory disorder of the central nervous system.  Elucidation of the effects of fingolimod - mediated by the modulation of sphingosine 1-phosphate (S1P) receptors - has indicated that its therapeutic activity could be due to regulation of the migration of selected lymphocyte subsets into the central nervous system and direct effects on neural cells, particularly astrocytes.  An improved understanding of the biol. of S1P receptors has also been gained.  This article describes the discovery and development of fingolimod, which was approved by the US Food and Drug Administration in Sept. 2010 as a first-line treatment for relapsing forms of multiple sclerosis, thereby becoming the first oral disease-modifying therapy to be approved for multiple sclerosis in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80U6QfXSJMbVg90H21EOLACvtfcHk0lgzp1Ak0PQiJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL&md5=0f6dd60ef115079f3652e9d12d82e215</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3248%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520Discovery%2520and%2520development%2520of%2520an%2520oral%2520drug%2520to%2520treat%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D883%26epage%3D897%26doi%3D10.1038%2Fnrd3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span><span class="refDoi"> DOI: 10.1124/jpet.103.062828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.+Y.+Sunauthor=R.+Hajduauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.+J.+Sheiauthor=+Singerauthor=M.+Tianauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+cell+regulation+and+cardiovascular+effects+of+sphingosine+1-phosphate+receptor+agonists+in+rodents+are+mediated+via+distinct+receptor+subtypes&doi=10.1124%2Fjpet.103.062828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0ljdKTh4JEgiJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.%2BY.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.%2BJ.%26aulast%3DSinger%26aulast%3DTian%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520cell%2520regulation%2520and%2520cardiovascular%2520effects%2520of%2520sphingosine%25201-phosphate%2520receptor%2520agonists%2520in%2520rodents%2520are%2520mediated%2520via%2520distinct%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768%26doi%3D10.1124%2Fjpet.103.062828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Fryer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muthukumarana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nodop Mazurek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinallo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modis, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, G. A.</span><span> </span><span class="NLM_article-title">The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P<sub>1</sub>) and hypertension (S1P<sub>3</sub>) in rat</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e52985</span><span class="refDoi"> DOI: 10.1371/journal.pone.0052985</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1371%2Fjournal.pone.0052985" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e52985&author=R.+M.+Fryerauthor=A.+Muthukumaranaauthor=P.+C.+Harrisonauthor=S.+Nodop+Mazurekauthor=R.+R.+Chenauthor=K.+E.+Harringtonauthor=R.+M.+Dinalloauthor=J.+C.+Horanauthor=L.+Patnaudeauthor=L.+K.+Modisauthor=G.+A.+Reinhart&title=The+clinically-tested+S1P+receptor+agonists%2C+FTY720+and+BAF312%2C+demonstrate+subtype-specific+bradycardia+%28S1P1%29+and+hypertension+%28S1P3%29+in+rat&doi=10.1371%2Fjournal.pone.0052985"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0052985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0052985%26sid%3Dliteratum%253Aachs%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DMuthukumarana%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DP.%2BC.%26aulast%3DNodop%2BMazurek%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%2BR.%26aulast%3DHarrington%26aufirst%3DK.%2BE.%26aulast%3DDinallo%26aufirst%3DR.%2BM.%26aulast%3DHoran%26aufirst%3DJ.%2BC.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DModis%26aufirst%3DL.%2BK.%26aulast%3DReinhart%26aufirst%3DG.%2BA.%26atitle%3DThe%2520clinically-tested%2520S1P%2520receptor%2520agonists%252C%2520FTY720%2520and%2520BAF312%252C%2520demonstrate%2520subtype-specific%2520bradycardia%2520%2528S1P1%2529%2520and%2520hypertension%2520%2528S1P3%2529%2520in%2520rat%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De52985%26doi%3D10.1371%2Fjournal.pone.0052985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Gergely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groenewegen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitaliti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sing, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttringer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallstrom, E.</span><span> </span><span class="NLM_article-title">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02061.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1111%2Fj.1476-5381.2012.02061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=22646698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1035-1047&author=P.+Gergelyauthor=B.+Nuesslein-Hildesheimauthor=D.+Gueriniauthor=V.+Brinkmannauthor=M.+Traebertauthor=C.+Brunsauthor=S.+Panauthor=N.+S.+Grayauthor=K.+Hinterdingauthor=N.+G.+Cookeauthor=A.+Groenewegenauthor=A.+Vitalitiauthor=T.+Singauthor=O.+Luttringerauthor=J.+Yangauthor=A.+Gardinauthor=N.+Wangauthor=W.+J.+Crumbauthor=M.+Saltzmanauthor=M.+Rosenbergauthor=E.+Wallstrom&title=The+selective+sphingosine+1-phosphate+receptor+modulator+BAF312+redirects+lymphocyte+distribution+and+has+species-specific+effects+on+heart+rate&doi=10.1111%2Fj.1476-5381.2012.02061.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span></div><div class="casAuthors">Gergely, P.; Nuesslein-Hildesheim, B.; Guerini, D.; Brinkmann, V.; Traebert, M.; Bruns, C.; Pan, S.; Gray, N. S.; Hinterding, K.; Cooke, N. G.; Groenewegen, A.; Vitaliti, A.; Sing, T.; Luttringer, O.; Yang, J.; Gardin, A.; Wang, N.; Crumb, W. J., Jr.; Saltzman, M.; Rosenberg, M.; Wallstrom, E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-1047</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose BAF312 is a next-generation sphingosine 1-phosphate (S1P) receptor modulator, selective for S1P1 and S1P5 receptors.  S1P1 receptors are essential for lymphocyte egress from lymph nodes and a drug target in immune-mediated diseases.  Here, we have characterized the immunomodulatory potential of BAF312 and the S1P receptor-mediated effects on heart rate using preclin. and human data.  Exptl. Approach BAF312 was tested in a rat exptl. autoimmune encephalomyelitis (EAE) model.  Electrophysiol. recordings of G-protein-coupled inwardly rectifying potassium (GIRK) channels were carried out in human atrial myocytes.  A Phase I multiple-dose trial studied the pharmacokinetics, pharmacodynamics and safety of BAF312 in 48 healthy subjects.  Key Results BAF312 effectively suppressed EAE in rats by internalizing S1P1 receptors, rendering them insensitive to the egress signal from lymph nodes.  In healthy volunteers, BAF312 caused preferential decreases in CD4+ T cells, Tnaive, Tcentral memory and B cells within 4-6 h.  Cell counts returned to normal ranges within a week after stopping treatment, in line with the elimination half-life of BAF312.  Despite sparing S1P3 receptors (assocd. with bradycardia in mice), BAF312 induced rapid, transient (day 1 only) bradycardia in humans.  BAF312-mediated activation of GIRK channels in human atrial myocytes can fully explain the bradycardia.  Conclusion and Implications This study illustrates species-specific differences in S1P receptor specificity for first-dose cardiac effects.  Based on its profound but rapidly reversible inhibition of lymphocyte trafficking, BAF312 may have potential as a treatment for immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr42VfW58NMyLVg90H21EOLACvtfcHk0ljdKTh4JEgiJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bE&md5=0034be62fb68b10abefff50f0220be2a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02061.x%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DTraebert%26aufirst%3DM.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DGroenewegen%26aufirst%3DA.%26aulast%3DVitaliti%26aufirst%3DA.%26aulast%3DSing%26aufirst%3DT.%26aulast%3DLuttringer%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCrumb%26aufirst%3DW.%2BJ.%26aulast%3DSaltzman%26aufirst%3DM.%26aulast%3DRosenberg%26aufirst%3DM.%26aulast%3DWallstrom%26aufirst%3DE.%26atitle%3DThe%2520selective%2520sphingosine%25201-phosphate%2520receptor%2520modulator%2520BAF312%2520redirects%2520lymphocyte%2520distribution%2520and%2520has%2520species-specific%2520effects%2520on%2520heart%2520rate%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D1035%26epage%3D1047%26doi%3D10.1111%2Fj.1476-5381.2012.02061.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Murakami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takasugi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koide, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasamori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, N.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P<sub>3</sub> receptor: Investigation based on a new S1P<sub>3</sub> receptor antagonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span><span class="refDoi"> DOI: 10.1124/mol.109.061481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1124%2Fmol.109.061481" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=704-713&author=A.+Murakamiauthor=H.+Takasugiauthor=S.+Ohnumaauthor=Y.+Koideauthor=A.+Sakuraiauthor=S.+Takedaauthor=T.+Hasegawaauthor=J.+Sasamoriauthor=T.+Konnoauthor=K.+Hayashiauthor=Y.+Watanabeauthor=K.+Moriauthor=Y.+Satoauthor=A.+Takahashiauthor=N.+Mochizukiauthor=N.+Takakura&title=Sphingosine+1-phosphate+%28S1P%29+regulates+vascular+contraction+via+S1P3+receptor%3A+Investigation+based+on+a+new+S1P3+receptor+antagonist&doi=10.1124%2Fmol.109.061481"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fmol.109.061481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.109.061481%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DA.%26aulast%3DTakasugi%26aufirst%3DH.%26aulast%3DOhnuma%26aufirst%3DS.%26aulast%3DKoide%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DSasamori%26aufirst%3DJ.%26aulast%3DKonno%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DMochizuki%26aufirst%3DN.%26aulast%3DTakakura%26aufirst%3DN.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520regulates%2520vascular%2520contraction%2520via%2520S1P3%2520receptor%253A%2520Investigation%2520based%2520on%2520a%2520new%2520S1P3%2520receptor%2520antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D704%26epage%3D713%26doi%3D10.1124%2Fmol.109.061481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Li, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pappalardo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, F.</span><span> </span><span class="NLM_article-title">Induction of antiproliferative connective tissue growth factor expression in Wilms’ tumor cells by sphingosine-1-phosphate receptor 2</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1649</span><span class="NLM_x">–</span> <span class="NLM_lpage">1656</span><span class="refDoi"> DOI: 10.1158/1541-7786.MCR-07-2048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1158%2F1541-7786.MCR-07-2048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=18922980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Cmsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=1649-1656&author=M.+H.+Liauthor=T.+Sanchezauthor=A.+Pappalardoauthor=K.+R.+Lynchauthor=T.+Hlaauthor=F.+Ferrer&title=Induction+of+antiproliferative+connective+tissue+growth+factor+expression+in+Wilms%E2%80%99+tumor+cells+by+sphingosine-1-phosphate+receptor+2&doi=10.1158%2F1541-7786.MCR-07-2048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2</span></div><div class="casAuthors">Li, Mei-Hong; Sanchez, Teresa; Pappalardo, Anna; Lynch, Kevin R.; Hla, Timothy; Ferrer, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1649-1656</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Connective tissue growth factor (CTGF), a member of the CCN family of secreted matricellular proteins, regulates fibrosis, angiogenesis, cell proliferation, apoptosis, tumor growth, and metastasis.  However, the role of CTGF and its regulation mechanism in Wilms' tumor remains largely unknown.  We found that the bioactive lipid sphingosine-1-phosphate (S1P) induced CTGF expression in a concn.- and time-dependent manner in a Wilms' tumor cell line (WiT49), whereas FTY720-phosphate, an S1P analog that binds all S1P receptors except S1P2, did not.  Further, the specific S1P2 antagonist JTE-013 completely inhibited S1P-induced CTGF expression, whereas the S1P1 antagonist VPC44116 did not, indicating that this effect was mediated by S1P2.  This was confirmed by adenoviral transduction of S1P2 in WiT49 cells, which showed that overexpression of S1P2 increased the expression of CTGF.  Induction of CTGF by S1P was sensitive to ROCK inhibitor Y-27632 and c-Jun N-terminal kinase inhibitor SP600125, suggesting the requirement of RhoA/ROCK and c-Jun N-terminal kinase pathways for S1P-induced CTGF expression.  Interestingly, the expression levels of CTGF were decreased in 8 of 10 Wilms' tumor tissues compared with matched normal tissues by quant. real-time PCR and Western blot anal.  In vitro, human recombinant CTGF significantly inhibited the proliferation of WiT49 cells.  In addn., overexpression of CTGF resulted in significant inhibition of WiT49 cell growth.  Taken together, these data suggest that CTGF protein induced by S1P2 might act as a growth inhibitor in Wilms' tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0itj-FE9CkrVg90H21EOLACvtfcHk0liC9-xESYBioA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Cmsb%252FI&md5=991604878a73ab45c95f38552849e53d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-07-2048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-07-2048%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%2BH.%26aulast%3DSanchez%26aufirst%3DT.%26aulast%3DPappalardo%26aufirst%3DA.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DFerrer%26aufirst%3DF.%26atitle%3DInduction%2520of%2520antiproliferative%2520connective%2520tissue%2520growth%2520factor%2520expression%2520in%2520Wilms%25E2%2580%2599%2520tumor%2520cells%2520by%2520sphingosine-1-phosphate%2520receptor%25202%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2008%26volume%3D6%26spage%3D1649%26epage%3D1656%26doi%3D10.1158%2F1541-7786.MCR-07-2048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Plano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, A. K.</span><span> </span><span class="NLM_article-title">Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5509</span><span class="NLM_x">–</span> <span class="NLM_lpage">5524</span><span class="refDoi"> DOI: 10.1021/jm4011687</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4011687" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5509-5524&author=D.+Planoauthor=S.+Aminauthor=A.+K.+Sharma&title=Importance+of+sphingosine+kinase+%28SphK%29+as+a+target+in+developing+cancer+therapeutics+and+recent+developments+in+the+synthesis+of+novel+SphK+inhibitors&doi=10.1021%2Fjm4011687"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm4011687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4011687%26sid%3Dliteratum%253Aachs%26aulast%3DPlano%26aufirst%3DD.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26atitle%3DImportance%2520of%2520sphingosine%2520kinase%2520%2528SphK%2529%2520as%2520a%2520target%2520in%2520developing%2520cancer%2520therapeutics%2520and%2520recent%2520developments%2520in%2520the%2520synthesis%2520of%2520novel%2520SphK%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5509%26epage%3D5524%26doi%3D10.1021%2Fjm4011687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ishii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klauschen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier-Schellersheim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, R. N.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span><span class="refDoi"> DOI: 10.1038/nature07713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1038%2Fnature07713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=19204730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=524-528&author=M.+Ishiiauthor=J.+G.+Egenauthor=F.+Klauschenauthor=M.+Meier-Schellersheimauthor=Y.+Saekiauthor=J.+Vacherauthor=R.+L.+Proiaauthor=R.+N.+Germain&title=Sphingosine-1-phosphate+mobilizes+osteoclast+precursors+and+regulates+bone+homeostasis&doi=10.1038%2Fnature07713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis</span></div><div class="casAuthors">Ishii, Masaru; Egen, Jackson G.; Klauschen, Frederick; Meier-Schellersheim, Martin; Saeki, Yukihiko; Vacher, Jean; Proia, Richard L.; Germain, Ronald N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">7237</span>),
    <span class="NLM_cas:pages">524-528</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Osteoclasts are the only somatic cells with bone-resorbing capacity and, as such, they have a crit. role not only in normal bone homeostasis (called bone remodelling') but also in the pathogenesis of bone destructive disorders such as rheumatoid arthritis and osteoporosis.  A major focus of research in the field has been on gene regulation by osteoclastogenic cytokines such as receptor activator of NF-κB-ligand (RANKL, also known as TNFSF11) and TNF-α, both of which have been well documented to contribute to osteoclast terminal differentiation.  A crucial process that has been less well studied is the trafficking of osteoclast precursors to and from the bone surface, where they undergo cell fusion to form the fully differentiated multinucleated cells that mediate bone resorption.  Here we report that sphingosine-1-phosphate (S1P), a lipid mediator enriched in blood, induces chemotaxis and regulates the migration of osteoclast precursors not only in culture but also in vivo, contributing to the dynamic control of bone mineral homeostasis.  Cells with the properties of osteoclast precursors express functional S1P1 receptors and exhibit pos. chemotaxis along an S1P gradient in vitro.  Intravital two-photon imaging of bone tissues showed that a potent S1P1 agonist, SEW2871, stimulated motility of osteoclast precursor-contg. monocytoid populations in vivo.  Osteoclast/monocyte (CD11b, also known as ITGAM) lineage-specific conditional S1P1 knockout mice showed osteoporotic changes due to increased osteoclast attachment to the bone surface.  Furthermore, treatment with the S1P1 agonist FTY720 relieved ovariectomy-induced osteoporosis in mice by reducing the no. of mature osteoclasts attached to the bone surface.  Together, these data provide evidence that S1P controls the migratory behavior of osteoclast precursors, dynamically regulating bone mineral homeostasis, and identifies a crit. control point in osteoclastogenesis that may have potential as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5nhHArE-y5LVg90H21EOLACvtfcHk0litD7rPzjU1XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCqsrg%253D&md5=3615d96c5b372559422cb6242e8d6c35</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature07713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07713%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DM.%26aulast%3DEgen%26aufirst%3DJ.%2BG.%26aulast%3DKlauschen%26aufirst%3DF.%26aulast%3DMeier-Schellersheim%26aufirst%3DM.%26aulast%3DSaeki%26aufirst%3DY.%26aulast%3DVacher%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DGermain%26aufirst%3DR.%2BN.%26atitle%3DSphingosine-1-phosphate%2520mobilizes%2520osteoclast%2520precursors%2520and%2520regulates%2520bone%2520homeostasis%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D524%26epage%3D528%26doi%3D10.1038%2Fnature07713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Cross, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccio, L.</span><span> </span><span class="NLM_article-title">Rituximab combination therapy in relapsing multiple sclerosis</span> <span class="citation_source-journal">Ther. Adv. Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span><span class="refDoi"> DOI: 10.1177/1756285612461165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1177%2F1756285612461165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=23139702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVSlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=311-319&author=A.+H.+Crossauthor=R.+S.+Kleinauthor=L.+Piccio&title=Rituximab+combination+therapy+in+relapsing+multiple+sclerosis&doi=10.1177%2F1756285612461165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Rituximab combination therapy in relapsing multiple sclerosis</span></div><div class="casAuthors">Cross, Anne H.; Klein, Robyn S.; Piccio, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Neurological Disorders</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">311-319, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">TANDCF</span>;
        ISSN:<span class="NLM_cas:issn">1756-2856</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  In multiple sclerosis (MS), the presence of B cells, plasma cells and excess Igs in central nervous system lesions and in the cerebrospinal fluid implicate the humoral immune system in disease pathogenesis.  However, until the advent of specific B-cell-depleting therapies, the crit. role of B cells and their products in MS was unproven.  Rituximab, a monoclonal antibody that depletes B cells by targeting the CD20 mol., has been shown to effectively reduce disease activity in patients with relapsing MS as a single agent.  Our investigator-initiated phase II study is the only published clin. trial in which rituximab was used as an add-on therapy in patients with relapsing MS who had an inadequate response to std. injectable disease-modifying therapies (DMTs).  The primary endpoint, magnetic resonance imaging (MRI) gadolinium-enhanced (GdE) lesion no. before vs. after rituximab, showed significant benefit of rituximab (74% of post-treatment MRI scans being free of GdE lesions compared with 26% free of GdE lesions at baseline; p<0.0001).  No differences were noted comparing patients on different DMTs.  Several secondary clin. endpoints, safety and lab. measurements (including B- and T- cell nos. in the blood and cerebrospinal fluid (CSF), serum and CSF chemokine levels, antibodies to myelin proteins) were assessed.  Surprisingly, the decline in B-cell no. was accompanied by a significant redn. in the no. of T cells in both the peripheral blood and CSF.  Rituximab therapy was assocd. with a significant decline of two lymphoid chemokines, CXCL13 and CCL19.  No significant changes were obsd. in serum antibody levels against myelin proteins [myelin basic protein (MBP) and myelin/oligodendrocyte glycoprotein (MOG)] after treatment.  These results suggest that B cells play a role in MS independent from antibody prodn. and possibly related to their role in antigen presentation to T cells or to their chemokine/cytokine prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_V9wmb18qQLVg90H21EOLACvtfcHk0litD7rPzjU1XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVSlsb0%253D&md5=07769c61a17ad6d0df3e78de79943b52</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1177%2F1756285612461165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1756285612461165%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DA.%2BH.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26aulast%3DPiccio%26aufirst%3DL.%26atitle%3DRituximab%2520combination%2520therapy%2520in%2520relapsing%2520multiple%2520sclerosis%26jtitle%3DTher.%2520Adv.%2520Neurol.%2520Disord.%26date%3D2012%26volume%3D5%26spage%3D311%26epage%3D319%26doi%3D10.1177%2F1756285612461165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Dong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice</span> <span class="citation_source-journal">Clin. Exp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1111/cei.12304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1111%2Fcei.12304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=24611843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1KrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2014&pages=94-101&author=J.+Dongauthor=H.+Wangauthor=G.+Wuauthor=J.+Zhaoauthor=L.+Zhangauthor=L.+Zuoauthor=W.+Zhuauthor=J.+Gongauthor=Y.+Liauthor=L.+Guauthor=J.+Li&title=Oral+treatment+with+SEW2871%2C+a+sphingosine-1-phosphate+type+1+receptor+agonist%2C+ameliorates+experimental+colitis+in+interleukin-10+gene+deficient+mice&doi=10.1111%2Fcei.12304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice</span></div><div class="casAuthors">Dong, J.; Wang, H.; Wu, G.; Zhao, J.; Zhang, L.; Zuo, L.; Zhu, W.; Gong, J.; Li, Y.; Gu, L.; Li, J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-101</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : SEW2871, a selective sphingosine-1-phosphate type 1 receptor (S1P1) agonist, has been shown to be effective in protecting kidneys against ischemia-reperfusion injury by reducing CD4+ T cell infiltration in mice.  However, the effects of SEW2871 on colitis remain unclear.  The aim of this study was to investigate the effects of SEW2871 on established colitis in interleukin (IL)-10 gene-deficient (IL-10-/-) mice, a murine model of Crohn's disease (CD).  SEW2871 was administered by gavage at a dose of 20 mg/kg/day for 2 wk to IL-10-/- mice.  Severity of colitis, serum amyloid A, tissue myeloperoxidase (MPO), T cells in blood and colon lamina propria (LP) and proinflammatory cytokine productions were evaluated.  Furthermore, the phospho-signal transducer and activator of transcription (STAT)-3 (p-STAT-3) expression in lymphocytes isolated from colon LP was also assessed.  The 2-wk administration of SEW2871 ameliorated established colitis in IL-10-/- mice, assocd. with a redn. of serum amyloid A concn., a decreased colon MPO concn., a depletion of the peripheral CD4+CD45+ T cells and a redn. of the homing of T cells into colon LP.  Moreover, typical cytokines of T helper type 1 (Th1) and Th17 cells and p-STAT-3 expression were also suppressed by SEW2871 treatment.  SEW2871 treatment ameliorates established exptl. colitis in IL-10-/- mice, which may provide a new therapeutic approach for human CD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh40KVSx1HQLVg90H21EOLACvtfcHk0litD7rPzjU1XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1KrsLk%253D&md5=41efa767cdc4f55c36d6ec4a0d7882fa</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fcei.12304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcei.12304%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZuo%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DOral%2520treatment%2520with%2520SEW2871%252C%2520a%2520sphingosine-1-phosphate%2520type%25201%2520receptor%2520agonist%252C%2520ameliorates%2520experimental%2520colitis%2520in%2520interleukin-10%2520gene%2520deficient%2520mice%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2014%26volume%3D177%26spage%3D94%26epage%3D101%26doi%3D10.1111%2Fcei.12304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">McCandless, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. S.</span><span> </span><span class="NLM_article-title">IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">183</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span><span class="refDoi"> DOI: 10.4049/jimmunol.0802258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.4049%2Fjimmunol.0802258" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2009&pages=613-620&author=E.+E.+McCandlessauthor=M.+Buddeauthor=J.+R.+Leesauthor=D.+Dorseyauthor=E.+Lyngauthor=R.+S.+Klein&title=IL-1R+signaling+within+the+central+nervous+system+regulates+CXCL12+expression+at+the+blood-brain+barrier+and+disease+severity+during+experimental+autoimmune+encephalomyelitis&doi=10.4049%2Fjimmunol.0802258"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0802258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0802258%26sid%3Dliteratum%253Aachs%26aulast%3DMcCandless%26aufirst%3DE.%2BE.%26aulast%3DBudde%26aufirst%3DM.%26aulast%3DLees%26aufirst%3DJ.%2BR.%26aulast%3DDorsey%26aufirst%3DD.%26aulast%3DLyng%26aufirst%3DE.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26atitle%3DIL-1R%2520signaling%2520within%2520the%2520central%2520nervous%2520system%2520regulates%2520CXCL12%2520expression%2520at%2520the%2520blood-brain%2520barrier%2520and%2520disease%2520severity%2520during%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D183%26spage%3D613%26epage%3D620%26doi%3D10.4049%2Fjimmunol.0802258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Moberly, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohatagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noveck, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truitt, K. E.</span><span> </span><span class="NLM_article-title">Pharmacological modulation of peripheral T and B lymphocytes by a selective sphingosine 1-phosphate receptor-1 modulator</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">996</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span><span class="refDoi"> DOI: 10.1177/0091270011408728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1177%2F0091270011408728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=21566200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ShtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=996-1006&author=J.+B.+Moberlyauthor=S.+Rohatagiauthor=H.+Zahirauthor=C.+Hsuauthor=R.+J.+Noveckauthor=K.+E.+Truitt&title=Pharmacological+modulation+of+peripheral+T+and+B+lymphocytes+by+a+selective+sphingosine+1-phosphate+receptor-1+modulator&doi=10.1177%2F0091270011408728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological modulation of peripheral T and B lymphocytes by a selective sphingosine 1-phosphate receptor-1 modulator</span></div><div class="casAuthors">Moberly, James B.; Rohatagi, Shashank; Zahir, Hamim; Hsu, Ching; Noveck, Robert J.; Truitt, Kenneth E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">996-1006</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">CS-0777 is a selective sphingosine 1-phosphate receptor-1 (S1P1) modulator under development for treatment of autoimmune conditions.  A randomized, double-blind, placebo-controlled study was conducted to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of CS-0777 in escalating dose cohorts of healthy male participants (0.1, 0.3, 1.0, and 2.5 mg; 6 active, 2 placebo per cohort).  Primary pharmacodynamic parameters were abs. lymphocyte counts and lymphocyte subsets (CD4 and CD8 T and B cells).  CS-0777 resulted in a pronounced, dose-dependent decrease in abs. lymphocyte counts (mean percent decrease from baseline at 24 h postdose: 7%, 26%, 52%, 79%, and 85%, for placebo and 0.1, 0.3, 1.0, and 2.5 mg, resp.).  Dose-related decreases of similar magnitude were obsd. for T and B cell subsets.  Mean total white blood cell and neutrophil counts remained within normal ranges for all dose levels.  CS-0777 was well tolerated, and there were no serious or severe adverse events.  Mild, asymptomatic bradycardia and transaminase elevations (<3-fold upper limit of normal), similar to findings for other S1P receptor modulators, were obsd. at the highest dose level (2.5 mg).  Therefore, CS-0777 shows potent activity in humans and may hold potential for treatment of autoimmune conditions such as multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR8u0a5KeOdLVg90H21EOLACvtfcHk0lhf9XSD99fdGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ShtLbO&md5=504f2b5e6fc73885abc263d5d6252218</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1177%2F0091270011408728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270011408728%26sid%3Dliteratum%253Aachs%26aulast%3DMoberly%26aufirst%3DJ.%2BB.%26aulast%3DRohatagi%26aufirst%3DS.%26aulast%3DZahir%26aufirst%3DH.%26aulast%3DHsu%26aufirst%3DC.%26aulast%3DNoveck%26aufirst%3DR.%2BJ.%26aulast%3DTruitt%26aufirst%3DK.%2BE.%26atitle%3DPharmacological%2520modulation%2520of%2520peripheral%2520T%2520and%2520B%2520lymphocytes%2520by%2520a%2520selective%2520sphingosine%25201-phosphate%2520receptor-1%2520modulator%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2012%26volume%3D52%26spage%3D996%26epage%3D1006%26doi%3D10.1177%2F0091270011408728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Graler, M. H.</span><span> </span><span class="NLM_article-title">Targeting sphingosine 1-phosphate (S1P) levels and S1P receptor functions for therapeutic immune interventions</span> <span class="citation_source-journal">Cell. Physiol. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span><span class="refDoi"> DOI: 10.1159/000315108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1159%2F000315108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=20502007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A280%3ADC%252BC3czmvFyjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=79-86&author=M.+H.+Graler&title=Targeting+sphingosine+1-phosphate+%28S1P%29+levels+and+S1P+receptor+functions+for+therapeutic+immune+interventions&doi=10.1159%2F000315108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting sphingosine 1-phosphate (S1P) levels and S1P receptor functions for therapeutic immune interventions</span></div><div class="casAuthors">Graler Markus H</div><div class="citationInfo"><span class="NLM_cas:title">Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is an important regulator of many different immune functions including lymphocyte circulation, antigen presentation, and T cell development.  It stimulates five G protein-coupled receptors designated S1P(1-5), which are also expressed by immune cells.  S1P receptors couple to different heterotrimeric G proteins including G alpha i, q, and 12/13, and elicit cellular signalling events by activating the small GTPases Rac and Rho and protein kinases Akt, ERK, and JNK, and by inducing cellular calcium flux and inhibiting cAMP accumulation, amongst others.  S1P is the exit signal for lymphocytes leaving lymphoid organs and present in blood and lymph at high nanomolar concentrations due to the S1P-producing activity of sphingosine kinases (SK).  The S1P-degrading enzyme S1P-lyase maintains low amounts of S1P in lymphoid organs.  Disrupting this concentration difference by S1P receptor agonists and antagonists like FTY720, SEW2871, and VPC23019, by an anti-S1P antibody, or by inhibiting the S1P-lyase has therapeutic potential for autoimmune diseases like multiple sclerosis (MS) and rheumatoid arthritis and for many other disorders like cancer, fibrosis, inflammation, macular degeneration, diabetic retinopathy, and glaucoma.  This report aims to provide a brief overview of concepts, approaches, pharmaceutical compounds, and targets that are currently used to modulate S1P-driven immune functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkVD7D529OLvcsfMJQC1ZdfW6udTcc2eYcTwh9rOPWGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czmvFyjsw%253D%253D&md5=d69921fd8a1a5da3e88fbda25eef84a5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1159%2F000315108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000315108%26sid%3Dliteratum%253Aachs%26aulast%3DGraler%26aufirst%3DM.%2BH.%26atitle%3DTargeting%2520sphingosine%25201-phosphate%2520%2528S1P%2529%2520levels%2520and%2520S1P%2520receptor%2520functions%2520for%2520therapeutic%2520immune%2520interventions%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2010%26volume%3D26%26spage%3D79%26epage%3D86%26doi%3D10.1159%2F000315108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Holman, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ransohoff, R. M.</span><span> </span><span class="NLM_article-title">The blood-brain barrier, chemokines and multiple sclerosis</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Basis Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1812</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span><span class="refDoi"> DOI: 10.1016/j.bbadis.2010.07.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.bbadis.2010.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=20692338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFyrsrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1812&publication_year=2011&pages=220-230&author=D.+W.+Holmanauthor=R.+S.+Kleinauthor=R.+M.+Ransohoff&title=The+blood-brain+barrier%2C+chemokines+and+multiple+sclerosis&doi=10.1016%2Fj.bbadis.2010.07.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The blood-brain barrier, chemokines and multiple sclerosis</span></div><div class="casAuthors">Holman, David W.; Klein, Robyn S.; Ransohoff, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1812</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">220-230</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  The infiltration of leukocytes into the central nervous system (CNS) is an essential step in the neuropathogenesis of multiple sclerosis (MS).  Leukocyte extravasation from the bloodstream is a multi-step process that depends on several factors including fluid dynamics within the vasculature and mol. interactions between circulating leukocytes and the vascular endothelium.  An important step in this cascade is the presence of chemokines on the vascular endothelial cell surface.  Chemokines displayed along the endothelial lumen bind chemokine receptors on circulating leukocytes, initiating intracellular signaling that culminates in integrin activation, leukocyte arrest, and extravasation.  The presence of chemokines at the endothelial lumen can help guide the movement of leukocytes through peripheral tissues during normal immune surveillance, host defense or inflammation.  The expression and display of homeostatic or inflammatory chemokines therefore critically det. which leukocyte subsets extravasate and enter the peripheral tissues.  Within the CNS, however, infiltrating leukocytes that cross the endothelium face addnl. boundaries to parenchymal entry, including the abluminal presence of localizing cues that prevent egress from perivascular spaces.  This review focuses on the differential display of chemokines along endothelial surfaces and how they impact leukocyte extravasation into parenchymal tissues, esp. within the CNS.  In particular, the display of chemokines by endothelial cells of the blood brain barrier may be altered during CNS autoimmune disease, promoting leukocyte entry into this immunol. distinct site.  Recent advances in microscopic techniques, including two-photon and intravital imaging have provided new insights into the mechanisms of chemokine-mediated capture of leukocytes within the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLo3vZY9znMLVg90H21EOLACvtfcHk0ljE0-L7zytJ6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFyrsrbE&md5=8ee0a39f62aefddf52741b6fc41aa377</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2010.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2010.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DHolman%26aufirst%3DD.%2BW.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26aulast%3DRansohoff%26aufirst%3DR.%2BM.%26atitle%3DThe%2520blood-brain%2520barrier%252C%2520chemokines%2520and%2520multiple%2520sclerosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2011%26volume%3D1812%26spage%3D220%26epage%3D230%26doi%3D10.1016%2Fj.bbadis.2010.07.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ohno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, M.</span><span> </span><span class="NLM_article-title">The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span><span class="refDoi"> DOI: 10.1002/bdd.719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1002%2Fbdd.719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=20623701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2nur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=396-406&author=T.+Ohnoauthor=C.+Hasegawaauthor=S.+Nakadeauthor=J.+Kitagawaauthor=N.+Hondaauthor=M.+Ogawa&title=The+prediction+of+human+response+to+ONO-4641%2C+a+sphingosine+1-phosphate+receptor+modulator%2C+from+preclinical+data+based+on+pharmacokinetic-pharmacodynamic+modeling&doi=10.1002%2Fbdd.719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling</span></div><div class="casAuthors">Ohno, Tomoya; Hasegawa, Chihiro; Nakade, Susumu; Kitagawa, Junsaku; Honda, Naoki; Ogawa, Mikio</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">396-406</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The pharmacokinetic (PK) and pharmacodynamic (PD) parameters of ONO-4641 in humans were estd. using preclin. data in order to provide essential information to better design future clin. studies.  The characterization of PK/PD was measured in terms of decreased lymphocyte counts in blood after administration of ONO-4641, a sphingosine 1-phosphate receptor modulator.  Using a two-compartment model, human PK parameters were estd. from preclin. PK data of cynomolgus monkey and in vitro human metab. data.  To est. human PD parameters, the relationship between lymphocyte counts and plasma concns. of ONO-4641 in cynomolgus monkeys was detd.  The relationship between lymphocyte counts and plasma concns. of ONO-4641 was described by an indirect-response model.  The indirect-response model had an Imax value of 0.828 and an IC50 value of 1.29 ng/mL based on the cynomolgus monkey data.  These parameters were used to represent human PD parameters for the simulation of lymphocyte counts.  Other human PD parameters such as input and output rate consts. for lymphocytes were obtained from the literature.  Based on these estd. human PK and PD parameters, human lymphocyte counts after administration of ONO-4641 were simulated.  In conclusion, the simulation of human lymphocyte counts based on preclin. data led to the acquisition of useful information for designing future clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiwKY4yjGAbbVg90H21EOLACvtfcHk0ljE0-L7zytJ6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2nur3E&md5=84a6f29097d798b219a6dc97537569c6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fbdd.719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.719%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DC.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DKitagawa%26aufirst%3DJ.%26aulast%3DHonda%26aufirst%3DN.%26aulast%3DOgawa%26aufirst%3DM.%26atitle%3DThe%2520prediction%2520of%2520human%2520response%2520to%2520ONO-4641%252C%2520a%2520sphingosine%25201-phosphate%2520receptor%2520modulator%252C%2520from%2520preclinical%2520data%2520based%2520on%2520pharmacokinetic-pharmacodynamic%2520modeling%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2010%26volume%3D31%26spage%3D396%26epage%3D406%26doi%3D10.1002%2Fbdd.719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">McCandless, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woerner, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. S.</span><span> </span><span class="NLM_article-title">Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span><span class="refDoi"> DOI: 10.2353/ajpath.2008.070918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.2353%2Fajpath.2008.070918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=18276777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A280%3ADC%252BD1c7kslyitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2008&pages=799-808&author=E.+E.+McCandlessauthor=L.+Piccioauthor=B.+M.+Woernerauthor=R.+E.+Schmidtauthor=J.+B.+Rubinauthor=A.+H.+Crossauthor=R.+S.+Klein&title=Pathological+expression+of+CXCL12+at+the+blood-brain+barrier+correlates+with+severity+of+multiple+sclerosis&doi=10.2353%2Fajpath.2008.070918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis</span></div><div class="casAuthors">McCandless Erin E; Piccio Laura; Woerner B Mark; Schmidt Robert E; Rubin Joshua B; Cross Anne H; Klein Robyn S</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">799-808</span>
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    </div><div class="casAbstract">Dysregulation of blood-brain barrier (BBB) function and transendothelial migration of leukocytes are essential components of the development and propagation of active lesions in multiple sclerosis (MS).  Animal studies indicate that polarized expression of the chemokine CXCL12 at the BBB prevents leukocyte extravasation into the central nervous system (CNS) and that disruption of CXCL12 polarity promotes entry of autoreactive leukocytes and inflammation.  In the present study, we examined expression of CXCL12 and its receptor, CXCR4, within CNS tissues from MS and non-MS patients.  Immunohistochemical analysis of CXCL12 expression at the BBB revealed basolateral localization in tissues derived from non-MS patients and at uninvolved sites in tissues from MS patients.  In contrast, within active MS lesions, CXCL12 expression was redistributed toward vessel lumena and was associated with CXCR4 activation in infiltrating leukocytes, as revealed by phospho-CXCR4-specific antibodies.  Quantitative assessment of CXCL12 expression by the CNS microvasculature established a positive correlation between CXCL12 redistribution, leukocyte infiltration, and severity of histological disease.  These results suggest that CXCL12 normally functions to localize infiltrating leukocytes to perivascular spaces, preventing CNS parenchymal infiltration.  In the patient cohort studied, altered patterns of CXCL12 expression at the BBB were specifically associated with MS, possibly facilitating trafficking of CXCR4-expressing mononuclear cells into and out of the perivascular space and leading to progression of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQozRdQ6NLRap0d-O_J5C0AfW6udTcc2eZi27s1QRkrtrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7kslyitA%253D%253D&md5=d232e834a7fc299e534176a1cbdcb24e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2008.070918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2008.070918%26sid%3Dliteratum%253Aachs%26aulast%3DMcCandless%26aufirst%3DE.%2BE.%26aulast%3DPiccio%26aufirst%3DL.%26aulast%3DWoerner%26aufirst%3DB.%2BM.%26aulast%3DSchmidt%26aufirst%3DR.%2BE.%26aulast%3DRubin%26aufirst%3DJ.%2BB.%26aulast%3DCross%26aufirst%3DA.%2BH.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26atitle%3DPathological%2520expression%2520of%2520CXCL12%2520at%2520the%2520blood-brain%2520barrier%2520correlates%2520with%2520severity%2520of%2520multiple%2520sclerosis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2008%26volume%3D172%26spage%3D799%26epage%3D808%26doi%3D10.2353%2Fajpath.2008.070918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, P. R.</span><span> </span><span class="NLM_article-title">Pharmacologic targeting of sphingosine-1-phosphate receptor 1 improves the renal microcirculation during sepsis in the mouse</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1124/jpet.114.219394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1124%2Fjpet.114.219394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=25355645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFSrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2015&pages=61-66&author=Z.+Wangauthor=C.+R.+Simsauthor=N.+K.+Patilauthor=N.+Gokdenauthor=P.+R.+Mayeux&title=Pharmacologic+targeting+of+sphingosine-1-phosphate+receptor+1+improves+the+renal+microcirculation+during+sepsis+in+the+mouse&doi=10.1124%2Fjpet.114.219394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic targeting of sphingosine-1-phosphate receptor 1 improves the renal microcirculation during sepsis in the mouse</span></div><div class="casAuthors">Wang, Zhen; Sims, Clark R.; Patil, Naeem K.; Gokden, Neriman; Mayeux, Philip R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-66, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Microvascular failure is hallmark of sepsis in humans and is recognized as a strong predictor of mortality.  In the mouse subjected to cecal ligation and puncture (CLP) to induce a clin. relevant sepsis, renal microvascular permeability increases and peritubular capillary perfusion declines rapidly in the kidney leading to acute kidney injury (AKI).  Sphingosine-1-phosphate (S1P) is a key regulator of microvascular endothelial function.  To investigate the role of S1P in the development of microvascular permeability and peritubular capillary hypoperfusion in the kidney during CLP-induced AKI, we used a pharmacol. approach and a clin. relevant delayed dosing paradigm.  Evans blue dye was used to measure renal microvascular permeability and intravital video microscopy was used to quantitate renal cortical capillary perfusion.  The S1P receptor 1 (S1P1) agonist SEW2871 [5-[4-phenyl-5-(trifluoromethyl)-2-thienyl]-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole] and S1P2 antagonist JTE-013 [N-(2,6-dichloro-4-pyridinyl)-2-[1,3-dimethyl-4-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-hydrazinecarboxamide] were administered at the time of CLP and produced a dose-dependent but partial redn. in renal microvascular permeability at 6 h after CLP.  However, neither agent improved capillary perfusion at 6 h.  With delayed administration at 6 h after CLP, only SEW2871 reversed microvascular permeability when measured at 18 h.  Importantly, SEW2871 also restored capillary perfusion and improved renal function.  These data suggest that S1P1 and S1P2 do not regulate the early decline in renal capillary perfusion.  However, later in the course of sepsis, pharmacol. stimulation of S1P1, even when delaying therapy until after injury has occurred, improves capillary and renal function, suggesting this approach should be evaluated as an adjunct therapy during sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH5Z_PovE0k7Vg90H21EOLACvtfcHk0lizLmWroerBrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFSrsrw%253D&md5=5a307d0daebe8a8ec0b2943e2c798a5b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.219394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.219394%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DSims%26aufirst%3DC.%2BR.%26aulast%3DPatil%26aufirst%3DN.%2BK.%26aulast%3DGokden%26aufirst%3DN.%26aulast%3DMayeux%26aufirst%3DP.%2BR.%26atitle%3DPharmacologic%2520targeting%2520of%2520sphingosine-1-phosphate%2520receptor%25201%2520improves%2520the%2520renal%2520microcirculation%2520during%2520sepsis%2520in%2520the%2520mouse%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D352%26spage%3D61%26epage%3D66%26doi%3D10.1124%2Fjpet.114.219394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">The role of imaging in proof of concept for CNS drug discovery and development</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span><span class="refDoi"> DOI: 10.1038/npp.2008.166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1038%2Fnpp.2008.166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=18843264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVyru7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=187-203&author=D.+F.+Wongauthor=J.+Tauscherauthor=G.+Grunder&title=The+role+of+imaging+in+proof+of+concept+for+CNS+drug+discovery+and+development&doi=10.1038%2Fnpp.2008.166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development</span></div><div class="casAuthors">Wong, Dean F.; Tauscher, Johannes; Grunder, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">187-203</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Neuroimaging, particularly that of neuroreceptor radioisotope and functional magnetic resonance imaging (fMRI), has played a fundamental role in neuropharmacol. and neurophysiol.  Because of the unique and pioneering role, esp. of the radiolabeling of central nervous system (CNS) drugs for receptor and neurotransmitter system imaging, there is an increasingly major role to aid in CNS drug development.  One component is providing evidence for proof of concept of the target for which candidate drugs are being tested for receptor occupancy mechanism of action and ultimately rational drug dosing.  There is also a role for other areas of neuroimaging, including fMRI and magnetic resonance spectroscopy in other magnetic resonance-based techniques that, together with radioisotope imaging, represent CNS mol. imaging.  ' The role of these approaches and a review of the recent advances in such neuroimaging for proof-of-concept studies is the subject for this paper.  Moreover, hypothetical examples and possible algorithms for early discovery/phase I development using neuroimaging provide specific working approaches.  In summary, this article reviews the vital biomarker approach of neuroimaging in proof of concept studies.  Neuropsychopharmacol. (2009) 34, 187-203; doi:10.1038/npp.2008.166; published online 8 Oct. 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8I0KCciAqxbVg90H21EOLACvtfcHk0lizLmWroerBrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVyru7rN&md5=c5c7b9b30303e57ceabf287e7eec35b6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2008.166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2008.166%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DTauscher%26aufirst%3DJ.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DThe%2520role%2520of%2520imaging%2520in%2520proof%2520of%2520concept%2520for%2520CNS%2520drug%2520discovery%2520and%2520development%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D187%26epage%3D203%26doi%3D10.1038%2Fnpp.2008.166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Eckelman, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilbourn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span> </span><span class="NLM_article-title">Discussion of targeting proteins in vivo: in vitro guidelines</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2006.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.nucmedbio.2006.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=16720235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvVOktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=449-451&author=W.+C.+Eckelmanauthor=M.+R.+Kilbournauthor=C.+A.+Mathis&title=Discussion+of+targeting+proteins+in+vivo%3A+in+vitro+guidelines&doi=10.1016%2Fj.nucmedbio.2006.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discussion of targeting proteins in vivo: in vitro guidelines</span></div><div class="casAuthors">Eckelman, William C.; Kilbourn, Michael R.; Mathis, Chester A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">449-451</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIy27VHTsB7bVg90H21EOLACvtfcHk0lizLmWroerBrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvVOktrg%253D&md5=51382e8f751cf418a0807c2e23e21a85</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2006.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2006.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DEckelman%26aufirst%3DW.%2BC.%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26atitle%3DDiscussion%2520of%2520targeting%2520proteins%2520in%2520vivo%253A%2520in%2520vitro%2520guidelines%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2006%26volume%3D33%26spage%3D449%26epage%3D451%26doi%3D10.1016%2Fj.nucmedbio.2006.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Eckelman, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span> </span><span class="NLM_article-title">Targeting proteins in vivo: in vitro guidelines</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2006.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.nucmedbio.2006.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=16546669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ehsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=161-164&author=W.+C.+Eckelmanauthor=C.+A.+Mathis&title=Targeting+proteins+in+vivo%3A+in+vitro+guidelines&doi=10.1016%2Fj.nucmedbio.2006.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting proteins in vivo: In vitro guidelines</span></div><div class="casAuthors">Eckelman, William C.; Mathis, Chester A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-164</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review with refs.  The development of targeted mols. for in vivo imaging is a natural outgrowth of the development of targeted biochems. and pharmaceuticals used in vitro.  After choosing a receptor or enzyme crucial to a specific disease, the use of a math. model to choose potential receptor-specific radiopharmaceuticals is key.  The prepn. of non-radioactive substituted ligands is often the next step.  The prepn. of the non-radioactive compd. better defines the radioactive compd. because classical anal. methods can be used.  Combined liq. chromatog./mass spectrometry anal. is recommended to define the metabolites of a potential radiopharmaceutical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAU4s7JwGz-bVg90H21EOLACvtfcHk0lizLmWroerBrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ehsLg%253D&md5=8521ecb3fb7a529d2283055e26a6985e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2006.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2006.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DEckelman%26aufirst%3DW.%2BC.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26atitle%3DTargeting%2520proteins%2520in%2520vivo%253A%2520in%2520vitro%2520guidelines%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2006%26volume%3D33%26spage%3D161%26epage%3D164%26doi%3D10.1016%2Fj.nucmedbio.2006.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Briard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigaud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auberson, Y. P.</span><span> </span><span class="NLM_article-title">BZM055, an iodinated radiotracer candidate for PET and SPECT imaging of myelin and FTY720 brain distribution</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.1002/cmdc.201000477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1002%2Fcmdc.201000477" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=667-677&author=E.+Briardauthor=D.+Orainauthor=C.+Beerliauthor=A.+Billichauthor=M.+Streiffauthor=M.+Bigaudauthor=Y.+P.+Auberson&title=BZM055%2C+an+iodinated+radiotracer+candidate+for+PET+and+SPECT+imaging+of+myelin+and+FTY720+brain+distribution&doi=10.1002%2Fcmdc.201000477"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000477%26sid%3Dliteratum%253Aachs%26aulast%3DBriard%26aufirst%3DE.%26aulast%3DOrain%26aufirst%3DD.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DStreiff%26aufirst%3DM.%26aulast%3DBigaud%26aufirst%3DM.%26aulast%3DAuberson%26aufirst%3DY.%2BP.%26atitle%3DBZM055%252C%2520an%2520iodinated%2520radiotracer%2520candidate%2520for%2520PET%2520and%2520SPECT%2520imaging%2520of%2520myelin%2520and%2520FTY720%2520brain%2520distribution%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D667%26epage%3D677%26doi%3D10.1002%2Fcmdc.201000477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Prasad, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haufe, G.</span><span> </span><span class="NLM_article-title">Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5168</span><span class="NLM_x">–</span> <span class="NLM_lpage">5181</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.bmc.2014.08.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5168-5181&author=V.+P.+Prasadauthor=S.+Wagnerauthor=P.+Keulauthor=S.+Hermannauthor=B.+Levkauauthor=M.+Sch%C3%A4fersauthor=G.+Haufe&title=Synthesis+of+fluorinated+analogues+of+sphingosine-1-phosphate+antagonists+as+potential+radiotracers+for+molecular+imaging+using+positron+emission+tomography&doi=10.1016%2Fj.bmc.2014.08.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DV.%2BP.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DKeul%26aufirst%3DP.%26aulast%3DHermann%26aufirst%3DS.%26aulast%3DLevkau%26aufirst%3DB.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26aulast%3DHaufe%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520fluorinated%2520analogues%2520of%2520sphingosine-1-phosphate%2520antagonists%2520as%2520potential%2520radiotracers%2520for%2520molecular%2520imaging%2520using%2520positron%2520emission%2520tomography%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5168%26epage%3D5181%26doi%3D10.1016%2Fj.bmc.2014.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Shaikh, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haufe, G.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of fluorinated fingolimod (FTY720) analogues for sphingosine-1-phosphate receptor molecular imaging by positron emission tomography</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3471</span><span class="NLM_x">–</span> <span class="NLM_lpage">3484</span><span class="refDoi"> DOI: 10.1021/jm502021d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm502021d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsFGns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3471-3484&author=R.+S.+Shaikhauthor=S.+S.+Schilsonauthor=S.+Wagnerauthor=S.+Hermannauthor=P.+Keulauthor=B.+Levkauauthor=M.+Schafersauthor=G.+Haufe&title=Synthesis+and+evaluation+of+fluorinated+fingolimod+%28FTY720%29+analogues+for+sphingosine-1-phosphate+receptor+molecular+imaging+by+positron+emission+tomography&doi=10.1021%2Fjm502021d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Fluorinated Fingolimod (FTY720) Analogues for Sphingosine-1-Phosphate Receptor Molecular Imaging by Positron Emission Tomography</span></div><div class="casAuthors">Shaikh, Rizwan S.; Schilson, Stefanie S.; Wagner, Stefan; Hermann, Sven; Keul, Petra; Levkau, Bodo; Schaefers, Michael; Haufe, Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3471-3484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sphingosine-1-phosphate (S1P) is a lysophospholipid that evokes a variety of biol. responses via stimulation of a set of cognate G-protein coupled receptors (GPCRs): S1P1-S1P5.  S1P and its receptors (S1PRs) play important roles in the immune, cardiovascular, and central nervous systems and have also been implicated in carcinogenesis.  Recently, the S1P analog Fingolimod (FTY720) has been approved for the treatment of patients with relapsing multiple sclerosis.  This work presents the synthesis of various fluorinated structural analogs of FTY720, their in vitro and in vivo biol. testing, and their development and application as [18F]radiotracers for the study of S1PR biodistribution and imaging in mice using small-animal positron emission tomog. (PET).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLd-TV-43IobVg90H21EOLACvtfcHk0lgPWkOv82pD3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsFGns74%253D&md5=226bcd232b68e3eefa3939b7c24e3fdf</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm502021d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm502021d%26sid%3Dliteratum%253Aachs%26aulast%3DShaikh%26aufirst%3DR.%2BS.%26aulast%3DSchilson%26aufirst%3DS.%2BS.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DHermann%26aufirst%3DS.%26aulast%3DKeul%26aufirst%3DP.%26aulast%3DLevkau%26aufirst%3DB.%26aulast%3DSchafers%26aufirst%3DM.%26aulast%3DHaufe%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520fluorinated%2520fingolimod%2520%2528FTY720%2529%2520analogues%2520for%2520sphingosine-1-phosphate%2520receptor%2520molecular%2520imaging%2520by%2520positron%2520emission%2520tomography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3471%26epage%3D3484%26doi%3D10.1021%2Fjm502021d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Yue, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span> </span><span class="NLM_article-title">A potent and selective C-11 labeled PET tracer for imaging sphingosine-1-phosphate receptor 2 in the CNS demonstrates sexually dimorphic expression</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">7928</span><span class="NLM_x">–</span> <span class="NLM_lpage">7939</span><span class="refDoi"> DOI: 10.1039/C5OB00951K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1039%2FC5OB00951K" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=7928-7939&author=X.+Yueauthor=H.+Jinauthor=H.+Liuauthor=A.+J.+Rosenbergauthor=R.+S.+Kleinauthor=Z.+Tu&title=A+potent+and+selective+C-11+labeled+PET+tracer+for+imaging+sphingosine-1-phosphate+receptor+2+in+the+CNS+demonstrates+sexually+dimorphic+expression&doi=10.1039%2FC5OB00951K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC5OB00951K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB00951K%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DRosenberg%26aufirst%3DA.%2BJ.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26aulast%3DTu%26aufirst%3DZ.%26atitle%3DA%2520potent%2520and%2520selective%2520C-11%2520labeled%2520PET%2520tracer%2520for%2520imaging%2520sphingosine-1-phosphate%2520receptor%25202%2520in%2520the%2520CNS%2520demonstrates%2520sexually%2520dimorphic%2520expression%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D7928%26epage%3D7939%26doi%3D10.1039%2FC5OB00951K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Jin, H.; Yang, H.; Liu, H.; Zhang, Y.; Zhang, X.; Rosenberg, A. J.; Liu, Y.; Lapi, S. E.; Tu, Z.</span><span> </span><span class="NLM_article-title">A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury</span>.  <span class="citation_source-journal">J. Nucl. Cardiol.</span> [Online early access]. DOI:<span class="refDoi"> DOI: 10.1007/s12350-015-0391-1</span> . Published Online: Feb 02,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1007%2Fs12350-015-0391-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=26843200" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=H.+Jin&author=H.+Yang&author=H.+Liu&author=Y.+Zhang&author=X.+Zhang&author=A.+J.+Rosenberg&author=Y.+Liu&author=S.+E.+Lapi&author=Z.+Tu&title=A+promising+carbon-11-labeled+sphingosine-1-phosphate+receptor+1-specific+PET+tracer+for+imaging+vascular+injury&doi=10.1007%2Fs12350-015-0391-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs12350-015-0391-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12350-015-0391-1%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DH.%26atitle%3DA%2520promising%2520carbon-11-labeled%2520sphingosine-1-phosphate%2520receptor%25201-specific%2520PET%2520tracer%2520for%2520imaging%2520vascular%2520injury%26jtitle%3DJ.%2520Nucl.%2520Cardiol.%26doi%3D10.1007%2Fs12350-015-0391-1%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Liu, H.; Jin, H.; Yue, X.; Luo, Z.; Liu, C.; Rosenberg, A. J.; Tu, Z.</span><span> </span><span class="NLM_article-title">PET imaging study of S1PR1 expression in a rat model of multiple sclerosis</span>.  <span class="citation_source-journal">Mol. Imaging Biol.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1007/s11307-016-0944-y</span> . Published Online: Mar 14,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1007%2Fs11307-016-0944-y" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=H.+Liu&author=H.+Jin&author=X.+Yue&author=Z.+Luo&author=C.+Liu&author=A.+J.+Rosenberg&author=Z.+Tu&title=PET+imaging+study+of+S1PR1+expression+in+a+rat+model+of+multiple+sclerosis&doi=10.1007%2Fs11307-016-0944-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs11307-016-0944-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-016-0944-y%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DPET%2520imaging%2520study%2520of%2520S1PR1%2520expression%2520in%2520a%2520rat%2520model%2520of%2520multiple%2520sclerosis%26jtitle%3DMol.%2520Imaging%2520Biol.%26doi%3D10.1007%2Fs11307-016-0944-y%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Deng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span> </span><span class="NLM_article-title">Identification of benzoxazole analogs as novel, S1P<sub>3</sub> sparing S1P<sub>1</sub> agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3973</span><span class="NLM_x">–</span> <span class="NLM_lpage">3977</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.04.095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.bmcl.2012.04.095" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3973-3977&author=G.+Dengauthor=Q.+Mengauthor=Q.+Liuauthor=X.+Xuauthor=Q.+Xuauthor=F.+Renauthor=T.+B.+Guoauthor=H.+Luauthor=J.+N.+Xiangauthor=J.+D.+Elliottauthor=X.+Lin&title=Identification+of+benzoxazole+analogs+as+novel%2C+S1P3+sparing+S1P1+agonists&doi=10.1016%2Fj.bmcl.2012.04.095"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.04.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.04.095%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DT.%2BB.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DIdentification%2520of%2520benzoxazole%2520analogs%2520as%2520novel%252C%2520S1P3%2520sparing%2520S1P1%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3973%26epage%3D3977%26doi%3D10.1016%2Fj.bmcl.2012.04.095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Quattropani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosignani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorbais, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzerelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beltran, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eligert, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novo-Perez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hantson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Souza, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrighi, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschert, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bombrun, A.</span><span> </span><span class="NLM_article-title">Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacy</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span><span class="refDoi"> DOI: 10.1002/cmdc.201402557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1002%2Fcmdc.201402557" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=688-714&author=A.+Quattropaniauthor=W.+H.+Sauerauthor=S.+Crosignaniauthor=J.+Dorbaisauthor=P.+Gerberauthor=J.+Gonzalezauthor=D.+Marinauthor=M.+Muzerelleauthor=F.+Beltranauthor=A.+Nicholsauthor=K.+Georgiauthor=M.+Schneiderauthor=P.+A.+Vitteauthor=V.+Eligertauthor=L.+Novo-Perezauthor=J.+Hantsonauthor=S.+Nockauthor=S.+Carboniauthor=A.+L.+de+Souzaauthor=J.+F.+Arrighiauthor=U.+Boschertauthor=A.+Bombrun&title=Pharmacophore-based+design+of+novel+oxadiazoles+as+selective+sphingosine-1-phosphate+%28S1P%29+receptor+agonists+with+in+vivo+efficacy&doi=10.1002%2Fcmdc.201402557"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402557%26sid%3Dliteratum%253Aachs%26aulast%3DQuattropani%26aufirst%3DA.%26aulast%3DSauer%26aufirst%3DW.%2BH.%26aulast%3DCrosignani%26aufirst%3DS.%26aulast%3DDorbais%26aufirst%3DJ.%26aulast%3DGerber%26aufirst%3DP.%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DMarin%26aufirst%3DD.%26aulast%3DMuzerelle%26aufirst%3DM.%26aulast%3DBeltran%26aufirst%3DF.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DGeorgi%26aufirst%3DK.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DVitte%26aufirst%3DP.%2BA.%26aulast%3DEligert%26aufirst%3DV.%26aulast%3DNovo-Perez%26aufirst%3DL.%26aulast%3DHantson%26aufirst%3DJ.%26aulast%3DNock%26aufirst%3DS.%26aulast%3DCarboni%26aufirst%3DS.%26aulast%3Dde%2BSouza%26aufirst%3DA.%2BL.%26aulast%3DArrighi%26aufirst%3DJ.%2BF.%26aulast%3DBoschert%26aufirst%3DU.%26aulast%3DBombrun%26aufirst%3DA.%26atitle%3DPharmacophore-based%2520design%2520of%2520novel%2520oxadiazoles%2520as%2520selective%2520sphingosine-1-phosphate%2520%2528S1P%2529%2520receptor%2520agonists%2520with%2520in%2520vivo%2520efficacy%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D688%26epage%3D714%26doi%3D10.1002%2Fcmdc.201402557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickham, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P<sub>1</sub>) receptor agonists with exceptional selectivity against S1P<sub>2</sub> and S1P<sub>3</sub></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6169</span><span class="NLM_x">–</span> <span class="NLM_lpage">6173</span><span class="refDoi"> DOI: 10.1021/jm0503244</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0503244" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6169-6173&author=Z.+Liauthor=W.+Chenauthor=J.+J.+Haleauthor=C.+L.+Lynchauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.+J.+Sheiauthor=G.+Chrebetauthor=S.+A.+Parentauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Forrestauthor=E.+J.+Quackenbushauthor=L.+A.+Wickhamauthor=H.+Vargasauthor=R.+M.+Evansauthor=H.+Rosenauthor=S.+Mandala&title=Discovery+of+potent+3%2C5-diphenyl-1%2C2%2C4-oxadiazole+sphingosine-1-phosphate-1+%28S1P1%29+receptor+agonists+with+exceptional+selectivity+against+S1P2+and+S1P3&doi=10.1021%2Fjm0503244"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm0503244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503244%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.%2BJ.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DParent%26aufirst%3DS.%2BA.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DQuackenbush%26aufirst%3DE.%2BJ.%26aulast%3DWickham%26aufirst%3DL.%2BA.%26aulast%3DVargas%26aufirst%3DH.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520potent%25203%252C5-diphenyl-1%252C2%252C4-oxadiazole%2520sphingosine-1-phosphate-1%2520%2528S1P1%2529%2520receptor%2520agonists%2520with%2520exceptional%2520selectivity%2520against%2520S1P2%2520and%2520S1P3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6169%26epage%3D6173%26doi%3D10.1021%2Fjm0503244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Rosenberg, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span> </span><span class="NLM_article-title">A practical process for the preparation of [<sup>32</sup>P]S1P and binding assay for S1P receptor ligands</span> <span class="citation_source-journal">Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1016/j.apradiso.2015.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.apradiso.2015.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=25931137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsVaru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2015&pages=5-9&author=A.+J.+Rosenbergauthor=H.+Liuauthor=Z.+Tu&title=A+practical+process+for+the+preparation+of+%5B32P%5DS1P+and+binding+assay+for+S1P+receptor+ligands&doi=10.1016%2Fj.apradiso.2015.04.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A practical process for the preparation of [32P]S1P and binding assay for S1P receptor ligands</span></div><div class="casAuthors">Rosenberg, Adam J.; Liu, Hui; Tu, Zhude</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5-9</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sphingosine-1-phosphate receptors (S1PRs) are important regulators of vascular permeability, inflammation, angiogenesis and vascular maturation.  Identifying a specific S1PR PET radioligand is imperative, but it is hindered by the complexity and variability of current for binding affinity measurement procedures.  Herein, we report a streamlined protocol for radiosynthesis of [32P]S1P with good radiochem. yield (36-50%) and high radiochem. purity (>99%).  We also report a reproducible procedure for detg. the binding affinity for compds. targeting S1PRs in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9aB8MOaj7qbVg90H21EOLACvtfcHk0lj3YX9pDyGhQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsVaru7c%253D&md5=bcaf97b500b7adcb34e57198a9825034</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.apradiso.2015.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apradiso.2015.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DA.%2BJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DTu%26aufirst%3DZ.%26atitle%3DA%2520practical%2520process%2520for%2520the%2520preparation%2520of%2520%255B32P%255DS1P%2520and%2520binding%2520assay%2520for%2520S1P%2520receptor%2520ligands%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2015%26volume%3D102%26spage%3D5%26epage%3D9%26doi%3D10.1016%2Fj.apradiso.2015.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) receptor subtypes S1P<sub>1</sub> and S1P<sub>3</sub>, respectively, regulate lymphocyte recirculation and heart rate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13839</span><span class="NLM_x">–</span> <span class="NLM_lpage">13848</span><span class="refDoi"> DOI: 10.1074/jbc.M311743200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1074%2Fjbc.M311743200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=14732717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1elsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13839-13848&author=M.+G.+Sannaauthor=J.+Liaoauthor=E.+Joauthor=C.+Alfonsoauthor=M.+Y.+Ahnauthor=M.+S.+Petersonauthor=B.+Webbauthor=S.+Lefebvreauthor=J.+Chunauthor=N.+Grayauthor=H.+Rosen&title=Sphingosine+1-phosphate+%28S1P%29+receptor+subtypes+S1P1+and+S1P3%2C+respectively%2C+regulate+lymphocyte+recirculation+and+heart+rate&doi=10.1074%2Fjbc.M311743200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate</span></div><div class="casAuthors">Sanna, M. Germana; Liao, Jiayu; Jo, Euijung; Alfonso, Christopher; Ahn, Min-Young; Peterson, Melissa S.; Webb, Bill; Lefebvre, Sophie; Chun, Jerold; Gray, Nathanael; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">13839-13848</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) influences heart rate, coronary artery caliber, endothelial integrity, and lymphocyte recirculation through five related high affinity G-protein-coupled receptors.  Inhibition of lymphocyte recirculation by non-selective S1P receptor agonists produces clin. immunosuppression preventing transplant rejection but is assocd. with transient bradycardia.  Understanding the contribution of individual receptors has been limited by the embryonic lethality of the S1P1 knock-out and the unavailability of selective agonists or antagonists.  A potent, S1P1-receptor selective agonist structurally unrelated to S1P was found to activate multiple signals triggered by S1P, including guanosine 5'-3-O-(thio)triphosphate binding, calcium flux, Akt and ERK1/2 phosphorylation, and stimulation of migration of S1P1- but not S1P3-expressing cells in vitro.  The agonist also alters lymphocyte trafficking in vivo.  Use of selective agonism together with deletant mice lacking S1P3 receptor reveals that agonism of S1P1 receptor alone is sufficient to control lymphocyte recirculation.  Moreover, S1P1 receptor agonist plasma levels are causally assocd. with induction and maintenance of lymphopenia.  S1P3, and not S1P1, is directly implicated in sinus bradycardia.  The sustained bradycardia induced by S1P receptor non-selective immunosuppressive agonists in wild-type mice is abolished in S1P3-/- mice, whereas S1P1-selective agonist does not produce bradycardia.  Sepn. of receptor subtype usage for control of lymphocyte recirculation and heart rate may allow the identification of selective immunosuppressive S1P1 receptor agonists with an enhanced therapeutic window.  S1P1-selective agonists will be of broad utility in understanding cell functions in vitro, and vascular physiol. in vivo, and the success of the chem. approach for S1P1 suggests that selective tools for the resoln. of function across this broad lipid receptor family are now possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoztTB58pXPA7Vg90H21EOLACvtfcHk0lhYZiJlXaRRHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1elsb8%253D&md5=5b720513c7c550bfdf55e5344efc8f16</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M311743200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M311743200%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DAhn%26aufirst%3DM.%2BY.%26aulast%3DPeterson%26aufirst%3DM.%2BS.%26aulast%3DWebb%26aufirst%3DB.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520receptor%2520subtypes%2520S1P1%2520and%2520S1P3%252C%2520respectively%252C%2520regulate%2520lymphocyte%2520recirculation%2520and%2520heart%2520rate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13839%26epage%3D13848%26doi%3D10.1074%2Fjbc.M311743200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Chen, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrbrich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engle, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothfuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geraci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotchkiss, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2011.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.nucmedbio.2011.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=22033021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=137-144&author=D.+L.+Chenauthor=D.+Zhouauthor=W.+Chuauthor=P.+Herrbrichauthor=J.+T.+Engleauthor=E.+Griffinauthor=L.+A.+Jonesauthor=J.+M.+Rothfussauthor=M.+Geraciauthor=R.+S.+Hotchkissauthor=R.+H.+Mach&title=Radiolabeled+isatin+binding+to+caspase-3+activation+induced+by+anti-Fas+antibody&doi=10.1016%2Fj.nucmedbio.2011.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody</span></div><div class="casAuthors">Chen, Delphine L.; Zhou, Dong; Chu, Wenhua; Herrbrich, Phillip; Engle, Jacquelyn T.; Griffin, Elizabeth; Jones, Lynne A.; Rothfuss, Justin M.; Geraci, Marco; Hotchkiss, Richard S.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-144</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Introduction: Noninvasive imaging methods that can distinguish apoptosis from necrosis may be useful in furthering our understanding of diseases characterized by apoptotic dysregulation as well as aiding drug development targeting apoptotic pathways.  We evaluated the ability of radiolabeled isatins to quantify caspase-3 activity induced by the activation of the extrinsic apoptotic pathway by the anti-Fas antibody in mice.  Methods: The behavior of three different radiolabeled isatins ([18F]WC-II-89, [18F]WC-IV-3 and [11C]WC-98) was characterized in mice with and without anti-Fas antibody treatment by microPET imaging and biodistribution studies.  The activity of [18F]WC-II-89 was also compared with [99mTc]mebrofenin.  The effect of pan-caspase inhibition with quinolyl-valyl-O-methylaspartyl-[2,6-difluorophenoxy]-Me ketone (Q-VD-OPh) on [18F]WC-II-89 uptake was studied.  Caspase-3 activity was confirmed by a fluorometric enzyme assay.  Results: All three tracers behaved similarly in microPET and biodistribution studies.  Increased retention of all tracers was obsd. in the livers of treated animals and several other organs, all of which demonstrated increased caspase-3 enzyme activity; however, impaired hepatobiliary excretion made attribution of these findings to caspase-3 activity difficult.  The isatin [18F]WC-II-89 was retained at statistically significantly higher levels in the organs after anti-Fas antibody treatment while [99mTc]mebrofenin activity cleared, suggesting specific binding to activated caspase-3, but the magnitude of increased binding was still relatively low.  Caspase inhibition with Q-VD-OPh partially blocked [18F]WC-II-89 retention but completely blocked caspase-3 enzyme activity in the liver.  Conclusions: The radiolabeled isatins appear to bind specifically to caspase-3 in vivo, but their sensitivity is limited.  Further optimization is required for these tracers to be useful for clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKP_ynhcVQXLVg90H21EOLACvtfcHk0lhYZiJlXaRRHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFyrsQ%253D%253D&md5=1f9673c2f02e4ae269ad1e9dd20a73bf</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2011.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2011.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%2BL.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DW.%26aulast%3DHerrbrich%26aufirst%3DP.%26aulast%3DEngle%26aufirst%3DJ.%2BT.%26aulast%3DGriffin%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DRothfuss%26aufirst%3DJ.%2BM.%26aulast%3DGeraci%26aufirst%3DM.%26aulast%3DHotchkiss%26aufirst%3DR.%2BS.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DRadiolabeled%2520isatin%2520binding%2520to%2520caspase-3%2520activation%2520induced%2520by%2520anti-Fas%2520antibody%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2012%26volume%3D39%26spage%3D137%26epage%3D144%26doi%3D10.1016%2Fj.nucmedbio.2011.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Sic, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flittner, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Munchow, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieper, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kienzler, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleuser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zirlik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lougaris, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plebani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeffler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaramuzza, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimbacher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eibel, H.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span><span class="refDoi"> DOI: 10.1016/j.jaci.2014.01.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.jaci.2014.01.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=24679343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvV2lt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2014&pages=420-428&author=H.+Sicauthor=H.+Krausauthor=J.+Madlauthor=K.+A.+Flittnerauthor=A.+L.+von+Munchowauthor=K.+Pieperauthor=M.+Rizziauthor=A.+K.+Kienzlerauthor=K.+Ayataauthor=S.+Rauerauthor=B.+Kleuserauthor=U.+Salzerauthor=M.+Burgerauthor=K.+Zirlikauthor=V.+Lougarisauthor=A.+Plebaniauthor=W.+Romerauthor=C.+Loefflerauthor=S.+Scaramuzzaauthor=A.+Villaauthor=E.+Noguchiauthor=B.+Grimbacherauthor=H.+Eibel&title=Sphingosine-1-phosphate+receptors+control+B-cell+migration+through+signaling+components+associated+with+primary+immunodeficiencies%2C+chronic+lymphocytic+leukemia%2C+and+multiple+sclerosis&doi=10.1016%2Fj.jaci.2014.01.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis</span></div><div class="casAuthors">Sic, Heiko; Kraus, Helene; Madl, Josef; Flittner, Karl-Andreas; von Muenchow, Audrey Lilly; Pieper, Kathrin; Rizzi, Marta; Kienzler, Anne-Kathrin; Ayata, Korcan; Rauer, Sebastian; Kleuser, Burkhard; Salzer, Ulrich; Burger, Meike; Zirlik, Katja; Lougaris, Vassilios; Plebani, Alessandro; Roemer, Winfried; Loeffler, Christoph; Scaramuzza, Samantha; Villa, Anna; Noguchi, Emiko; Grimbacher, Bodo; Eibel, Hermann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">420-428.e15</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Five different G protein-coupled sphingosine-1-phosphate (S1P) receptors (S1P1-S1P5) regulate a variety of physiol. and pathophysiol. processes, including lymphocyte circulation, multiple sclerosis (MS), and cancer.  Although B-lymphocyte circulation plays an important role in these processes and is essential for normal immune responses, little is known about S1P receptors in human B cells.  To explore their function and signaling, we studied B-cell lines and primary B cells from control subjects, patients with leukemia, patients with S1P receptor inhibitor-treated MS, and patients with primary immunodeficiencies.  S1P receptor expression was analyzed by using multicolor immunofluorescence microscopy and quant. PCR.  Transwell assays were used to study cell migration.  S1P receptor internalization was visualized by means of time-lapse imaging with fluorescent S1P receptor fusion proteins expressed by using lentiviral gene transfer.  B-lymphocyte subsets were characterized by means of flow cytometry and immunofluorescence microscopy.  Showing that different B-cell populations express different combinations of S1P receptors, we found that S1P1 promotes migration, whereas S1P4 modulates and S1P2 inhibits S1P1 signals.  Expression of CD69 in activated B lymphocytes and B cells from patients with chronic lymphocytic leukemia inhibited S1P-induced migration.  Studying B-cell lines, normal B lymphocytes, and B cells from patients with primary immunodeficiencies, we identified Bruton tyrosine kinase, β-arrestin 2, LPS-responsive beige-like anchor protein, dedicator of cytokinesis 8, and Wiskott-Aldrich syndrome protein as crit. signaling components downstream of S1P1.  Thus S1P receptor signaling regulates human B-cell circulation and might be a factor contributing to the pathol. of MS, chronic lymphocytic leukemia, and primary immunodeficiencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwa3JsqrmZELVg90H21EOLACvtfcHk0lhYZiJlXaRRHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvV2lt74%253D&md5=2c89249349108ac663d4030a3594bc66</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2014.01.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2014.01.037%26sid%3Dliteratum%253Aachs%26aulast%3DSic%26aufirst%3DH.%26aulast%3DKraus%26aufirst%3DH.%26aulast%3DMadl%26aufirst%3DJ.%26aulast%3DFlittner%26aufirst%3DK.%2BA.%26aulast%3Dvon%2BMunchow%26aufirst%3DA.%2BL.%26aulast%3DPieper%26aufirst%3DK.%26aulast%3DRizzi%26aufirst%3DM.%26aulast%3DKienzler%26aufirst%3DA.%2BK.%26aulast%3DAyata%26aufirst%3DK.%26aulast%3DRauer%26aufirst%3DS.%26aulast%3DKleuser%26aufirst%3DB.%26aulast%3DSalzer%26aufirst%3DU.%26aulast%3DBurger%26aufirst%3DM.%26aulast%3DZirlik%26aufirst%3DK.%26aulast%3DLougaris%26aufirst%3DV.%26aulast%3DPlebani%26aufirst%3DA.%26aulast%3DRomer%26aufirst%3DW.%26aulast%3DLoeffler%26aufirst%3DC.%26aulast%3DScaramuzza%26aufirst%3DS.%26aulast%3DVilla%26aufirst%3DA.%26aulast%3DNoguchi%26aufirst%3DE.%26aulast%3DGrimbacher%26aufirst%3DB.%26aulast%3DEibel%26aufirst%3DH.%26atitle%3DSphingosine-1-phosphate%2520receptors%2520control%2520B-cell%2520migration%2520through%2520signaling%2520components%2520associated%2520with%2520primary%2520immunodeficiencies%252C%2520chronic%2520lymphocytic%2520leukemia%252C%2520and%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2014%26volume%3D134%26spage%3D420%26epage%3D428%26doi%3D10.1016%2Fj.jaci.2014.01.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Cavone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buonvicino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratesi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakiki, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peruzzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caporale, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annunziato, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiarugi, A.</span><span> </span><span class="NLM_article-title">Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound</span> <span class="citation_source-journal">Brain, Behav., Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span><span class="refDoi"> DOI: 10.1016/j.bbi.2015.06.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.bbi.2015.06.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2015&pages=78-86&author=L.+Cavoneauthor=R.+Feliciauthor=A.+Lapucciauthor=D.+Buonvicinoauthor=S.+Pratesiauthor=M.+Muzziauthor=B.+Hakikiauthor=L.+Maggiauthor=B.+Peruzziauthor=R.+Caporaleauthor=F.+Annunziatoauthor=M.+P.+Amatoauthor=A.+Chiarugi&title=Dysregulation+of+sphingosine+1+phosphate+receptor-1+%28S1P1%29+signaling+and+regulatory+lymphocyte-dependent+immunosuppression+in+a+model+of+post-fingolimod+MS+rebound&doi=10.1016%2Fj.bbi.2015.06.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bbi.2015.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbi.2015.06.019%26sid%3Dliteratum%253Aachs%26aulast%3DCavone%26aufirst%3DL.%26aulast%3DFelici%26aufirst%3DR.%26aulast%3DLapucci%26aufirst%3DA.%26aulast%3DBuonvicino%26aufirst%3DD.%26aulast%3DPratesi%26aufirst%3DS.%26aulast%3DMuzzi%26aufirst%3DM.%26aulast%3DHakiki%26aufirst%3DB.%26aulast%3DMaggi%26aufirst%3DL.%26aulast%3DPeruzzi%26aufirst%3DB.%26aulast%3DCaporale%26aufirst%3DR.%26aulast%3DAnnunziato%26aufirst%3DF.%26aulast%3DAmato%26aufirst%3DM.%2BP.%26aulast%3DChiarugi%26aufirst%3DA.%26atitle%3DDysregulation%2520of%2520sphingosine%25201%2520phosphate%2520receptor-1%2520%2528S1P1%2529%2520signaling%2520and%2520regulatory%2520lymphocyte-dependent%2520immunosuppression%2520in%2520a%2520model%2520of%2520post-fingolimod%2520MS%2520rebound%26jtitle%3DBrain%252C%2520Behav.%252C%2520Immun.%26date%3D2015%26volume%3D50%26spage%3D78%26epage%3D86%26doi%3D10.1016%2Fj.bbi.2015.06.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Poulain, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Déprez, B. t. P.</span><span> </span><span class="NLM_article-title">Parallel synthesis of 1,2,4-oxadiazoles from carboxylic acids using an improved, uronium-based, activation</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1495</span><span class="NLM_x">–</span> <span class="NLM_lpage">1498</span><span class="refDoi"> DOI: 10.1016/S0040-4039(00)02293-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2FS0040-4039%2800%2902293-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=1495-1498&author=R.+F.+Poulainauthor=A.+L.+Tartarauthor=B.+t.+P.+D%C3%A9prez&title=Parallel+synthesis+of+1%2C2%2C4-oxadiazoles+from+carboxylic+acids+using+an+improved%2C+uronium-based%2C+activation&doi=10.1016%2FS0040-4039%2800%2902293-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2902293-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252902293-0%26sid%3Dliteratum%253Aachs%26aulast%3DPoulain%26aufirst%3DR.%2BF.%26aulast%3DTartar%26aufirst%3DA.%2BL.%26aulast%3DD%25C3%25A9prez%26aufirst%3DB.%2Bt.%2BP.%26atitle%3DParallel%2520synthesis%2520of%25201%252C2%252C4-oxadiazoles%2520from%2520carboxylic%2520acids%2520using%2520an%2520improved%252C%2520uronium-based%252C%2520activation%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D1495%26epage%3D1498%26doi%3D10.1016%2FS0040-4039%2800%2902293-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Waterhouse, R. N.</span><span> </span><span class="NLM_article-title">Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1016/j.mibio.2003.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.mibio.2003.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=14667492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=376-389&author=R.+N.+Waterhouse&title=Determination+of+lipophilicity+and+its+use+as+a+predictor+of+blood-brain+barrier+penetration+of+molecular+imaging+agents&doi=10.1016%2Fj.mibio.2003.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents</span></div><div class="casAuthors">Waterhouse Rikki N</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">376-89</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">Compound lipophilicity is a fundamental physicochemical property that plays a pivotal role in the absorption, distribution, metabolism, and elimination (ADME) of therapeutic drugs.  Lipophilicity is expressed in several different ways, including terms such as Log P, clogP, delta Log P, and Log D.  Often a parabolic relationship exists between measured lipophilicity and in vivo brain penetration of drugs, where those moderate in lipophilicity often exhibit highest uptake.  Reduced brain extraction of more lipophilic compounds is associated with increased non-specific binding to plasma proteins.  More lipophilic compounds can also be more vulnerable to P450 metabolism, leading to faster clearance.  Very polar compounds normally exhibit high water solubility, fast clearance through the kidneys, and often contain ionizable functional groups that limit blood-brain barrier (BBB) penetration.  The brain penetration and specific to non-specific binding ratios exhibited in vivo by positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiotracers involves a complex interplay between many critical factors, including lipophilicity, receptor affinity, metabolism, molecular size and shape, ionization potential, and specific binding to BBB efflux pumps or binding sites on albumin or other plasma proteins.  This paper explores situations in which lipophilicity is a good predictor of BBB penetration, as well as those where this correlation is poor.  The more commonly used methods for measuring lipophilicity are presented, and the various terms often found in the literature outlined.  An attempt is made to describe how this information can be used in optimizing the development of PET and SPECT tracers that target the central nervous system (CNS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8j0SWnHPWbmmfW6udTcc2eYUdwnrHWm907ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D&md5=cfff94825034cffcce30e56d703745cf</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DWaterhouse%26aufirst%3DR.%2BN.%26atitle%3DDetermination%2520of%2520lipophilicity%2520and%2520its%2520use%2520as%2520a%2520predictor%2520of%2520blood-brain%2520barrier%2520penetration%2520of%2520molecular%2520imaging%2520agents%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D376%26epage%3D389%26doi%3D10.1016%2Fj.mibio.2003.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Komiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shioya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span> </span><span class="NLM_article-title">Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis</span> <span class="citation_source-journal">Clin. Exp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1111/j.1365-2249.2012.04669.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1111%2Fj.1365-2249.2012.04669.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=23199323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKrtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2013&pages=54-62&author=T.+Komiyaauthor=K.+Satoauthor=H.+Shioyaauthor=Y.+Inagakiauthor=H.+Hagiyaauthor=R.+Kozakiauthor=M.+Imaiauthor=Y.+Takadaauthor=T.+Maedaauthor=H.+Kurataauthor=M.+Kuronoauthor=R.+Suzukiauthor=K.+Otsukiauthor=H.+Habashitaauthor=S.+Nakade&title=Efficacy+and+immunomodulatory+actions+of+ONO-4641%2C+a+novel+selective+agonist+for+sphingosine+1-phosphate+receptors+1+and+5%2C+in+preclinical+models+of+multiple+sclerosis&doi=10.1111%2Fj.1365-2249.2012.04669.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis</span></div><div class="casAuthors">Komiya, T.; Sato, K.; Shioya, H.; Inagaki, Y.; Hagiya, H.; Kozaki, R.; Imai, M.; Takada, Y.; Maeda, T.; Kurata, H.; Kurono, M.; Suzuki, R.; Otsuki, K.; Habashita, H.; Nakade, S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-62</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary: ONO-4641 is a next-generation sphingosine 1-phosphate (S1P) receptor agonist selective for S1P receptors 1 and 5.  The objective of the study was to characterize the immunomodulatory effects of ONO-4641 using preclin. data.  ONO-4641 was tested in both in-vitro pharmacol. studies as well as in-vivo models of transient or relapsing-remitting exptl. autoimmune encephalomyelitis (EAE).  In vitro, ONO-4641 showed highly potent agonistic activities vs. S1P receptors 1 and 5 [half maximal effective concn. (EC50) values of 0·0273 and 0·334 nM, resp.], and had profound S1P receptor 1 down-regulating effects on the cell membrane.  ONO-4641 decreased peripheral blood lymphocyte counts in rats by inhibiting lymphocyte egress from secondary lymphoid tissues.  In a rat exptl. autoimmune encephalomyelitis(EAE) model, ONO-4641 suppressed the onset of disease and inhibited lymphocyte infiltration into the spinal cord in a dose-dependent manner at doses of 0·03 and 0·1 mg/kg.  Furthermore, ONO-4641 prevented relapse of disease in a non-obese diabetic mouse model of relapsing-remitting EAE.  These observations suggest that ONO-4641 may provide therapeutic benefits in the treatment of multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFV76b9p5RfbVg90H21EOLACvtfcHk0lj1k2iAvu646A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKrtL3E&md5=d4cd1078e245580132c50e1bb43aa039</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2249.2012.04669.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2249.2012.04669.x%26sid%3Dliteratum%253Aachs%26aulast%3DKomiya%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DShioya%26aufirst%3DH.%26aulast%3DInagaki%26aufirst%3DY.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DKozaki%26aufirst%3DR.%26aulast%3DImai%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DT.%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DHabashita%26aufirst%3DH.%26aulast%3DNakade%26aufirst%3DS.%26atitle%3DEfficacy%2520and%2520immunomodulatory%2520actions%2520of%2520ONO-4641%252C%2520a%2520novel%2520selective%2520agonist%2520for%2520sphingosine%25201-phosphate%2520receptors%25201%2520and%25205%252C%2520in%2520preclinical%2520models%2520of%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2013%26volume%3D171%26spage%3D54%26epage%3D62%26doi%3D10.1111%2Fj.1365-2249.2012.04669.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Gibson, R. E.</span><span> </span><span class="NLM_article-title"><i>In Vitro</i> Approaches to Site-Specific Imaging Agents</span>. In  <span class="citation_source-book">Targeted Molecular Imaging</span>; <span class="NLM_contrib-group">Welch, M. J.; Eckelman, W. C.</span>, Eds.; <span class="NLM_publisher-name">CRC Press, Taylor & Francis Group</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=3-15&author=R.+E.+Gibsonauthor=M.+J.+Welch&author=W.+C.+Eckelman&title=Targeted+Molecular+Imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DR.%2BE.%26atitle%3DIn%2520Vitro%2520Approaches%2520to%2520Site-Specific%2520Imaging%2520Agents%26btitle%3DTargeted%2520Molecular%2520Imaging%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26pub%3DCRC%2520Press%252C%2520Taylor%2520%2526%2520Francis%2520Group%26date%3D2012%26spage%3D3%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desale, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemons, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuerer, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Crystal structure of a lipid G protein-coupled receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">851</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1126/science.1215904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1126%2Fscience.1215904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=22344443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFGqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2012&pages=851-855&author=M.+A.+Hansonauthor=C.+B.+Rothauthor=E.+Joauthor=M.+T.+Griffithauthor=F.+L.+Scottauthor=G.+Reinhartauthor=H.+Desaleauthor=B.+Clemonsauthor=S.+M.+Cahalanauthor=S.+C.+Schuererauthor=M.+G.+Sannaauthor=G.+W.+Hanauthor=P.+Kuhnauthor=H.+Rosenauthor=R.+C.+Stevens&title=Crystal+structure+of+a+lipid+G+protein-coupled+receptor&doi=10.1126%2Fscience.1215904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of a Lipid G Protein-Coupled Receptor</span></div><div class="casAuthors">Hanson, Michael A.; Roth, Christopher B.; Jo, Euijung; Griffith, Mark T.; Scott, Fiona L.; Reinhart, Greg; Desale, Hans; Clemons, Bryan; Cahalan, Stuart M.; Schuerer, Stephan C.; Sanna, M. Germana; Han, Gye Won; Kuhn, Peter; Rosen, Hugh; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">6070</span>),
    <span class="NLM_cas:pages">851-855</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The lyso-phospholipid sphingosine 1-phosphate modulates lymphocyte trafficking, endothelial development and integrity, heart rate, and vascular tone and maturation by activating G protein-coupled sphingosine 1-phosphate receptors.  Here, we present the crystal structure of the sphingosine 1-phosphate receptor 1 fused to T4-lysozyme (S1P1-T4L) in complex with an antagonist sphingolipid mimic.  Extracellular access to the binding pocket is occluded by the amino terminus and extracellular loops of the receptor.  Access is gained by ligands entering laterally between helixes I and VII within the transmembrane region of the receptor.  This structure, along with mutagenesis, agonist structure-activity relationship data, and modeling, provides a detailed view of the mol. recognition and requirement for hydrophobic vol. that activates S1P1, resulting in the modulation of immune and stromal cell responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobT5pNdDDFZrVg90H21EOLACvtfcHk0lj1k2iAvu646A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFGqtbY%253D&md5=08f0e812c991a8b1cd1c0bb4739d5062</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1126%2Fscience.1215904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1215904%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DRoth%26aufirst%3DC.%2BB.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DGriffith%26aufirst%3DM.%2BT.%26aulast%3DScott%26aufirst%3DF.%2BL.%26aulast%3DReinhart%26aufirst%3DG.%26aulast%3DDesale%26aufirst%3DH.%26aulast%3DClemons%26aufirst%3DB.%26aulast%3DCahalan%26aufirst%3DS.%2BM.%26aulast%3DSchuerer%26aufirst%3DS.%2BC.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520a%2520lipid%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D2012%26volume%3D335%26spage%3D851%26epage%3D855%26doi%3D10.1126%2Fscience.1215904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassoun, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McVerry, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burne, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuder, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G.</span><span> </span><span class="NLM_article-title">Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">1245</span><span class="NLM_x">–</span> <span class="NLM_lpage">1251</span><span class="refDoi"> DOI: 10.1164/rccm.200309-1258OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1164%2Frccm.200309-1258OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=15020292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A280%3ADC%252BD2c3mt1Clsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2004&pages=1245-1251&author=X.+Pengauthor=P.+M.+Hassounauthor=S.+Sammaniauthor=B.+J.+McVerryauthor=M.+J.+Burneauthor=H.+Rabbauthor=D.+Pearseauthor=R.+M.+Tuderauthor=J.+G.+Garcia&title=Protective+effects+of+sphingosine+1-phosphate+in+murine+endotoxin-induced+inflammatory+lung+injury&doi=10.1164%2Frccm.200309-1258OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury</span></div><div class="casAuthors">Peng Xinqi; Hassoun Paul M; Sammani Saad; McVerry Bryan J; Burne Melissa J; Rabb Hamid; Pearse David; Tuder Rubin M; Garcia Joe G N</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1245-51</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">Our prior in vitro studies indicate that sphingosine 1-phosphate (S1P), a phospholipid angiogenic factor, produces endothelial cell barrier enhancement through ligation of endothelial differentiation gene family receptors.  We hypothesized that S1P may reduce the vascular leak associated with acute lung injury and found that S1P infusion produced a rapid and significant reduction in lung weight gain (more than 50%) in the isolated perfused murine lung.  The effect of S1P was next assessed in a murine model of LPS-mediated microvascular permeability and inflammation with marked increases in parameters of lung injury at both 6 and 24 hours after intratracheal LPS.  Each parameter assessed was significantly reduced by intravenous S1P (1 microM final) and in selected experiments by the S1P analogue FTY720 (0.1 mg/kg, intraperitoneally) delivered 1 hour after LPS.  S1P produced an approximately 40-50% reduction in LPS-mediated extravasation of Evans blue dye albumin, bronchoalveolar lavage protein content, and lung tissue myeloperoxidase activity (reflecting phagocyte infiltration).  Consistent with systemic barrier enhancement, S1P significantly decreased Evans blue dye albumin extravasation and myeloperoxidase content in renal tissues of LPS-treated mice.  These studies indicate that S1P significantly decreases pulmonary/renal vascular leakage and inflammation in a murine model of LPS-mediated acute lung injury and may represent a novel therapeutic strategy for vascular barrier dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRiebTs11HvNK91pGlMMoT5fW6udTcc2eZHP5Hdsxvjs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3mt1Clsw%253D%253D&md5=5f67d3bba728e98969349e4ee9110b19</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1164%2Frccm.200309-1258OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200309-1258OC%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DHassoun%26aufirst%3DP.%2BM.%26aulast%3DSammani%26aufirst%3DS.%26aulast%3DMcVerry%26aufirst%3DB.%2BJ.%26aulast%3DBurne%26aufirst%3DM.%2BJ.%26aulast%3DRabb%26aufirst%3DH.%26aulast%3DPearse%26aufirst%3DD.%26aulast%3DTuder%26aufirst%3DR.%2BM.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%26atitle%3DProtective%2520effects%2520of%2520sphingosine%25201-phosphate%2520in%2520murine%2520endotoxin-induced%2520inflammatory%2520lung%2520injury%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2004%26volume%3D169%26spage%3D1245%26epage%3D1251%26doi%3D10.1164%2Frccm.200309-1258OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Kono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergner, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">2076</span><span class="NLM_x">–</span> <span class="NLM_lpage">2086</span><span class="refDoi"> DOI: 10.1172/JCI71194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1172%2FJCI71194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=24667638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVSnsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=2076-2086&author=M.+Konoauthor=A.+E.+Tuckerauthor=J.+Tranauthor=J.+B.+Bergnerauthor=E.+M.+Turnerauthor=R.+L.+Proia&title=Sphingosine-1-phosphate+receptor+1+reporter+mice+reveal+receptor+activation+sites+in+vivo&doi=10.1172%2FJCI71194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo</span></div><div class="casAuthors">Kono, Mari; Tucker, Ana E.; Tran, Jennifer; Bergner, Jennifer B.; Turner, Ewa M.; Proia, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2076-2086</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Activation of the GPCR sphingosine-1-phosphate receptor 1 (S1P1) by sphingosine-1-phosphate (S1P) regulates key physiol. processes.  S1P1 activation also has been implicated in pathol. processes, including autoimmunity and inflammation; however, the in vivo sites of S1P1 activation under normal and disease conditions are unclear.  Here, we describe the development of a mouse model that allows in vivo evaluation of S1P1 activation.  These mice, known as S1P1 GFP signaling mice, produce a S1P1 fusion protein contg. a transcription factor linked by a protease cleavage site at the C terminus as well as a β-arrestin/protease fusion protein.  Activated S1P1 recruits the β-arrestin/protease, resulting in the release of the transcription factor, which stimulates the expression of a GFP reporter gene.  Under normal conditions, S1P1 was activated in endothelial cells of lymphoid tissues and in cells in the marginal zone of the spleen, while administration of an S1P1 agonist promoted S1P1 activation in endothelial cells and hepatocytes.  In S1P1 GFP signaling mice, LPS-mediated systemic inflammation activated S1P1 in endothelial cells and hepatocytes via hematopoietically derived S1P.  These data demonstrate that S1P1 GFP signaling mice can be used to evaluate S1P1 activation and S1P1-active compds. in vivo.  Furthermore, this strategy could be potentially applied to any GPCR to identify sites of receptor activation during normal physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofbElmvv4firVg90H21EOLACvtfcHk0lg6TsE104Nhpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVSnsb0%253D&md5=d74297d12775ec9a389dd7443e2b5867</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1172%2FJCI71194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI71194%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DM.%26aulast%3DTucker%26aufirst%3DA.%2BE.%26aulast%3DTran%26aufirst%3DJ.%26aulast%3DBergner%26aufirst%3DJ.%2BB.%26aulast%3DTurner%26aufirst%3DE.%2BM.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DSphingosine-1-phosphate%2520receptor%25201%2520reporter%2520mice%2520reveal%2520receptor%2520activation%2520sites%2520in%2520vivo%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2014%26volume%3D124%26spage%3D2076%26epage%3D2086%26doi%3D10.1172%2FJCI71194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leaf, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsolais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Full pharmacological efficacy of a novel S1P<sub>1</sub> agonist that does not require S1P-like headgroup interactions</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1308</span><span class="NLM_x">–</span> <span class="NLM_lpage">1318</span><span class="refDoi"> DOI: 10.1124/mol.108.049783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1124%2Fmol.108.049783" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1308-1318&author=P.+J.+Gonzalez-Cabreraauthor=E.+Joauthor=M.+G.+Sannaauthor=S.+Brownauthor=N.+Leafauthor=D.+Marsolaisauthor=M.+T.+Schaefferauthor=J.+Chapmanauthor=M.+Cameronauthor=M.+Guerreroauthor=E.+Robertsauthor=H.+Rosen&title=Full+pharmacological+efficacy+of+a+novel+S1P1+agonist+that+does+not+require+S1P-like+headgroup+interactions&doi=10.1124%2Fmol.108.049783"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.049783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.049783%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DLeaf%26aufirst%3DN.%26aulast%3DMarsolais%26aufirst%3DD.%26aulast%3DSchaeffer%26aufirst%3DM.%2BT.%26aulast%3DChapman%26aufirst%3DJ.%26aulast%3DCameron%26aufirst%3DM.%26aulast%3DGuerrero%26aufirst%3DM.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DFull%2520pharmacological%2520efficacy%2520of%2520a%2520novel%2520S1P1%2520agonist%2520that%2520does%2520not%2520require%2520S1P-like%2520headgroup%2520interactions%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D1308%26epage%3D1318%26doi%3D10.1124%2Fmol.108.049783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Tomlinson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoghi, K. I.</span><span> </span><span class="NLM_article-title">Quantification of skeletal blood flow and fluoride metabolism in rats using PET in a pre-clinical stress fracture model</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span><span class="refDoi"> DOI: 10.1007/s11307-011-0505-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1007%2Fs11307-011-0505-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=21785919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A280%3ADC%252BC38zkvF2lsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=348-354&author=R.+E.+Tomlinsonauthor=M.+J.+Silvaauthor=K.+I.+Shoghi&title=Quantification+of+skeletal+blood+flow+and+fluoride+metabolism+in+rats+using+PET+in+a+pre-clinical+stress+fracture+model&doi=10.1007%2Fs11307-011-0505-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of skeletal blood flow and fluoride metabolism in rats using PET in a pre-clinical stress fracture model</span></div><div class="casAuthors">Tomlinson Ryan E; Silva Matthew J; Shoghi Kooresh I</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">348-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Blood flow is an important factor in bone production and repair, but its role in osteogenesis induced by mechanical loading is unknown.  Here, we present techniques for evaluating blood flow and fluoride metabolism in a pre-clinical stress fracture model of osteogenesis in rats.  PROCEDURES:  Bone formation was induced by forelimb compression in adult rats. (15)O water and (18)F fluoride PET imaging were used to evaluate blood flow and fluoride kinetics 7 days after loading. (15)O water was modeled using a one-compartment, two-parameter model, while a two-compartment, three-parameter model was used to model (18)F fluoride.  Input functions were created from the heart, and a stochastic search algorithm was implemented to provide initial parameter values in conjunction with a Levenberg-Marquardt optimization algorithm.  RESULTS:  Loaded limbs are shown to have a 26% increase in blood flow rate, 113% increase in fluoride flow rate, 133% increase in fluoride flux, and 13% increase in fluoride incorporation into bone as compared to non-loaded limbs (p < 0.05 for all results).  CONCLUSIONS:  The results shown here are consistent with previous studies, confirming this technique is suitable for evaluating the vascular response and mineral kinetics of osteogenic mechanical loading.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSjLNsoYxXU4K-9TkgmBqTqfW6udTcc2eZ90IVO7c9QLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zkvF2lsA%253D%253D&md5=f84e5878a797a6e454d20c8baeae0abb</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs11307-011-0505-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-011-0505-3%26sid%3Dliteratum%253Aachs%26aulast%3DTomlinson%26aufirst%3DR.%2BE.%26aulast%3DSilva%26aufirst%3DM.%2BJ.%26aulast%3DShoghi%26aufirst%3DK.%2BI.%26atitle%3DQuantification%2520of%2520skeletal%2520blood%2520flow%2520and%2520fluoride%2520metabolism%2520in%2520rats%2520using%2520PET%2520in%2520a%2520pre-clinical%2520stress%2520fracture%2520model%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2012%26volume%3D14%26spage%3D348%26epage%3D354%26doi%3D10.1007%2Fs11307-011-0505-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Shiomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochi, H.</span><span> </span><span class="NLM_article-title">Assessment of hepatic blood flow by PET with <sup>15</sup>O water: Correlation between per-rectal portal scintigraphy with <sup>99</sup>Tc<sup>m</sup>-pertechnetate and scintigraphy with <sup>99</sup>Tc<sup>m</sup>-GSA</span> <span class="citation_source-journal">Nucl. Med. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span><span class="refDoi"> DOI: 10.1097/00006231-200006000-00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1097%2F00006231-200006000-00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10894562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252FjtFOqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=533-538&author=S.+Shiomiauthor=Y.+Iwataauthor=N.+Sasakiauthor=H.+Morikawaauthor=A.+Tamoriauthor=D.+Habuauthor=T.+Takedaauthor=S.+Nishiguchiauthor=T.+Kurokiauthor=H.+Ochi&title=Assessment+of+hepatic+blood+flow+by+PET+with+15O+water%3A+Correlation+between+per-rectal+portal+scintigraphy+with+99Tcm-pertechnetate+and+scintigraphy+with+99Tcm-GSA&doi=10.1097%2F00006231-200006000-00006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of hepatic blood flow by PET with 15O water: correlation between per-rectal portal scintigraphy with 99Tc(m)-pertechnetate and scintigraphy with 99Tc(m)-GSA</span></div><div class="casAuthors">Shiomi S; Iwata Y; Sasaki N; Morikawa H; Tamori A; Habu D; Takeda T; Nishiguchi S; Kuroki T; Ochi H</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear medicine communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">533-8</span>
        ISSN:<span class="NLM_cas:issn">0143-3636</span>.
    </div><div class="casAbstract">We performed positron emission tomography with 15O water (H2(15)O) to measure hepatic arterial and portal blood flow.  In addition, portal haemodynamics and hepatic functional reserve were measured by per-rectal portal scintigraphy and scintigraphy with galactosyl human serum albumin, respectively.  We studied 15 patients who had cirrhosis of the liver with underlying viral infection.  After the intravenous injection of H2(15)O, positron emission tomography was performed.  Blood samples were obtained after beginning the emission scan.  The blood samples and positron emission tomographic images were analysed to calculate the radioactivity in the blood and liver.  One-compartment model analysis was used to estimate hepatic arterial and portal blood flow.  Computer acquisition of gamma-camera data was started just before the injection of 99Tc(m)-galactosyl human serum albumin.  A receptor index and an index of blood clearance were calculated on the basis of the radioactivity of the liver and heart.  A 99Tc(m)-pertechnetate solution was instilled into the rectum; serial scintigrams were performed and radioactivity curves for the liver and heart were recorded sequentially.  A per-rectal portal shunt index was calculated from the curves.  Median portal blood flow was 80 ml x 100 g(-1) x min(-1), median hepatic arterial blood flow was 56 ml x 100 g(-1) x min(-1), and median total hepatic blood flow was 138 ml x 100 g(-1) x min(-1) in patients with cirrhosis.  The correlations between portal blood flow and the Child-Turcotte classification score, portal shunt index and receptor index were all significant.  Our results show that hepatic arterial and portal blood flow can be measured by positron emission tomography with H2(15)O non-invasively and physiologically.  This technique may be useful in pathophysiological studies of liver disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlcGkJPlr_tu2qxNLjzXe8fW6udTcc2eY9pPhX1V6zEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252FjtFOqtQ%253D%253D&md5=408603c2df444139497388c0f6096ff4</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1097%2F00006231-200006000-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00006231-200006000-00006%26sid%3Dliteratum%253Aachs%26aulast%3DShiomi%26aufirst%3DS.%26aulast%3DIwata%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DN.%26aulast%3DMorikawa%26aufirst%3DH.%26aulast%3DTamori%26aufirst%3DA.%26aulast%3DHabu%26aufirst%3DD.%26aulast%3DTakeda%26aufirst%3DT.%26aulast%3DNishiguchi%26aufirst%3DS.%26aulast%3DKuroki%26aufirst%3DT.%26aulast%3DOchi%26aufirst%3DH.%26atitle%3DAssessment%2520of%2520hepatic%2520blood%2520flow%2520by%2520PET%2520with%252015O%2520water%253A%2520Correlation%2520between%2520per-rectal%2520portal%2520scintigraphy%2520with%252099Tcm-pertechnetate%2520and%2520scintigraphy%2520with%252099Tcm-GSA%26jtitle%3DNucl.%2520Med.%2520Commun.%26date%3D2000%26volume%3D21%26spage%3D533%26epage%3D538%26doi%3D10.1097%2F00006231-200006000-00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Ghibellini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwer, K. L.</span><span> </span><span class="NLM_article-title">Use of Tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: Integration of in vitro, pharmacokinetic modeling, and simulation studies</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1860</span><span class="refDoi"> DOI: 10.1007/s11095-008-9597-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1007%2Fs11095-008-9597-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=1851-1860&author=G.+Ghibelliniauthor=E.+M.+Leslieauthor=G.+M.+Pollackauthor=K.+L.+Brouwer&title=Use+of+Tc-99m+mebrofenin+as+a+clinical+probe+to+assess+altered+hepatobiliary+transport%3A+Integration+of+in+vitro%2C+pharmacokinetic+modeling%2C+and+simulation+studies&doi=10.1007%2Fs11095-008-9597-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2Fs11095-008-9597-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-008-9597-0%26sid%3Dliteratum%253Aachs%26aulast%3DGhibellini%26aufirst%3DG.%26aulast%3DLeslie%26aufirst%3DE.%2BM.%26aulast%3DPollack%26aufirst%3DG.%2BM.%26aulast%3DBrouwer%26aufirst%3DK.%2BL.%26atitle%3DUse%2520of%2520Tc-99m%2520mebrofenin%2520as%2520a%2520clinical%2520probe%2520to%2520assess%2520altered%2520hepatobiliary%2520transport%253A%2520Integration%2520of%2520in%2520vitro%252C%2520pharmacokinetic%2520modeling%252C%2520and%2520simulation%2520studies%26jtitle%3DPharm.%2520Res.%26date%3D2008%26volume%3D25%26spage%3D1851%26epage%3D1860%26doi%3D10.1007%2Fs11095-008-9597-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Joseph, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhargava, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tronco, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palestro, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span> </span><span class="NLM_article-title">Systemic and local release of inflammatory cytokines regulates hepatobiliary excretion of <sup>99m</sup>Tc-mebrofenin</span> <span class="citation_source-journal">Nucl. Med. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">336</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><span class="refDoi"> DOI: 10.1097/MNM.0b013e3282f81460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1097%2FMNM.0b013e3282f81460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=18317297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislSlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=336-344&author=B.+Josephauthor=K.+K.+Bhargavaauthor=G.+G.+Troncoauthor=C.+J.+Palestroauthor=S.+Gupta&title=Systemic+and+local+release+of+inflammatory+cytokines+regulates+hepatobiliary+excretion+of+99mTc-mebrofenin&doi=10.1097%2FMNM.0b013e3282f81460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic and local release of inflammatory cytokines regulates hepatobiliary excretion of 99mTc-mebrofenin</span></div><div class="casAuthors">Joseph, Brigid; Bhargava, Kuldeep K.; Tronco, Gene G.; Palestro, Christopher J.; Gupta, Sanjeev</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine Communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">336-344</span>CODEN:
                <span class="NLM_cas:coden">NMCODC</span>;
        ISSN:<span class="NLM_cas:issn">0143-3636</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objectives: Imaging agents capable of providing cell compartment-specific information will facilitate studies of pathophysiol. mechanisms, natural history of diseases, and therapeutic development.  To demonstrate the effects of liver injury on the disposal of the org. anion mebrofenin, we performed animal studies.  Methods: Acute liver injury was induced in Fischer 344 rats with 0.25-1 mL/kg single doses of carbon tetrachloride followed by studies of animals over 4 wk.  The liver injury was analyzed by blood tests and histol. grading.  Addnl. rats were treated with lipopolysaccharide, interleukin-6 or tumor necrosis factor-α to activate inflammatory events.  Hepatic clearance of Tc-mebrofenin was studied with dynamic imaging and fractional retention after 60 min of peak hepatic mebrofenin activity was detd.  Results: In healthy rats, only 24±2% of peak mebrofenin activity was retained in the liver after 60 min.  By contrast, 24 h after carbon tetrachloride, virtually all mebrofenin activity was retained in the liver (P<0.001).  Three weeks were required for mebrofenin excretion to become normal after carbon tetrachloride administration.  In this situation, we found that Kupffer cell activity was increased.  In addn., the abnormality in mebrofenin excretion was reproduced by lipopolysaccharide, which activates Kupffer cells.  Moreover, mebrofenin excretion was highly sensitive to interleukin-6 and/or tumor necrosis factor-α, which help mediate the Kupffer cell response.  Conclusion: Hepatobiliary excretion of mebrofenin was affected rapidly and over an extended period by inflammatory cytokines released after liver injury.  The remarkable sensitivity of mebrofenin excretion to cytokines suggests that Tc-mebrofenin imaging will be helpful for assessing cytokine-mediated liver inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-tvCdJkl42LVg90H21EOLACvtfcHk0liv2hCH1550Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislSlsLs%253D&md5=22f957f3660f2f1198e23815327024d3</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1097%2FMNM.0b013e3282f81460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMNM.0b013e3282f81460%26sid%3Dliteratum%253Aachs%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DBhargava%26aufirst%3DK.%2BK.%26aulast%3DTronco%26aufirst%3DG.%2BG.%26aulast%3DPalestro%26aufirst%3DC.%2BJ.%26aulast%3DGupta%26aufirst%3DS.%26atitle%3DSystemic%2520and%2520local%2520release%2520of%2520inflammatory%2520cytokines%2520regulates%2520hepatobiliary%2520excretion%2520of%252099mTc-mebrofenin%26jtitle%3DNucl.%2520Med.%2520Commun.%26date%3D2008%26volume%3D29%26spage%3D336%26epage%3D344%26doi%3D10.1097%2FMNM.0b013e3282f81460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Schurer, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spicer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P<sub>1</sub> and S1P<sub>3</sub> determine efficiency of chemical probe identification by ultrahigh-throughput screening</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span><span class="refDoi"> DOI: 10.1021/cb800051m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb800051m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=486-498&author=S.+C.+Schurerauthor=S.+J.+Brownauthor=P.+J.+Gonzalez-Cabreraauthor=M.+T.+Schaefferauthor=J.+Chapmanauthor=E.+Joauthor=P.+Chaseauthor=T.+Spicerauthor=P.+Hodderauthor=H.+Rosen&title=Ligand-binding+pocket+shape+differences+between+sphingosine+1-phosphate+%28S1P%29+receptors+S1P1+and+S1P3+determine+efficiency+of+chemical+probe+identification+by+ultrahigh-throughput+screening&doi=10.1021%2Fcb800051m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fcb800051m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb800051m%26sid%3Dliteratum%253Aachs%26aulast%3DSchurer%26aufirst%3DS.%2BC.%26aulast%3DBrown%26aufirst%3DS.%2BJ.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DSchaeffer%26aufirst%3DM.%2BT.%26aulast%3DChapman%26aufirst%3DJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DChase%26aufirst%3DP.%26aulast%3DSpicer%26aufirst%3DT.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DLigand-binding%2520pocket%2520shape%2520differences%2520between%2520sphingosine%25201-phosphate%2520%2528S1P%2529%2520receptors%2520S1P1%2520and%2520S1P3%2520determine%2520efficiency%2520of%2520chemical%2520probe%2520identification%2520by%2520ultrahigh-throughput%2520screening%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2008%26volume%3D3%26spage%3D486%26epage%3D498%26doi%3D10.1021%2Fcb800051m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Brenner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galluzzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepp, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span> </span><span class="NLM_article-title">Decoding cell death signals in liver inflammation</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span><span class="refDoi"> DOI: 10.1016/j.jhep.2013.03.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.jhep.2013.03.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=23567086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVygt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2013&pages=583-594&author=C.+Brennerauthor=L.+Galluzziauthor=O.+Keppauthor=G.+Kroemer&title=Decoding+cell+death+signals+in+liver+inflammation&doi=10.1016%2Fj.jhep.2013.03.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Decoding cell death signals in liver inflammation</span></div><div class="casAuthors">Brenner, Catherine; Galluzzi, Lorenzo; Kepp, Oliver; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">583-594</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Inflammation can be either beneficial or detrimental to the liver, depending on multiple factors.  Mild (i.e., limited in intensity and destined to resolve) inflammatory responses have indeed been shown to exert consistent hepatoprotective effects, contributing to tissue repair and promoting the re-establishment of homeostasis.  Conversely, excessive (i.e., disproportionate in intensity and permanent) inflammation may induce a massive loss of hepatocytes and hence exacerbate the severity of various hepatic conditions, including ischemia-reperfusion injury, systemic metabolic alterations (e.g., obesity, diabetes, non-alc. fatty liver disorders), alc. hepatitis, intoxication by xenobiotics and infection, de facto being assocd. with irreversible liver damage, fibrosis, and carcinogenesis.  Both liver-resident cells (e.g., Kupffer cells, hepatic stellate cells, sinusoidal endothelial cells) and cells that are recruited in response to injury (e.g., monocytes, macrophages, dendritic cells, natural killer cells) emit pro-inflammatory signals including - but not limited to - cytokines, chemokines, lipid messengers, and reactive oxygen species that contribute to the apoptotic or necrotic demise of hepatocytes.  In turn, dying hepatocytes release damage-assocd. mol. patterns that-upon binding to evolutionary conserved pattern recognition receptors-activate cells of the innate immune system to further stimulate inflammatory responses, hence establishing a highly hepatotoxic feedforward cycle of inflammation and cell death.  In this review, we discuss the cellular and mol. mechanisms that account for the most deleterious effect of hepatic inflammation at the cellular level, i.e., the initiation of a massive cell death response among hepatocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWF2KIq_DTz7Vg90H21EOLACvtfcHk0liDxYzjX6EDyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVygt78%253D&md5=59b70460b5113fe091b3eb175b329424</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2013.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2013.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DBrenner%26aufirst%3DC.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DDecoding%2520cell%2520death%2520signals%2520in%2520liver%2520inflammation%26jtitle%3DJ.%2520Hepatol.%26date%3D2013%26volume%3D59%26spage%3D583%26epage%3D594%26doi%3D10.1016%2Fj.jhep.2013.03.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Schroder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juan, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltusch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giegold, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeilschifter, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huwiler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radeke, H. H.</span><span> </span><span class="NLM_article-title">The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen</span> <span class="citation_source-journal">Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1139</span><span class="NLM_x">–</span> <span class="NLM_lpage">1148</span><span class="refDoi"> DOI: 10.1016/j.molimm.2011.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.molimm.2011.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=21435724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A280%3ADC%252BC3MvktFShtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2011&pages=1139-1148&author=M.+Schroderauthor=C.+Richterauthor=M.+H.+Juanauthor=K.+Maltuschauthor=O.+Giegoldauthor=G.+Quintiniauthor=J.+M.+Pfeilschifterauthor=A.+Huwilerauthor=H.+H.+Radeke&title=The+sphingosine+kinase+1+and+S1P1+axis+specifically+counteracts+LPS-induced+IL-12p70+production+in+immune+cells+of+the+spleen&doi=10.1016%2Fj.molimm.2011.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen</span></div><div class="casAuthors">Schroder Matthias; Richter Cornelia; Juan Martina Herrero San; Maltusch Katrin; Giegold Oliver; Quintini Gianluca; Pfeilschifter Josef M; Huwiler Andrea; Radeke Heinfried H</div><div class="citationInfo"><span class="NLM_cas:title">Molecular immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">1139-48</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sphingosine-1-phosphate (S1P) has been implicated in angiogenesis, inflammation, cancerogenesis, neurological excitability and immune regulation and is synthesized by two different sphingosine kinases (SphK).  It was suggested that mice lacking the gene for SphK1 exhibit no obvious phenotype, because SphK2 compensates for its absence.  However, recent investigations revealed that under challenge SphK1 contributed to pro-inflammatory processes favoring Th2 and Th17 rather than Th1-type reactions.  To investigate the immune modulatory role of SphK1 as opposed to SphK2 specifically for the Th1 propagating IL-12p70 we compared WT and SphK1(-/-) splenocytes and Flt3-ligand differentiated BMCs of WT and SphK1(-/-), representing dendritic cells as major producers of IL-12p70, incubated with LPS.  We determined the impact on IL-12p70 in comparison to other inflammatory cytokines, and on DC and macrophage surface marker expression, SphK mRNA, protein expression and enzymatic activity in splenocytes.  Our data demonstrated that SphK1 deficiency enhanced LPS-induced IL-12p70 production although SphK2 was present.  To further characterize SphK1-dependent IL-12p70 regulation we exogenously applied S1P, SEW2871 and the new potent S1P1 agonist CYM5442.  Both S1P and S1P1-specific analogs fully compensated the increase of IL-12p70 production in SphK1-deficient splenocytes.  The use of pertussis toxin, to block G(i)-coupled signaling downstream of S1P1, again increased IL-12p70 and neglected the compensation achieved by addition of S1P and S1P1 agonists pointing on the importance of this specific S1P-receptor.  Given that, in parallel to a prominent IL-12p35 increase following LPS stimulation, LPS also enhanced SphK expression and total SphK activity, we concluded that SphK1-derived S1P acting via S1P1 is a major mechanism of this negative IL-12p70 feedback loop, which did not affect other cytokines.  Moreover, our data showed that SphK2 activity failed to compensate for SphK1 deficiency.  These findings clearly point to a divergent and cytokine-specific impact of immune cell SphK1 and SphK2 in chronic inflammation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-br9jjE3qx02yPDyEFiigfW6udTcc2eYv1F0stWSGq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MvktFShtQ%253D%253D&md5=73b8d4a15ad68dba5257d96d44b3d765</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2011.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2011.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DSchroder%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DC.%26aulast%3DJuan%26aufirst%3DM.%2BH.%26aulast%3DMaltusch%26aufirst%3DK.%26aulast%3DGiegold%26aufirst%3DO.%26aulast%3DQuintini%26aufirst%3DG.%26aulast%3DPfeilschifter%26aufirst%3DJ.%2BM.%26aulast%3DHuwiler%26aufirst%3DA.%26aulast%3DRadeke%26aufirst%3DH.%2BH.%26atitle%3DThe%2520sphingosine%2520kinase%25201%2520and%2520S1P1%2520axis%2520specifically%2520counteracts%2520LPS-induced%2520IL-12p70%2520production%2520in%2520immune%2520cells%2520of%2520the%2520spleen%26jtitle%3DMol.%2520Immunol.%26date%3D2011%26volume%3D48%26spage%3D1139%26epage%3D1148%26doi%3D10.1016%2Fj.molimm.2011.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothfuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponde, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [<sup>18</sup>F]6-(2-fluoropropyl)-4-methyl-pyridin-2-amine as a potential PET tracer for inducible nitric oxide synthase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2443</span><span class="NLM_x">–</span> <span class="NLM_lpage">2453</span><span class="refDoi"> DOI: 10.1021/jm801556h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801556h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2443-2453&author=D.+Zhouauthor=H.+Leeauthor=J.+M.+Rothfussauthor=D.+L.+Chenauthor=D.+E.+Pondeauthor=M.+J.+Welchauthor=R.+H.+Mach&title=Design+and+synthesis+of+2-amino-4-methylpyridine+analogues+as+inhibitors+for+inducible+nitric+oxide+synthase+and+in+vivo+evaluation+of+%5B18F%5D6-%282-fluoropropyl%29-4-methyl-pyridin-2-amine+as+a+potential+PET+tracer+for+inducible+nitric+oxide+synthase&doi=10.1021%2Fjm801556h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm801556h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801556h%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DRothfuss%26aufirst%3DJ.%2BM.%26aulast%3DChen%26aufirst%3DD.%2BL.%26aulast%3DPonde%26aufirst%3DD.%2BE.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DDesign%2520and%2520synthesis%2520of%25202-amino-4-methylpyridine%2520analogues%2520as%2520inhibitors%2520for%2520inducible%2520nitric%2520oxide%2520synthase%2520and%2520in%2520vivo%2520evaluation%2520of%2520%255B18F%255D6-%25282-fluoropropyl%2529-4-methyl-pyridin-2-amine%2520as%2520a%2520potential%2520PET%2520tracer%2520for%2520inducible%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2443%26epage%3D2453%26doi%3D10.1021%2Fjm801556h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kirsten Yakoub, Sascha Jung, Christian Sattler, Helen Damerow, Judith Weber, Annika Kretzschmann, Aylin S. Cankaya, Markus Piel, Frank Rösch, Anne S. Haugaard, Bente Frølund, Tanja Schirmeister, <span class="NLM_string-name hlFld-ContribAuthor">Hartmut Lüddens</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Function Evaluation of Imidazopyridine Derivatives Selective for δ-Subunit-Containing γ-Aminobutyric Acid Type A (GABAA) Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 1951-1968. <a href="https://doi.org/10.1021/acs.jmedchem.7b01484" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01484</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01484%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Function%252BEvaluation%252Bof%252BImidazopyridine%252BDerivatives%252BSelective%252Bfor%252B%2525CE%2525B4-Subunit-Containing%252B%2525CE%2525B3-Aminobutyric%252BAcid%252BType%252BA%252B%252528GABAA%252529%252BReceptors%26aulast%3DYakoub%26aufirst%3DKirsten%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D06102017%26date%3D26022018%26date%3D16022018%26volume%3D61%26issue%3D5%26spage%3D1951%26epage%3D1968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Zonghua  Luo</span>, <span class="hlFld-ContribAuthor ">Jiwei  Gu</span>, <span class="hlFld-ContribAuthor ">Hao  Jiang</span>, <span class="hlFld-ContribAuthor ">Sumit  Joshi</span>, <span class="hlFld-ContribAuthor ">Kooresh I.  Shoghi</span>, <span class="hlFld-ContribAuthor ">Yun  Zhou</span>, <span class="hlFld-ContribAuthor ">Robert J.  Gropler</span>, <span class="hlFld-ContribAuthor ">Tammie L. S.  Benzinger</span>, <span class="hlFld-ContribAuthor ">Zhude  Tu</span>. </span><span class="cited-content_cbyCitation_article-title">In vivo Characterization of Four 18F-Labeled S1PR1 Tracers for Neuroinflammation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2020,</strong> <em>22 </em>
                                    (5)
                                     , 1362-1369. <a href="https://doi.org/10.1007/s11307-020-01514-8" title="DOI URL">https://doi.org/10.1007/s11307-020-01514-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-020-01514-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-020-01514-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DIn%252Bvivo%252BCharacterization%252Bof%252BFour%252B18F-Labeled%252BS1PR1%252BTracers%252Bfor%252BNeuroinflammation%26aulast%3DLiu%26aufirst%3DHui%26date%3D2020%26date%3D2020%26volume%3D22%26issue%3D5%26spage%3D1362%26epage%3D1369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zonghua  Luo</span>, <span class="hlFld-ContribAuthor ">Qianwa  Liang</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Joshi  Sumit</span>, <span class="hlFld-ContribAuthor ">Hao  Jiang</span>, <span class="hlFld-ContribAuthor ">Robyn S.  Klein</span>, <span class="hlFld-ContribAuthor ">Zhude  Tu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and characterization of [125I]TZ6544, a promising radioligand for investigating sphingosine-1-phosphate receptor 2. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2020,</strong> <em>88-89 </em>, 52-61. <a href="https://doi.org/10.1016/j.nucmedbio.2020.07.007" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2020.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2020.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2020.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DSynthesis%252Band%252Bcharacterization%252Bof%252B%25255B125I%25255DTZ6544%25252C%252Ba%252Bpromising%252Bradioligand%252Bfor%252Binvestigating%252Bsphingosine-1-phosphate%252Breceptor%252B2%26aulast%3DLuo%26aufirst%3DZonghua%26date%3D2020%26volume%3D88-89%26spage%3D52%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga A.  Sukocheva</span>, <span class="hlFld-ContribAuthor ">Hideki  Furuya</span>, <span class="hlFld-ContribAuthor ">Mei Li  Ng</span>, <span class="hlFld-ContribAuthor ">Markus  Friedemann</span>, <span class="hlFld-ContribAuthor ">Mario  Menschikowski</span>, <span class="hlFld-ContribAuthor ">Vadim V.  Tarasov</span>, <span class="hlFld-ContribAuthor ">Vladimir N.  Chubarev</span>, <span class="hlFld-ContribAuthor ">Sergey G.  Klochkov</span>, <span class="hlFld-ContribAuthor ">Margarita E.  Neganova</span>, <span class="hlFld-ContribAuthor ">Arduino A.  Mangoni</span>, <span class="hlFld-ContribAuthor ">Gjumrakch  Aliev</span>, <span class="hlFld-ContribAuthor ">Anupam  Bishayee</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>207 </em>, 107464. <a href="https://doi.org/10.1016/j.pharmthera.2019.107464" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2019.107464</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2019.107464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2019.107464%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DSphingosine%252Bkinase%252Band%252Bsphingosine-1-phosphate%252Breceptor%252Bsignaling%252Bpathway%252Bin%252Binflammatory%252Bgastrointestinal%252Bdisease%252Band%252Bcancers%25253A%252BA%252Bnovel%252Btherapeutic%252Btarget%26aulast%3DSukocheva%26aufirst%3DOlga%2BA.%26date%3D2020%26volume%3D207%26spage%3D107464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga A.  Sukocheva</span>, <span class="hlFld-ContribAuthor ">Elena  Lukina</span>, <span class="hlFld-ContribAuthor ">Eileen  McGowan</span>, <span class="hlFld-ContribAuthor ">Anupam  Bishayee</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 123-158. <a href="https://doi.org/10.1016/bs.apcsb.2019.11.003" title="DOI URL">https://doi.org/10.1016/bs.apcsb.2019.11.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apcsb.2019.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apcsb.2019.11.003%26sid%3Dliteratum%253Aachs%26atitle%3DSphingolipids%252Bas%252Bmediators%252Bof%252Binflammation%252Band%252Bnovel%252Btherapeutic%252Btarget%252Bin%252Binflammatory%252Bbowel%252Bdisease%26aulast%3DSukocheva%26aufirst%3DOlga%2BA.%26date%3D2020%26spage%3D123%26epage%3D158%26pub%3DElsevier%26atitle%3DInflammatory%252BDisorders%252B-%252BPart%252BB%26date%3D2020%26volume%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">João  Franco Machado</span>, <span class="hlFld-ContribAuthor ">Rúben  Silva</span>, <span class="hlFld-ContribAuthor ">Rita  Melo</span>, <span class="hlFld-ContribAuthor ">João  G. Correia</span>. </span><span class="cited-content_cbyCitation_article-title">Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and Theranostics. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (1)
                                     , 49. <a href="https://doi.org/10.3390/molecules24010049" title="DOI URL">https://doi.org/10.3390/molecules24010049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24010049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24010049%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DLess%252BExploited%252BGPCRs%252Bin%252BPrecision%252BMedicine%25253A%252BTargets%252Bfor%252BMolecular%252BImaging%252Band%252BTheranostics%26aulast%3DFranco%2BMachado%26aufirst%3DJo%25C3%25A3o%26date%3D2019%26date%3D2018%26volume%3D24%26issue%3D1%26spage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zonghua  Luo</span>, <span class="hlFld-ContribAuthor ">Junbin  Han</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Adam J.  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Delphine L.  Chen</span>, <span class="hlFld-ContribAuthor ">Robert J.  Gropler</span>, <span class="hlFld-ContribAuthor ">Joel S.  Perlmutter</span>, <span class="hlFld-ContribAuthor ">Zhude  Tu</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses and
              in vitro
              biological evaluation of S1PR1 ligands and PET studies of four F-18 labeled radiotracers in the brain of nonhuman primates. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (47)
                                     , 9171-9184. <a href="https://doi.org/10.1039/C8OB02609B" title="DOI URL">https://doi.org/10.1039/C8OB02609B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB02609B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB02609B%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSyntheses%252Band%252Bin%252Bvitro%252Bbiological%252Bevaluation%252Bof%252BS1PR1%252Bligands%252Band%252BPET%252Bstudies%252Bof%252Bfour%252BF-18%252Blabeled%252Bradiotracers%252Bin%252Bthe%252Bbrain%252Bof%252Bnonhuman%252Bprimates%26aulast%3DLuo%26aufirst%3DZonghua%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D47%26spage%3D9171%26epage%3D9184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Hongjun  Jin</span>, <span class="hlFld-ContribAuthor ">Junbin  Han</span>, <span class="hlFld-ContribAuthor ">Xuyi  Yue</span>, <span class="hlFld-ContribAuthor ">Hao  Yang</span>, <span class="hlFld-ContribAuthor ">Mohamed A.  Zayed</span>, <span class="hlFld-ContribAuthor ">Robert J.  Gropler</span>, <span class="hlFld-ContribAuthor ">Zhude  Tu</span>. </span><span class="cited-content_cbyCitation_article-title">Upregulated Sphingosine 1-Phosphate Receptor 1 Expression in Human and Murine Atherosclerotic Plaques. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2018,</strong> <em>20 </em>
                                    (3)
                                     , 448-456. <a href="https://doi.org/10.1007/s11307-017-1141-3" title="DOI URL">https://doi.org/10.1007/s11307-017-1141-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-017-1141-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-017-1141-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DUpregulated%252BSphingosine%252B1-Phosphate%252BReceptor%252B1%252BExpression%252Bin%252BHuman%252Band%252BMurine%252BAtherosclerotic%252BPlaques%26aulast%3DLiu%26aufirst%3DHui%26date%3D2018%26date%3D2017%26volume%3D20%26issue%3D3%26spage%3D448%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zonghua  Luo</span>, <span class="hlFld-ContribAuthor ">Adam J.  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Junbin  Han</span>, <span class="hlFld-ContribAuthor ">Zhude  Tu</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses and in vitro evaluation of new S1PR1 compounds and initial evaluation of a lead F-18 radiotracer in rodents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>150 </em>, 796-808. <a href="https://doi.org/10.1016/j.ejmech.2018.03.035" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.035%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSyntheses%252Band%252Bin%2525C2%2525A0vitro%252Bevaluation%252Bof%252Bnew%252BS1PR1%252Bcompounds%252Band%252Binitial%252Bevaluation%252Bof%252Ba%252Blead%252BF-18%252Bradiotracer%252Bin%252Brodents%26aulast%3DLuo%26aufirst%3DZonghua%26date%3D2018%26volume%3D150%26spage%3D796%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Long  Zhao</span>, <span class="hlFld-ContribAuthor ">Cheng-He  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advance in oxazole-based medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>144 </em>, 444-492. <a href="https://doi.org/10.1016/j.ejmech.2017.12.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.12.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.12.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvance%252Bin%252Boxazole-based%252Bmedicinal%252Bchemistry%26aulast%3DZhang%26aufirst%3DHui-Zhen%26date%3D2018%26volume%3D144%26spage%3D444%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy  Rohrbach</span>, <span class="hlFld-ContribAuthor ">Michael  Maceyka</span>, <span class="hlFld-ContribAuthor ">Sarah  Spiegel</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Biochemistry and Molecular Biology</span><span> <strong>2017,</strong> <em>52 </em>
                                    (5)
                                     , 543-553. <a href="https://doi.org/10.1080/10409238.2017.1337706" title="DOI URL">https://doi.org/10.1080/10409238.2017.1337706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10409238.2017.1337706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10409238.2017.1337706%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DSphingosine%252Bkinase%252Band%252Bsphingosine-1-phosphate%252Bin%252Bliver%252Bpathobiology%26aulast%3DRohrbach%26aufirst%3DTimothy%26date%3D2017%26date%3D2017%26volume%3D52%26issue%3D5%26spage%3D543%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romina E.  Avanzo</span>, <span class="hlFld-ContribAuthor ">José M.  Padrón</span>, <span class="hlFld-ContribAuthor ">Norma B.  D'Accorso</span>, <span class="hlFld-ContribAuthor ">Mirta L.  Fascio</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl d-ribofuranosides. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (16)
                                     , 3674-3677. <a href="https://doi.org/10.1016/j.bmcl.2017.07.015" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.07.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.07.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bin%252Bvitro%252Bantiproliferative%252Bactivities%252Bof%252B%2525285-aryl-1%25252C2%25252C4-oxadiazole-3-yl%252529%252Bmethyl%252Bd-ribofuranosides%26aulast%3DAvanzo%26aufirst%3DRomina%2BE.%26date%3D2017%26volume%3D27%26issue%3D16%26spage%3D3674%26epage%3D3677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Cooper</span>, <span class="hlFld-ContribAuthor ">Sameek  Singh</span>, <span class="hlFld-ContribAuthor ">Sarah  Hook</span>, <span class="hlFld-ContribAuthor ">Joel D. A.  Tyndall</span>, <span class="hlFld-ContribAuthor ">Andrea J.  Vernall</span>, . </span><span class="cited-content_cbyCitation_article-title">Chemical Tools for Studying Lipid-Binding Class A G Protein–Coupled Receptors. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2017,</strong> <em>69 </em>
                                    (3)
                                     , 316-353. <a href="https://doi.org/10.1124/pr.116.013243" title="DOI URL">https://doi.org/10.1124/pr.116.013243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.116.013243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.116.013243%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DChemical%252BTools%252Bfor%252BStudying%252BLipid-Binding%252BClass%252BA%252BG%252BProtein%2525E2%252580%252593Coupled%252BReceptors%26aulast%3DCooper%26aufirst%3DAnna%26date%3D2017%26date%3D2017%26volume%3D69%26issue%3D3%26spage%3D316%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0017.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of S1P, FTY720, and (S)-FTY720-phosphate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of S1P receptor imaging agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Benzoxazole Cores<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(OAc)<sub>2</sub>, SPhos, CsF, R<sup>1</sup>B(OH)<sub>2</sub>, 1,4-dioxane/H<sub>2</sub>O for <b>7b</b>–<b>g</b>; (b) NaH, R<sup>1</sup>OH, DMSO for <b>7a</b>; (c) (i) (COCl)<sub>2</sub>, cat. DMF, CH<sub>2</sub>Cl<sub>2</sub>; (ii) Et<sub>3</sub>N, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (d) <i>p</i>-TsOH, toluene for <b>11a</b>, <b>11b</b>, <b>11e</b>, <b>11h</b>; (e) (i) <i>p</i>-TsOH, toluene; (ii) Cs<sub>2</sub>CO<sub>3</sub>, fluoroethyltosylate, DMF for <b>11c</b>, <b>11d</b>; (f) Ph<sub>3</sub>P, DIAD, THF for <b>11f</b>; (g) PPTS, toluene for <b>11g</b>.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Benzoxazole Targets<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIBAI-H, THF; (b) cyanuric chloride, DMF, CH<sub>2</sub>Cl<sub>2</sub>; (c) methyl azetidine-3-carboxylate hydrochloride, <i>i</i>-Pr<sub>2</sub>NEt, MeCN; (d) LiOH, THF/H<sub>2</sub>O; (e) Pd(OAc)<sub>2</sub>, SPhos, KF, 2-carboxythiophene-5-boronic acid, 1,4-Dioxane/H<sub>2</sub>O; (f) Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub>, XPhos, NaO<sup><i>t</i></sup>Bu, methylpiperidine-4-carboxylate; (g) LiOH, THF/H<sub>2</sub>O.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Benzoxazole Targets<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIBAI-H, THF; (b) cyanuric chloride, DMF, CH<sub>2</sub>Cl<sub>2</sub>; (c) methyl azetidine-3-carboxylate hydrochloride, <i>i</i>-Pr<sub>2</sub>NEt, MeCN; (d) LiOH, THF/H<sub>2</sub>O; (e) Pd(OAc)<sub>2</sub>, SPhos, KF, 2-carboxythiophene-5-boronic acid, 1,4-dioxane/H<sub>2</sub>O; (f) Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub>, XPhos, NaO<sup><i>t</i></sup>Bu, methylpiperidine-4-carboxylate; (g) LiOH, THF/H<sub>2</sub>O.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Radiolabeling Precursor <b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TBTU, HOBt, <b>25</b>, DMF; (b) MnO<sub>2</sub>, 1,4-dioxane (c) methyl azetidine-3-carboxylate hydrochloride, NaBH<sub>3</sub>CN, AcOH, DIPEA, MeOH.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Direct Radiolabeling Precursor <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (CH<sub>2</sub>OTs)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, MeCN; (b) (i) DIPEA, 1,2-DCE/MeOH; (ii) NaBH(OAc)<sub>3</sub>, AcOH, 1,2-DCE.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Radiosynthesis of [<sup>18</sup>F]<b>28c</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Representative <i>in vitro</i> autoradiographic images of serial liver sections from LPS-treated and sham mice after incubation with [<sup>18</sup>F]<b>28c</b> under baseline or blocking conditions. (B) IHC staining for S1P<sub>1</sub> in mouse liver sections. Positive staining for S1P<sub>1</sub> (brown, indicated by black arrows) was observed in the liver of both LPS-treated (left) and sham (right) mice. The number of S1P<sub>1</sub>-positive cells in the liver of LPS-treated mice was much greater than that in sham mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Representative summed 120 min transverse PET/CT images of [<sup>18</sup>F]<b>28c</b> in a sham (left) and LPS-treated (right) mouse. (B) Liver time–activity curves (TAC) of [<sup>18</sup>F]<b>28c</b> standardized uptake values (SUV) in sham and LPS-treated mice. (C) Sham vs LPS-treated summed liver SUVs from 100 to 120 min postinjection. <i>P</i> < 0.001. (D) Liver TACs of [<sup>15</sup>O]H<sub>2</sub>O in sham and LPS-treated mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/medium/jm-2016-003907_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Liver uptake in LPS-treated and sham mice 30 min (A) and 60 min (B) postinjection of [<sup>18</sup>F]<b>28c</b> or [<sup>99m</sup>Tc]mebrofenin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00390/20160708/images/large/jm-2016-003907_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00390&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i113">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27752" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27752" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 54 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">O’Sullivan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dev, K. K.</span><span> </span><span class="NLM_article-title">The structure and function of the S1P1 receptor</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span><span class="refDoi"> DOI: 10.1016/j.tips.2013.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.tips.2013.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=23763867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlGltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=401-412&author=C.+O%E2%80%99Sullivanauthor=K.+K.+Dev&title=The+structure+and+function+of+the+S1P1+receptor&doi=10.1016%2Fj.tips.2013.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The structure and function of the S1P1 receptor</span></div><div class="casAuthors">O'Sullivan, Catherine; Dev, Kumlesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">401-412</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) receptors (S1PRs) belong to the class A family of G protein-coupled receptors (GPCRs).  S1PRs are widely expressed on many cell types, including those of the immune, cardiovascular, and central nervous systems.  The S1PR family is rapidly gaining attention as an important mediator of many cellular processes, including cell differentiation, migration, survival, angiogenesis, calcium homeostasis, inflammation and immunity.  Importantly, S1PRs are known drug targets for multiple sclerosis (MS), for which the newly developed oral therapy fingolimod, an S1PR modulator, has recently been approved for clin. use.  Much progress has also recently been made in the field of structural biol. and in the modeling of heterotrimeric GPCRs allowing the crystal structure of the S1PR1 subtype to be elucidated and key interactions defined.  Here, we outline the structure and function of S1PR1, highlighting the key residues involved in receptor activation, signaling, transmembrane interactions, ligand binding, post-translational modification, and protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpczbmBBxVca7Vg90H21EOLACvtfcHk0lgtkEHSx2MyUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlGltLw%253D&md5=bed981847f79833ad5a49325b2e500b5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DC.%26aulast%3DDev%26aufirst%3DK.%2BK.%26atitle%3DThe%2520structure%2520and%2520function%2520of%2520the%2520S1P1%2520receptor%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D401%26epage%3D412%26doi%3D10.1016%2Fj.tips.2013.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Rosen, H.; Germana Sanna, M.; Gonzalez-Cabrera, P. J.; Roberts, E.</span><span> </span><span class="NLM_article-title">The Organization of the Sphingosine 1-Phosphate Signaling System</span>. In  <span class="citation_source-book">Sphingosine-1-Phosphate Signaling in Immunology and Infectious Diseases</span>, <span class="NLM_edition">2014/04/15</span> ed.; <span class="NLM_contrib-group">Oldstone, M. B. A.; Rosen, H.</span>, Eds.; <span class="NLM_publisher-name">Springer International Publishing</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">378</span>, pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1007%2F978-3-319-05879-5_1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=1-21&author=H.+Rosen&author=M.+Germana+Sanna&author=P.+J.+Gonzalez-Cabrera&author=E.+Robertsauthor=M.+B.+A.+Oldstone&author=H.+Rosen&title=Sphingosine-1-Phosphate+Signaling+in+Immunology+and+Infectious+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-05879-5_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-05879-5_1%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DThe%2520Organization%2520of%2520the%2520Sphingosine%25201-Phosphate%2520Signaling%2520System%26btitle%3DSphingosine-1-Phosphate%2520Signaling%2520in%2520Immunology%2520and%2520Infectious%2520Diseases%26aulast%3DOldstone%26aufirst%3DM.%2BB.%2BA.%26pub%3DSpringer%2520International%2520Publishing%26date%3D2014%26volume%3D378%26spage%3D1%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornancin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechtcheriakova, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urtz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span> </span><span class="NLM_article-title">Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">47408</span><span class="NLM_x">–</span> <span class="NLM_lpage">47415</span><span class="refDoi"> DOI: 10.1074/jbc.M307687200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1074%2Fjbc.M307687200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=13129923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Cqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=47408-47415&author=A.+Billichauthor=F.+Bornancinauthor=P.+Devayauthor=D.+Mechtcheriakovaauthor=N.+Urtzauthor=T.+Baumruker&title=Phosphorylation+of+the+immunomodulatory+drug+FTY720+by+sphingosine+kinases&doi=10.1074%2Fjbc.M307687200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases</span></div><div class="casAuthors">Billich, Andreas; Bornancin, Frederic; Devay, Piroska; Mechtcheriakova, Diana; Urtz, Nicole; Baumruker, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">47408-47415</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The immunomodulatory drug FTY720 is phosphorylated in vivo, and the resulting FTY720 phosphate as a ligand for sphingosine-1-phosphate receptors is responsible for the unique biol. effects of the compd.  So far, phosphorylation of FTY720 by murine sphingosine kinase (SPHK) 1a had been documented.  We found that, while FTY720 is also phosphorylated by human SPHK1, the human type 2 isoform phosphorylates the drug 30-fold more efficiently, because of a lower Km of FTY720 for SPHK2.  Similarly, murine SPHK2 was more efficient than SPHK1a.  Among splice variants of the human SPHKs, an N-terminally extended SPHK2 isoform was even more active than SPHK2 itself.  Further SPHK superfamily members, namely ceramide kinase and a "SPHK-like" protein, failed to phosphorylate sphingosine and FTY720.  Thus, only SPHK1 and 2 appear to be capable of phosphorylating FTY720.  Using selective assay conditions, SPHK1 and 2 activities in murine tissues were measured.  While activity of SPHK2 toward sphingosine was generally lower than of SPHK1, FTY720 phosphorylation was higher under conditions favoring SPHK2.  In human endothelial cells, while activity of SPHK1 toward sphingosine was 2-fold higher than of SPHK2, FTY720 phosphorylation was 7-fold faster under SPHK2 assay conditions.  Finally, FTY720 was poorly phosphorylated in human blood as compared with rodent blood, in line with the low activity of SPHK1 and in particular of SPHK2 in human blood.  To conclude, both SPHK1 and 2 are capable of phosphorylating FTY720, but SPHK2 is quant. more important than SPHK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR5e-dVWnBT7Vg90H21EOLACvtfcHk0ljGB_itAaqEmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Cqtr0%253D&md5=26820503680682863dc76a69ea02fc7e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M307687200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M307687200%26sid%3Dliteratum%253Aachs%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DDevay%26aufirst%3DP.%26aulast%3DMechtcheriakova%26aufirst%3DD.%26aulast%3DUrtz%26aufirst%3DN.%26aulast%3DBaumruker%26aufirst%3DT.%26atitle%3DPhosphorylation%2520of%2520the%2520immunomodulatory%2520drug%2520FTY720%2520by%2520sphingosine%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D47408%26epage%3D47415%26doi%3D10.1074%2Fjbc.M307687200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1126/science.1070238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1126%2Fscience.1070238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=11923495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVWhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.+J.+Sheiauthor=D.+Cardauthor=C.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+lymphocyte+trafficking+by+sphingosine-1-phosphate+receptor+agonists&doi=10.1126%2Fscience.1070238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span></div><div class="casAuthors">Mandala, Suzanne; Hajdu, Richard; Bergstrom, James; Quackenbush, Elizabeth; Xie, Jenny; Milligan, James; Thornton, Rosemary; Shei, Gan-Ju; Card, Deborah; Keohane, Carolann; Rosenbach, Mark; Hale, Jeffrey; Lynch, Christopher L.; Rupprecht, Kathleen; Parsons, William; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5566</span>),
    <span class="NLM_cas:pages">346-349</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Blood lymphocyte nos., essential for the development of efficient immune responses, are maintained by recirculation through secondary Lymphoid organs.  We show that lymphocyte trafficking is altered by the lysophospholipid sphingosine-1-phosphate (S1P) and by a phosphoryl metabolite of the immunosuppressive agent FTY720.  Both species were high-affinity agonists of at least four of the five S1P receptors.  These agonists produce lymphopenia in blood and thoracic duct lymph by sequestration of lymphocytes in lymph nodes, but not spleen.  S1P receptor agonists induced emptying of lymphoid sinuses by retention of lymphocytes on the abluminal side of sinus-lining endothelium and inhibition of egress into lymph.  Inhibition of lymphocyte recirculation by activation of S1P receptors may result in therapeutically useful immunosuppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPvwG_lLsA8LVg90H21EOLACvtfcHk0ljGB_itAaqEmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVWhsrc%253D&md5=b57cbcffe41d144e701dbd42459cf38a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1070238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1070238%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.%2BJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520lymphocyte%2520trafficking%2520by%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349%26doi%3D10.1126%2Fscience.1070238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmouder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aradhye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span><span class="refDoi"> DOI: 10.1038/nrd3248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1038%2Fnrd3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=21031003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=883-897&author=V.+Brinkmannauthor=A.+Billichauthor=T.+Baumrukerauthor=P.+Heiningauthor=R.+Schmouderauthor=G.+Francisauthor=S.+Aradhyeauthor=P.+Burtin&title=Fingolimod+%28FTY720%29%3A+Discovery+and+development+of+an+oral+drug+to+treat+multiple+sclerosis&doi=10.1038%2Fnrd3248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span></div><div class="casAuthors">Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmouder, Robert; Francis, Gordon; Aradhye, Shreeram; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">883-897</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory drug, has opened up new approaches to the treatment of multiple sclerosis, the most common inflammatory disorder of the central nervous system.  Elucidation of the effects of fingolimod - mediated by the modulation of sphingosine 1-phosphate (S1P) receptors - has indicated that its therapeutic activity could be due to regulation of the migration of selected lymphocyte subsets into the central nervous system and direct effects on neural cells, particularly astrocytes.  An improved understanding of the biol. of S1P receptors has also been gained.  This article describes the discovery and development of fingolimod, which was approved by the US Food and Drug Administration in Sept. 2010 as a first-line treatment for relapsing forms of multiple sclerosis, thereby becoming the first oral disease-modifying therapy to be approved for multiple sclerosis in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80U6QfXSJMbVg90H21EOLACvtfcHk0lgmBMoZMcYJEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL&md5=0f6dd60ef115079f3652e9d12d82e215</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3248%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520Discovery%2520and%2520development%2520of%2520an%2520oral%2520drug%2520to%2520treat%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D883%26epage%3D897%26doi%3D10.1038%2Fnrd3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span><span class="refDoi"> DOI: 10.1124/jpet.103.062828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.+Y.+Sunauthor=R.+Hajduauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.+J.+Sheiauthor=+Singerauthor=M.+Tianauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+cell+regulation+and+cardiovascular+effects+of+sphingosine+1-phosphate+receptor+agonists+in+rodents+are+mediated+via+distinct+receptor+subtypes&doi=10.1124%2Fjpet.103.062828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0lgkO6JimYprdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.%2BY.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.%2BJ.%26aulast%3DSinger%26aulast%3DTian%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520cell%2520regulation%2520and%2520cardiovascular%2520effects%2520of%2520sphingosine%25201-phosphate%2520receptor%2520agonists%2520in%2520rodents%2520are%2520mediated%2520via%2520distinct%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768%26doi%3D10.1124%2Fjpet.103.062828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Fryer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muthukumarana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nodop Mazurek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinallo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modis, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, G. A.</span><span> </span><span class="NLM_article-title">The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P<sub>1</sub>) and hypertension (S1P<sub>3</sub>) in rat</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e52985</span><span class="refDoi"> DOI: 10.1371/journal.pone.0052985</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1371%2Fjournal.pone.0052985" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e52985&author=R.+M.+Fryerauthor=A.+Muthukumaranaauthor=P.+C.+Harrisonauthor=S.+Nodop+Mazurekauthor=R.+R.+Chenauthor=K.+E.+Harringtonauthor=R.+M.+Dinalloauthor=J.+C.+Horanauthor=L.+Patnaudeauthor=L.+K.+Modisauthor=G.+A.+Reinhart&title=The+clinically-tested+S1P+receptor+agonists%2C+FTY720+and+BAF312%2C+demonstrate+subtype-specific+bradycardia+%28S1P1%29+and+hypertension+%28S1P3%29+in+rat&doi=10.1371%2Fjournal.pone.0052985"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0052985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0052985%26sid%3Dliteratum%253Aachs%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DMuthukumarana%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DP.%2BC.%26aulast%3DNodop%2BMazurek%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%2BR.%26aulast%3DHarrington%26aufirst%3DK.%2BE.%26aulast%3DDinallo%26aufirst%3DR.%2BM.%26aulast%3DHoran%26aufirst%3DJ.%2BC.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DModis%26aufirst%3DL.%2BK.%26aulast%3DReinhart%26aufirst%3DG.%2BA.%26atitle%3DThe%2520clinically-tested%2520S1P%2520receptor%2520agonists%252C%2520FTY720%2520and%2520BAF312%252C%2520demonstrate%2520subtype-specific%2520bradycardia%2520%2528S1P1%2529%2520and%2520hypertension%2520%2528S1P3%2529%2520in%2520rat%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De52985%26doi%3D10.1371%2Fjournal.pone.0052985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Gergely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groenewegen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitaliti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sing, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttringer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallstrom, E.</span><span> </span><span class="NLM_article-title">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02061.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1111%2Fj.1476-5381.2012.02061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=22646698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1035-1047&author=P.+Gergelyauthor=B.+Nuesslein-Hildesheimauthor=D.+Gueriniauthor=V.+Brinkmannauthor=M.+Traebertauthor=C.+Brunsauthor=S.+Panauthor=N.+S.+Grayauthor=K.+Hinterdingauthor=N.+G.+Cookeauthor=A.+Groenewegenauthor=A.+Vitalitiauthor=T.+Singauthor=O.+Luttringerauthor=J.+Yangauthor=A.+Gardinauthor=N.+Wangauthor=W.+J.+Crumbauthor=M.+Saltzmanauthor=M.+Rosenbergauthor=E.+Wallstrom&title=The+selective+sphingosine+1-phosphate+receptor+modulator+BAF312+redirects+lymphocyte+distribution+and+has+species-specific+effects+on+heart+rate&doi=10.1111%2Fj.1476-5381.2012.02061.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span></div><div class="casAuthors">Gergely, P.; Nuesslein-Hildesheim, B.; Guerini, D.; Brinkmann, V.; Traebert, M.; Bruns, C.; Pan, S.; Gray, N. S.; Hinterding, K.; Cooke, N. G.; Groenewegen, A.; Vitaliti, A.; Sing, T.; Luttringer, O.; Yang, J.; Gardin, A.; Wang, N.; Crumb, W. J., Jr.; Saltzman, M.; Rosenberg, M.; Wallstrom, E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-1047</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose BAF312 is a next-generation sphingosine 1-phosphate (S1P) receptor modulator, selective for S1P1 and S1P5 receptors.  S1P1 receptors are essential for lymphocyte egress from lymph nodes and a drug target in immune-mediated diseases.  Here, we have characterized the immunomodulatory potential of BAF312 and the S1P receptor-mediated effects on heart rate using preclin. and human data.  Exptl. Approach BAF312 was tested in a rat exptl. autoimmune encephalomyelitis (EAE) model.  Electrophysiol. recordings of G-protein-coupled inwardly rectifying potassium (GIRK) channels were carried out in human atrial myocytes.  A Phase I multiple-dose trial studied the pharmacokinetics, pharmacodynamics and safety of BAF312 in 48 healthy subjects.  Key Results BAF312 effectively suppressed EAE in rats by internalizing S1P1 receptors, rendering them insensitive to the egress signal from lymph nodes.  In healthy volunteers, BAF312 caused preferential decreases in CD4+ T cells, Tnaive, Tcentral memory and B cells within 4-6 h.  Cell counts returned to normal ranges within a week after stopping treatment, in line with the elimination half-life of BAF312.  Despite sparing S1P3 receptors (assocd. with bradycardia in mice), BAF312 induced rapid, transient (day 1 only) bradycardia in humans.  BAF312-mediated activation of GIRK channels in human atrial myocytes can fully explain the bradycardia.  Conclusion and Implications This study illustrates species-specific differences in S1P receptor specificity for first-dose cardiac effects.  Based on its profound but rapidly reversible inhibition of lymphocyte trafficking, BAF312 may have potential as a treatment for immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr42VfW58NMyLVg90H21EOLACvtfcHk0li0_7HvDOkqzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKkt7bE&md5=0034be62fb68b10abefff50f0220be2a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02061.x%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DTraebert%26aufirst%3DM.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DGroenewegen%26aufirst%3DA.%26aulast%3DVitaliti%26aufirst%3DA.%26aulast%3DSing%26aufirst%3DT.%26aulast%3DLuttringer%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCrumb%26aufirst%3DW.%2BJ.%26aulast%3DSaltzman%26aufirst%3DM.%26aulast%3DRosenberg%26aufirst%3DM.%26aulast%3DWallstrom%26aufirst%3DE.%26atitle%3DThe%2520selective%2520sphingosine%25201-phosphate%2520receptor%2520modulator%2520BAF312%2520redirects%2520lymphocyte%2520distribution%2520and%2520has%2520species-specific%2520effects%2520on%2520heart%2520rate%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D1035%26epage%3D1047%26doi%3D10.1111%2Fj.1476-5381.2012.02061.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Murakami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takasugi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koide, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasamori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, N.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P<sub>3</sub> receptor: Investigation based on a new S1P<sub>3</sub> receptor antagonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span><span class="refDoi"> DOI: 10.1124/mol.109.061481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1124%2Fmol.109.061481" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=704-713&author=A.+Murakamiauthor=H.+Takasugiauthor=S.+Ohnumaauthor=Y.+Koideauthor=A.+Sakuraiauthor=S.+Takedaauthor=T.+Hasegawaauthor=J.+Sasamoriauthor=T.+Konnoauthor=K.+Hayashiauthor=Y.+Watanabeauthor=K.+Moriauthor=Y.+Satoauthor=A.+Takahashiauthor=N.+Mochizukiauthor=N.+Takakura&title=Sphingosine+1-phosphate+%28S1P%29+regulates+vascular+contraction+via+S1P3+receptor%3A+Investigation+based+on+a+new+S1P3+receptor+antagonist&doi=10.1124%2Fmol.109.061481"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fmol.109.061481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.109.061481%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DA.%26aulast%3DTakasugi%26aufirst%3DH.%26aulast%3DOhnuma%26aufirst%3DS.%26aulast%3DKoide%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DSasamori%26aufirst%3DJ.%26aulast%3DKonno%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DMochizuki%26aufirst%3DN.%26aulast%3DTakakura%26aufirst%3DN.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520regulates%2520vascular%2520contraction%2520via%2520S1P3%2520receptor%253A%2520Investigation%2520based%2520on%2520a%2520new%2520S1P3%2520receptor%2520antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D704%26epage%3D713%26doi%3D10.1124%2Fmol.109.061481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Li, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pappalardo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, F.</span><span> </span><span class="NLM_article-title">Induction of antiproliferative connective tissue growth factor expression in Wilms’ tumor cells by sphingosine-1-phosphate receptor 2</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1649</span><span class="NLM_x">–</span> <span class="NLM_lpage">1656</span><span class="refDoi"> DOI: 10.1158/1541-7786.MCR-07-2048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1158%2F1541-7786.MCR-07-2048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=18922980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Cmsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=1649-1656&author=M.+H.+Liauthor=T.+Sanchezauthor=A.+Pappalardoauthor=K.+R.+Lynchauthor=T.+Hlaauthor=F.+Ferrer&title=Induction+of+antiproliferative+connective+tissue+growth+factor+expression+in+Wilms%E2%80%99+tumor+cells+by+sphingosine-1-phosphate+receptor+2&doi=10.1158%2F1541-7786.MCR-07-2048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2</span></div><div class="casAuthors">Li, Mei-Hong; Sanchez, Teresa; Pappalardo, Anna; Lynch, Kevin R.; Hla, Timothy; Ferrer, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1649-1656</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Connective tissue growth factor (CTGF), a member of the CCN family of secreted matricellular proteins, regulates fibrosis, angiogenesis, cell proliferation, apoptosis, tumor growth, and metastasis.  However, the role of CTGF and its regulation mechanism in Wilms' tumor remains largely unknown.  We found that the bioactive lipid sphingosine-1-phosphate (S1P) induced CTGF expression in a concn.- and time-dependent manner in a Wilms' tumor cell line (WiT49), whereas FTY720-phosphate, an S1P analog that binds all S1P receptors except S1P2, did not.  Further, the specific S1P2 antagonist JTE-013 completely inhibited S1P-induced CTGF expression, whereas the S1P1 antagonist VPC44116 did not, indicating that this effect was mediated by S1P2.  This was confirmed by adenoviral transduction of S1P2 in WiT49 cells, which showed that overexpression of S1P2 increased the expression of CTGF.  Induction of CTGF by S1P was sensitive to ROCK inhibitor Y-27632 and c-Jun N-terminal kinase inhibitor SP600125, suggesting the requirement of RhoA/ROCK and c-Jun N-terminal kinase pathways for S1P-induced CTGF expression.  Interestingly, the expression levels of CTGF were decreased in 8 of 10 Wilms' tumor tissues compared with matched normal tissues by quant. real-time PCR and Western blot anal.  In vitro, human recombinant CTGF significantly inhibited the proliferation of WiT49 cells.  In addn., overexpression of CTGF resulted in significant inhibition of WiT49 cell growth.  Taken together, these data suggest that CTGF protein induced by S1P2 might act as a growth inhibitor in Wilms' tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0itj-FE9CkrVg90H21EOLACvtfcHk0li0_7HvDOkqzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Cmsb%252FI&md5=991604878a73ab45c95f38552849e53d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-07-2048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-07-2048%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%2BH.%26aulast%3DSanchez%26aufirst%3DT.%26aulast%3DPappalardo%26aufirst%3DA.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DFerrer%26aufirst%3DF.%26atitle%3DInduction%2520of%2520antiproliferative%2520connective%2520tissue%2520growth%2520factor%2520expression%2520in%2520Wilms%25E2%2580%2599%2520tumor%2520cells%2520by%2520sphingosine-1-phosphate%2520receptor%25202%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2008%26volume%3D6%26spage%3D1649%26epage%3D1656%26doi%3D10.1158%2F1541-7786.MCR-07-2048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Plano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, A. K.</span><span> </span><span class="NLM_article-title">Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5509</span><span class="NLM_x">–</span> <span class="NLM_lpage">5524</span><span class="refDoi"> DOI: 10.1021/jm4011687</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4011687" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5509-5524&author=D.+Planoauthor=S.+Aminauthor=A.+K.+Sharma&title=Importance+of+sphingosine+kinase+%28SphK%29+as+a+target+in+developing+cancer+therapeutics+and+recent+developments+in+the+synthesis+of+novel+SphK+inhibitors&doi=10.1021%2Fjm4011687"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm4011687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4011687%26sid%3Dliteratum%253Aachs%26aulast%3DPlano%26aufirst%3DD.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26atitle%3DImportance%2520of%2520sphingosine%2520kinase%2520%2528SphK%2529%2520as%2520a%2520target%2520in%2520developing%2520cancer%2520therapeutics%2520and%2520recent%2520developments%2520in%2520the%2520synthesis%2520of%2520novel%2520SphK%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5509%26epage%3D5524%26doi%3D10.1021%2Fjm4011687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ishii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klauschen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier-Schellersheim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, R. N.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span><span class="refDoi"> DOI: 10.1038/nature07713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1038%2Fnature07713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=19204730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=524-528&author=M.+Ishiiauthor=J.+G.+Egenauthor=F.+Klauschenauthor=M.+Meier-Schellersheimauthor=Y.+Saekiauthor=J.+Vacherauthor=R.+L.+Proiaauthor=R.+N.+Germain&title=Sphingosine-1-phosphate+mobilizes+osteoclast+precursors+and+regulates+bone+homeostasis&doi=10.1038%2Fnature07713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis</span></div><div class="casAuthors">Ishii, Masaru; Egen, Jackson G.; Klauschen, Frederick; Meier-Schellersheim, Martin; Saeki, Yukihiko; Vacher, Jean; Proia, Richard L.; Germain, Ronald N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">7237</span>),
    <span class="NLM_cas:pages">524-528</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Osteoclasts are the only somatic cells with bone-resorbing capacity and, as such, they have a crit. role not only in normal bone homeostasis (called bone remodelling') but also in the pathogenesis of bone destructive disorders such as rheumatoid arthritis and osteoporosis.  A major focus of research in the field has been on gene regulation by osteoclastogenic cytokines such as receptor activator of NF-κB-ligand (RANKL, also known as TNFSF11) and TNF-α, both of which have been well documented to contribute to osteoclast terminal differentiation.  A crucial process that has been less well studied is the trafficking of osteoclast precursors to and from the bone surface, where they undergo cell fusion to form the fully differentiated multinucleated cells that mediate bone resorption.  Here we report that sphingosine-1-phosphate (S1P), a lipid mediator enriched in blood, induces chemotaxis and regulates the migration of osteoclast precursors not only in culture but also in vivo, contributing to the dynamic control of bone mineral homeostasis.  Cells with the properties of osteoclast precursors express functional S1P1 receptors and exhibit pos. chemotaxis along an S1P gradient in vitro.  Intravital two-photon imaging of bone tissues showed that a potent S1P1 agonist, SEW2871, stimulated motility of osteoclast precursor-contg. monocytoid populations in vivo.  Osteoclast/monocyte (CD11b, also known as ITGAM) lineage-specific conditional S1P1 knockout mice showed osteoporotic changes due to increased osteoclast attachment to the bone surface.  Furthermore, treatment with the S1P1 agonist FTY720 relieved ovariectomy-induced osteoporosis in mice by reducing the no. of mature osteoclasts attached to the bone surface.  Together, these data provide evidence that S1P controls the migratory behavior of osteoclast precursors, dynamically regulating bone mineral homeostasis, and identifies a crit. control point in osteoclastogenesis that may have potential as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5nhHArE-y5LVg90H21EOLACvtfcHk0liEvjbZl6hm1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCqsrg%253D&md5=3615d96c5b372559422cb6242e8d6c35</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature07713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07713%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DM.%26aulast%3DEgen%26aufirst%3DJ.%2BG.%26aulast%3DKlauschen%26aufirst%3DF.%26aulast%3DMeier-Schellersheim%26aufirst%3DM.%26aulast%3DSaeki%26aufirst%3DY.%26aulast%3DVacher%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DGermain%26aufirst%3DR.%2BN.%26atitle%3DSphingosine-1-phosphate%2520mobilizes%2520osteoclast%2520precursors%2520and%2520regulates%2520bone%2520homeostasis%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D524%26epage%3D528%26doi%3D10.1038%2Fnature07713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Cross, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccio, L.</span><span> </span><span class="NLM_article-title">Rituximab combination therapy in relapsing multiple sclerosis</span> <span class="citation_source-journal">Ther. Adv. Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span><span class="refDoi"> DOI: 10.1177/1756285612461165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1177%2F1756285612461165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=23139702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVSlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=311-319&author=A.+H.+Crossauthor=R.+S.+Kleinauthor=L.+Piccio&title=Rituximab+combination+therapy+in+relapsing+multiple+sclerosis&doi=10.1177%2F1756285612461165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Rituximab combination therapy in relapsing multiple sclerosis</span></div><div class="casAuthors">Cross, Anne H.; Klein, Robyn S.; Piccio, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Neurological Disorders</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">311-319, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">TANDCF</span>;
        ISSN:<span class="NLM_cas:issn">1756-2856</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  In multiple sclerosis (MS), the presence of B cells, plasma cells and excess Igs in central nervous system lesions and in the cerebrospinal fluid implicate the humoral immune system in disease pathogenesis.  However, until the advent of specific B-cell-depleting therapies, the crit. role of B cells and their products in MS was unproven.  Rituximab, a monoclonal antibody that depletes B cells by targeting the CD20 mol., has been shown to effectively reduce disease activity in patients with relapsing MS as a single agent.  Our investigator-initiated phase II study is the only published clin. trial in which rituximab was used as an add-on therapy in patients with relapsing MS who had an inadequate response to std. injectable disease-modifying therapies (DMTs).  The primary endpoint, magnetic resonance imaging (MRI) gadolinium-enhanced (GdE) lesion no. before vs. after rituximab, showed significant benefit of rituximab (74% of post-treatment MRI scans being free of GdE lesions compared with 26% free of GdE lesions at baseline; p<0.0001).  No differences were noted comparing patients on different DMTs.  Several secondary clin. endpoints, safety and lab. measurements (including B- and T- cell nos. in the blood and cerebrospinal fluid (CSF), serum and CSF chemokine levels, antibodies to myelin proteins) were assessed.  Surprisingly, the decline in B-cell no. was accompanied by a significant redn. in the no. of T cells in both the peripheral blood and CSF.  Rituximab therapy was assocd. with a significant decline of two lymphoid chemokines, CXCL13 and CCL19.  No significant changes were obsd. in serum antibody levels against myelin proteins [myelin basic protein (MBP) and myelin/oligodendrocyte glycoprotein (MOG)] after treatment.  These results suggest that B cells play a role in MS independent from antibody prodn. and possibly related to their role in antigen presentation to T cells or to their chemokine/cytokine prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_V9wmb18qQLVg90H21EOLACvtfcHk0liEvjbZl6hm1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVSlsb0%253D&md5=07769c61a17ad6d0df3e78de79943b52</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1177%2F1756285612461165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1756285612461165%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DA.%2BH.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26aulast%3DPiccio%26aufirst%3DL.%26atitle%3DRituximab%2520combination%2520therapy%2520in%2520relapsing%2520multiple%2520sclerosis%26jtitle%3DTher.%2520Adv.%2520Neurol.%2520Disord.%26date%3D2012%26volume%3D5%26spage%3D311%26epage%3D319%26doi%3D10.1177%2F1756285612461165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Dong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice</span> <span class="citation_source-journal">Clin. Exp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1111/cei.12304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1111%2Fcei.12304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=24611843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1KrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2014&pages=94-101&author=J.+Dongauthor=H.+Wangauthor=G.+Wuauthor=J.+Zhaoauthor=L.+Zhangauthor=L.+Zuoauthor=W.+Zhuauthor=J.+Gongauthor=Y.+Liauthor=L.+Guauthor=J.+Li&title=Oral+treatment+with+SEW2871%2C+a+sphingosine-1-phosphate+type+1+receptor+agonist%2C+ameliorates+experimental+colitis+in+interleukin-10+gene+deficient+mice&doi=10.1111%2Fcei.12304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice</span></div><div class="casAuthors">Dong, J.; Wang, H.; Wu, G.; Zhao, J.; Zhang, L.; Zuo, L.; Zhu, W.; Gong, J.; Li, Y.; Gu, L.; Li, J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-101</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : SEW2871, a selective sphingosine-1-phosphate type 1 receptor (S1P1) agonist, has been shown to be effective in protecting kidneys against ischemia-reperfusion injury by reducing CD4+ T cell infiltration in mice.  However, the effects of SEW2871 on colitis remain unclear.  The aim of this study was to investigate the effects of SEW2871 on established colitis in interleukin (IL)-10 gene-deficient (IL-10-/-) mice, a murine model of Crohn's disease (CD).  SEW2871 was administered by gavage at a dose of 20 mg/kg/day for 2 wk to IL-10-/- mice.  Severity of colitis, serum amyloid A, tissue myeloperoxidase (MPO), T cells in blood and colon lamina propria (LP) and proinflammatory cytokine productions were evaluated.  Furthermore, the phospho-signal transducer and activator of transcription (STAT)-3 (p-STAT-3) expression in lymphocytes isolated from colon LP was also assessed.  The 2-wk administration of SEW2871 ameliorated established colitis in IL-10-/- mice, assocd. with a redn. of serum amyloid A concn., a decreased colon MPO concn., a depletion of the peripheral CD4+CD45+ T cells and a redn. of the homing of T cells into colon LP.  Moreover, typical cytokines of T helper type 1 (Th1) and Th17 cells and p-STAT-3 expression were also suppressed by SEW2871 treatment.  SEW2871 treatment ameliorates established exptl. colitis in IL-10-/- mice, which may provide a new therapeutic approach for human CD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh40KVSx1HQLVg90H21EOLACvtfcHk0liu5pWlCn_CGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1KrsLk%253D&md5=41efa767cdc4f55c36d6ec4a0d7882fa</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fcei.12304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcei.12304%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZuo%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DOral%2520treatment%2520with%2520SEW2871%252C%2520a%2520sphingosine-1-phosphate%2520type%25201%2520receptor%2520agonist%252C%2520ameliorates%2520experimental%2520colitis%2520in%2520interleukin-10%2520gene%2520deficient%2520mice%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2014%26volume%3D177%26spage%3D94%26epage%3D101%26doi%3D10.1111%2Fcei.12304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">McCandless, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. S.</span><span> </span><span class="NLM_article-title">IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">183</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span><span class="refDoi"> DOI: 10.4049/jimmunol.0802258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.4049%2Fjimmunol.0802258" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2009&pages=613-620&author=E.+E.+McCandlessauthor=M.+Buddeauthor=J.+R.+Leesauthor=D.+Dorseyauthor=E.+Lyngauthor=R.+S.+Klein&title=IL-1R+signaling+within+the+central+nervous+system+regulates+CXCL12+expression+at+the+blood-brain+barrier+and+disease+severity+during+experimental+autoimmune+encephalomyelitis&doi=10.4049%2Fjimmunol.0802258"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0802258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0802258%26sid%3Dliteratum%253Aachs%26aulast%3DMcCandless%26aufirst%3DE.%2BE.%26aulast%3DBudde%26aufirst%3DM.%26aulast%3DLees%26aufirst%3DJ.%2BR.%26aulast%3DDorsey%26aufirst%3DD.%26aulast%3DLyng%26aufirst%3DE.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26atitle%3DIL-1R%2520signaling%2520within%2520the%2520central%2520nervous%2520system%2520regulates%2520CXCL12%2520expression%2520at%2520the%2520blood-brain%2520barrier%2520and%2520disease%2520severity%2520during%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D183%26spage%3D613%26epage%3D620%26doi%3D10.4049%2Fjimmunol.0802258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Moberly, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohatagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noveck, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truitt, K. E.</span><span> </span><span class="NLM_article-title">Pharmacological modulation of peripheral T and B lymphocytes by a selective sphingosine 1-phosphate receptor-1 modulator</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">996</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span><span class="refDoi"> DOI: 10.1177/0091270011408728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1177%2F0091270011408728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=21566200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ShtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=996-1006&author=J.+B.+Moberlyauthor=S.+Rohatagiauthor=H.+Zahirauthor=C.+Hsuauthor=R.+J.+Noveckauthor=K.+E.+Truitt&title=Pharmacological+modulation+of+peripheral+T+and+B+lymphocytes+by+a+selective+sphingosine+1-phosphate+receptor-1+modulator&doi=10.1177%2F0091270011408728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological modulation of peripheral T and B lymphocytes by a selective sphingosine 1-phosphate receptor-1 modulator</span></div><div class="casAuthors">Moberly, James B.; Rohatagi, Shashank; Zahir, Hamim; Hsu, Ching; Noveck, Robert J.; Truitt, Kenneth E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">996-1006</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">CS-0777 is a selective sphingosine 1-phosphate receptor-1 (S1P1) modulator under development for treatment of autoimmune conditions.  A randomized, double-blind, placebo-controlled study was conducted to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of CS-0777 in escalating dose cohorts of healthy male participants (0.1, 0.3, 1.0, and 2.5 mg; 6 active, 2 placebo per cohort).  Primary pharmacodynamic parameters were abs. lymphocyte counts and lymphocyte subsets (CD4 and CD8 T and B cells).  CS-0777 resulted in a pronounced, dose-dependent decrease in abs. lymphocyte counts (mean percent decrease from baseline at 24 h postdose: 7%, 26%, 52%, 79%, and 85%, for placebo and 0.1, 0.3, 1.0, and 2.5 mg, resp.).  Dose-related decreases of similar magnitude were obsd. for T and B cell subsets.  Mean total white blood cell and neutrophil counts remained within normal ranges for all dose levels.  CS-0777 was well tolerated, and there were no serious or severe adverse events.  Mild, asymptomatic bradycardia and transaminase elevations (<3-fold upper limit of normal), similar to findings for other S1P receptor modulators, were obsd. at the highest dose level (2.5 mg).  Therefore, CS-0777 shows potent activity in humans and may hold potential for treatment of autoimmune conditions such as multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR8u0a5KeOdLVg90H21EOLACvtfcHk0liu5pWlCn_CGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ShtLbO&md5=504f2b5e6fc73885abc263d5d6252218</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1177%2F0091270011408728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270011408728%26sid%3Dliteratum%253Aachs%26aulast%3DMoberly%26aufirst%3DJ.%2BB.%26aulast%3DRohatagi%26aufirst%3DS.%26aulast%3DZahir%26aufirst%3DH.%26aulast%3DHsu%26aufirst%3DC.%26aulast%3DNoveck%26aufirst%3DR.%2BJ.%26aulast%3DTruitt%26aufirst%3DK.%2BE.%26atitle%3DPharmacological%2520modulation%2520of%2520peripheral%2520T%2520and%2520B%2520lymphocytes%2520by%2520a%2520selective%2520sphingosine%25201-phosphate%2520receptor-1%2520modulator%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2012%26volume%3D52%26spage%3D996%26epage%3D1006%26doi%3D10.1177%2F0091270011408728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Graler, M. H.</span><span> </span><span class="NLM_article-title">Targeting sphingosine 1-phosphate (S1P) levels and S1P receptor functions for therapeutic immune interventions</span> <span class="citation_source-journal">Cell. Physiol. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span><span class="refDoi"> DOI: 10.1159/000315108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1159%2F000315108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=20502007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A280%3ADC%252BC3czmvFyjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=79-86&author=M.+H.+Graler&title=Targeting+sphingosine+1-phosphate+%28S1P%29+levels+and+S1P+receptor+functions+for+therapeutic+immune+interventions&doi=10.1159%2F000315108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting sphingosine 1-phosphate (S1P) levels and S1P receptor functions for therapeutic immune interventions</span></div><div class="casAuthors">Graler Markus H</div><div class="citationInfo"><span class="NLM_cas:title">Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is an important regulator of many different immune functions including lymphocyte circulation, antigen presentation, and T cell development.  It stimulates five G protein-coupled receptors designated S1P(1-5), which are also expressed by immune cells.  S1P receptors couple to different heterotrimeric G proteins including G alpha i, q, and 12/13, and elicit cellular signalling events by activating the small GTPases Rac and Rho and protein kinases Akt, ERK, and JNK, and by inducing cellular calcium flux and inhibiting cAMP accumulation, amongst others.  S1P is the exit signal for lymphocytes leaving lymphoid organs and present in blood and lymph at high nanomolar concentrations due to the S1P-producing activity of sphingosine kinases (SK).  The S1P-degrading enzyme S1P-lyase maintains low amounts of S1P in lymphoid organs.  Disrupting this concentration difference by S1P receptor agonists and antagonists like FTY720, SEW2871, and VPC23019, by an anti-S1P antibody, or by inhibiting the S1P-lyase has therapeutic potential for autoimmune diseases like multiple sclerosis (MS) and rheumatoid arthritis and for many other disorders like cancer, fibrosis, inflammation, macular degeneration, diabetic retinopathy, and glaucoma.  This report aims to provide a brief overview of concepts, approaches, pharmaceutical compounds, and targets that are currently used to modulate S1P-driven immune functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkVD7D529OLvcsfMJQC1ZdfW6udTcc2eai-hzkRcgAArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czmvFyjsw%253D%253D&md5=d69921fd8a1a5da3e88fbda25eef84a5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1159%2F000315108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000315108%26sid%3Dliteratum%253Aachs%26aulast%3DGraler%26aufirst%3DM.%2BH.%26atitle%3DTargeting%2520sphingosine%25201-phosphate%2520%2528S1P%2529%2520levels%2520and%2520S1P%2520receptor%2520functions%2520for%2520therapeutic%2520immune%2520interventions%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2010%26volume%3D26%26spage%3D79%26epage%3D86%26doi%3D10.1159%2F000315108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Holman, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ransohoff, R. M.</span><span> </span><span class="NLM_article-title">The blood-brain barrier, chemokines and multiple sclerosis</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Basis Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1812</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span><span class="refDoi"> DOI: 10.1016/j.bbadis.2010.07.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.bbadis.2010.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=20692338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFyrsrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1812&publication_year=2011&pages=220-230&author=D.+W.+Holmanauthor=R.+S.+Kleinauthor=R.+M.+Ransohoff&title=The+blood-brain+barrier%2C+chemokines+and+multiple+sclerosis&doi=10.1016%2Fj.bbadis.2010.07.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The blood-brain barrier, chemokines and multiple sclerosis</span></div><div class="casAuthors">Holman, David W.; Klein, Robyn S.; Ransohoff, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1812</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">220-230</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  The infiltration of leukocytes into the central nervous system (CNS) is an essential step in the neuropathogenesis of multiple sclerosis (MS).  Leukocyte extravasation from the bloodstream is a multi-step process that depends on several factors including fluid dynamics within the vasculature and mol. interactions between circulating leukocytes and the vascular endothelium.  An important step in this cascade is the presence of chemokines on the vascular endothelial cell surface.  Chemokines displayed along the endothelial lumen bind chemokine receptors on circulating leukocytes, initiating intracellular signaling that culminates in integrin activation, leukocyte arrest, and extravasation.  The presence of chemokines at the endothelial lumen can help guide the movement of leukocytes through peripheral tissues during normal immune surveillance, host defense or inflammation.  The expression and display of homeostatic or inflammatory chemokines therefore critically det. which leukocyte subsets extravasate and enter the peripheral tissues.  Within the CNS, however, infiltrating leukocytes that cross the endothelium face addnl. boundaries to parenchymal entry, including the abluminal presence of localizing cues that prevent egress from perivascular spaces.  This review focuses on the differential display of chemokines along endothelial surfaces and how they impact leukocyte extravasation into parenchymal tissues, esp. within the CNS.  In particular, the display of chemokines by endothelial cells of the blood brain barrier may be altered during CNS autoimmune disease, promoting leukocyte entry into this immunol. distinct site.  Recent advances in microscopic techniques, including two-photon and intravital imaging have provided new insights into the mechanisms of chemokine-mediated capture of leukocytes within the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLo3vZY9znMLVg90H21EOLACvtfcHk0likWjlS1dCvxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFyrsrbE&md5=8ee0a39f62aefddf52741b6fc41aa377</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2010.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2010.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DHolman%26aufirst%3DD.%2BW.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26aulast%3DRansohoff%26aufirst%3DR.%2BM.%26atitle%3DThe%2520blood-brain%2520barrier%252C%2520chemokines%2520and%2520multiple%2520sclerosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2011%26volume%3D1812%26spage%3D220%26epage%3D230%26doi%3D10.1016%2Fj.bbadis.2010.07.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ohno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitagawa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, M.</span><span> </span><span class="NLM_article-title">The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span><span class="refDoi"> DOI: 10.1002/bdd.719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1002%2Fbdd.719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=20623701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2nur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=396-406&author=T.+Ohnoauthor=C.+Hasegawaauthor=S.+Nakadeauthor=J.+Kitagawaauthor=N.+Hondaauthor=M.+Ogawa&title=The+prediction+of+human+response+to+ONO-4641%2C+a+sphingosine+1-phosphate+receptor+modulator%2C+from+preclinical+data+based+on+pharmacokinetic-pharmacodynamic+modeling&doi=10.1002%2Fbdd.719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling</span></div><div class="casAuthors">Ohno, Tomoya; Hasegawa, Chihiro; Nakade, Susumu; Kitagawa, Junsaku; Honda, Naoki; Ogawa, Mikio</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">396-406</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The pharmacokinetic (PK) and pharmacodynamic (PD) parameters of ONO-4641 in humans were estd. using preclin. data in order to provide essential information to better design future clin. studies.  The characterization of PK/PD was measured in terms of decreased lymphocyte counts in blood after administration of ONO-4641, a sphingosine 1-phosphate receptor modulator.  Using a two-compartment model, human PK parameters were estd. from preclin. PK data of cynomolgus monkey and in vitro human metab. data.  To est. human PD parameters, the relationship between lymphocyte counts and plasma concns. of ONO-4641 in cynomolgus monkeys was detd.  The relationship between lymphocyte counts and plasma concns. of ONO-4641 was described by an indirect-response model.  The indirect-response model had an Imax value of 0.828 and an IC50 value of 1.29 ng/mL based on the cynomolgus monkey data.  These parameters were used to represent human PD parameters for the simulation of lymphocyte counts.  Other human PD parameters such as input and output rate consts. for lymphocytes were obtained from the literature.  Based on these estd. human PK and PD parameters, human lymphocyte counts after administration of ONO-4641 were simulated.  In conclusion, the simulation of human lymphocyte counts based on preclin. data led to the acquisition of useful information for designing future clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiwKY4yjGAbbVg90H21EOLACvtfcHk0likWjlS1dCvxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2nur3E&md5=84a6f29097d798b219a6dc97537569c6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fbdd.719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.719%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DC.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DKitagawa%26aufirst%3DJ.%26aulast%3DHonda%26aufirst%3DN.%26aulast%3DOgawa%26aufirst%3DM.%26atitle%3DThe%2520prediction%2520of%2520human%2520response%2520to%2520ONO-4641%252C%2520a%2520sphingosine%25201-phosphate%2520receptor%2520modulator%252C%2520from%2520preclinical%2520data%2520based%2520on%2520pharmacokinetic-pharmacodynamic%2520modeling%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2010%26volume%3D31%26spage%3D396%26epage%3D406%26doi%3D10.1002%2Fbdd.719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">McCandless, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woerner, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. S.</span><span> </span><span class="NLM_article-title">Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span><span class="refDoi"> DOI: 10.2353/ajpath.2008.070918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.2353%2Fajpath.2008.070918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=18276777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A280%3ADC%252BD1c7kslyitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2008&pages=799-808&author=E.+E.+McCandlessauthor=L.+Piccioauthor=B.+M.+Woernerauthor=R.+E.+Schmidtauthor=J.+B.+Rubinauthor=A.+H.+Crossauthor=R.+S.+Klein&title=Pathological+expression+of+CXCL12+at+the+blood-brain+barrier+correlates+with+severity+of+multiple+sclerosis&doi=10.2353%2Fajpath.2008.070918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis</span></div><div class="casAuthors">McCandless Erin E; Piccio Laura; Woerner B Mark; Schmidt Robert E; Rubin Joshua B; Cross Anne H; Klein Robyn S</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">799-808</span>
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    </div><div class="casAbstract">Dysregulation of blood-brain barrier (BBB) function and transendothelial migration of leukocytes are essential components of the development and propagation of active lesions in multiple sclerosis (MS).  Animal studies indicate that polarized expression of the chemokine CXCL12 at the BBB prevents leukocyte extravasation into the central nervous system (CNS) and that disruption of CXCL12 polarity promotes entry of autoreactive leukocytes and inflammation.  In the present study, we examined expression of CXCL12 and its receptor, CXCR4, within CNS tissues from MS and non-MS patients.  Immunohistochemical analysis of CXCL12 expression at the BBB revealed basolateral localization in tissues derived from non-MS patients and at uninvolved sites in tissues from MS patients.  In contrast, within active MS lesions, CXCL12 expression was redistributed toward vessel lumena and was associated with CXCR4 activation in infiltrating leukocytes, as revealed by phospho-CXCR4-specific antibodies.  Quantitative assessment of CXCL12 expression by the CNS microvasculature established a positive correlation between CXCL12 redistribution, leukocyte infiltration, and severity of histological disease.  These results suggest that CXCL12 normally functions to localize infiltrating leukocytes to perivascular spaces, preventing CNS parenchymal infiltration.  In the patient cohort studied, altered patterns of CXCL12 expression at the BBB were specifically associated with MS, possibly facilitating trafficking of CXCR4-expressing mononuclear cells into and out of the perivascular space and leading to progression of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQozRdQ6NLRap0d-O_J5C0AfW6udTcc2eai-hzkRcgAArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7kslyitA%253D%253D&md5=d232e834a7fc299e534176a1cbdcb24e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2008.070918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2008.070918%26sid%3Dliteratum%253Aachs%26aulast%3DMcCandless%26aufirst%3DE.%2BE.%26aulast%3DPiccio%26aufirst%3DL.%26aulast%3DWoerner%26aufirst%3DB.%2BM.%26aulast%3DSchmidt%26aufirst%3DR.%2BE.%26aulast%3DRubin%26aufirst%3DJ.%2BB.%26aulast%3DCross%26aufirst%3DA.%2BH.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26atitle%3DPathological%2520expression%2520of%2520CXCL12%2520at%2520the%2520blood-brain%2520barrier%2520correlates%2520with%2520severity%2520of%2520multiple%2520sclerosis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2008%26volume%3D172%26spage%3D799%26epage%3D808%26doi%3D10.2353%2Fajpath.2008.070918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gokden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, P. R.</span><span> </span><span class="NLM_article-title">Pharmacologic targeting of sphingosine-1-phosphate receptor 1 improves the renal microcirculation during sepsis in the mouse</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1124/jpet.114.219394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1124%2Fjpet.114.219394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=25355645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFSrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2015&pages=61-66&author=Z.+Wangauthor=C.+R.+Simsauthor=N.+K.+Patilauthor=N.+Gokdenauthor=P.+R.+Mayeux&title=Pharmacologic+targeting+of+sphingosine-1-phosphate+receptor+1+improves+the+renal+microcirculation+during+sepsis+in+the+mouse&doi=10.1124%2Fjpet.114.219394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic targeting of sphingosine-1-phosphate receptor 1 improves the renal microcirculation during sepsis in the mouse</span></div><div class="casAuthors">Wang, Zhen; Sims, Clark R.; Patil, Naeem K.; Gokden, Neriman; Mayeux, Philip R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-66, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Microvascular failure is hallmark of sepsis in humans and is recognized as a strong predictor of mortality.  In the mouse subjected to cecal ligation and puncture (CLP) to induce a clin. relevant sepsis, renal microvascular permeability increases and peritubular capillary perfusion declines rapidly in the kidney leading to acute kidney injury (AKI).  Sphingosine-1-phosphate (S1P) is a key regulator of microvascular endothelial function.  To investigate the role of S1P in the development of microvascular permeability and peritubular capillary hypoperfusion in the kidney during CLP-induced AKI, we used a pharmacol. approach and a clin. relevant delayed dosing paradigm.  Evans blue dye was used to measure renal microvascular permeability and intravital video microscopy was used to quantitate renal cortical capillary perfusion.  The S1P receptor 1 (S1P1) agonist SEW2871 [5-[4-phenyl-5-(trifluoromethyl)-2-thienyl]-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole] and S1P2 antagonist JTE-013 [N-(2,6-dichloro-4-pyridinyl)-2-[1,3-dimethyl-4-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-hydrazinecarboxamide] were administered at the time of CLP and produced a dose-dependent but partial redn. in renal microvascular permeability at 6 h after CLP.  However, neither agent improved capillary perfusion at 6 h.  With delayed administration at 6 h after CLP, only SEW2871 reversed microvascular permeability when measured at 18 h.  Importantly, SEW2871 also restored capillary perfusion and improved renal function.  These data suggest that S1P1 and S1P2 do not regulate the early decline in renal capillary perfusion.  However, later in the course of sepsis, pharmacol. stimulation of S1P1, even when delaying therapy until after injury has occurred, improves capillary and renal function, suggesting this approach should be evaluated as an adjunct therapy during sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH5Z_PovE0k7Vg90H21EOLACvtfcHk0ljBwWooWkBlNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFSrsrw%253D&md5=5a307d0daebe8a8ec0b2943e2c798a5b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.219394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.219394%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DSims%26aufirst%3DC.%2BR.%26aulast%3DPatil%26aufirst%3DN.%2BK.%26aulast%3DGokden%26aufirst%3DN.%26aulast%3DMayeux%26aufirst%3DP.%2BR.%26atitle%3DPharmacologic%2520targeting%2520of%2520sphingosine-1-phosphate%2520receptor%25201%2520improves%2520the%2520renal%2520microcirculation%2520during%2520sepsis%2520in%2520the%2520mouse%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D352%26spage%3D61%26epage%3D66%26doi%3D10.1124%2Fjpet.114.219394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">The role of imaging in proof of concept for CNS drug discovery and development</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span><span class="refDoi"> DOI: 10.1038/npp.2008.166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1038%2Fnpp.2008.166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=18843264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVyru7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=187-203&author=D.+F.+Wongauthor=J.+Tauscherauthor=G.+Grunder&title=The+role+of+imaging+in+proof+of+concept+for+CNS+drug+discovery+and+development&doi=10.1038%2Fnpp.2008.166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development</span></div><div class="casAuthors">Wong, Dean F.; Tauscher, Johannes; Grunder, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">187-203</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Neuroimaging, particularly that of neuroreceptor radioisotope and functional magnetic resonance imaging (fMRI), has played a fundamental role in neuropharmacol. and neurophysiol.  Because of the unique and pioneering role, esp. of the radiolabeling of central nervous system (CNS) drugs for receptor and neurotransmitter system imaging, there is an increasingly major role to aid in CNS drug development.  One component is providing evidence for proof of concept of the target for which candidate drugs are being tested for receptor occupancy mechanism of action and ultimately rational drug dosing.  There is also a role for other areas of neuroimaging, including fMRI and magnetic resonance spectroscopy in other magnetic resonance-based techniques that, together with radioisotope imaging, represent CNS mol. imaging.  ' The role of these approaches and a review of the recent advances in such neuroimaging for proof-of-concept studies is the subject for this paper.  Moreover, hypothetical examples and possible algorithms for early discovery/phase I development using neuroimaging provide specific working approaches.  In summary, this article reviews the vital biomarker approach of neuroimaging in proof of concept studies.  Neuropsychopharmacol. (2009) 34, 187-203; doi:10.1038/npp.2008.166; published online 8 Oct. 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8I0KCciAqxbVg90H21EOLACvtfcHk0ljBwWooWkBlNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVyru7rN&md5=c5c7b9b30303e57ceabf287e7eec35b6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2008.166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2008.166%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DTauscher%26aufirst%3DJ.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DThe%2520role%2520of%2520imaging%2520in%2520proof%2520of%2520concept%2520for%2520CNS%2520drug%2520discovery%2520and%2520development%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D187%26epage%3D203%26doi%3D10.1038%2Fnpp.2008.166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Eckelman, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilbourn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span> </span><span class="NLM_article-title">Discussion of targeting proteins in vivo: in vitro guidelines</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2006.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.nucmedbio.2006.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=16720235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvVOktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=449-451&author=W.+C.+Eckelmanauthor=M.+R.+Kilbournauthor=C.+A.+Mathis&title=Discussion+of+targeting+proteins+in+vivo%3A+in+vitro+guidelines&doi=10.1016%2Fj.nucmedbio.2006.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discussion of targeting proteins in vivo: in vitro guidelines</span></div><div class="casAuthors">Eckelman, William C.; Kilbourn, Michael R.; Mathis, Chester A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">449-451</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIy27VHTsB7bVg90H21EOLACvtfcHk0ljBwWooWkBlNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvVOktrg%253D&md5=51382e8f751cf418a0807c2e23e21a85</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2006.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2006.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DEckelman%26aufirst%3DW.%2BC.%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26atitle%3DDiscussion%2520of%2520targeting%2520proteins%2520in%2520vivo%253A%2520in%2520vitro%2520guidelines%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2006%26volume%3D33%26spage%3D449%26epage%3D451%26doi%3D10.1016%2Fj.nucmedbio.2006.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Eckelman, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span> </span><span class="NLM_article-title">Targeting proteins in vivo: in vitro guidelines</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2006.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.nucmedbio.2006.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=16546669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ehsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=161-164&author=W.+C.+Eckelmanauthor=C.+A.+Mathis&title=Targeting+proteins+in+vivo%3A+in+vitro+guidelines&doi=10.1016%2Fj.nucmedbio.2006.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting proteins in vivo: In vitro guidelines</span></div><div class="casAuthors">Eckelman, William C.; Mathis, Chester A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-164</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review with refs.  The development of targeted mols. for in vivo imaging is a natural outgrowth of the development of targeted biochems. and pharmaceuticals used in vitro.  After choosing a receptor or enzyme crucial to a specific disease, the use of a math. model to choose potential receptor-specific radiopharmaceuticals is key.  The prepn. of non-radioactive substituted ligands is often the next step.  The prepn. of the non-radioactive compd. better defines the radioactive compd. because classical anal. methods can be used.  Combined liq. chromatog./mass spectrometry anal. is recommended to define the metabolites of a potential radiopharmaceutical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAU4s7JwGz-bVg90H21EOLACvtfcHk0liXTb-V7xHp_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ehsLg%253D&md5=8521ecb3fb7a529d2283055e26a6985e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2006.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2006.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DEckelman%26aufirst%3DW.%2BC.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26atitle%3DTargeting%2520proteins%2520in%2520vivo%253A%2520in%2520vitro%2520guidelines%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2006%26volume%3D33%26spage%3D161%26epage%3D164%26doi%3D10.1016%2Fj.nucmedbio.2006.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Briard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigaud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auberson, Y. P.</span><span> </span><span class="NLM_article-title">BZM055, an iodinated radiotracer candidate for PET and SPECT imaging of myelin and FTY720 brain distribution</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.1002/cmdc.201000477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1002%2Fcmdc.201000477" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=667-677&author=E.+Briardauthor=D.+Orainauthor=C.+Beerliauthor=A.+Billichauthor=M.+Streiffauthor=M.+Bigaudauthor=Y.+P.+Auberson&title=BZM055%2C+an+iodinated+radiotracer+candidate+for+PET+and+SPECT+imaging+of+myelin+and+FTY720+brain+distribution&doi=10.1002%2Fcmdc.201000477"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000477%26sid%3Dliteratum%253Aachs%26aulast%3DBriard%26aufirst%3DE.%26aulast%3DOrain%26aufirst%3DD.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DStreiff%26aufirst%3DM.%26aulast%3DBigaud%26aufirst%3DM.%26aulast%3DAuberson%26aufirst%3DY.%2BP.%26atitle%3DBZM055%252C%2520an%2520iodinated%2520radiotracer%2520candidate%2520for%2520PET%2520and%2520SPECT%2520imaging%2520of%2520myelin%2520and%2520FTY720%2520brain%2520distribution%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D667%26epage%3D677%26doi%3D10.1002%2Fcmdc.201000477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Prasad, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haufe, G.</span><span> </span><span class="NLM_article-title">Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5168</span><span class="NLM_x">–</span> <span class="NLM_lpage">5181</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.bmc.2014.08.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5168-5181&author=V.+P.+Prasadauthor=S.+Wagnerauthor=P.+Keulauthor=S.+Hermannauthor=B.+Levkauauthor=M.+Sch%C3%A4fersauthor=G.+Haufe&title=Synthesis+of+fluorinated+analogues+of+sphingosine-1-phosphate+antagonists+as+potential+radiotracers+for+molecular+imaging+using+positron+emission+tomography&doi=10.1016%2Fj.bmc.2014.08.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DV.%2BP.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DKeul%26aufirst%3DP.%26aulast%3DHermann%26aufirst%3DS.%26aulast%3DLevkau%26aufirst%3DB.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DM.%26aulast%3DHaufe%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520fluorinated%2520analogues%2520of%2520sphingosine-1-phosphate%2520antagonists%2520as%2520potential%2520radiotracers%2520for%2520molecular%2520imaging%2520using%2520positron%2520emission%2520tomography%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5168%26epage%3D5181%26doi%3D10.1016%2Fj.bmc.2014.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Shaikh, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haufe, G.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of fluorinated fingolimod (FTY720) analogues for sphingosine-1-phosphate receptor molecular imaging by positron emission tomography</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3471</span><span class="NLM_x">–</span> <span class="NLM_lpage">3484</span><span class="refDoi"> DOI: 10.1021/jm502021d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm502021d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsFGns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3471-3484&author=R.+S.+Shaikhauthor=S.+S.+Schilsonauthor=S.+Wagnerauthor=S.+Hermannauthor=P.+Keulauthor=B.+Levkauauthor=M.+Schafersauthor=G.+Haufe&title=Synthesis+and+evaluation+of+fluorinated+fingolimod+%28FTY720%29+analogues+for+sphingosine-1-phosphate+receptor+molecular+imaging+by+positron+emission+tomography&doi=10.1021%2Fjm502021d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Fluorinated Fingolimod (FTY720) Analogues for Sphingosine-1-Phosphate Receptor Molecular Imaging by Positron Emission Tomography</span></div><div class="casAuthors">Shaikh, Rizwan S.; Schilson, Stefanie S.; Wagner, Stefan; Hermann, Sven; Keul, Petra; Levkau, Bodo; Schaefers, Michael; Haufe, Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3471-3484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sphingosine-1-phosphate (S1P) is a lysophospholipid that evokes a variety of biol. responses via stimulation of a set of cognate G-protein coupled receptors (GPCRs): S1P1-S1P5.  S1P and its receptors (S1PRs) play important roles in the immune, cardiovascular, and central nervous systems and have also been implicated in carcinogenesis.  Recently, the S1P analog Fingolimod (FTY720) has been approved for the treatment of patients with relapsing multiple sclerosis.  This work presents the synthesis of various fluorinated structural analogs of FTY720, their in vitro and in vivo biol. testing, and their development and application as [18F]radiotracers for the study of S1PR biodistribution and imaging in mice using small-animal positron emission tomog. (PET).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLd-TV-43IobVg90H21EOLACvtfcHk0liXTb-V7xHp_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsFGns74%253D&md5=226bcd232b68e3eefa3939b7c24e3fdf</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm502021d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm502021d%26sid%3Dliteratum%253Aachs%26aulast%3DShaikh%26aufirst%3DR.%2BS.%26aulast%3DSchilson%26aufirst%3DS.%2BS.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DHermann%26aufirst%3DS.%26aulast%3DKeul%26aufirst%3DP.%26aulast%3DLevkau%26aufirst%3DB.%26aulast%3DSchafers%26aufirst%3DM.%26aulast%3DHaufe%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520fluorinated%2520fingolimod%2520%2528FTY720%2529%2520analogues%2520for%2520sphingosine-1-phosphate%2520receptor%2520molecular%2520imaging%2520by%2520positron%2520emission%2520tomography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3471%26epage%3D3484%26doi%3D10.1021%2Fjm502021d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Yue, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span> </span><span class="NLM_article-title">A potent and selective C-11 labeled PET tracer for imaging sphingosine-1-phosphate receptor 2 in the CNS demonstrates sexually dimorphic expression</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">7928</span><span class="NLM_x">–</span> <span class="NLM_lpage">7939</span><span class="refDoi"> DOI: 10.1039/C5OB00951K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1039%2FC5OB00951K" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=7928-7939&author=X.+Yueauthor=H.+Jinauthor=H.+Liuauthor=A.+J.+Rosenbergauthor=R.+S.+Kleinauthor=Z.+Tu&title=A+potent+and+selective+C-11+labeled+PET+tracer+for+imaging+sphingosine-1-phosphate+receptor+2+in+the+CNS+demonstrates+sexually+dimorphic+expression&doi=10.1039%2FC5OB00951K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC5OB00951K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB00951K%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DRosenberg%26aufirst%3DA.%2BJ.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26aulast%3DTu%26aufirst%3DZ.%26atitle%3DA%2520potent%2520and%2520selective%2520C-11%2520labeled%2520PET%2520tracer%2520for%2520imaging%2520sphingosine-1-phosphate%2520receptor%25202%2520in%2520the%2520CNS%2520demonstrates%2520sexually%2520dimorphic%2520expression%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D7928%26epage%3D7939%26doi%3D10.1039%2FC5OB00951K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Jin, H.; Yang, H.; Liu, H.; Zhang, Y.; Zhang, X.; Rosenberg, A. J.; Liu, Y.; Lapi, S. E.; Tu, Z.</span><span> </span><span class="NLM_article-title">A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury</span>.  <span class="citation_source-journal">J. Nucl. Cardiol.</span> [Online early access]. DOI:<span class="refDoi"> DOI: 10.1007/s12350-015-0391-1</span> . Published Online: Feb 02,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1007%2Fs12350-015-0391-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=26843200" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=H.+Jin&author=H.+Yang&author=H.+Liu&author=Y.+Zhang&author=X.+Zhang&author=A.+J.+Rosenberg&author=Y.+Liu&author=S.+E.+Lapi&author=Z.+Tu&title=A+promising+carbon-11-labeled+sphingosine-1-phosphate+receptor+1-specific+PET+tracer+for+imaging+vascular+injury&doi=10.1007%2Fs12350-015-0391-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs12350-015-0391-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12350-015-0391-1%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DH.%26atitle%3DA%2520promising%2520carbon-11-labeled%2520sphingosine-1-phosphate%2520receptor%25201-specific%2520PET%2520tracer%2520for%2520imaging%2520vascular%2520injury%26jtitle%3DJ.%2520Nucl.%2520Cardiol.%26doi%3D10.1007%2Fs12350-015-0391-1%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Liu, H.; Jin, H.; Yue, X.; Luo, Z.; Liu, C.; Rosenberg, A. J.; Tu, Z.</span><span> </span><span class="NLM_article-title">PET imaging study of S1PR1 expression in a rat model of multiple sclerosis</span>.  <span class="citation_source-journal">Mol. Imaging Biol.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1007/s11307-016-0944-y</span> . Published Online: Mar 14,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1007%2Fs11307-016-0944-y" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=H.+Liu&author=H.+Jin&author=X.+Yue&author=Z.+Luo&author=C.+Liu&author=A.+J.+Rosenberg&author=Z.+Tu&title=PET+imaging+study+of+S1PR1+expression+in+a+rat+model+of+multiple+sclerosis&doi=10.1007%2Fs11307-016-0944-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs11307-016-0944-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-016-0944-y%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DPET%2520imaging%2520study%2520of%2520S1PR1%2520expression%2520in%2520a%2520rat%2520model%2520of%2520multiple%2520sclerosis%26jtitle%3DMol.%2520Imaging%2520Biol.%26doi%3D10.1007%2Fs11307-016-0944-y%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Deng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span> </span><span class="NLM_article-title">Identification of benzoxazole analogs as novel, S1P<sub>3</sub> sparing S1P<sub>1</sub> agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3973</span><span class="NLM_x">–</span> <span class="NLM_lpage">3977</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.04.095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.bmcl.2012.04.095" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3973-3977&author=G.+Dengauthor=Q.+Mengauthor=Q.+Liuauthor=X.+Xuauthor=Q.+Xuauthor=F.+Renauthor=T.+B.+Guoauthor=H.+Luauthor=J.+N.+Xiangauthor=J.+D.+Elliottauthor=X.+Lin&title=Identification+of+benzoxazole+analogs+as+novel%2C+S1P3+sparing+S1P1+agonists&doi=10.1016%2Fj.bmcl.2012.04.095"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.04.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.04.095%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DT.%2BB.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DIdentification%2520of%2520benzoxazole%2520analogs%2520as%2520novel%252C%2520S1P3%2520sparing%2520S1P1%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3973%26epage%3D3977%26doi%3D10.1016%2Fj.bmcl.2012.04.095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Quattropani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosignani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorbais, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzerelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beltran, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eligert, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novo-Perez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hantson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Souza, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrighi, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschert, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bombrun, A.</span><span> </span><span class="NLM_article-title">Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacy</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span><span class="refDoi"> DOI: 10.1002/cmdc.201402557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1002%2Fcmdc.201402557" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=688-714&author=A.+Quattropaniauthor=W.+H.+Sauerauthor=S.+Crosignaniauthor=J.+Dorbaisauthor=P.+Gerberauthor=J.+Gonzalezauthor=D.+Marinauthor=M.+Muzerelleauthor=F.+Beltranauthor=A.+Nicholsauthor=K.+Georgiauthor=M.+Schneiderauthor=P.+A.+Vitteauthor=V.+Eligertauthor=L.+Novo-Perezauthor=J.+Hantsonauthor=S.+Nockauthor=S.+Carboniauthor=A.+L.+de+Souzaauthor=J.+F.+Arrighiauthor=U.+Boschertauthor=A.+Bombrun&title=Pharmacophore-based+design+of+novel+oxadiazoles+as+selective+sphingosine-1-phosphate+%28S1P%29+receptor+agonists+with+in+vivo+efficacy&doi=10.1002%2Fcmdc.201402557"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402557%26sid%3Dliteratum%253Aachs%26aulast%3DQuattropani%26aufirst%3DA.%26aulast%3DSauer%26aufirst%3DW.%2BH.%26aulast%3DCrosignani%26aufirst%3DS.%26aulast%3DDorbais%26aufirst%3DJ.%26aulast%3DGerber%26aufirst%3DP.%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DMarin%26aufirst%3DD.%26aulast%3DMuzerelle%26aufirst%3DM.%26aulast%3DBeltran%26aufirst%3DF.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DGeorgi%26aufirst%3DK.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DVitte%26aufirst%3DP.%2BA.%26aulast%3DEligert%26aufirst%3DV.%26aulast%3DNovo-Perez%26aufirst%3DL.%26aulast%3DHantson%26aufirst%3DJ.%26aulast%3DNock%26aufirst%3DS.%26aulast%3DCarboni%26aufirst%3DS.%26aulast%3Dde%2BSouza%26aufirst%3DA.%2BL.%26aulast%3DArrighi%26aufirst%3DJ.%2BF.%26aulast%3DBoschert%26aufirst%3DU.%26aulast%3DBombrun%26aufirst%3DA.%26atitle%3DPharmacophore-based%2520design%2520of%2520novel%2520oxadiazoles%2520as%2520selective%2520sphingosine-1-phosphate%2520%2528S1P%2529%2520receptor%2520agonists%2520with%2520in%2520vivo%2520efficacy%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D688%26epage%3D714%26doi%3D10.1002%2Fcmdc.201402557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickham, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P<sub>1</sub>) receptor agonists with exceptional selectivity against S1P<sub>2</sub> and S1P<sub>3</sub></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6169</span><span class="NLM_x">–</span> <span class="NLM_lpage">6173</span><span class="refDoi"> DOI: 10.1021/jm0503244</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0503244" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6169-6173&author=Z.+Liauthor=W.+Chenauthor=J.+J.+Haleauthor=C.+L.+Lynchauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.+J.+Sheiauthor=G.+Chrebetauthor=S.+A.+Parentauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Forrestauthor=E.+J.+Quackenbushauthor=L.+A.+Wickhamauthor=H.+Vargasauthor=R.+M.+Evansauthor=H.+Rosenauthor=S.+Mandala&title=Discovery+of+potent+3%2C5-diphenyl-1%2C2%2C4-oxadiazole+sphingosine-1-phosphate-1+%28S1P1%29+receptor+agonists+with+exceptional+selectivity+against+S1P2+and+S1P3&doi=10.1021%2Fjm0503244"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm0503244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503244%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.%2BJ.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DParent%26aufirst%3DS.%2BA.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DQuackenbush%26aufirst%3DE.%2BJ.%26aulast%3DWickham%26aufirst%3DL.%2BA.%26aulast%3DVargas%26aufirst%3DH.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520potent%25203%252C5-diphenyl-1%252C2%252C4-oxadiazole%2520sphingosine-1-phosphate-1%2520%2528S1P1%2529%2520receptor%2520agonists%2520with%2520exceptional%2520selectivity%2520against%2520S1P2%2520and%2520S1P3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6169%26epage%3D6173%26doi%3D10.1021%2Fjm0503244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Rosenberg, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span> </span><span class="NLM_article-title">A practical process for the preparation of [<sup>32</sup>P]S1P and binding assay for S1P receptor ligands</span> <span class="citation_source-journal">Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1016/j.apradiso.2015.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.apradiso.2015.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=25931137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsVaru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2015&pages=5-9&author=A.+J.+Rosenbergauthor=H.+Liuauthor=Z.+Tu&title=A+practical+process+for+the+preparation+of+%5B32P%5DS1P+and+binding+assay+for+S1P+receptor+ligands&doi=10.1016%2Fj.apradiso.2015.04.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A practical process for the preparation of [32P]S1P and binding assay for S1P receptor ligands</span></div><div class="casAuthors">Rosenberg, Adam J.; Liu, Hui; Tu, Zhude</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5-9</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Sphingosine-1-phosphate receptors (S1PRs) are important regulators of vascular permeability, inflammation, angiogenesis and vascular maturation.  Identifying a specific S1PR PET radioligand is imperative, but it is hindered by the complexity and variability of current for binding affinity measurement procedures.  Herein, we report a streamlined protocol for radiosynthesis of [32P]S1P with good radiochem. yield (36-50%) and high radiochem. purity (>99%).  We also report a reproducible procedure for detg. the binding affinity for compds. targeting S1PRs in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9aB8MOaj7qbVg90H21EOLACvtfcHk0lj2lO9y6WbTVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsVaru7c%253D&md5=bcaf97b500b7adcb34e57198a9825034</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.apradiso.2015.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apradiso.2015.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DA.%2BJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DTu%26aufirst%3DZ.%26atitle%3DA%2520practical%2520process%2520for%2520the%2520preparation%2520of%2520%255B32P%255DS1P%2520and%2520binding%2520assay%2520for%2520S1P%2520receptor%2520ligands%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2015%26volume%3D102%26spage%3D5%26epage%3D9%26doi%3D10.1016%2Fj.apradiso.2015.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) receptor subtypes S1P<sub>1</sub> and S1P<sub>3</sub>, respectively, regulate lymphocyte recirculation and heart rate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13839</span><span class="NLM_x">–</span> <span class="NLM_lpage">13848</span><span class="refDoi"> DOI: 10.1074/jbc.M311743200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1074%2Fjbc.M311743200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=14732717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1elsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13839-13848&author=M.+G.+Sannaauthor=J.+Liaoauthor=E.+Joauthor=C.+Alfonsoauthor=M.+Y.+Ahnauthor=M.+S.+Petersonauthor=B.+Webbauthor=S.+Lefebvreauthor=J.+Chunauthor=N.+Grayauthor=H.+Rosen&title=Sphingosine+1-phosphate+%28S1P%29+receptor+subtypes+S1P1+and+S1P3%2C+respectively%2C+regulate+lymphocyte+recirculation+and+heart+rate&doi=10.1074%2Fjbc.M311743200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate</span></div><div class="casAuthors">Sanna, M. Germana; Liao, Jiayu; Jo, Euijung; Alfonso, Christopher; Ahn, Min-Young; Peterson, Melissa S.; Webb, Bill; Lefebvre, Sophie; Chun, Jerold; Gray, Nathanael; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">13839-13848</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) influences heart rate, coronary artery caliber, endothelial integrity, and lymphocyte recirculation through five related high affinity G-protein-coupled receptors.  Inhibition of lymphocyte recirculation by non-selective S1P receptor agonists produces clin. immunosuppression preventing transplant rejection but is assocd. with transient bradycardia.  Understanding the contribution of individual receptors has been limited by the embryonic lethality of the S1P1 knock-out and the unavailability of selective agonists or antagonists.  A potent, S1P1-receptor selective agonist structurally unrelated to S1P was found to activate multiple signals triggered by S1P, including guanosine 5'-3-O-(thio)triphosphate binding, calcium flux, Akt and ERK1/2 phosphorylation, and stimulation of migration of S1P1- but not S1P3-expressing cells in vitro.  The agonist also alters lymphocyte trafficking in vivo.  Use of selective agonism together with deletant mice lacking S1P3 receptor reveals that agonism of S1P1 receptor alone is sufficient to control lymphocyte recirculation.  Moreover, S1P1 receptor agonist plasma levels are causally assocd. with induction and maintenance of lymphopenia.  S1P3, and not S1P1, is directly implicated in sinus bradycardia.  The sustained bradycardia induced by S1P receptor non-selective immunosuppressive agonists in wild-type mice is abolished in S1P3-/- mice, whereas S1P1-selective agonist does not produce bradycardia.  Sepn. of receptor subtype usage for control of lymphocyte recirculation and heart rate may allow the identification of selective immunosuppressive S1P1 receptor agonists with an enhanced therapeutic window.  S1P1-selective agonists will be of broad utility in understanding cell functions in vitro, and vascular physiol. in vivo, and the success of the chem. approach for S1P1 suggests that selective tools for the resoln. of function across this broad lipid receptor family are now possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoztTB58pXPA7Vg90H21EOLACvtfcHk0lj2lO9y6WbTVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1elsb8%253D&md5=5b720513c7c550bfdf55e5344efc8f16</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M311743200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M311743200%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DAhn%26aufirst%3DM.%2BY.%26aulast%3DPeterson%26aufirst%3DM.%2BS.%26aulast%3DWebb%26aufirst%3DB.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520receptor%2520subtypes%2520S1P1%2520and%2520S1P3%252C%2520respectively%252C%2520regulate%2520lymphocyte%2520recirculation%2520and%2520heart%2520rate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13839%26epage%3D13848%26doi%3D10.1074%2Fjbc.M311743200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Chen, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrbrich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engle, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothfuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geraci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotchkiss, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2011.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.nucmedbio.2011.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=22033021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=137-144&author=D.+L.+Chenauthor=D.+Zhouauthor=W.+Chuauthor=P.+Herrbrichauthor=J.+T.+Engleauthor=E.+Griffinauthor=L.+A.+Jonesauthor=J.+M.+Rothfussauthor=M.+Geraciauthor=R.+S.+Hotchkissauthor=R.+H.+Mach&title=Radiolabeled+isatin+binding+to+caspase-3+activation+induced+by+anti-Fas+antibody&doi=10.1016%2Fj.nucmedbio.2011.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody</span></div><div class="casAuthors">Chen, Delphine L.; Zhou, Dong; Chu, Wenhua; Herrbrich, Phillip; Engle, Jacquelyn T.; Griffin, Elizabeth; Jones, Lynne A.; Rothfuss, Justin M.; Geraci, Marco; Hotchkiss, Richard S.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-144</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Introduction: Noninvasive imaging methods that can distinguish apoptosis from necrosis may be useful in furthering our understanding of diseases characterized by apoptotic dysregulation as well as aiding drug development targeting apoptotic pathways.  We evaluated the ability of radiolabeled isatins to quantify caspase-3 activity induced by the activation of the extrinsic apoptotic pathway by the anti-Fas antibody in mice.  Methods: The behavior of three different radiolabeled isatins ([18F]WC-II-89, [18F]WC-IV-3 and [11C]WC-98) was characterized in mice with and without anti-Fas antibody treatment by microPET imaging and biodistribution studies.  The activity of [18F]WC-II-89 was also compared with [99mTc]mebrofenin.  The effect of pan-caspase inhibition with quinolyl-valyl-O-methylaspartyl-[2,6-difluorophenoxy]-Me ketone (Q-VD-OPh) on [18F]WC-II-89 uptake was studied.  Caspase-3 activity was confirmed by a fluorometric enzyme assay.  Results: All three tracers behaved similarly in microPET and biodistribution studies.  Increased retention of all tracers was obsd. in the livers of treated animals and several other organs, all of which demonstrated increased caspase-3 enzyme activity; however, impaired hepatobiliary excretion made attribution of these findings to caspase-3 activity difficult.  The isatin [18F]WC-II-89 was retained at statistically significantly higher levels in the organs after anti-Fas antibody treatment while [99mTc]mebrofenin activity cleared, suggesting specific binding to activated caspase-3, but the magnitude of increased binding was still relatively low.  Caspase inhibition with Q-VD-OPh partially blocked [18F]WC-II-89 retention but completely blocked caspase-3 enzyme activity in the liver.  Conclusions: The radiolabeled isatins appear to bind specifically to caspase-3 in vivo, but their sensitivity is limited.  Further optimization is required for these tracers to be useful for clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKP_ynhcVQXLVg90H21EOLACvtfcHk0lj2lO9y6WbTVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFyrsQ%253D%253D&md5=1f9673c2f02e4ae269ad1e9dd20a73bf</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2011.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2011.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%2BL.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DW.%26aulast%3DHerrbrich%26aufirst%3DP.%26aulast%3DEngle%26aufirst%3DJ.%2BT.%26aulast%3DGriffin%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DRothfuss%26aufirst%3DJ.%2BM.%26aulast%3DGeraci%26aufirst%3DM.%26aulast%3DHotchkiss%26aufirst%3DR.%2BS.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DRadiolabeled%2520isatin%2520binding%2520to%2520caspase-3%2520activation%2520induced%2520by%2520anti-Fas%2520antibody%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2012%26volume%3D39%26spage%3D137%26epage%3D144%26doi%3D10.1016%2Fj.nucmedbio.2011.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Sic, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flittner, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Munchow, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieper, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kienzler, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleuser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zirlik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lougaris, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plebani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeffler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaramuzza, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimbacher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eibel, H.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span><span class="refDoi"> DOI: 10.1016/j.jaci.2014.01.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.jaci.2014.01.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=24679343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvV2lt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2014&pages=420-428&author=H.+Sicauthor=H.+Krausauthor=J.+Madlauthor=K.+A.+Flittnerauthor=A.+L.+von+Munchowauthor=K.+Pieperauthor=M.+Rizziauthor=A.+K.+Kienzlerauthor=K.+Ayataauthor=S.+Rauerauthor=B.+Kleuserauthor=U.+Salzerauthor=M.+Burgerauthor=K.+Zirlikauthor=V.+Lougarisauthor=A.+Plebaniauthor=W.+Romerauthor=C.+Loefflerauthor=S.+Scaramuzzaauthor=A.+Villaauthor=E.+Noguchiauthor=B.+Grimbacherauthor=H.+Eibel&title=Sphingosine-1-phosphate+receptors+control+B-cell+migration+through+signaling+components+associated+with+primary+immunodeficiencies%2C+chronic+lymphocytic+leukemia%2C+and+multiple+sclerosis&doi=10.1016%2Fj.jaci.2014.01.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis</span></div><div class="casAuthors">Sic, Heiko; Kraus, Helene; Madl, Josef; Flittner, Karl-Andreas; von Muenchow, Audrey Lilly; Pieper, Kathrin; Rizzi, Marta; Kienzler, Anne-Kathrin; Ayata, Korcan; Rauer, Sebastian; Kleuser, Burkhard; Salzer, Ulrich; Burger, Meike; Zirlik, Katja; Lougaris, Vassilios; Plebani, Alessandro; Roemer, Winfried; Loeffler, Christoph; Scaramuzza, Samantha; Villa, Anna; Noguchi, Emiko; Grimbacher, Bodo; Eibel, Hermann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">420-428.e15</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Five different G protein-coupled sphingosine-1-phosphate (S1P) receptors (S1P1-S1P5) regulate a variety of physiol. and pathophysiol. processes, including lymphocyte circulation, multiple sclerosis (MS), and cancer.  Although B-lymphocyte circulation plays an important role in these processes and is essential for normal immune responses, little is known about S1P receptors in human B cells.  To explore their function and signaling, we studied B-cell lines and primary B cells from control subjects, patients with leukemia, patients with S1P receptor inhibitor-treated MS, and patients with primary immunodeficiencies.  S1P receptor expression was analyzed by using multicolor immunofluorescence microscopy and quant. PCR.  Transwell assays were used to study cell migration.  S1P receptor internalization was visualized by means of time-lapse imaging with fluorescent S1P receptor fusion proteins expressed by using lentiviral gene transfer.  B-lymphocyte subsets were characterized by means of flow cytometry and immunofluorescence microscopy.  Showing that different B-cell populations express different combinations of S1P receptors, we found that S1P1 promotes migration, whereas S1P4 modulates and S1P2 inhibits S1P1 signals.  Expression of CD69 in activated B lymphocytes and B cells from patients with chronic lymphocytic leukemia inhibited S1P-induced migration.  Studying B-cell lines, normal B lymphocytes, and B cells from patients with primary immunodeficiencies, we identified Bruton tyrosine kinase, β-arrestin 2, LPS-responsive beige-like anchor protein, dedicator of cytokinesis 8, and Wiskott-Aldrich syndrome protein as crit. signaling components downstream of S1P1.  Thus S1P receptor signaling regulates human B-cell circulation and might be a factor contributing to the pathol. of MS, chronic lymphocytic leukemia, and primary immunodeficiencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwa3JsqrmZELVg90H21EOLACvtfcHk0lgyxMMQRZBMOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvV2lt74%253D&md5=2c89249349108ac663d4030a3594bc66</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2014.01.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2014.01.037%26sid%3Dliteratum%253Aachs%26aulast%3DSic%26aufirst%3DH.%26aulast%3DKraus%26aufirst%3DH.%26aulast%3DMadl%26aufirst%3DJ.%26aulast%3DFlittner%26aufirst%3DK.%2BA.%26aulast%3Dvon%2BMunchow%26aufirst%3DA.%2BL.%26aulast%3DPieper%26aufirst%3DK.%26aulast%3DRizzi%26aufirst%3DM.%26aulast%3DKienzler%26aufirst%3DA.%2BK.%26aulast%3DAyata%26aufirst%3DK.%26aulast%3DRauer%26aufirst%3DS.%26aulast%3DKleuser%26aufirst%3DB.%26aulast%3DSalzer%26aufirst%3DU.%26aulast%3DBurger%26aufirst%3DM.%26aulast%3DZirlik%26aufirst%3DK.%26aulast%3DLougaris%26aufirst%3DV.%26aulast%3DPlebani%26aufirst%3DA.%26aulast%3DRomer%26aufirst%3DW.%26aulast%3DLoeffler%26aufirst%3DC.%26aulast%3DScaramuzza%26aufirst%3DS.%26aulast%3DVilla%26aufirst%3DA.%26aulast%3DNoguchi%26aufirst%3DE.%26aulast%3DGrimbacher%26aufirst%3DB.%26aulast%3DEibel%26aufirst%3DH.%26atitle%3DSphingosine-1-phosphate%2520receptors%2520control%2520B-cell%2520migration%2520through%2520signaling%2520components%2520associated%2520with%2520primary%2520immunodeficiencies%252C%2520chronic%2520lymphocytic%2520leukemia%252C%2520and%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2014%26volume%3D134%26spage%3D420%26epage%3D428%26doi%3D10.1016%2Fj.jaci.2014.01.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Cavone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buonvicino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratesi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakiki, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peruzzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caporale, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annunziato, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiarugi, A.</span><span> </span><span class="NLM_article-title">Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound</span> <span class="citation_source-journal">Brain, Behav., Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span><span class="refDoi"> DOI: 10.1016/j.bbi.2015.06.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.bbi.2015.06.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2015&pages=78-86&author=L.+Cavoneauthor=R.+Feliciauthor=A.+Lapucciauthor=D.+Buonvicinoauthor=S.+Pratesiauthor=M.+Muzziauthor=B.+Hakikiauthor=L.+Maggiauthor=B.+Peruzziauthor=R.+Caporaleauthor=F.+Annunziatoauthor=M.+P.+Amatoauthor=A.+Chiarugi&title=Dysregulation+of+sphingosine+1+phosphate+receptor-1+%28S1P1%29+signaling+and+regulatory+lymphocyte-dependent+immunosuppression+in+a+model+of+post-fingolimod+MS+rebound&doi=10.1016%2Fj.bbi.2015.06.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bbi.2015.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbi.2015.06.019%26sid%3Dliteratum%253Aachs%26aulast%3DCavone%26aufirst%3DL.%26aulast%3DFelici%26aufirst%3DR.%26aulast%3DLapucci%26aufirst%3DA.%26aulast%3DBuonvicino%26aufirst%3DD.%26aulast%3DPratesi%26aufirst%3DS.%26aulast%3DMuzzi%26aufirst%3DM.%26aulast%3DHakiki%26aufirst%3DB.%26aulast%3DMaggi%26aufirst%3DL.%26aulast%3DPeruzzi%26aufirst%3DB.%26aulast%3DCaporale%26aufirst%3DR.%26aulast%3DAnnunziato%26aufirst%3DF.%26aulast%3DAmato%26aufirst%3DM.%2BP.%26aulast%3DChiarugi%26aufirst%3DA.%26atitle%3DDysregulation%2520of%2520sphingosine%25201%2520phosphate%2520receptor-1%2520%2528S1P1%2529%2520signaling%2520and%2520regulatory%2520lymphocyte-dependent%2520immunosuppression%2520in%2520a%2520model%2520of%2520post-fingolimod%2520MS%2520rebound%26jtitle%3DBrain%252C%2520Behav.%252C%2520Immun.%26date%3D2015%26volume%3D50%26spage%3D78%26epage%3D86%26doi%3D10.1016%2Fj.bbi.2015.06.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Poulain, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Déprez, B. t. P.</span><span> </span><span class="NLM_article-title">Parallel synthesis of 1,2,4-oxadiazoles from carboxylic acids using an improved, uronium-based, activation</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1495</span><span class="NLM_x">–</span> <span class="NLM_lpage">1498</span><span class="refDoi"> DOI: 10.1016/S0040-4039(00)02293-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2FS0040-4039%2800%2902293-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=1495-1498&author=R.+F.+Poulainauthor=A.+L.+Tartarauthor=B.+t.+P.+D%C3%A9prez&title=Parallel+synthesis+of+1%2C2%2C4-oxadiazoles+from+carboxylic+acids+using+an+improved%2C+uronium-based%2C+activation&doi=10.1016%2FS0040-4039%2800%2902293-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2902293-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252902293-0%26sid%3Dliteratum%253Aachs%26aulast%3DPoulain%26aufirst%3DR.%2BF.%26aulast%3DTartar%26aufirst%3DA.%2BL.%26aulast%3DD%25C3%25A9prez%26aufirst%3DB.%2Bt.%2BP.%26atitle%3DParallel%2520synthesis%2520of%25201%252C2%252C4-oxadiazoles%2520from%2520carboxylic%2520acids%2520using%2520an%2520improved%252C%2520uronium-based%252C%2520activation%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26spage%3D1495%26epage%3D1498%26doi%3D10.1016%2FS0040-4039%2800%2902293-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Waterhouse, R. N.</span><span> </span><span class="NLM_article-title">Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1016/j.mibio.2003.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.mibio.2003.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=14667492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=376-389&author=R.+N.+Waterhouse&title=Determination+of+lipophilicity+and+its+use+as+a+predictor+of+blood-brain+barrier+penetration+of+molecular+imaging+agents&doi=10.1016%2Fj.mibio.2003.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents</span></div><div class="casAuthors">Waterhouse Rikki N</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">376-89</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">Compound lipophilicity is a fundamental physicochemical property that plays a pivotal role in the absorption, distribution, metabolism, and elimination (ADME) of therapeutic drugs.  Lipophilicity is expressed in several different ways, including terms such as Log P, clogP, delta Log P, and Log D.  Often a parabolic relationship exists between measured lipophilicity and in vivo brain penetration of drugs, where those moderate in lipophilicity often exhibit highest uptake.  Reduced brain extraction of more lipophilic compounds is associated with increased non-specific binding to plasma proteins.  More lipophilic compounds can also be more vulnerable to P450 metabolism, leading to faster clearance.  Very polar compounds normally exhibit high water solubility, fast clearance through the kidneys, and often contain ionizable functional groups that limit blood-brain barrier (BBB) penetration.  The brain penetration and specific to non-specific binding ratios exhibited in vivo by positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiotracers involves a complex interplay between many critical factors, including lipophilicity, receptor affinity, metabolism, molecular size and shape, ionization potential, and specific binding to BBB efflux pumps or binding sites on albumin or other plasma proteins.  This paper explores situations in which lipophilicity is a good predictor of BBB penetration, as well as those where this correlation is poor.  The more commonly used methods for measuring lipophilicity are presented, and the various terms often found in the literature outlined.  An attempt is made to describe how this information can be used in optimizing the development of PET and SPECT tracers that target the central nervous system (CNS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8j0SWnHPWbmmfW6udTcc2eb6SNbI9Oqw9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtw%253D%253D&md5=cfff94825034cffcce30e56d703745cf</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DWaterhouse%26aufirst%3DR.%2BN.%26atitle%3DDetermination%2520of%2520lipophilicity%2520and%2520its%2520use%2520as%2520a%2520predictor%2520of%2520blood-brain%2520barrier%2520penetration%2520of%2520molecular%2520imaging%2520agents%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D376%26epage%3D389%26doi%3D10.1016%2Fj.mibio.2003.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Komiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shioya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span> </span><span class="NLM_article-title">Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis</span> <span class="citation_source-journal">Clin. Exp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1111/j.1365-2249.2012.04669.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1111%2Fj.1365-2249.2012.04669.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=23199323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKrtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2013&pages=54-62&author=T.+Komiyaauthor=K.+Satoauthor=H.+Shioyaauthor=Y.+Inagakiauthor=H.+Hagiyaauthor=R.+Kozakiauthor=M.+Imaiauthor=Y.+Takadaauthor=T.+Maedaauthor=H.+Kurataauthor=M.+Kuronoauthor=R.+Suzukiauthor=K.+Otsukiauthor=H.+Habashitaauthor=S.+Nakade&title=Efficacy+and+immunomodulatory+actions+of+ONO-4641%2C+a+novel+selective+agonist+for+sphingosine+1-phosphate+receptors+1+and+5%2C+in+preclinical+models+of+multiple+sclerosis&doi=10.1111%2Fj.1365-2249.2012.04669.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis</span></div><div class="casAuthors">Komiya, T.; Sato, K.; Shioya, H.; Inagaki, Y.; Hagiya, H.; Kozaki, R.; Imai, M.; Takada, Y.; Maeda, T.; Kurata, H.; Kurono, M.; Suzuki, R.; Otsuki, K.; Habashita, H.; Nakade, S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-62</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary: ONO-4641 is a next-generation sphingosine 1-phosphate (S1P) receptor agonist selective for S1P receptors 1 and 5.  The objective of the study was to characterize the immunomodulatory effects of ONO-4641 using preclin. data.  ONO-4641 was tested in both in-vitro pharmacol. studies as well as in-vivo models of transient or relapsing-remitting exptl. autoimmune encephalomyelitis (EAE).  In vitro, ONO-4641 showed highly potent agonistic activities vs. S1P receptors 1 and 5 [half maximal effective concn. (EC50) values of 0·0273 and 0·334 nM, resp.], and had profound S1P receptor 1 down-regulating effects on the cell membrane.  ONO-4641 decreased peripheral blood lymphocyte counts in rats by inhibiting lymphocyte egress from secondary lymphoid tissues.  In a rat exptl. autoimmune encephalomyelitis(EAE) model, ONO-4641 suppressed the onset of disease and inhibited lymphocyte infiltration into the spinal cord in a dose-dependent manner at doses of 0·03 and 0·1 mg/kg.  Furthermore, ONO-4641 prevented relapse of disease in a non-obese diabetic mouse model of relapsing-remitting EAE.  These observations suggest that ONO-4641 may provide therapeutic benefits in the treatment of multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFV76b9p5RfbVg90H21EOLACvtfcHk0lifmkw-KMG54w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKrtL3E&md5=d4cd1078e245580132c50e1bb43aa039</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2249.2012.04669.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2249.2012.04669.x%26sid%3Dliteratum%253Aachs%26aulast%3DKomiya%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DShioya%26aufirst%3DH.%26aulast%3DInagaki%26aufirst%3DY.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DKozaki%26aufirst%3DR.%26aulast%3DImai%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DT.%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DHabashita%26aufirst%3DH.%26aulast%3DNakade%26aufirst%3DS.%26atitle%3DEfficacy%2520and%2520immunomodulatory%2520actions%2520of%2520ONO-4641%252C%2520a%2520novel%2520selective%2520agonist%2520for%2520sphingosine%25201-phosphate%2520receptors%25201%2520and%25205%252C%2520in%2520preclinical%2520models%2520of%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2013%26volume%3D171%26spage%3D54%26epage%3D62%26doi%3D10.1111%2Fj.1365-2249.2012.04669.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Gibson, R. E.</span><span> </span><span class="NLM_article-title"><i>In Vitro</i> Approaches to Site-Specific Imaging Agents</span>. In  <span class="citation_source-book">Targeted Molecular Imaging</span>; <span class="NLM_contrib-group">Welch, M. J.; Eckelman, W. C.</span>, Eds.; <span class="NLM_publisher-name">CRC Press, Taylor & Francis Group</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=3-15&author=R.+E.+Gibsonauthor=M.+J.+Welch&author=W.+C.+Eckelman&title=Targeted+Molecular+Imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DR.%2BE.%26atitle%3DIn%2520Vitro%2520Approaches%2520to%2520Site-Specific%2520Imaging%2520Agents%26btitle%3DTargeted%2520Molecular%2520Imaging%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26pub%3DCRC%2520Press%252C%2520Taylor%2520%2526%2520Francis%2520Group%26date%3D2012%26spage%3D3%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desale, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemons, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuerer, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Crystal structure of a lipid G protein-coupled receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">851</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1126/science.1215904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1126%2Fscience.1215904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=22344443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFGqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2012&pages=851-855&author=M.+A.+Hansonauthor=C.+B.+Rothauthor=E.+Joauthor=M.+T.+Griffithauthor=F.+L.+Scottauthor=G.+Reinhartauthor=H.+Desaleauthor=B.+Clemonsauthor=S.+M.+Cahalanauthor=S.+C.+Schuererauthor=M.+G.+Sannaauthor=G.+W.+Hanauthor=P.+Kuhnauthor=H.+Rosenauthor=R.+C.+Stevens&title=Crystal+structure+of+a+lipid+G+protein-coupled+receptor&doi=10.1126%2Fscience.1215904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of a Lipid G Protein-Coupled Receptor</span></div><div class="casAuthors">Hanson, Michael A.; Roth, Christopher B.; Jo, Euijung; Griffith, Mark T.; Scott, Fiona L.; Reinhart, Greg; Desale, Hans; Clemons, Bryan; Cahalan, Stuart M.; Schuerer, Stephan C.; Sanna, M. Germana; Han, Gye Won; Kuhn, Peter; Rosen, Hugh; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">6070</span>),
    <span class="NLM_cas:pages">851-855</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The lyso-phospholipid sphingosine 1-phosphate modulates lymphocyte trafficking, endothelial development and integrity, heart rate, and vascular tone and maturation by activating G protein-coupled sphingosine 1-phosphate receptors.  Here, we present the crystal structure of the sphingosine 1-phosphate receptor 1 fused to T4-lysozyme (S1P1-T4L) in complex with an antagonist sphingolipid mimic.  Extracellular access to the binding pocket is occluded by the amino terminus and extracellular loops of the receptor.  Access is gained by ligands entering laterally between helixes I and VII within the transmembrane region of the receptor.  This structure, along with mutagenesis, agonist structure-activity relationship data, and modeling, provides a detailed view of the mol. recognition and requirement for hydrophobic vol. that activates S1P1, resulting in the modulation of immune and stromal cell responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobT5pNdDDFZrVg90H21EOLACvtfcHk0lifmkw-KMG54w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFGqtbY%253D&md5=08f0e812c991a8b1cd1c0bb4739d5062</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1126%2Fscience.1215904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1215904%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DRoth%26aufirst%3DC.%2BB.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DGriffith%26aufirst%3DM.%2BT.%26aulast%3DScott%26aufirst%3DF.%2BL.%26aulast%3DReinhart%26aufirst%3DG.%26aulast%3DDesale%26aufirst%3DH.%26aulast%3DClemons%26aufirst%3DB.%26aulast%3DCahalan%26aufirst%3DS.%2BM.%26aulast%3DSchuerer%26aufirst%3DS.%2BC.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520a%2520lipid%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D2012%26volume%3D335%26spage%3D851%26epage%3D855%26doi%3D10.1126%2Fscience.1215904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassoun, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McVerry, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burne, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuder, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G.</span><span> </span><span class="NLM_article-title">Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">1245</span><span class="NLM_x">–</span> <span class="NLM_lpage">1251</span><span class="refDoi"> DOI: 10.1164/rccm.200309-1258OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1164%2Frccm.200309-1258OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=15020292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A280%3ADC%252BD2c3mt1Clsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2004&pages=1245-1251&author=X.+Pengauthor=P.+M.+Hassounauthor=S.+Sammaniauthor=B.+J.+McVerryauthor=M.+J.+Burneauthor=H.+Rabbauthor=D.+Pearseauthor=R.+M.+Tuderauthor=J.+G.+Garcia&title=Protective+effects+of+sphingosine+1-phosphate+in+murine+endotoxin-induced+inflammatory+lung+injury&doi=10.1164%2Frccm.200309-1258OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury</span></div><div class="casAuthors">Peng Xinqi; Hassoun Paul M; Sammani Saad; McVerry Bryan J; Burne Melissa J; Rabb Hamid; Pearse David; Tuder Rubin M; Garcia Joe G N</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1245-51</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">Our prior in vitro studies indicate that sphingosine 1-phosphate (S1P), a phospholipid angiogenic factor, produces endothelial cell barrier enhancement through ligation of endothelial differentiation gene family receptors.  We hypothesized that S1P may reduce the vascular leak associated with acute lung injury and found that S1P infusion produced a rapid and significant reduction in lung weight gain (more than 50%) in the isolated perfused murine lung.  The effect of S1P was next assessed in a murine model of LPS-mediated microvascular permeability and inflammation with marked increases in parameters of lung injury at both 6 and 24 hours after intratracheal LPS.  Each parameter assessed was significantly reduced by intravenous S1P (1 microM final) and in selected experiments by the S1P analogue FTY720 (0.1 mg/kg, intraperitoneally) delivered 1 hour after LPS.  S1P produced an approximately 40-50% reduction in LPS-mediated extravasation of Evans blue dye albumin, bronchoalveolar lavage protein content, and lung tissue myeloperoxidase activity (reflecting phagocyte infiltration).  Consistent with systemic barrier enhancement, S1P significantly decreased Evans blue dye albumin extravasation and myeloperoxidase content in renal tissues of LPS-treated mice.  These studies indicate that S1P significantly decreases pulmonary/renal vascular leakage and inflammation in a murine model of LPS-mediated acute lung injury and may represent a novel therapeutic strategy for vascular barrier dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRiebTs11HvNK91pGlMMoT5fW6udTcc2eaQhywnOGHgZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3mt1Clsw%253D%253D&md5=5f67d3bba728e98969349e4ee9110b19</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1164%2Frccm.200309-1258OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200309-1258OC%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DHassoun%26aufirst%3DP.%2BM.%26aulast%3DSammani%26aufirst%3DS.%26aulast%3DMcVerry%26aufirst%3DB.%2BJ.%26aulast%3DBurne%26aufirst%3DM.%2BJ.%26aulast%3DRabb%26aufirst%3DH.%26aulast%3DPearse%26aufirst%3DD.%26aulast%3DTuder%26aufirst%3DR.%2BM.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%26atitle%3DProtective%2520effects%2520of%2520sphingosine%25201-phosphate%2520in%2520murine%2520endotoxin-induced%2520inflammatory%2520lung%2520injury%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2004%26volume%3D169%26spage%3D1245%26epage%3D1251%26doi%3D10.1164%2Frccm.200309-1258OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Kono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergner, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">2076</span><span class="NLM_x">–</span> <span class="NLM_lpage">2086</span><span class="refDoi"> DOI: 10.1172/JCI71194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1172%2FJCI71194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=24667638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVSnsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=2076-2086&author=M.+Konoauthor=A.+E.+Tuckerauthor=J.+Tranauthor=J.+B.+Bergnerauthor=E.+M.+Turnerauthor=R.+L.+Proia&title=Sphingosine-1-phosphate+receptor+1+reporter+mice+reveal+receptor+activation+sites+in+vivo&doi=10.1172%2FJCI71194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo</span></div><div class="casAuthors">Kono, Mari; Tucker, Ana E.; Tran, Jennifer; Bergner, Jennifer B.; Turner, Ewa M.; Proia, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2076-2086</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Activation of the GPCR sphingosine-1-phosphate receptor 1 (S1P1) by sphingosine-1-phosphate (S1P) regulates key physiol. processes.  S1P1 activation also has been implicated in pathol. processes, including autoimmunity and inflammation; however, the in vivo sites of S1P1 activation under normal and disease conditions are unclear.  Here, we describe the development of a mouse model that allows in vivo evaluation of S1P1 activation.  These mice, known as S1P1 GFP signaling mice, produce a S1P1 fusion protein contg. a transcription factor linked by a protease cleavage site at the C terminus as well as a β-arrestin/protease fusion protein.  Activated S1P1 recruits the β-arrestin/protease, resulting in the release of the transcription factor, which stimulates the expression of a GFP reporter gene.  Under normal conditions, S1P1 was activated in endothelial cells of lymphoid tissues and in cells in the marginal zone of the spleen, while administration of an S1P1 agonist promoted S1P1 activation in endothelial cells and hepatocytes.  In S1P1 GFP signaling mice, LPS-mediated systemic inflammation activated S1P1 in endothelial cells and hepatocytes via hematopoietically derived S1P.  These data demonstrate that S1P1 GFP signaling mice can be used to evaluate S1P1 activation and S1P1-active compds. in vivo.  Furthermore, this strategy could be potentially applied to any GPCR to identify sites of receptor activation during normal physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofbElmvv4firVg90H21EOLACvtfcHk0lghy8foxxqO4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVSnsb0%253D&md5=d74297d12775ec9a389dd7443e2b5867</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1172%2FJCI71194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI71194%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DM.%26aulast%3DTucker%26aufirst%3DA.%2BE.%26aulast%3DTran%26aufirst%3DJ.%26aulast%3DBergner%26aufirst%3DJ.%2BB.%26aulast%3DTurner%26aufirst%3DE.%2BM.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DSphingosine-1-phosphate%2520receptor%25201%2520reporter%2520mice%2520reveal%2520receptor%2520activation%2520sites%2520in%2520vivo%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2014%26volume%3D124%26spage%3D2076%26epage%3D2086%26doi%3D10.1172%2FJCI71194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leaf, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsolais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Full pharmacological efficacy of a novel S1P<sub>1</sub> agonist that does not require S1P-like headgroup interactions</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1308</span><span class="NLM_x">–</span> <span class="NLM_lpage">1318</span><span class="refDoi"> DOI: 10.1124/mol.108.049783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1124%2Fmol.108.049783" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1308-1318&author=P.+J.+Gonzalez-Cabreraauthor=E.+Joauthor=M.+G.+Sannaauthor=S.+Brownauthor=N.+Leafauthor=D.+Marsolaisauthor=M.+T.+Schaefferauthor=J.+Chapmanauthor=M.+Cameronauthor=M.+Guerreroauthor=E.+Robertsauthor=H.+Rosen&title=Full+pharmacological+efficacy+of+a+novel+S1P1+agonist+that+does+not+require+S1P-like+headgroup+interactions&doi=10.1124%2Fmol.108.049783"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.049783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.049783%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DLeaf%26aufirst%3DN.%26aulast%3DMarsolais%26aufirst%3DD.%26aulast%3DSchaeffer%26aufirst%3DM.%2BT.%26aulast%3DChapman%26aufirst%3DJ.%26aulast%3DCameron%26aufirst%3DM.%26aulast%3DGuerrero%26aufirst%3DM.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DFull%2520pharmacological%2520efficacy%2520of%2520a%2520novel%2520S1P1%2520agonist%2520that%2520does%2520not%2520require%2520S1P-like%2520headgroup%2520interactions%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D1308%26epage%3D1318%26doi%3D10.1124%2Fmol.108.049783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Tomlinson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoghi, K. I.</span><span> </span><span class="NLM_article-title">Quantification of skeletal blood flow and fluoride metabolism in rats using PET in a pre-clinical stress fracture model</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span><span class="refDoi"> DOI: 10.1007/s11307-011-0505-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1007%2Fs11307-011-0505-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=21785919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A280%3ADC%252BC38zkvF2lsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=348-354&author=R.+E.+Tomlinsonauthor=M.+J.+Silvaauthor=K.+I.+Shoghi&title=Quantification+of+skeletal+blood+flow+and+fluoride+metabolism+in+rats+using+PET+in+a+pre-clinical+stress+fracture+model&doi=10.1007%2Fs11307-011-0505-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of skeletal blood flow and fluoride metabolism in rats using PET in a pre-clinical stress fracture model</span></div><div class="casAuthors">Tomlinson Ryan E; Silva Matthew J; Shoghi Kooresh I</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">348-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Blood flow is an important factor in bone production and repair, but its role in osteogenesis induced by mechanical loading is unknown.  Here, we present techniques for evaluating blood flow and fluoride metabolism in a pre-clinical stress fracture model of osteogenesis in rats.  PROCEDURES:  Bone formation was induced by forelimb compression in adult rats. (15)O water and (18)F fluoride PET imaging were used to evaluate blood flow and fluoride kinetics 7 days after loading. (15)O water was modeled using a one-compartment, two-parameter model, while a two-compartment, three-parameter model was used to model (18)F fluoride.  Input functions were created from the heart, and a stochastic search algorithm was implemented to provide initial parameter values in conjunction with a Levenberg-Marquardt optimization algorithm.  RESULTS:  Loaded limbs are shown to have a 26% increase in blood flow rate, 113% increase in fluoride flow rate, 133% increase in fluoride flux, and 13% increase in fluoride incorporation into bone as compared to non-loaded limbs (p < 0.05 for all results).  CONCLUSIONS:  The results shown here are consistent with previous studies, confirming this technique is suitable for evaluating the vascular response and mineral kinetics of osteogenic mechanical loading.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSjLNsoYxXU4K-9TkgmBqTqfW6udTcc2eZrelPEcHSwLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zkvF2lsA%253D%253D&md5=f84e5878a797a6e454d20c8baeae0abb</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs11307-011-0505-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-011-0505-3%26sid%3Dliteratum%253Aachs%26aulast%3DTomlinson%26aufirst%3DR.%2BE.%26aulast%3DSilva%26aufirst%3DM.%2BJ.%26aulast%3DShoghi%26aufirst%3DK.%2BI.%26atitle%3DQuantification%2520of%2520skeletal%2520blood%2520flow%2520and%2520fluoride%2520metabolism%2520in%2520rats%2520using%2520PET%2520in%2520a%2520pre-clinical%2520stress%2520fracture%2520model%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2012%26volume%3D14%26spage%3D348%26epage%3D354%26doi%3D10.1007%2Fs11307-011-0505-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Shiomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochi, H.</span><span> </span><span class="NLM_article-title">Assessment of hepatic blood flow by PET with <sup>15</sup>O water: Correlation between per-rectal portal scintigraphy with <sup>99</sup>Tc<sup>m</sup>-pertechnetate and scintigraphy with <sup>99</sup>Tc<sup>m</sup>-GSA</span> <span class="citation_source-journal">Nucl. Med. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span><span class="refDoi"> DOI: 10.1097/00006231-200006000-00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1097%2F00006231-200006000-00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10894562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252FjtFOqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=533-538&author=S.+Shiomiauthor=Y.+Iwataauthor=N.+Sasakiauthor=H.+Morikawaauthor=A.+Tamoriauthor=D.+Habuauthor=T.+Takedaauthor=S.+Nishiguchiauthor=T.+Kurokiauthor=H.+Ochi&title=Assessment+of+hepatic+blood+flow+by+PET+with+15O+water%3A+Correlation+between+per-rectal+portal+scintigraphy+with+99Tcm-pertechnetate+and+scintigraphy+with+99Tcm-GSA&doi=10.1097%2F00006231-200006000-00006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of hepatic blood flow by PET with 15O water: correlation between per-rectal portal scintigraphy with 99Tc(m)-pertechnetate and scintigraphy with 99Tc(m)-GSA</span></div><div class="casAuthors">Shiomi S; Iwata Y; Sasaki N; Morikawa H; Tamori A; Habu D; Takeda T; Nishiguchi S; Kuroki T; Ochi H</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear medicine communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">533-8</span>
        ISSN:<span class="NLM_cas:issn">0143-3636</span>.
    </div><div class="casAbstract">We performed positron emission tomography with 15O water (H2(15)O) to measure hepatic arterial and portal blood flow.  In addition, portal haemodynamics and hepatic functional reserve were measured by per-rectal portal scintigraphy and scintigraphy with galactosyl human serum albumin, respectively.  We studied 15 patients who had cirrhosis of the liver with underlying viral infection.  After the intravenous injection of H2(15)O, positron emission tomography was performed.  Blood samples were obtained after beginning the emission scan.  The blood samples and positron emission tomographic images were analysed to calculate the radioactivity in the blood and liver.  One-compartment model analysis was used to estimate hepatic arterial and portal blood flow.  Computer acquisition of gamma-camera data was started just before the injection of 99Tc(m)-galactosyl human serum albumin.  A receptor index and an index of blood clearance were calculated on the basis of the radioactivity of the liver and heart.  A 99Tc(m)-pertechnetate solution was instilled into the rectum; serial scintigrams were performed and radioactivity curves for the liver and heart were recorded sequentially.  A per-rectal portal shunt index was calculated from the curves.  Median portal blood flow was 80 ml x 100 g(-1) x min(-1), median hepatic arterial blood flow was 56 ml x 100 g(-1) x min(-1), and median total hepatic blood flow was 138 ml x 100 g(-1) x min(-1) in patients with cirrhosis.  The correlations between portal blood flow and the Child-Turcotte classification score, portal shunt index and receptor index were all significant.  Our results show that hepatic arterial and portal blood flow can be measured by positron emission tomography with H2(15)O non-invasively and physiologically.  This technique may be useful in pathophysiological studies of liver disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlcGkJPlr_tu2qxNLjzXe8fW6udTcc2eZrelPEcHSwLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252FjtFOqtQ%253D%253D&md5=408603c2df444139497388c0f6096ff4</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1097%2F00006231-200006000-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00006231-200006000-00006%26sid%3Dliteratum%253Aachs%26aulast%3DShiomi%26aufirst%3DS.%26aulast%3DIwata%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DN.%26aulast%3DMorikawa%26aufirst%3DH.%26aulast%3DTamori%26aufirst%3DA.%26aulast%3DHabu%26aufirst%3DD.%26aulast%3DTakeda%26aufirst%3DT.%26aulast%3DNishiguchi%26aufirst%3DS.%26aulast%3DKuroki%26aufirst%3DT.%26aulast%3DOchi%26aufirst%3DH.%26atitle%3DAssessment%2520of%2520hepatic%2520blood%2520flow%2520by%2520PET%2520with%252015O%2520water%253A%2520Correlation%2520between%2520per-rectal%2520portal%2520scintigraphy%2520with%252099Tcm-pertechnetate%2520and%2520scintigraphy%2520with%252099Tcm-GSA%26jtitle%3DNucl.%2520Med.%2520Commun.%26date%3D2000%26volume%3D21%26spage%3D533%26epage%3D538%26doi%3D10.1097%2F00006231-200006000-00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Ghibellini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwer, K. L.</span><span> </span><span class="NLM_article-title">Use of Tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: Integration of in vitro, pharmacokinetic modeling, and simulation studies</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1860</span><span class="refDoi"> DOI: 10.1007/s11095-008-9597-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1007%2Fs11095-008-9597-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=1851-1860&author=G.+Ghibelliniauthor=E.+M.+Leslieauthor=G.+M.+Pollackauthor=K.+L.+Brouwer&title=Use+of+Tc-99m+mebrofenin+as+a+clinical+probe+to+assess+altered+hepatobiliary+transport%3A+Integration+of+in+vitro%2C+pharmacokinetic+modeling%2C+and+simulation+studies&doi=10.1007%2Fs11095-008-9597-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2Fs11095-008-9597-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-008-9597-0%26sid%3Dliteratum%253Aachs%26aulast%3DGhibellini%26aufirst%3DG.%26aulast%3DLeslie%26aufirst%3DE.%2BM.%26aulast%3DPollack%26aufirst%3DG.%2BM.%26aulast%3DBrouwer%26aufirst%3DK.%2BL.%26atitle%3DUse%2520of%2520Tc-99m%2520mebrofenin%2520as%2520a%2520clinical%2520probe%2520to%2520assess%2520altered%2520hepatobiliary%2520transport%253A%2520Integration%2520of%2520in%2520vitro%252C%2520pharmacokinetic%2520modeling%252C%2520and%2520simulation%2520studies%26jtitle%3DPharm.%2520Res.%26date%3D2008%26volume%3D25%26spage%3D1851%26epage%3D1860%26doi%3D10.1007%2Fs11095-008-9597-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Joseph, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhargava, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tronco, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palestro, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span> </span><span class="NLM_article-title">Systemic and local release of inflammatory cytokines regulates hepatobiliary excretion of <sup>99m</sup>Tc-mebrofenin</span> <span class="citation_source-journal">Nucl. Med. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">336</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><span class="refDoi"> DOI: 10.1097/MNM.0b013e3282f81460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1097%2FMNM.0b013e3282f81460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=18317297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislSlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=336-344&author=B.+Josephauthor=K.+K.+Bhargavaauthor=G.+G.+Troncoauthor=C.+J.+Palestroauthor=S.+Gupta&title=Systemic+and+local+release+of+inflammatory+cytokines+regulates+hepatobiliary+excretion+of+99mTc-mebrofenin&doi=10.1097%2FMNM.0b013e3282f81460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic and local release of inflammatory cytokines regulates hepatobiliary excretion of 99mTc-mebrofenin</span></div><div class="casAuthors">Joseph, Brigid; Bhargava, Kuldeep K.; Tronco, Gene G.; Palestro, Christopher J.; Gupta, Sanjeev</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine Communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">336-344</span>CODEN:
                <span class="NLM_cas:coden">NMCODC</span>;
        ISSN:<span class="NLM_cas:issn">0143-3636</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objectives: Imaging agents capable of providing cell compartment-specific information will facilitate studies of pathophysiol. mechanisms, natural history of diseases, and therapeutic development.  To demonstrate the effects of liver injury on the disposal of the org. anion mebrofenin, we performed animal studies.  Methods: Acute liver injury was induced in Fischer 344 rats with 0.25-1 mL/kg single doses of carbon tetrachloride followed by studies of animals over 4 wk.  The liver injury was analyzed by blood tests and histol. grading.  Addnl. rats were treated with lipopolysaccharide, interleukin-6 or tumor necrosis factor-α to activate inflammatory events.  Hepatic clearance of Tc-mebrofenin was studied with dynamic imaging and fractional retention after 60 min of peak hepatic mebrofenin activity was detd.  Results: In healthy rats, only 24±2% of peak mebrofenin activity was retained in the liver after 60 min.  By contrast, 24 h after carbon tetrachloride, virtually all mebrofenin activity was retained in the liver (P<0.001).  Three weeks were required for mebrofenin excretion to become normal after carbon tetrachloride administration.  In this situation, we found that Kupffer cell activity was increased.  In addn., the abnormality in mebrofenin excretion was reproduced by lipopolysaccharide, which activates Kupffer cells.  Moreover, mebrofenin excretion was highly sensitive to interleukin-6 and/or tumor necrosis factor-α, which help mediate the Kupffer cell response.  Conclusion: Hepatobiliary excretion of mebrofenin was affected rapidly and over an extended period by inflammatory cytokines released after liver injury.  The remarkable sensitivity of mebrofenin excretion to cytokines suggests that Tc-mebrofenin imaging will be helpful for assessing cytokine-mediated liver inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-tvCdJkl42LVg90H21EOLACvtfcHk0lj4-dZpdgdpzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislSlsLs%253D&md5=22f957f3660f2f1198e23815327024d3</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1097%2FMNM.0b013e3282f81460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMNM.0b013e3282f81460%26sid%3Dliteratum%253Aachs%26aulast%3DJoseph%26aufirst%3DB.%26aulast%3DBhargava%26aufirst%3DK.%2BK.%26aulast%3DTronco%26aufirst%3DG.%2BG.%26aulast%3DPalestro%26aufirst%3DC.%2BJ.%26aulast%3DGupta%26aufirst%3DS.%26atitle%3DSystemic%2520and%2520local%2520release%2520of%2520inflammatory%2520cytokines%2520regulates%2520hepatobiliary%2520excretion%2520of%252099mTc-mebrofenin%26jtitle%3DNucl.%2520Med.%2520Commun.%26date%3D2008%26volume%3D29%26spage%3D336%26epage%3D344%26doi%3D10.1097%2FMNM.0b013e3282f81460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Schurer, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spicer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P<sub>1</sub> and S1P<sub>3</sub> determine efficiency of chemical probe identification by ultrahigh-throughput screening</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span><span class="refDoi"> DOI: 10.1021/cb800051m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb800051m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=486-498&author=S.+C.+Schurerauthor=S.+J.+Brownauthor=P.+J.+Gonzalez-Cabreraauthor=M.+T.+Schaefferauthor=J.+Chapmanauthor=E.+Joauthor=P.+Chaseauthor=T.+Spicerauthor=P.+Hodderauthor=H.+Rosen&title=Ligand-binding+pocket+shape+differences+between+sphingosine+1-phosphate+%28S1P%29+receptors+S1P1+and+S1P3+determine+efficiency+of+chemical+probe+identification+by+ultrahigh-throughput+screening&doi=10.1021%2Fcb800051m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fcb800051m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb800051m%26sid%3Dliteratum%253Aachs%26aulast%3DSchurer%26aufirst%3DS.%2BC.%26aulast%3DBrown%26aufirst%3DS.%2BJ.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DSchaeffer%26aufirst%3DM.%2BT.%26aulast%3DChapman%26aufirst%3DJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DChase%26aufirst%3DP.%26aulast%3DSpicer%26aufirst%3DT.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DLigand-binding%2520pocket%2520shape%2520differences%2520between%2520sphingosine%25201-phosphate%2520%2528S1P%2529%2520receptors%2520S1P1%2520and%2520S1P3%2520determine%2520efficiency%2520of%2520chemical%2520probe%2520identification%2520by%2520ultrahigh-throughput%2520screening%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2008%26volume%3D3%26spage%3D486%26epage%3D498%26doi%3D10.1021%2Fcb800051m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Brenner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galluzzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepp, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span> </span><span class="NLM_article-title">Decoding cell death signals in liver inflammation</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span><span class="refDoi"> DOI: 10.1016/j.jhep.2013.03.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.jhep.2013.03.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=23567086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVygt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2013&pages=583-594&author=C.+Brennerauthor=L.+Galluzziauthor=O.+Keppauthor=G.+Kroemer&title=Decoding+cell+death+signals+in+liver+inflammation&doi=10.1016%2Fj.jhep.2013.03.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Decoding cell death signals in liver inflammation</span></div><div class="casAuthors">Brenner, Catherine; Galluzzi, Lorenzo; Kepp, Oliver; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">583-594</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Inflammation can be either beneficial or detrimental to the liver, depending on multiple factors.  Mild (i.e., limited in intensity and destined to resolve) inflammatory responses have indeed been shown to exert consistent hepatoprotective effects, contributing to tissue repair and promoting the re-establishment of homeostasis.  Conversely, excessive (i.e., disproportionate in intensity and permanent) inflammation may induce a massive loss of hepatocytes and hence exacerbate the severity of various hepatic conditions, including ischemia-reperfusion injury, systemic metabolic alterations (e.g., obesity, diabetes, non-alc. fatty liver disorders), alc. hepatitis, intoxication by xenobiotics and infection, de facto being assocd. with irreversible liver damage, fibrosis, and carcinogenesis.  Both liver-resident cells (e.g., Kupffer cells, hepatic stellate cells, sinusoidal endothelial cells) and cells that are recruited in response to injury (e.g., monocytes, macrophages, dendritic cells, natural killer cells) emit pro-inflammatory signals including - but not limited to - cytokines, chemokines, lipid messengers, and reactive oxygen species that contribute to the apoptotic or necrotic demise of hepatocytes.  In turn, dying hepatocytes release damage-assocd. mol. patterns that-upon binding to evolutionary conserved pattern recognition receptors-activate cells of the innate immune system to further stimulate inflammatory responses, hence establishing a highly hepatotoxic feedforward cycle of inflammation and cell death.  In this review, we discuss the cellular and mol. mechanisms that account for the most deleterious effect of hepatic inflammation at the cellular level, i.e., the initiation of a massive cell death response among hepatocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWF2KIq_DTz7Vg90H21EOLACvtfcHk0lh5YadDr5TByg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVygt78%253D&md5=59b70460b5113fe091b3eb175b329424</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2013.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2013.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DBrenner%26aufirst%3DC.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DDecoding%2520cell%2520death%2520signals%2520in%2520liver%2520inflammation%26jtitle%3DJ.%2520Hepatol.%26date%3D2013%26volume%3D59%26spage%3D583%26epage%3D594%26doi%3D10.1016%2Fj.jhep.2013.03.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Schroder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juan, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltusch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giegold, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeilschifter, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huwiler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radeke, H. H.</span><span> </span><span class="NLM_article-title">The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen</span> <span class="citation_source-journal">Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1139</span><span class="NLM_x">–</span> <span class="NLM_lpage">1148</span><span class="refDoi"> DOI: 10.1016/j.molimm.2011.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=10.1016%2Fj.molimm.2011.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=21435724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;key=1%3ACAS%3A280%3ADC%252BC3MvktFShtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2011&pages=1139-1148&author=M.+Schroderauthor=C.+Richterauthor=M.+H.+Juanauthor=K.+Maltuschauthor=O.+Giegoldauthor=G.+Quintiniauthor=J.+M.+Pfeilschifterauthor=A.+Huwilerauthor=H.+H.+Radeke&title=The+sphingosine+kinase+1+and+S1P1+axis+specifically+counteracts+LPS-induced+IL-12p70+production+in+immune+cells+of+the+spleen&doi=10.1016%2Fj.molimm.2011.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen</span></div><div class="casAuthors">Schroder Matthias; Richter Cornelia; Juan Martina Herrero San; Maltusch Katrin; Giegold Oliver; Quintini Gianluca; Pfeilschifter Josef M; Huwiler Andrea; Radeke Heinfried H</div><div class="citationInfo"><span class="NLM_cas:title">Molecular immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">9-10</span>),
    <span class="NLM_cas:pages">1139-48</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sphingosine-1-phosphate (S1P) has been implicated in angiogenesis, inflammation, cancerogenesis, neurological excitability and immune regulation and is synthesized by two different sphingosine kinases (SphK).  It was suggested that mice lacking the gene for SphK1 exhibit no obvious phenotype, because SphK2 compensates for its absence.  However, recent investigations revealed that under challenge SphK1 contributed to pro-inflammatory processes favoring Th2 and Th17 rather than Th1-type reactions.  To investigate the immune modulatory role of SphK1 as opposed to SphK2 specifically for the Th1 propagating IL-12p70 we compared WT and SphK1(-/-) splenocytes and Flt3-ligand differentiated BMCs of WT and SphK1(-/-), representing dendritic cells as major producers of IL-12p70, incubated with LPS.  We determined the impact on IL-12p70 in comparison to other inflammatory cytokines, and on DC and macrophage surface marker expression, SphK mRNA, protein expression and enzymatic activity in splenocytes.  Our data demonstrated that SphK1 deficiency enhanced LPS-induced IL-12p70 production although SphK2 was present.  To further characterize SphK1-dependent IL-12p70 regulation we exogenously applied S1P, SEW2871 and the new potent S1P1 agonist CYM5442.  Both S1P and S1P1-specific analogs fully compensated the increase of IL-12p70 production in SphK1-deficient splenocytes.  The use of pertussis toxin, to block G(i)-coupled signaling downstream of S1P1, again increased IL-12p70 and neglected the compensation achieved by addition of S1P and S1P1 agonists pointing on the importance of this specific S1P-receptor.  Given that, in parallel to a prominent IL-12p35 increase following LPS stimulation, LPS also enhanced SphK expression and total SphK activity, we concluded that SphK1-derived S1P acting via S1P1 is a major mechanism of this negative IL-12p70 feedback loop, which did not affect other cytokines.  Moreover, our data showed that SphK2 activity failed to compensate for SphK1 deficiency.  These findings clearly point to a divergent and cytokine-specific impact of immune cell SphK1 and SphK2 in chronic inflammation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-br9jjE3qx02yPDyEFiigfW6udTcc2eYrfcoPCmdwOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MvktFShtQ%253D%253D&md5=73b8d4a15ad68dba5257d96d44b3d765</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2011.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2011.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DSchroder%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DC.%26aulast%3DJuan%26aufirst%3DM.%2BH.%26aulast%3DMaltusch%26aufirst%3DK.%26aulast%3DGiegold%26aufirst%3DO.%26aulast%3DQuintini%26aufirst%3DG.%26aulast%3DPfeilschifter%26aufirst%3DJ.%2BM.%26aulast%3DHuwiler%26aufirst%3DA.%26aulast%3DRadeke%26aufirst%3DH.%2BH.%26atitle%3DThe%2520sphingosine%2520kinase%25201%2520and%2520S1P1%2520axis%2520specifically%2520counteracts%2520LPS-induced%2520IL-12p70%2520production%2520in%2520immune%2520cells%2520of%2520the%2520spleen%26jtitle%3DMol.%2520Immunol.%26date%3D2011%26volume%3D48%26spage%3D1139%26epage%3D1148%26doi%3D10.1016%2Fj.molimm.2011.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothfuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponde, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [<sup>18</sup>F]6-(2-fluoropropyl)-4-methyl-pyridin-2-amine as a potential PET tracer for inducible nitric oxide synthase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2443</span><span class="NLM_x">–</span> <span class="NLM_lpage">2453</span><span class="refDoi"> DOI: 10.1021/jm801556h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801556h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2443-2453&author=D.+Zhouauthor=H.+Leeauthor=J.+M.+Rothfussauthor=D.+L.+Chenauthor=D.+E.+Pondeauthor=M.+J.+Welchauthor=R.+H.+Mach&title=Design+and+synthesis+of+2-amino-4-methylpyridine+analogues+as+inhibitors+for+inducible+nitric+oxide+synthase+and+in+vivo+evaluation+of+%5B18F%5D6-%282-fluoropropyl%29-4-methyl-pyridin-2-amine+as+a+potential+PET+tracer+for+inducible+nitric+oxide+synthase&doi=10.1021%2Fjm801556h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm801556h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801556h%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DRothfuss%26aufirst%3DJ.%2BM.%26aulast%3DChen%26aufirst%3DD.%2BL.%26aulast%3DPonde%26aufirst%3DD.%2BE.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DDesign%2520and%2520synthesis%2520of%25202-amino-4-methylpyridine%2520analogues%2520as%2520inhibitors%2520for%2520inducible%2520nitric%2520oxide%2520synthase%2520and%2520in%2520vivo%2520evaluation%2520of%2520%255B18F%255D6-%25282-fluoropropyl%2529-4-methyl-pyridin-2-amine%2520as%2520a%2520potential%2520PET%2520tracer%2520for%2520inducible%2520nitric%2520oxide%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2443%26epage%3D2453%26doi%3D10.1021%2Fjm801556h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i109"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00390">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_08377"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00390">10.1021/acs.jmedchem.6b00390</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings of the final products (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00390/suppl_file/jm6b00390_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00390/suppl_file/jm6b00390_si_001.csv">jm6b00390_si_001.csv (1.54 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00390&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00390%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00390" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799d918ba041248","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
